source,citation,relation,ID,title,authors,journal,year,fulltext_online_link,fulltext_location
10.1517~13543784.17.7.973.pdf,"1. Coelho JM, Turton JF, Kaufmann ME, et al. Occurrence of carbapenem-resistant Acinetobacter baumannii clones at multiple hospitals in London and Southeast England. J Clin Microbiol 2006;44(10):3623-7 2. Falagas ME, Rafailidis PI, Kofteridis D, et al. Risk factors of carbapenem-resistant Klebsiella pneumoniae infections: a matched case control study.",references,6781183Occurrence of Carbapenem-Resistant Acinetobacter baumannii Clones at Multiple Hospitals in London and Southeast England,Occurrence of Carbapenem-Resistant Acinetobacter baumannii Clones at Multiple Hospitals in London and Southeast England,"[[u'Juliana', u'M.', u'Coelho'], [u'Jane', u'F.', u'Turton'], [u'Mary', u'E.', u'Kaufmann'], [u'Judith', u'', u'Glover'], [u'Neil', u'', u'Woodford'], [u'Marina', u'', u'Warner'], [u'Marie-France', u'', u'Palepou'], [u'Rachel', u'', u'Pike'], [u'Tyrone', u'L.', u'Pitt'], [u'Bharat', u'C.', u'Patel'], [u'David', u'M.', u'Livermore']]",,2006,[u'http://jcm.asm.org/cgi/reprint/44/10/3623.pdf'],./output/10.1517~13543784.17.7.973.pdf/6781183
6781183Occurrence of Carbapenem-Resistant Acinetobacter baumannii Clones at Multiple Hospitals in London and Southeast England,"Queenan, A., Bush, K., , Carbapenemases: the Versatile  -Lactamases, Clinical Microbiology Reviews, 2007",cited-by,10.1128/CMR.00001-07,Carbapenemases: the Versatile  -Lactamases,"[['Anne', 'Marie', 'Queenan'], ['Karen', '', 'Bush']]",Clinical Microbiology Reviews,2007,"[u'http://cmr.asm.org/cgi/reprint/20/3/440.pdf', u'http://cmr.asm.org/cgi/doi/10.1128/CMR.00001-07']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1128~CMR.00001-07
6781183Occurrence of Carbapenem-Resistant Acinetobacter baumannii Clones at Multiple Hospitals in London and Southeast England,"Livermore, D., , Has the era of untreatable infections arrived?, Journal of Antimicrobial Chemotherapy, 2009",cited-by,10.1093/jac/dkp255,Has the era of untreatable infections arrived?,"[['D.', 'M.', 'Livermore']]",Journal of Antimicrobial Chemotherapy,2009,[u'http://www.jac.oxfordjournals.org/cgi/doi/10.1093/jac/dkp255'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1093~jac~dkp255
6781183Occurrence of Carbapenem-Resistant Acinetobacter baumannii Clones at Multiple Hospitals in London and Southeast England,"Karageorgopoulos, D., Falagas, M., , Current control and treatment of multidrug-resistant Acinetobacter baumannii infections, Lancet Infectious Diseases, 2008",cited-by,10.1016/S1473-3099(08)70279-2,Current control and treatment of multidrug-resistant Acinetobacter baumannii infections,"[['Drosos', 'E', 'Karageorgopoulos'], ['Matthew', 'E', 'Falagas']]",Lancet Infectious Diseases,2008,"[u'http://www.sciencedirect.com/science/article/pii/S1473309908702792', u'http://linkinghub.elsevier.com/retrieve/pii/S1473309908702792']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1016~S1473-3099(08)70279-2
6781183Occurrence of Carbapenem-Resistant Acinetobacter baumannii Clones at Multiple Hospitals in London and Southeast England,"Turton, J., Gabriel, S., Valderrey, C., et. al, Use of sequence-based typing and multiplex PCR to identify clonal lineages of outbreak strains of Acinetobacter baumannii, Clinical Microbiology and Infection, 2007",cited-by,10.1111/j.1469-0691.2007.01759.x,Use of sequence-based typing and multiplex PCR to identify clonal lineages of outbreak strains of Acinetobacter baumannii,"[['J.', 'F.', 'Turton'], ['S.', 'N.', 'Gabriel'], ['C.', '', 'Valderrey'], ['M.', 'E.', 'Kaufmann'], ['T.', 'L.', 'Pitt']]",Clinical Microbiology and Infection,2007,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1469-0691.2007.01759.x'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1111~j.1469-0691.2007.01759.x
6781183Occurrence of Carbapenem-Resistant Acinetobacter baumannii Clones at Multiple Hospitals in London and Southeast England,"Walsh, T., , Clinically significant carbapenemases: an update, Current Opinion in Infectious Diseases, 2008",cited-by,10.1097/QCO.0b013e328303670b,Clinically significant carbapenemases: an update,"[['Timothy', 'R', 'Walsh']]",Current Opinion in Infectious Diseases,2008,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00001432-200808000-00007'],
6781183Occurrence of Carbapenem-Resistant Acinetobacter baumannii Clones at Multiple Hospitals in London and Southeast England,"Wareham, D., Bean, D., Khanna, P., et. al, Bloodstream infection due to Acinetobacter spp: epidemiology, risk factors and impact of multi-drug resistance, European Journal of Clinical Microbiology & Infectious Diseases, 2008",cited-by,10.1007/s10096-008-0473-y,"Bloodstream infection due to Acinetobacter spp: epidemiology, risk factors and impact of multi-drug resistance","[['D.', 'W.', 'Wareham'], ['D.', 'C.', 'Bean'], ['P.', '', 'Khanna'], ['E.', 'M.', 'Hennessy'], ['D.', '', 'Krahe'], ['A.', '', 'Ely'], ['M.', '', 'Millar']]",European Journal of Clinical Microbiology & Infectious Diseases,2008,"[u'http://www.springerlink.com/content/p2j46t5q81441586', u'http://www.springerlink.com/index/p2j46t5q81441586.pdf', u'http://www.springerlink.com/index/10.1007/s10096-008-0473-y', u'http://www.springerlink.com/index/pdf/10.1007/s10096-008-0473-y']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1007~s10096-008-0473-y
6781183Occurrence of Carbapenem-Resistant Acinetobacter baumannii Clones at Multiple Hospitals in London and Southeast England,"Turner, P., , Meropenem activity against European isolates: report on the MYSTIC (Meropenem Yearly Susceptibility Test Information Collection) 2006 results, Diagnostic Microbiology and Infectious Disease, 2008",cited-by,10.1016/j.diagmicrobio.2007.09.006,Meropenem activity against European isolates: report on the MYSTIC (Meropenem Yearly Susceptibility Test Information Collection) 2006 results,"[['Philip', 'J.', 'Turner']]",Diagnostic Microbiology and Infectious Disease,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0732889307003938', u'http://linkinghub.elsevier.com/retrieve/pii/S0732889307003938']",
6781183Occurrence of Carbapenem-Resistant Acinetobacter baumannii Clones at Multiple Hospitals in London and Southeast England,"Hawkey, P., , The growing burden of antimicrobial resistance, Journal of Antimicrobial Chemotherapy, 2008",cited-by,10.1093/jac/dkn241,The growing burden of antimicrobial resistance,"[['P.', 'M.', 'Hawkey']]",Journal of Antimicrobial Chemotherapy,2008,"[u'http://jac.oxfordjournals.org/cgi/reprint/62/suppl_1/i1.pdf', u'http://www.jac.oxfordjournals.org/cgi/doi/10.1093/jac/dkn241']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1093~jac~dkn241
6781183Occurrence of Carbapenem-Resistant Acinetobacter baumannii Clones at Multiple Hospitals in London and Southeast England,"Gülmez, D., Woodford, N., Palepou, M., et. al, Carbapenem-resistant Escherichia coli and Klebsiella pneumoniae isolates from Turkey with OXA-48-like carbapenemases and outer membrane protein loss, International Journal of Antimicrobial Agents, 2008",cited-by,10.1016/j.ijantimicag.2008.01.017,Carbapenem-resistant Escherichia coli and Klebsiella pneumoniae isolates from Turkey with OXA-48-like carbapenemases and outer membrane protein loss,"[['Dolunay', '', 'G\xc3\xbclmez'], ['Neil', '', 'Woodford'], ['Marie-France', 'I.', 'Palepou'], ['Shazad', '', 'Mushtaq'], ['Gokhan', '', 'Metan'], ['Yusuf', '', 'Yakupogullari'], ['Sesin', '', 'Kocagoz'], ['Omrum', '', 'Uzun'], ['Gulsen', '', 'Hascelik'], ['David', 'M.', 'Livermore']]",International Journal of Antimicrobial Agents,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0924857908000472', u'http://linkinghub.elsevier.com/retrieve/pii/S0924857908000472']",
6781183Occurrence of Carbapenem-Resistant Acinetobacter baumannii Clones at Multiple Hospitals in London and Southeast England,"Rossolini, G., Mantengoli, E., , Antimicrobial resistance in Europe and its potential impact on empirical therapy, Clinical Microbiology and Infection, 2008",cited-by,10.1111/j.1469-0691.2008.02126.x,Antimicrobial resistance in Europe and its potential impact on empirical therapy,"[['G.', 'M.', 'Rossolini'], ['E.', '', 'Mantengoli']]",Clinical Microbiology and Infection,2008,[u'http://blackwell-synergy.com/doi/abs/10.1111/j.1469-0691.2008.02126.x'],
6781183Occurrence of Carbapenem-Resistant Acinetobacter baumannii Clones at Multiple Hospitals in London and Southeast England,"Livermore, D., Hope, R., Brick, G., et. al, Non-susceptibility trends among Pseudomonas aeruginosa and other non-fermentative Gram-negative bacteria from bacteraemias in the UK and Ireland, 2001-06, , 2008",cited-by,"6753440Non-susceptibility trends among Pseudomonas aeruginosa and other non-fermentative Gram-negative bacteria from bacteraemias in the UK and Ireland, 2001-06","Non-susceptibility trends among Pseudomonas aeruginosa and other non-fermentative Gram-negative bacteria from bacteraemias in the UK and Ireland, 2001-06","[['David', 'M.', 'Livermore'], ['Russell', '', 'Hope'], ['Geraldine', '', 'Brick'], ['Mark', '', 'Lillie'], ['Rosy', '', 'Reynolds']]",,2008,[u'http://jac.oxfordjournals.org/cgi/reprint/62/suppl_2/ii55.pdf'],
6781183Occurrence of Carbapenem-Resistant Acinetobacter baumannii Clones at Multiple Hospitals in London and Southeast England,"Gordon, N., Wareham, D., , A review of clinical and microbiological outcomes following treatment of infections involving multidrug-resistant Acinetobacter baumannii with tigecycline, Journal of Antimicrobial Chemotherapy, 2009",cited-by,10.1093/jac/dkn555,A review of clinical and microbiological outcomes following treatment of infections involving multidrug-resistant Acinetobacter baumannii with tigecycline,"[['N.', 'C.', 'Gordon'], ['D.', 'W.', 'Wareham']]",Journal of Antimicrobial Chemotherapy,2009,[u'http://www.jac.oxfordjournals.org/cgi/doi/10.1093/jac/dkn555'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1093~jac~dkn555
6781183Occurrence of Carbapenem-Resistant Acinetobacter baumannii Clones at Multiple Hospitals in London and Southeast England,", Antimicrobial Resistance: Acinetobacter baumannii: Epidemiology, Antimicrobial Resistance, and Treatment Options, Clinical Infectious Diseases, 2008",cited-by,10.1086/529198,"Antimicrobial Resistance: Acinetobacter baumannii: Epidemiology, Antimicrobial Resistance, and Treatment Options",[],Clinical Infectious Diseases,2008,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/529198'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1086~529198
6781183Occurrence of Carbapenem-Resistant Acinetobacter baumannii Clones at Multiple Hospitals in London and Southeast England,"Villegas, M., Kattan, J., Correa, A., et. al, Dissemination of Acinetobacter baumannii Clones with OXA-23 Carbapenemase in Colombian Hospitals, Antimicrobial Agents and Chemotherapy, 2007",cited-by,10.1128/AAC.00226-07,Dissemination of Acinetobacter baumannii Clones with OXA-23 Carbapenemase in Colombian Hospitals,"[['Maria', 'Virginia', 'Villegas'], ['Juan', 'Nicolas', 'Kattan'], ['Adriana', '', 'Correa'], ['Karen', '', 'Lolans'], ['Ana', 'Maria', 'Guzman'], ['Neil', '', 'Woodford'], ['David', '', 'Livermore'], ['John', 'P.', 'Quinn']]",Antimicrobial Agents and Chemotherapy,2007,"[u'http://aac.asm.org/cgi/reprint/51/6/2001.pdf', u'http://www.sld.cu/galerias/pdf/sitios/apua-cuba/r19-dissemination_of_acinetobacter_baumannii_clones_with_oxa-23_carbapenemase.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.00226-07']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1128~AAC.00226-07
6781183Occurrence of Carbapenem-Resistant Acinetobacter baumannii Clones at Multiple Hospitals in London and Southeast England,"Towner, K., , Acinetobacter: an old friend, but a new enemy, Journal of Hospital Infection, 2009",cited-by,10.1016/j.jhin.2009.03.032,"Acinetobacter: an old friend, but a new enemy","[['K.', 'J.', 'Towner']]",Journal of Hospital Infection,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0195670109001820', u'http://linkinghub.elsevier.com/retrieve/pii/S0195670109001820']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1016~j.jhin.2009.03.032
6781183Occurrence of Carbapenem-Resistant Acinetobacter baumannii Clones at Multiple Hospitals in London and Southeast England,"Poirel, L., Figueiredo, S., Cattoir, V., et. al, Acinetobacter radioresistens as a Silent Source of Carbapenem Resistance for Acinetobacter spp, Antimicrobial Agents and Chemotherapy, 2008",cited-by,10.1128/AAC.01304-07,Acinetobacter radioresistens as a Silent Source of Carbapenem Resistance for Acinetobacter spp,"[['Laurent', '', 'Poirel'], ['Samy', '', 'Figueiredo'], ['Vincent', '', 'Cattoir'], ['Alessandra', '', 'Carattoli'], ['Patrice', '', 'Nordmann']]",Antimicrobial Agents and Chemotherapy,2008,"[u'http://aac.asm.org/cgi/reprint/52/4/1252.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.01304-07']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1128~AAC.01304-07
6781183Occurrence of Carbapenem-Resistant Acinetobacter baumannii Clones at Multiple Hospitals in London and Southeast England,"Livermore, D., , Has the era of untreatable infections arrived?, , 0",cited-by,10721172Has the era of untreatable infections arrived?,Has the era of untreatable infections arrived?,"[['David', 'M.', 'Livermore']]",,0,[u'http://jac.oxfordjournals.org/cgi/reprint/64/suppl_1/i29.pdf'],
6781183Occurrence of Carbapenem-Resistant Acinetobacter baumannii Clones at Multiple Hospitals in London and Southeast England,"Falagas, M., Rafailidis, P., , Re-emergence of colistin in today's world of multidrug-resistant organisms: personal perspectives, Expert Opinion on Investigational Drugs, 2008",cited-by,10.1517/13543784.17.7.973,Re-emergence of colistin in today's world of multidrug-resistant organisms: personal perspectives,"[['Matthew', 'E', 'Falagas'], ['Petros', 'I', 'Rafailidis']]",Expert Opinion on Investigational Drugs,2008,[u'http://www.informapharmascience.com/doi/abs/10.1517/13543784.17.7.973'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1517~13543784.17.7.973
6781183Occurrence of Carbapenem-Resistant Acinetobacter baumannii Clones at Multiple Hospitals in London and Southeast England,"Rodloff, A., Leclercq, R., Debbia, E., et. al, Comparative analysis of antimicrobial susceptibility among organisms from France, Germany, Italy, Spain and the UK as part of the tigecycline evaluation and surveillance trial, Clinical Microbiology and Infection, 2008",cited-by,10.1111/j.1469-0691.2007.01943.x,"Comparative analysis of antimicrobial susceptibility among organisms from France, Germany, Italy, Spain and the UK as part of the tigecycline evaluation and surveillance trial","[['A.', 'C.', 'Rodloff'], ['R.', '', 'Leclercq'], ['E.', 'A.', 'Debbia'], ['R.', '', 'Cant\xc3\xb3n'], ['B.', 'A.', 'Oppenheim'], ['M.', 'J.', 'Dowzicky']]",Clinical Microbiology and Infection,2008,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1469-0691.2007.01943.x'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1111~j.1469-0691.2007.01943.x
6781183Occurrence of Carbapenem-Resistant Acinetobacter baumannii Clones at Multiple Hospitals in London and Southeast England,"Livermore, D., Pearson, A., , Antibiotic resistance: location, location, location, Clinical Microbiology and Infection, 2007",cited-by,10.1111/j.1469-0691.2007.01724.x,"Antibiotic resistance: location, location, location","[['D.', 'M.', 'Livermore'], ['A.', '', 'Pearson']]",Clinical Microbiology and Infection,2007,"[u'http://www.sld.cu/galerias/pdf/sitios/apua-cuba/r5-antibiotic_resistance._location,_location,_location.pdf', u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1469-0691.2007.01724.x']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1111~j.1469-0691.2007.01724.x
6781183Occurrence of Carbapenem-Resistant Acinetobacter baumannii Clones at Multiple Hospitals in London and Southeast England,"Livermore, D., , Introduction: the challenge of multiresistance, International Journal of Antimicrobial Agents, 2007",cited-by,10.1016/S0924-8579(07)00158-6,Introduction: the challenge of multiresistance,"[['David', 'M.', 'Livermore']]",International Journal of Antimicrobial Agents,2007,"[u'http://www.sciencedirect.com/science/article/pii/S0924857907001586', u'http://linkinghub.elsevier.com/retrieve/pii/S0924857907001586']",
6781183Occurrence of Carbapenem-Resistant Acinetobacter baumannii Clones at Multiple Hospitals in London and Southeast England,"Falagas, M., Rafailidis, P., Matthaiou, D., et. al, Pandrug-resistant Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumannii infections: Characteristics and outcome in a series of 28 patients, International Journal of Antimicrobial Agents, 2008",cited-by,10.1016/j.ijantimicag.2008.05.016,"Pandrug-resistant Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumannii infections: Characteristics and outcome in a series of 28 patients","[['Matthew', 'E.', 'Falagas'], ['Petros', 'I.', 'Rafailidis'], ['Dimitrios', 'K.', 'Matthaiou'], ['Simona', '', 'Virtzili'], ['Dimitra', '', 'Nikita'], ['Argyris', '', 'Michalopoulos']]",International Journal of Antimicrobial Agents,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0924857908002690', u'http://linkinghub.elsevier.com/retrieve/pii/S0924857908002690']",
6781183Occurrence of Carbapenem-Resistant Acinetobacter baumannii Clones at Multiple Hospitals in London and Southeast England,"Principe, L., D'Arezzo, S., Capone, A., et. al, In vitro activity of tigecycline in combination with various antimicrobials against multidrug resistant Acinetobacter baumannii, Annals of Clinical Microbiology and Antimicrobials, 2009",cited-by,10.1186/1476-0711-8-18,In vitro activity of tigecycline in combination with various antimicrobials against multidrug resistant Acinetobacter baumannii,"[['Luigi', '', 'Principe'], ['Silvia', '', ""D'Arezzo""], ['Alessandro', '', 'Capone'], ['Nicola', '', 'Petrosillo'], ['Paolo', '', 'Visca']]",Annals of Clinical Microbiology and Antimicrobials,2009,"[u'http://www.ann-clinmicrob.com/content/8/1/18', u'http://www.springerlink.com/content/75n31146lt1118g4', u'http://www.springerlink.com/index/75n31146lt1118g4.pdf', u'http://www.biomedcentral.com/content/pdf/1476-0711-8-18.pdf', u'http://www.lafayettegeneral.com/Images/Interior/article -1.pdf']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1186~1476-0711-8-18
6781183Occurrence of Carbapenem-Resistant Acinetobacter baumannii Clones at Multiple Hospitals in London and Southeast England,"Livermore, D., Hope, R., Brick, G., et. al, Non-susceptibility trends among Pseudomonas aeruginosa and other non-fermentative Gram-negative bacteria from bacteraemias in the UK and Ireland, 2001-06, Journal of Antimicrobial Chemotherapy, 2008",cited-by,10.1093/jac/dkn352,"Non-susceptibility trends among Pseudomonas aeruginosa and other non-fermentative Gram-negative bacteria from bacteraemias in the UK and Ireland, 2001-06","[['D.', 'M.', 'Livermore'], ['R.', '', 'Hope'], ['G.', '', 'Brick'], ['M.', '', 'Lillie'], ['R.', '', 'Reynolds']]",Journal of Antimicrobial Chemotherapy,2008,[u'http://www.jac.oxfordjournals.org/cgi/doi/10.1093/jac/dkn352'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1093~jac~dkn352
6781183Occurrence of Carbapenem-Resistant Acinetobacter baumannii Clones at Multiple Hospitals in London and Southeast England,"Tewes, F., Brillault, J., Couet, W., et. al, Formulation of rifampicin–cyclodextrin complexes for lung nebulization, Journal of Controlled Release, 2008",cited-by,10.1016/j.jconrel.2008.04.007,Formulation of rifampicin–cyclodextrin complexes for lung nebulization,"[['Fr\xc3\xa9d\xc3\xa9ric', '', 'Tewes'], ['Julien', '', 'Brillault'], ['William', '', 'Couet'], ['Jean-Christophe', '', 'Olivier']]",Journal of Controlled Release,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0168365908001946', u'http://linkinghub.elsevier.com/retrieve/pii/S0168365908001946']",
6781183Occurrence of Carbapenem-Resistant Acinetobacter baumannii Clones at Multiple Hospitals in London and Southeast England,"Tsakris, A., Ikonomidis, A., Poulou, A., et. al, Clusters of imipenem-resistant Acinetobacter baumannii clones producing different carbapenemases in an intensive care unit, Clinical Microbiology and Infection, 2008",cited-by,10.1111/j.1469-0691.2008.01996.x,Clusters of imipenem-resistant Acinetobacter baumannii clones producing different carbapenemases in an intensive care unit,"[['A.', '', 'Tsakris'], ['A.', '', 'Ikonomidis'], ['A.', '', 'Poulou'], ['N.', '', 'Spanakis'], ['D.', '', 'Vrizas'], ['M.', '', 'Diomidous'], ['S.', '', 'Pournaras'], ['F.', '', 'Markou']]",Clinical Microbiology and Infection,2008,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1469-0691.2008.01996.x'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1111~j.1469-0691.2008.01996.x
6781183Occurrence of Carbapenem-Resistant Acinetobacter baumannii Clones at Multiple Hospitals in London and Southeast England,"Fu, Y., Zhou, J., Zhou, H., et. al, Wide dissemination of OXA-23-producing carbapenem-resistant Acinetobacter baumannii clonal complex 22 in multiple cities of China, Journal of Antimicrobial Chemotherapy, 2010",cited-by,10.1093/jac/dkq027,Wide dissemination of OXA-23-producing carbapenem-resistant Acinetobacter baumannii clonal complex 22 in multiple cities of China,"[['Y.', '', 'Fu'], ['J.', '', 'Zhou'], ['H.', '', 'Zhou'], ['Q.', '', 'Yang'], ['Z.', '', 'Wei'], ['Y.', '', 'Yu'], ['L.', '', 'Li']]",Journal of Antimicrobial Chemotherapy,2010,[u'http://www.jac.oxfordjournals.org/cgi/doi/10.1093/jac/dkq027'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1093~jac~dkq027
6781183Occurrence of Carbapenem-Resistant Acinetobacter baumannii Clones at Multiple Hospitals in London and Southeast England,"Oteo, J., García-Estébanez, C., Migueláñez, S., et. al, Genotypic diversity of imipenem resistant isolates of Acinetobacter baumannii in Spain, Journal of Infection, 2007",cited-by,10.1016/j.jinf.2007.04.009,Genotypic diversity of imipenem resistant isolates of Acinetobacter baumannii in Spain,"[['Jes\xc3\xbas', '', 'Oteo'], ['Carmen', '', 'Garc\xc3\xada-Est\xc3\xa9banez'], ['Silvia', '', 'Miguel\xc3\xa1\xc3\xb1ez'], ['Jos\xc3\xa9', '', 'Campos'], ['Sara', '', 'Mart\xc3\xad'], ['Jordi', '', 'Vila'], ['Fernando', '', 'Docobo'], ['Nieves', '', 'Larrosa'], ['\xc3\x81lvaro', '', 'Pascual'], ['Vicente', '', 'Pintado'], ['Pere', '', 'Coll']]",Journal of Infection,2007,"[u'http://www.sciencedirect.com/science/article/pii/S0163445307000990', u'http://linkinghub.elsevier.com/retrieve/pii/S0163445307000990']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1016~j.jinf.2007.04.009
6781183Occurrence of Carbapenem-Resistant Acinetobacter baumannii Clones at Multiple Hospitals in London and Southeast England,"Mushtaq, S., Warner, M., Livermore, D., , Activity of the siderophore monobactam BAL30072 against multiresistant non-fermenters, Journal of Antimicrobial Chemotherapy, 2010",cited-by,10.1093/jac/dkp425,Activity of the siderophore monobactam BAL30072 against multiresistant non-fermenters,"[['S.', '', 'Mushtaq'], ['M.', '', 'Warner'], ['D.', '', 'Livermore']]",Journal of Antimicrobial Chemotherapy,2010,[u'http://www.jac.oxfordjournals.org/cgi/doi/10.1093/jac/dkp425'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1093~jac~dkp425
6781183Occurrence of Carbapenem-Resistant Acinetobacter baumannii Clones at Multiple Hospitals in London and Southeast England,"Kuo, H., Yang, C., Lin, M., et. al, Distribution of blaOXA-carrying imipenem-resistant Acinetobacter spp. in 3 hospitals in Taiwan, Diagnostic Microbiology and Infectious Disease, 2010",cited-by,10.1016/j.diagmicrobio.2009.09.013,Distribution of blaOXA-carrying imipenem-resistant Acinetobacter spp. in 3 hospitals in Taiwan,"[['Han-Yueh', '', 'Kuo'], ['Chih-Man', '', 'Yang'], ['Ming-Feng', '', 'Lin'], ['Wen-Lin', '', 'Cheng'], ['Ni', '', 'Tien'], ['Ming-Li', '', 'Liou']]",Diagnostic Microbiology and Infectious Disease,2010,"[u'http://www.sciencedirect.com/science/article/pii/S073288930900399X', u'http://linkinghub.elsevier.com/retrieve/pii/S073288930900399X']",
6781183Occurrence of Carbapenem-Resistant Acinetobacter baumannii Clones at Multiple Hospitals in London and Southeast England,"Wisplinghoff, H., Hippler, C., Bartual, S., et. al, Molecular epidemiology of clinical Acinetobacter baumannii and Acinetobacter genomic species 13TU isolates using a multilocus sequencing typing scheme, Clinical Microbiology and Infection, 2008",cited-by,10.1111/j.1469-0691.2008.02010.x,Molecular epidemiology of clinical Acinetobacter baumannii and Acinetobacter genomic species 13TU isolates using a multilocus sequencing typing scheme,"[['H.', '', 'Wisplinghoff'], ['C.', '', 'Hippler'], ['S.', 'G.', 'Bartual'], ['C.', '', 'Haefs'], ['D.', '', 'Stefanik'], ['P.', 'G.', 'Higgins'], ['H.', '', 'Seifert']]",Clinical Microbiology and Infection,2008,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1469-0691.2008.02010.x'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1111~j.1469-0691.2008.02010.x
6781183Occurrence of Carbapenem-Resistant Acinetobacter baumannii Clones at Multiple Hospitals in London and Southeast England,"Higgins, P., Dammhayn, C., Hackel, M., et. al, Global spread of carbapenem-resistant Acinetobacter baumannii, Journal of Antimicrobial Chemotherapy, 2010",cited-by,10.1093/jac/dkp428,Global spread of carbapenem-resistant Acinetobacter baumannii,"[['P.', 'G.', 'Higgins'], ['C.', '', 'Dammhayn'], ['M.', '', 'Hackel'], ['H.', '', 'Seifert']]",Journal of Antimicrobial Chemotherapy,2010,[u'http://www.jac.oxfordjournals.org/cgi/doi/10.1093/jac/dkp428'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1093~jac~dkp428
6781183Occurrence of Carbapenem-Resistant Acinetobacter baumannii Clones at Multiple Hospitals in London and Southeast England,"Karvellas, C., Pink, F., McPhail, M., et. al, Bacteremia, Acute Physiology and Chronic Health Evaluation II and Modified End Stage Liver Disease are independent predictors of mortality in critically ill nontransplanted patients with acute on chronic liver failure, Critical Care Medicine, 2010",cited-by,10.1097/CCM.0b013e3181b42a1c,"Bacteremia, Acute Physiology and Chronic Health Evaluation II and Modified End Stage Liver Disease are independent predictors of mortality in critically ill nontransplanted patients with acute on chronic liver failure","[['Constantine', 'J.', 'Karvellas'], ['Fred', '', 'Pink'], ['Mark', '', 'McPhail'], ['Mark', '', 'Austin'], ['Georg', '', 'Auzinger'], ['William', '', 'Bernal'], ['Elizabeth', '', 'Sizer'], ['Demetrios', 'J.', 'Kutsogiannis'], ['Ian', '', 'Eltringham'], ['Julia', 'A.', 'Wendon']]",Critical Care Medicine,2010,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00003246-201001000-00019'],
6781183Occurrence of Carbapenem-Resistant Acinetobacter baumannii Clones at Multiple Hospitals in London and Southeast England,"Livermore, D., Hill, R., Thomson, H., et. al, Antimicrobial treatment and clinical outcome for infections with carbapenem- and multiply-resistant Acinetobacter baumannii around London, International Journal of Antimicrobial Agents, 2010",cited-by,10.1016/j.ijantimicag.2009.09.014,Antimicrobial treatment and clinical outcome for infections with carbapenem- and multiply-resistant Acinetobacter baumannii around London,"[['David', 'M.', 'Livermore'], ['Robert', 'L. R.', 'Hill'], ['Hazel', '', 'Thomson'], ['Andr\xc3\xa9', '', 'Charlett'], ['Jane', 'F.', 'Turton'], ['Rachel', '', 'Pike'], ['Bharat', 'C.', 'Patel'], ['Rohini', '', 'Manuel'], ['Stephen', '', 'Gillespie'], ['Indran', '', 'Balakrishnan'], ['Stephen', 'P.', 'Barrett'], ['Nigel', '', 'Cumberland'], ['Mary', '', 'Twagira']]",International Journal of Antimicrobial Agents,2010,"[u'http://www.sciencedirect.com/science/article/pii/S0924857909004373', u'http://linkinghub.elsevier.com/retrieve/pii/S0924857909004373']",
6781183Occurrence of Carbapenem-Resistant Acinetobacter baumannii Clones at Multiple Hospitals in London and Southeast England,"Turton, J., Matos, J., Kaufmann, M., et. al, Variable number tandem repeat loci providing discrimination within widespread genotypes of Acinetobacter baumannii, European Journal of Clinical Microbiology & Infectious Diseases, 2009",cited-by,10.1007/s10096-008-0659-3,Variable number tandem repeat loci providing discrimination within widespread genotypes of Acinetobacter baumannii,"[['J.', 'F.', 'Turton'], ['J.', '', 'Matos'], ['M.', 'E.', 'Kaufmann'], ['T.', 'L.', 'Pitt']]",European Journal of Clinical Microbiology & Infectious Diseases,2009,"[u'http://www.springerlink.com/content/1153223632172707', u'http://www.springerlink.com/index/1153223632172707.pdf', u'http://www.springerlink.com/index/10.1007/s10096-008-0659-3', u'http://www.springerlink.com/index/pdf/10.1007/s10096-008-0659-3']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1007~s10096-008-0659-3
6781183Occurrence of Carbapenem-Resistant Acinetobacter baumannii Clones at Multiple Hospitals in London and Southeast England,"Zarrilli, R., Vitale, D., Popolo, A., et. al, A Plasmid-Borne blaOXA-58 Gene Confers Imipenem Resistance to Acinetobacter baumannii Isolates from a Lebanese Hospital, Antimicrobial Agents and Chemotherapy, 2008",cited-by,10.1128/AAC.00366-08,A Plasmid-Borne blaOXA-58 Gene Confers Imipenem Resistance to Acinetobacter baumannii Isolates from a Lebanese Hospital,"[['Raffaele', '', 'Zarrilli'], ['Domenico', '', 'Vitale'], ['Anna', 'Di', 'Popolo'], ['Maria', '', 'Bagattini'], ['Ziad', '', 'Daoud'], ['Asad', 'U.', 'Khan'], ['Claude', '', 'Afif'], ['Maria', '', 'Triassi']]",Antimicrobial Agents and Chemotherapy,2008,"[u'http://aac.asm.org/cgi/reprint/52/11/4115.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.00366-08']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1128~AAC.00366-08
6781183Occurrence of Carbapenem-Resistant Acinetobacter baumannii Clones at Multiple Hospitals in London and Southeast England,"Livermore, D., , The zeitgeist of resistance, , 0",cited-by,11713117The zeitgeist of resistance,The zeitgeist of resistance,"[['David', '', 'Livermore']]",,0,[u'http://jac.oxfordjournals.org/cgi/reprint/60/suppl_1/i59.pdf'],./output/10.1517~13543784.17.7.973.pdf/citedby/11713117The zeitgeist of resistance
6781183Occurrence of Carbapenem-Resistant Acinetobacter baumannii Clones at Multiple Hospitals in London and Southeast England,"Zhou, H., Yang, Q., Yu, Y., et. al, Clonal Spread of Imipenem-Resistant Acinetobacter baumannii among Different Cities of China, , 0",cited-by,11996472Clonal Spread of Imipenem-Resistant Acinetobacter baumannii among Different Cities of China,Clonal Spread of Imipenem-Resistant Acinetobacter baumannii among Different Cities of China,"[['Hua', '', 'Zhou'], ['Qing', '', 'Yang'], ['Yun-Song', '', 'Yu'], ['Ze-Qing', '', 'Wei'], ['Lan-Juan', '', 'Li']]",,0,[u'http://jcm.asm.org/cgi/reprint/45/12/4054.pdf'],./output/10.1517~13543784.17.7.973.pdf/citedby/11996472Clonal Spread of Imipenem-Resistant Acinetobacter baumannii among Different Cities of China
6781183Occurrence of Carbapenem-Resistant Acinetobacter baumannii Clones at Multiple Hospitals in London and Southeast England,"Bean, D., Wareham, D., , Paradoxical effect of 1-(1-naphthylmethyl)-piperazine on resistance to tetracyclines in multidrug-resistant Acinetobacter baumannii, Journal of Antimicrobial Chemotherapy, 2008",cited-by,10.1093/jac/dkn493,Paradoxical effect of 1-(1-naphthylmethyl)-piperazine on resistance to tetracyclines in multidrug-resistant Acinetobacter baumannii,"[['D.', 'C.', 'Bean'], ['D.', 'W.', 'Wareham']]",Journal of Antimicrobial Chemotherapy,2008,"[u'http://jac.oxfordjournals.org/cgi/reprint/63/2/349.pdf', u'http://www.jac.oxfordjournals.org/cgi/doi/10.1093/jac/dkn493']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1093~jac~dkn493
6781183Occurrence of Carbapenem-Resistant Acinetobacter baumannii Clones at Multiple Hospitals in London and Southeast England,"Enoch, D., Summers, C., Brown, N., et. al, Investigation and management of an outbreak of multidrug-carbapenem-resistant Acinetobacter baumannii in Cambridge, UK, Journal of Hospital Infection, 2008",cited-by,10.1016/j.jhin.2008.05.015,"Investigation and management of an outbreak of multidrug-carbapenem-resistant Acinetobacter baumannii in Cambridge, UK","[['D.', 'A.', 'Enoch'], ['C.', '', 'Summers'], ['N.', 'M.', 'Brown'], ['L.', '', 'Moore'], ['M.', 'I.', 'Gillham'], ['R.', 'M.', 'Burnstein'], ['R.', '', 'Thaxter'], ['L.', 'M.', 'Enoch'], ['B.', '', 'Matta'], ['O.', '', 'Sule']]",Journal of Hospital Infection,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0195670108002132', u'http://linkinghub.elsevier.com/retrieve/pii/S0195670108002132']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1016~j.jhin.2008.05.015
6781183Occurrence of Carbapenem-Resistant Acinetobacter baumannii Clones at Multiple Hospitals in London and Southeast England,"Griffith, M., Yun, H., Horvath, L., et. al, Minocycline Therapy for Traumatic Wound Infections Caused by the Multidrug-Resistant Acinetobacter baumannii-Acinetobacter calcoaceticus Complex, Infectious Diseases in Clinical Practice, 2008",cited-by,10.1097/ipc.0b013e318159d595,Minocycline Therapy for Traumatic Wound Infections Caused by the Multidrug-Resistant Acinetobacter baumannii-Acinetobacter calcoaceticus Complex,"[['Matthew', 'E.', 'Griffith'], ['Heather', 'C.', 'Yun'], ['Lynn', 'L.', 'Horvath'], ['Clinton', 'K.', 'Murray']]",Infectious Diseases in Clinical Practice,2008,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00019048-200801000-00006'],
6781183Occurrence of Carbapenem-Resistant Acinetobacter baumannii Clones at Multiple Hospitals in London and Southeast England,"Enoch, D., Birkett, C., Ludlam, H., , Non-fermentative Gram-negative bacteria, International Journal of Antimicrobial Agents, 2007",cited-by,10.1016/S0924-8579(07)72176-3,Non-fermentative Gram-negative bacteria,"[['D.', 'A.', 'Enoch'], ['C.', 'I.', 'Birkett'], ['H.', 'A.', 'Ludlam']]",International Journal of Antimicrobial Agents,2007,"[u'http://www.sciencedirect.com/science/article/pii/S0924857907721763', u'http://linkinghub.elsevier.com/retrieve/pii/S0924857907721763']",
6781183Occurrence of Carbapenem-Resistant Acinetobacter baumannii Clones at Multiple Hospitals in London and Southeast England,"Mushtaq, S., Warner, M., Livermore, D., , In vitro activity of ceftazidime+NXL104 against Pseudomonas aeruginosa and other non-fermenters, Journal of Antimicrobial Chemotherapy, 2010",cited-by,10.1093/jac/dkq306,In vitro activity of ceftazidime+NXL104 against Pseudomonas aeruginosa and other non-fermenters,"[['S.', '', 'Mushtaq'], ['M.', '', 'Warner'], ['D.', 'M.', 'Livermore']]",Journal of Antimicrobial Chemotherapy,2010,[u'http://www.jac.oxfordjournals.org/cgi/doi/10.1093/jac/dkq306'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1093~jac~dkq306
6781183Occurrence of Carbapenem-Resistant Acinetobacter baumannii Clones at Multiple Hospitals in London and Southeast England,"Popolo, A., Giannouli, M., Triassi, M., et. al, Molecular epidemiological investigation of multidrug-resistant Acinetobacter baumannii strains in four Mediterranean countries with a multilocus sequence typing scheme: Research Note, Clinical Microbiology and Infection, 2010",cited-by,10.1111/j.1469-0691.2010.03254.x,Molecular epidemiological investigation of multidrug-resistant Acinetobacter baumannii strains in four Mediterranean countries with a multilocus sequence typing scheme: Research Note,"[['A.', 'Di', 'Popolo'], ['M.', '', 'Giannouli'], ['M.', '', 'Triassi'], ['S.', '', 'Brisse'], ['R.', '', 'Zarrilli']]",Clinical Microbiology and Infection,2010,[u'http://blackwell-synergy.com/doi/abs/10.1111/j.1469-0691.2010.03254.x'],
6781183Occurrence of Carbapenem-Resistant Acinetobacter baumannii Clones at Multiple Hospitals in London and Southeast England,"Boo, T., Walsh, F., Crowley, B., , Molecular characterization of carbapenem-resistant Acinetobacter species in an Irish university hospital: predominance of Acinetobacter genomic species 3, Journal of Medical Microbiology, 2009",cited-by,10.1099/jmm.0.004911-0,Molecular characterization of carbapenem-resistant Acinetobacter species in an Irish university hospital: predominance of Acinetobacter genomic species 3,"[['T.', 'W.', 'Boo'], ['F.', '', 'Walsh'], ['B.', '', 'Crowley']]",Journal of Medical Microbiology,2009,"[u'http://jmm.sgmjournals.org/cgi/reprint/58/2/209.pdf', u'http://jmm.sgmjournals.org/cgi/doi/10.1099/jmm.0.004911-0']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1099~jmm.0.004911-0
6781183Occurrence of Carbapenem-Resistant Acinetobacter baumannii Clones at Multiple Hospitals in London and Southeast England,"Martins, A., Kuchenbecker, R., Sukiennik, T., et. al, Carbapenem-resistant Acinetobacter baumannii producing the OXA-23 enzyme: Dissemination in Southern Brazil, Infection, 2009",cited-by,10.1007/s15010-009-9003-9,Carbapenem-resistant Acinetobacter baumannii producing the OXA-23 enzyme: Dissemination in Southern Brazil,"[['A.', 'F.', 'Martins'], ['R.', '', 'Kuchenbecker'], ['T.', '', 'Sukiennik'], ['R.', '', 'Boff'], ['K.', 'C.', 'Reiter'], ['L.', '', 'Lutz'], ['A.', 'B. M. P.', 'Machado'], ['A.', 'L.', 'Barth']]",Infection,2009,"[u'http://www.springerlink.com/content/x07l7120q31k6013', u'http://www.springerlink.com/index/x07l7120q31k6013.pdf', u'http://www.springerlink.com/index/10.1007/s15010-009-9003-9', u'http://www.springerlink.com/index/pdf/10.1007/s15010-009-9003-9']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1007~s15010-009-9003-9
6781183Occurrence of Carbapenem-Resistant Acinetobacter baumannii Clones at Multiple Hospitals in London and Southeast England,"Barbolla, R., Centrón, D., Maimone, S., et. al, Molecular epidemiology of Acinetobacter baumannii spread in an adult intensive care unit under an endemic setting, American Journal of Infection Control, 2008",cited-by,10.1016/j.ajic.2007.09.010,Molecular epidemiology of Acinetobacter baumannii spread in an adult intensive care unit under an endemic setting,"[['Raquel', 'Eve', 'Barbolla'], ['Daniela', '', 'Centr\xc3\xb3n'], ['Stella', '', 'Maimone'], ['Fernanda', '', 'Rospide'], ['Claudia', '', 'Salgueira'], ['Javier', '', 'Altclas'], ['Mariana', '', 'Catalano']]",American Journal of Infection Control,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0196655308000497', u'http://linkinghub.elsevier.com/retrieve/pii/S0196655308000497']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1016~j.ajic.2007.09.010
6781183Occurrence of Carbapenem-Resistant Acinetobacter baumannii Clones at Multiple Hospitals in London and Southeast England,"Kulah, C., Mooij, M., Comert, F., et. al, Characterisation of carbapenem-resistant Acinetobacter baumannii outbreak strains producing OXA-58 in Turkey, International Journal of Antimicrobial Agents, 2010",cited-by,10.1016/j.ijantimicag.2010.03.017,Characterisation of carbapenem-resistant Acinetobacter baumannii outbreak strains producing OXA-58 in Turkey,"[['Canan', '', 'Kulah'], ['Marlies', 'J.', 'Mooij'], ['Fusun', '', 'Comert'], ['Elif', '', 'Aktas'], ['Guven', '', 'Celebi'], ['Nagihan', '', 'Ozlu'], ['Martine', 'C.', 'Rijnsburger'], ['Paul', 'H. M.', 'Savelkoul']]",International Journal of Antimicrobial Agents,2010,"[u'http://www.sciencedirect.com/science/article/pii/S0924857910001500', u'http://linkinghub.elsevier.com/retrieve/pii/S0924857910001500']",
6781183Occurrence of Carbapenem-Resistant Acinetobacter baumannii Clones at Multiple Hospitals in London and Southeast England,"Gordon, N., Wareham, D., , Evaluation of CHROMagar Acinetobacter for Detection of Enteric Carriage of Multidrug-Resistant Acinetobacter baumannii in Samples from Critically Ill Patients, Journal of Clinical Microbiology, 2009",cited-by,10.1128/JCM.00634-09,Evaluation of CHROMagar Acinetobacter for Detection of Enteric Carriage of Multidrug-Resistant Acinetobacter baumannii in Samples from Critically Ill Patients,"[['N.', 'C.', 'Gordon'], ['D.', 'W.', 'Wareham']]",Journal of Clinical Microbiology,2009,"[u'http://jcm.asm.org/cgi/reprint/47/7/2249.pdf', u'http://jcm.asm.org/cgi/doi/10.1128/JCM.00634-09']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1128~JCM.00634-09
6781183Occurrence of Carbapenem-Resistant Acinetobacter baumannii Clones at Multiple Hospitals in London and Southeast England,"Baughman, R., , The Use of Carbapenems in the Treatment of Serious Infections, Journal of Intensive Care Medicine, 2009",cited-by,10.1177/0885066609335660,The Use of Carbapenems in the Treatment of Serious Infections,"[['Robert', 'P.', 'Baughman']]",Journal of Intensive Care Medicine,2009,"[u'http://jic.sagepub.com/cgi/doi/10.1177/0885066609335660', u'http://dx.doi.org/10.1177/0885066609335660']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1177~0885066609335660
6781183Occurrence of Carbapenem-Resistant Acinetobacter baumannii Clones at Multiple Hospitals in London and Southeast England,"D’Arezzo, S., Capone, A., Petrosillo, N., et. al, Epidemic multidrug-resistant Acinetobacter baumannii related to European clonal types I and II in Rome (Italy), Clinical Microbiology and Infection, 2009",cited-by,10.1111/j.1469-0691.2009.02668.x,Epidemic multidrug-resistant Acinetobacter baumannii related to European clonal types I and II in Rome (Italy),"[['S.', '', 'D\xe2\x80\x99Arezzo'], ['A.', '', 'Capone'], ['N.', '', 'Petrosillo'], ['P.', '', 'Visca']]",Clinical Microbiology and Infection,2009,[u'http://blackwell-synergy.com/doi/abs/10.1111/j.1469-0691.2009.02668.x'],
6781183Occurrence of Carbapenem-Resistant Acinetobacter baumannii Clones at Multiple Hospitals in London and Southeast England,"Bassetti, M., Righi, E., Esposito, S., et. al, Drug treatment for multidrug-resistant Acinetobacter baumannii infections, Future Microbiology, 2008",cited-by,10.2217/17460913.3.6.649,Drug treatment for multidrug-resistant Acinetobacter baumannii infections,"[['Matteo', '', 'Bassetti'], ['Elda', '', 'Righi'], ['Silvano', '', 'Esposito'], ['Nicola', '', 'Petrosillo'], ['Laura', '', 'Nicolini']]",Future Microbiology,2008,[u'http://www.futuremedicine.com/doi/abs/10.2217/17460913.3.6.649'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.2217~17460913.3.6.649
6781183Occurrence of Carbapenem-Resistant Acinetobacter baumannii Clones at Multiple Hospitals in London and Southeast England,"Hornsey, M., Ellington, M., Doumith, M., et. al, AdeABC-mediated efflux and tigecycline MICs for epidemic clones of Acinetobacter baumannii, Journal of Antimicrobial Chemotherapy, 2010",cited-by,10.1093/jac/dkq218,AdeABC-mediated efflux and tigecycline MICs for epidemic clones of Acinetobacter baumannii,"[['M.', '', 'Hornsey'], ['M.', 'J.', 'Ellington'], ['M.', '', 'Doumith'], ['C.', 'P.', 'Thomas'], ['N.', 'C.', 'Gordon'], ['D.', 'W.', 'Wareham'], ['J.', '', 'Quinn'], ['K.', '', 'Lolans'], ['D.', 'M.', 'Livermore'], ['N.', '', 'Woodford']]",Journal of Antimicrobial Chemotherapy,2010,[u'http://www.jac.oxfordjournals.org/cgi/doi/10.1093/jac/dkq218'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1093~jac~dkq218
6781183Occurrence of Carbapenem-Resistant Acinetobacter baumannii Clones at Multiple Hospitals in London and Southeast England,"Wareham, D., Gordon, N., , Modifications to CHROMagar Acinetobacter for improved selective growth of multi-drug resistant Acinetobacter baumannii, Journal of Clinical Pathology, 2010",cited-by,10.1136/jcp.2010.083469,Modifications to CHROMagar Acinetobacter for improved selective growth of multi-drug resistant Acinetobacter baumannii,"[['D', 'W', 'Wareham'], ['N', 'C', 'Gordon']]",Journal of Clinical Pathology,2010,[u'http://dx.doi.org/10.1136/jcp.2010.083469'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1136~jcp.2010.083469
6781183Occurrence of Carbapenem-Resistant Acinetobacter baumannii Clones at Multiple Hospitals in London and Southeast England,"Whittington, A., Whitlow, G., Hewson, D., et. al, Bacterial contamination of stethoscopes on the intensive care unit, Anaesthesia, 2009",cited-by,10.1111/j.1365-2044.2009.05892.x,Bacterial contamination of stethoscopes on the intensive care unit,"[['A.', 'M.', 'Whittington'], ['G.', '', 'Whitlow'], ['D.', '', 'Hewson'], ['C.', '', 'Thomas'], ['S.', 'J.', 'Brett']]",Anaesthesia,2009,[u'http://blackwell-synergy.com/doi/abs/10.1111/j.1365-2044.2009.05892.x'],
6781183Occurrence of Carbapenem-Resistant Acinetobacter baumannii Clones at Multiple Hospitals in London and Southeast England,"Hello, S., Falcot, V., Lacassin, F., et. al, Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii in New Caledonia, Clinical Microbiology and Infection, 2008",cited-by,10.1111/j.1469-0691.2008.02068.x,Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii in New Caledonia,"[['S.', 'Le', 'Hello'], ['V.', '', 'Falcot'], ['F.', '', 'Lacassin'], ['F.', '', 'Baumann'], ['P.', '', 'Nordmann'], ['T.', '', 'Naas']]",Clinical Microbiology and Infection,2008,[u'http://blackwell-synergy.com/doi/abs/10.1111/j.1469-0691.2008.02068.x'],
6781183Occurrence of Carbapenem-Resistant Acinetobacter baumannii Clones at Multiple Hospitals in London and Southeast England,"Beccard, R., Wachtendorf, B., Schon, O., et. al, Production of III-nitride films for LED and laser applications by multiwafer MOVPE, , 1997",cited-by,10.1109/LEOS.1997.645475,Production of III-nitride films for LED and laser applications by multiwafer MOVPE,"[['R.', '', 'Beccard'], ['B.', '', 'Wachtendorf'], ['O.', '', 'Schon'], ['D.', '', 'Schmitz'], ['H.', '', 'Jurgensen'], ['E.', '', 'Woelk']]",,1997,[u'http://ieeexplore.ieee.org/xpls/abs_all.jsp?arnumber=645475'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1109~LEOS.1997.645475
6781183Occurrence of Carbapenem-Resistant Acinetobacter baumannii Clones at Multiple Hospitals in London and Southeast England,"Seifert, H., Dijkshoorn, L., , “Overview of the Microbial Characteristics, Taxonomy, and Epidemiology of Acinetobacter ”, , 0",cited-by,10.1007/978-0-387-77944-7_2,"“Overview of the Microbial Characteristics, Taxonomy, and Epidemiology of Acinetobacter ”","[['Harald', '', 'Seifert'], ['Lenie', '', 'Dijkshoorn']]",,0,"[u'http://www.springerlink.com/index/p77222g61h5050p8.pdf', u'http://www.springerlink.com/content/p77222g61h5050p8']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1007~978-0-387-77944-7_2
10.1517~13543784.17.7.973.pdf,"J Antimicrob Chemother 2007;60(5):1124-30 3. Falagas ME, Kasiakou SK. Colistin: the revival of polymyxins for the management of multidrug-resistant Gram-negative bacterial infections.",references,NOT found in MAS
10.1517~13543784.17.7.973.pdf,"Clin Infect Dis 2005;40(9):1333-41 •• A comprehensive review of various parameters of colistin, including chemistry/structure, mechanism of action and resistance, pharmacokinetic and pharmacodynamic properties, spectrum of activity, in vitro susceptibility testing, clinical use and indications, toxicity and adverse events, and co-administration with other antibiotics. 4. World Health Organization. International biological references preparation.",references,NOT found in MAS
10.1517~13543784.17.7.973.pdf,"Available from: www.who.int/ bloodproducts/catalogue/anti_July07.pdf, 2007 [Last accessed April 2008] 5. Monarch Pharmaceuticals, Inc. Coly-mycin M parenteral [packaging insert]. Monarch Pharmaceuticals, Bristol, TN, USA, 2002 6. Forest Laboratories, UK Ltd. Colomycin [packaging insert]. Forest Laboratories, Bexley, Kent, UK, 2002 7. Bergen PJ, Li J, Rayner CR, Nation RL.",references,NOT found in MAS
10.1517~13543784.17.7.973.pdf,"Colistin methanesulfonate is an inactive prodrug of colistin against Pseudomonas aeruginosa. Antimicrob Agents Chemother 2006;50(6):1953-8 •• A study that demonstrated the formation of colistin in microbiological media containing colistin methanesulfonate (CMS, which is thus a prodrug of colistin). 8. Anon. Colistin: summary report.",references,10.1128/AAC.00035-06,Colistin Methanesulfonate Is an Inactive Prodrug of Colistin against Pseudomonas aeruginosa,"[[u'Phillip', u'J.', u'Bergen'], [u'Jian', u'', u'Li'], [u'Craig', u'R.', u'Rayner'], [u'Roger', u'L.', u'Nation']]",Antimicrobial Agents and Chemotherapy,2006,"[u'http://aac.asm.org/cgi/reprint/50/6/1953.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.00035-06']",./output/10.1517~13543784.17.7.973.pdf/10.1128~AAC.00035-06
10.1128/AAC.00035-06,"Pamp, S., Gjermansen, M., Johansen, H., et. al, Tolerance to the antimicrobial peptide colistin in Pseudomonas aeruginosa biofilms is linked to metabolically active cells, and depends on the pmr and mexAB-oprM genes, Molecular Microbiology, 2008",cited-by,10.1111/j.1365-2958.2008.06152.x,"Tolerance to the antimicrobial peptide colistin in Pseudomonas aeruginosa biofilms is linked to metabolically active cells, and depends on the pmr and mexAB-oprM genes","[['S\xc3\xbcnje', 'Johanna', 'Pamp'], ['Morten', '', 'Gjermansen'], ['Helle', 'Krogh', 'Johansen'], ['Tim', '', 'Tolker-Nielsen']]",Molecular Microbiology,2008,"[u'http://www.biochem.wisc.edu/faculty/weibel/lab/wiki/Tolker_2008.pdf', u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2958.2008.06152.x']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1111~j.1365-2958.2008.06152.x
10.1128/AAC.00035-06,"Plachouras, D., Karvanen, M., Friberg, L., et. al, Population Pharmacokinetic Analysis of Colistin Methanesulfonate and Colistin after Intravenous Administration in Critically Ill Patients with Infections Caused by Gram-Negative Bacteria, Antimicrobial Agents and Chemotherapy, 2009",cited-by,10.1128/AAC.01361-08,Population Pharmacokinetic Analysis of Colistin Methanesulfonate and Colistin after Intravenous Administration in Critically Ill Patients with Infections Caused by Gram-Negative Bacteria,"[['D.', '', 'Plachouras'], ['M.', '', 'Karvanen'], ['L.', 'E.', 'Friberg'], ['E.', '', 'Papadomichelakis'], ['A.', '', 'Antoniadou'], ['I.', '', 'Tsangaris'], ['I.', '', 'Karaiskos'], ['G.', '', 'Poulakou'], ['F.', '', 'Kontopidou'], ['A.', '', 'Armaganidis'], ['O.', '', 'Cars'], ['H.', '', 'Giamarellou']]",Antimicrobial Agents and Chemotherapy,2009,"[u'http://aac.asm.org/cgi/reprint/53/8/3430.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.01361-08']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1128~AAC.01361-08
10.1128/AAC.00035-06,"Li, J., Nation, R., Owen, R., et. al, Antibiograms of Multidrug‐Resistant Clinical Acinetobacter baumannii: Promising Therapeutic Options for Treatment of Infection with Colistin‐Resistant Strains, Clinical Infectious Diseases, 2007",cited-by,10.1086/520658,Antibiograms of Multidrug‐Resistant Clinical Acinetobacter baumannii: Promising Therapeutic Options for Treatment of Infection with Colistin‐Resistant Strains,"[['Jian', '', 'Li'], ['Roger', 'L.', 'Nation'], ['Roxanne', 'J.', 'Owen'], ['Stephanie', '', 'Wong'], ['Denis', '', 'Spelman'], ['Clare', '', 'Franklin']]",Clinical Infectious Diseases,2007,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/520658'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1086~520658
10.1128/AAC.00035-06,"Tan, C., Li, J., Nation, R., , Activity of Colistin against Heteroresistant Acinetobacter baumannii and Emergence of Resistance in an In Vitro Pharmacokinetic/Pharmacodynamic Model, Antimicrobial Agents and Chemotherapy, 2007",cited-by,10.1128/AAC.01571-06,Activity of Colistin against Heteroresistant Acinetobacter baumannii and Emergence of Resistance in an In Vitro Pharmacokinetic/Pharmacodynamic Model,"[['Chun-Hong', '', 'Tan'], ['Jian', '', 'Li'], ['Roger', 'L.', 'Nation']]",Antimicrobial Agents and Chemotherapy,2007,"[u'http://aac.asm.org/cgi/reprint/51/9/3413.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.01571-06']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1128~AAC.01571-06
10.1128/AAC.00035-06,"Michalopoulos, A., Falagas, M., , Colistin and Polymyxin B in Critical Care, Critical Care Clinics, 2008",cited-by,10.1016/j.ccc.2007.12.003,Colistin and Polymyxin B in Critical Care,"[['Argyris', '', 'Michalopoulos'], ['Matthew', 'E.', 'Falagas']]",Critical Care Clinics,2008,"[u'http://www.sciencedirect.com/science/article/pii/S074907040700098X', u'http://linkinghub.elsevier.com/retrieve/pii/S074907040700098X']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1016~j.ccc.2007.12.003
10.1128/AAC.00035-06,"Zavascki, A., Goldani, L., Li, J., et. al, Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review, , 0",cited-by,10656588Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review,Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review,"[['Alexandre', 'Prehn', 'Zavascki'], ['Luciano', 'Zubaran', 'Goldani'], ['Jian', '', 'Li'], ['Roger', 'L.', 'Nation']]",,0,[u'http://jac.oxfordjournals.org/cgi/reprint/60/6/1206.pdf'],./output/10.1517~13543784.17.7.973.pdf/citedby/10656588Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review
10.1128/AAC.00035-06,"Nation, R., Li, J., , Colistin in the 21st century, Current Opinion in Infectious Diseases, 2009",cited-by,10.1097/QCO.0b013e328332e672,Colistin in the 21st century,"[['Roger', 'L', 'Nation'], ['Jian', '', 'Li']]",Current Opinion in Infectious Diseases,2009,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00001432-200912000-00004'],
10.1128/AAC.00035-06,"Yau, W., Owen, R., Poudyal, A., et. al, Colistin hetero-resistance in multidrug-resistant Acinetobacter baumannii clinical isolates from the Western Pacific region in the SENTRY antimicrobial surveillance programme, Journal of Infection, 2009",cited-by,10.1016/j.jinf.2008.11.002,Colistin hetero-resistance in multidrug-resistant Acinetobacter baumannii clinical isolates from the Western Pacific region in the SENTRY antimicrobial surveillance programme,"[['Wing', '', 'Yau'], ['Roxanne', 'J.', 'Owen'], ['Anima', '', 'Poudyal'], ['Jan', 'M.', 'Bell'], ['John', 'D.', 'Turnidge'], ['Heidi', 'H.', 'Yu'], ['Roger', 'L.', 'Nation'], ['Jian', '', 'Li']]",Journal of Infection,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0163445308003733', u'http://linkinghub.elsevier.com/retrieve/pii/S0163445308003733']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1016~j.jinf.2008.11.002
10.1128/AAC.00035-06,"Falagas, M., Rafailidis, P., , Re-emergence of colistin in today's world of multidrug-resistant organisms: personal perspectives, Expert Opinion on Investigational Drugs, 2008",cited-by,10.1517/13543784.17.7.973,Re-emergence of colistin in today's world of multidrug-resistant organisms: personal perspectives,"[['Matthew', 'E', 'Falagas'], ['Petros', 'I', 'Rafailidis']]",Expert Opinion on Investigational Drugs,2008,[u'http://www.informapharmascience.com/doi/abs/10.1517/13543784.17.7.973'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1517~13543784.17.7.973
10.1128/AAC.00035-06,"Kwa, A., Kasiakou, S., Tam, V., et. al, Polymyxin B: similarities to and differences from colistin (polymyxin E), Expert Review of Anti-infective Therapy, 2007",cited-by,10.1586/14787210.5.5.811,Polymyxin B: similarities to and differences from colistin (polymyxin E),"[['Andrea', '', 'Kwa'], ['Sofia', 'K', 'Kasiakou'], ['Vincent', 'H', 'Tam'], ['Matthew', 'E', 'Falagas']]",Expert Review of Anti-infective Therapy,2007,[u'http://www.future-drugs.com/doi/abs/10.1586/14787210.5.5.811'],
10.1128/AAC.00035-06,"Li, J., Nation, R., , Old Polymyxins Are Back: Is Resistance Close?, Clinical Infectious Diseases, 2006",cited-by,10.1086/506571,Old Polymyxins Are Back: Is Resistance Close?,"[['Jian', '', 'Li'], ['Roger', 'L.', 'Nation']]",Clinical Infectious Diseases,2006,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/506571'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1086~506571
10.1128/AAC.00035-06,"Wallace, S., Li, J., Nation, R., et. al, Subacute Toxicity of Colistin Methanesulfonate in Rats: Comparison of Various Intravenous Dosage Regimens, Antimicrobial Agents and Chemotherapy, 2008",cited-by,10.1128/AAC.01101-07,Subacute Toxicity of Colistin Methanesulfonate in Rats: Comparison of Various Intravenous Dosage Regimens,"[['Stephanie', 'J.', 'Wallace'], ['Jian', '', 'Li'], ['Roger', 'L.', 'Nation'], ['Craig', 'R.', 'Rayner'], ['David', '', 'Taylor'], ['Deborah', '', 'Middleton'], ['Robert', 'W.', 'Milne'], ['Kingsley', '', 'Coulthard'], ['John', 'D.', 'Turnidge']]",Antimicrobial Agents and Chemotherapy,2008,"[u'http://aac.asm.org/cgi/reprint/52/3/1159.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.01101-07']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1128~AAC.01101-07
10.1128/AAC.00035-06,"Kwa, A., , Polymyxins: A Review of the Current Status Including Recent Developments, , 0",cited-by,12288617Polymyxins: A Review of the Current Status Including Recent Developments,Polymyxins: A Review of the Current Status Including Recent Developments,"[['Andrea', 'L', 'Kwa']]",,0,[u'http://www.annals.edu.sg/pdf/37VolNo10Oct2008/V37N10p870.pdf'],./output/10.1517~13543784.17.7.973.pdf/citedby/12288617Polymyxins: A Review of the Current Status Including Recent Developments
10.1128/AAC.00035-06,"Dudhani, R., Turnidge, J., Nation, R., et. al, fAUC/MIC is the most predictive pharmacokinetic/pharmacodynamic index of colistin against Acinetobacter baumannii in murine thigh and lung infection models, Journal of Antimicrobial Chemotherapy, 2010",cited-by,10.1093/jac/dkq226,fAUC/MIC is the most predictive pharmacokinetic/pharmacodynamic index of colistin against Acinetobacter baumannii in murine thigh and lung infection models,"[['R.', 'V.', 'Dudhani'], ['J.', 'D.', 'Turnidge'], ['R.', 'L.', 'Nation'], ['J.', '', 'Li']]",Journal of Antimicrobial Chemotherapy,2010,[u'http://www.jac.oxfordjournals.org/cgi/doi/10.1093/jac/dkq226'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1093~jac~dkq226
10.1128/AAC.00035-06,"Wallace, S., Li, J., Rayner, C., et. al, Stability of Colistin Methanesulfonate in Pharmaceutical Products and Solutions for Administration to Patients, Antimicrobial Agents and Chemotherapy, 2008",cited-by,10.1128/AAC.00103-08,Stability of Colistin Methanesulfonate in Pharmaceutical Products and Solutions for Administration to Patients,"[['Stephanie', 'J.', 'Wallace'], ['Jian', '', 'Li'], ['Craig.', 'R.', 'Rayner'], ['Kingsley', '', 'Coulthard'], ['Roger', 'L.', 'Nation']]",Antimicrobial Agents and Chemotherapy,2008,"[u'http://aac.asm.org/cgi/reprint/52/9/3047.pdf', u'http://aac.asm.org/cgi/issue_pdf/toc_pdf/52/9.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.00103-08']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1128~AAC.00103-08
10.1128/AAC.00035-06,"Poudyal, A., Howden, B., Bell, J., et. al, In vitro pharmacodynamics of colistin against multidrug-resistant Klebsiella pneumoniae, Journal of Antimicrobial Chemotherapy, 2008",cited-by,10.1093/jac/dkn425,In vitro pharmacodynamics of colistin against multidrug-resistant Klebsiella pneumoniae,"[['A.', '', 'Poudyal'], ['B.', 'P.', 'Howden'], ['J.', 'M.', 'Bell'], ['W.', '', 'Gao'], ['R.', 'J.', 'Owen'], ['J.', 'D.', 'Turnidge'], ['R.', 'L.', 'Nation'], ['J.', '', 'Li']]",Journal of Antimicrobial Chemotherapy,2008,[u'http://www.jac.oxfordjournals.org/cgi/doi/10.1093/jac/dkn425'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1093~jac~dkn425
10.1128/AAC.00035-06,"Ma, Z., Wang, J., Nation, R., et. al, Renal Disposition of Colistin in the Isolated Perfused Rat Kidney, Antimicrobial Agents and Chemotherapy, 2009",cited-by,10.1128/AAC.00030-09,Renal Disposition of Colistin in the Isolated Perfused Rat Kidney,"[['Zheng', '', 'Ma'], ['Jiping', '', 'Wang'], ['Roger', 'L.', 'Nation'], ['Jian', '', 'Li'], ['John', 'D.', 'Turnidge'], ['Kingsley', '', 'Coulthard'], ['Robert', 'W.', 'Milne']]",Antimicrobial Agents and Chemotherapy,2009,"[u'http://aac.asm.org/cgi/reprint/53/7/2857.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.00030-09']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1128~AAC.00030-09
10.1128/AAC.00035-06,"MUTA, O., AKAIWA, Y., , Adaptive channel selection in frequency-selective fading environment, , 1999",cited-by,10.1109/ICC.1999.765582,Adaptive channel selection in frequency-selective fading environment,"[['Osamu', '', 'MUTA'], ['Yoshihiko', '', 'AKAIWA']]",,1999,"[u'http://ieeexplore.ieee.org/xpls/abs_all.jsp?arnumber=765582', u'http://ieeexplore.ieee.org/stamp/stamp.jsp?arnumber=00765582']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1109~ICC.1999.765582
10.1128/AAC.00035-06,"Monteiro, D., Madrid, M., , Planning of robot trajectories with genetic algorithms, , 1999",cited-by,10.1109/ROMOCO.1999.791079,Planning of robot trajectories with genetic algorithms,"[['D.', 'C.', 'Monteiro'], ['M.', 'K.', 'Madrid']]",,1999,"[u'http://ieeexplore.ieee.org/xpls/abs_all.jsp?arnumber=791079', u'http://ieeexplore.ieee.org/stamp/stamp.jsp?arnumber=00791079']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1109~ROMOCO.1999.791079
10.1128/AAC.00035-06,"Connolly, C., Grupen, R., , Harmonic control [robot applications], , 1992",cited-by,10.1109/ISIC.1992.225142,Harmonic control [robot applications],"[['C.', 'I.', 'Connolly'], ['R.', 'A.', 'Grupen']]",,1992,[u'http://ieeexplore.ieee.org/xpls/abs_all.jsp?arnumber=225142'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1109~ISIC.1992.225142
10.1128/AAC.00035-06,"Bergen, P., Li, J., Nation, R., et. al, Comparison of once-, twice- and thrice-daily dosing of colistin on antibacterial effect and emergence of resistance: studies with Pseudomonas aeruginosa in an in vitro pharmacodynamic model, , 0",cited-by,"11438016Comparison of once-, twice- and thrice-daily dosing of colistin on antibacterial effect and emergence of resistance: studies with Pseudomonas aeruginosa in an in vitro pharmacodynamic model","Comparison of once-, twice- and thrice-daily dosing of colistin on antibacterial effect and emergence of resistance: studies with Pseudomonas aeruginosa in an in vitro pharmacodynamic model","[['Phillip', 'J.', 'Bergen'], ['Jian', '', 'Li'], ['Roger', 'L.', 'Nation'], ['John', 'D.', 'Turnidge'], ['Kingsley', '', 'Coulthard']]",,0,[u'http://jac.oxfordjournals.org/cgi/reprint/61/3/636.pdf'],
10.1128/AAC.00035-06,"Frasca, D., Dahyot-Fizelier, C., Mimoz, O., , La colistine en réanimation, , 2008",cited-by,10.1016/j.reaurg.2008.01.005,La colistine en réanimation,"[['D.', '', 'Frasca'], ['C.', '', 'Dahyot-Fizelier'], ['O.', '', 'Mimoz']]",,2008,"[u'http://www.sciencedirect.com/science/article/pii/S1624069308000340', u'http://linkinghub.elsevier.com/retrieve/pii/S1624069308000340']",
10.1128/AAC.00035-06,"Morris, M., Hobson, R., , Neural network design of a dishwasher control board, , 2002",cited-by,10.1109/IJCNN.2002.1007534,Neural network design of a dishwasher control board,"[['M.', '', 'Morris'], ['R.', 'S.', 'Hobson']]",,2002,"[u'http://ieeexplore.ieee.org/stamp/stamp.jsp?arnumber=01007534', u'http://ieeexplore.ieee.org/xpls/abs_all.jsp?arnumber=1007534']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1109~IJCNN.2002.1007534
10.1517~13543784.17.7.973.pdf,"EMEA/MRL/016/95-Final. Veterinary Medicines and Inspections, European Agency for the Evaluation of Medical Products, London; 2002 9. Falagas ME, Kasiakou SK. Toxicity of polymyxins: a systematic review of the evidence from old and recent studies.",references,NOT found in MAS
10.1517~13543784.17.7.973.pdf,"Crit Care 2006;10(1):R27 • A synopsis of reported toxicity, mainly nephrotoxicity, associated with polymyxins in studies before and after 1995. 10. Falagas ME, Bliziotis IA, Tam VH.",references,NOT found in MAS
10.1517~13543784.17.7.973.pdf,"Intraventricular or intrathecal use of polymyxins in patients with Gram-negative meningitis: a systematic review of the available evidence. Int J Antimicrob Agents 2007;29(1):9-25 11. Catchpole CR, Andrews JM, Brenwald N, Wise R. A reassessment of the in vitro activity of colistin sulphomethate sodium.",references,10.1016/j.ijantimicag.2006.08.024,Intraventricular or intrathecal use of polymyxins in patients with Gram-negative meningitis: a systematic review of the available evidence,"[[u'Matthew', u'E.', u'Falagas'], [u'Ioannis', u'A.', u'Bliziotis'], [u'Vincent', u'H.', u'Tam']]",International Journal of Antimicrobial Agents,2007,"[u'http://www.sciencedirect.com/science/article/pii/S0924857906003815', u'http://www.infeksiyon.org/docs/pdf/makale1.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S0924857906003815']",
10.1016/j.ijantimicag.2006.08.024,"Karageorgopoulos, D., Falagas, M., , Current control and treatment of multidrug-resistant Acinetobacter baumannii infections, Lancet Infectious Diseases, 2008",cited-by,10.1016/S1473-3099(08)70279-2,Current control and treatment of multidrug-resistant Acinetobacter baumannii infections,"[['Drosos', 'E', 'Karageorgopoulos'], ['Matthew', 'E', 'Falagas']]",Lancet Infectious Diseases,2008,"[u'http://www.sciencedirect.com/science/article/pii/S1473309908702792', u'http://linkinghub.elsevier.com/retrieve/pii/S1473309908702792']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1016~S1473-3099(08)70279-2
10.1016/j.ijantimicag.2006.08.024,", Antimicrobial Resistance: Acinetobacter baumannii: Epidemiology, Antimicrobial Resistance, and Treatment Options, Clinical Infectious Diseases, 2008",cited-by,10.1086/529198,"Antimicrobial Resistance: Acinetobacter baumannii: Epidemiology, Antimicrobial Resistance, and Treatment Options",[],Clinical Infectious Diseases,2008,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/529198'],
10.1016/j.ijantimicag.2006.08.024,"Michalopoulos, A., Falagas, M., , Colistin and Polymyxin B in Critical Care, Critical Care Clinics, 2008",cited-by,10.1016/j.ccc.2007.12.003,Colistin and Polymyxin B in Critical Care,"[['Argyris', '', 'Michalopoulos'], ['Matthew', 'E.', 'Falagas']]",Critical Care Clinics,2008,"[u'http://www.sciencedirect.com/science/article/pii/S074907040700098X', u'http://linkinghub.elsevier.com/retrieve/pii/S074907040700098X']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1016~j.ccc.2007.12.003
10.1016/j.ijantimicag.2006.08.024,"Falagas, M., Kopterides, P., , Old antibiotics for infections in critically ill patients, Current Opinion in Critical Care, 2007",cited-by,10.1097/MCC.0b013e32827851d7,Old antibiotics for infections in critically ill patients,"[['Matthew', 'E', 'Falagas'], ['Petros', '', 'Kopterides']]",Current Opinion in Critical Care,2007,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00075198-200710000-00022'],
10.1016/j.ijantimicag.2006.08.024,"Nation, R., Li, J., , Colistin in the 21st century, Current Opinion in Infectious Diseases, 2009",cited-by,10.1097/QCO.0b013e328332e672,Colistin in the 21st century,"[['Roger', 'L', 'Nation'], ['Jian', '', 'Li']]",Current Opinion in Infectious Diseases,2009,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00001432-200912000-00004'],
10.1016/j.ijantimicag.2006.08.024,"Ziai, W., Lewin, J., , Update in the Diagnosis and Management of Central Nervous System Infections, Neurologic Clinics, 2008",cited-by,10.1016/j.ncl.2008.03.013,Update in the Diagnosis and Management of Central Nervous System Infections,"[['Wendy', 'C.', 'Ziai'], ['John', 'J.', 'Lewin']]",Neurologic Clinics,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0733861908000455', u'http://linkinghub.elsevier.com/retrieve/pii/S0733861908000455']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1016~j.ncl.2008.03.013
10.1016/j.ijantimicag.2006.08.024,"Falagas, M., Rafailidis, P., , Re-emergence of colistin in today's world of multidrug-resistant organisms: personal perspectives, Expert Opinion on Investigational Drugs, 2008",cited-by,10.1517/13543784.17.7.973,Re-emergence of colistin in today's world of multidrug-resistant organisms: personal perspectives,"[['Matthew', 'E', 'Falagas'], ['Petros', 'I', 'Rafailidis']]",Expert Opinion on Investigational Drugs,2008,[u'http://www.informapharmascience.com/doi/abs/10.1517/13543784.17.7.973'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1517~13543784.17.7.973
10.1016/j.ijantimicag.2006.08.024,"Kwa, A., Kasiakou, S., Tam, V., et. al, Polymyxin B: similarities to and differences from colistin (polymyxin E), Expert Review of Anti-infective Therapy, 2007",cited-by,10.1586/14787210.5.5.811,Polymyxin B: similarities to and differences from colistin (polymyxin E),"[['Andrea', '', 'Kwa'], ['Sofia', 'K', 'Kasiakou'], ['Vincent', 'H', 'Tam'], ['Matthew', 'E', 'Falagas']]",Expert Review of Anti-infective Therapy,2007,[u'http://www.future-drugs.com/doi/abs/10.1586/14787210.5.5.811'],
10.1016/j.ijantimicag.2006.08.024,"Kim, B., Peleg, A., Lodise, T., et. al, Management of meningitis due to antibiotic-resistant Acinetobacter species, Lancet Infectious Diseases, 2009",cited-by,10.1016/S1473-3099(09)70055-6,Management of meningitis due to antibiotic-resistant Acinetobacter species,"[['Baek-Nam', '', 'Kim'], ['Anton', 'Y', 'Peleg'], ['Thomas', 'P', 'Lodise'], ['Jeffrey', '', 'Lipman'], ['Jian', '', 'Li'], ['Roger', '', 'Nation'], ['David', 'L', 'Paterson']]",Lancet Infectious Diseases,2009,"[u'http://www.sciencedirect.com/science/article/pii/S1473309909700556', u'http://linkinghub.elsevier.com/retrieve/pii/S1473309909700556']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1016~S1473-3099(09)70055-6
10.1016/j.ijantimicag.2006.08.024,"Ziai, W., Lewin, J., , Improving the role of intraventricular antimicrobial agents in the management of meningitis, Current Opinion in Neurology, 2009",cited-by,10.1097/WCO.0b013e32832c1396,Improving the role of intraventricular antimicrobial agents in the management of meningitis,"[['Wendy', 'C', 'Ziai'], ['John', 'J', 'Lewin']]",Current Opinion in Neurology,2009,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00019052-200906000-00014'],
10.1016/j.ijantimicag.2006.08.024,"Yuan, Z., Tam, V., , Polymyxin B: a new strategy for multidrug-resistant Gram-negative organisms, Expert Opinion on Investigational Drugs, 2008",cited-by,10.1517/13543784.17.5.661,Polymyxin B: a new strategy for multidrug-resistant Gram-negative organisms,"[['Zhe', '', 'Yuan'], ['Vincent', 'H', 'Tam']]",Expert Opinion on Investigational Drugs,2008,[u'http://www.informapharmascience.com/doi/abs/10.1517/13543784.17.5.661'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1517~13543784.17.5.661
10.1016/j.ijantimicag.2006.08.024,"Kwa, A., , Polymyxins: A Review of the Current Status Including Recent Developments, , 0",cited-by,12288617Polymyxins: A Review of the Current Status Including Recent Developments,Polymyxins: A Review of the Current Status Including Recent Developments,"[['Andrea', 'L', 'Kwa']]",,0,[u'http://www.annals.edu.sg/pdf/37VolNo10Oct2008/V37N10p870.pdf'],./output/10.1517~13543784.17.7.973.pdf/citedby/12288617Polymyxins: A Review of the Current Status Including Recent Developments
10.1016/j.ijantimicag.2006.08.024,"Cascio, A., Conti, A., Sinardi, L., et. al, Post-neurosurgical multidrug-resistant Acinetobacter baumannii meningitis successfully treated with intrathecal colistin. A new case and a systematic review of the literature, International Journal of Infectious Diseases, 2010",cited-by,10.1016/j.ijid.2009.06.032,Post-neurosurgical multidrug-resistant Acinetobacter baumannii meningitis successfully treated with intrathecal colistin. A new case and a systematic review of the literature,"[['Antonio', '', 'Cascio'], ['Alfredo', '', 'Conti'], ['Luca', '', 'Sinardi'], ['Chiara', '', 'Iaria'], ['Filippo', 'Flavio', 'Angileri'], ['Giovanna', '', 'Stassi'], ['Teresa', '', 'David'], ['Antonio', '', 'Versaci'], ['Maurizio', '', 'Iaria'], ['Antonio', '', 'David']]",International Journal of Infectious Diseases,2010,"[u'http://www.sciencedirect.com/science/article/pii/S1201971209003191', u'http://linkinghub.elsevier.com/retrieve/pii/S1201971209003191']",
10.1016/j.ijantimicag.2006.08.024,"Cook, A., Mieure, K., Owen, R., et. al, Intracerebroventricular Administration of Drugs, Pharmacotherapy, 2009",cited-by,10.1592/phco.29.7.832,Intracerebroventricular Administration of Drugs,"[['Aaron', 'M', 'Cook'], ['Katherine', 'D', 'Mieure'], ['Robert', 'D', 'Owen'], ['Adam', 'B', 'Pesaturo'], ['Jimmi', '', 'Hatton']]",Pharmacotherapy,2009,[u'http://www.atypon-link.com/PPI/doi/abs/10.1592/phco.29.7.832'],
10.1016/j.ijantimicag.2006.08.024,"Murray, C., Hospenthal, D., , Acinetobacter Infection in the ICU, Critical Care Clinics, 2008",cited-by,10.1016/j.ccc.2007.12.005,Acinetobacter Infection in the ICU,"[['Clinton', 'K.', 'Murray'], ['Duane', 'R.', 'Hospenthal']]",Critical Care Clinics,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0749070407001005', u'http://linkinghub.elsevier.com/retrieve/pii/S0749070407001005']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1016~j.ccc.2007.12.005
10.1016/j.ijantimicag.2006.08.024,"Monteiro, D., Madrid, M., , Planning of robot trajectories with genetic algorithms, , 1999",cited-by,10.1109/ROMOCO.1999.791079,Planning of robot trajectories with genetic algorithms,"[['D.', 'C.', 'Monteiro'], ['M.', 'K.', 'Madrid']]",,1999,"[u'http://ieeexplore.ieee.org/xpls/abs_all.jsp?arnumber=791079', u'http://ieeexplore.ieee.org/stamp/stamp.jsp?arnumber=00791079']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1109~ROMOCO.1999.791079
10.1016/j.ijantimicag.2006.08.024,"Molina, J., Cordero, E., Palomino, J., et. al, Aminoglucósidos y polimixinas, Enfermedades Infecciosas Y Microbiologia Clinica, 2009",cited-by,10.1016/j.eimc.2009.02.001,Aminoglucósidos y polimixinas,"[['Jos\xc3\xa9', '', 'Molina'], ['Elisa', '', 'Cordero'], ['Juli\xc3\xa1n', '', 'Palomino'], ['Jer\xc3\xb3nimo', '', 'Pach\xc3\xb3n']]",Enfermedades Infecciosas Y Microbiologia Clinica,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0213005X09000986', u'http://linkinghub.elsevier.com/retrieve/pii/S0213005X09000986']",
10.1016/j.ijantimicag.2006.08.024,"Levin, A., Oliveira, M., , THE CHALLENGE OF MULTIDRUG RESISTANCE: THE TREATMENT OF GRAM-NEGATIVE ROD INFECTIONS, Shock, 2008",cited-by,10.1097/SHK.0b013e3181819cb8,THE CHALLENGE OF MULTIDRUG RESISTANCE: THE TREATMENT OF GRAM-NEGATIVE ROD INFECTIONS,"[['Anna', 'S.', 'Levin'], ['Maura', 'S.', 'Oliveira']]",Shock,2008,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00024382-200810001-00007'],
10.1016/j.ijantimicag.2006.08.024,"Barnos, B., , The electrified fence as a component of a physical protection system, , 1989",cited-by,10.1109/CCST.1989.751985,The electrified fence as a component of a physical protection system,"[['B.', 'W.', 'Barnos']]",,1989,[u'http://ieeexplore.ieee.org/xpls/abs_all.jsp?arnumber=751985'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1109~CCST.1989.751985
10.1016/j.ijantimicag.2006.08.024,"Razmkon, A., Mehrafshan, A., Bakhtazad, A., , Management of post-neurosurgical Acinetobacter infections: experiences obtained during an outbreak, Acta Neurochirurgica, 2011",cited-by,10.1007/s00701-010-0857-5,Management of post-neurosurgical Acinetobacter infections: experiences obtained during an outbreak,"[['Ali', '', 'Razmkon'], ['Ali', '', 'Mehrafshan'], ['Atefeh', '', 'Bakhtazad']]",Acta Neurochirurgica,2011,"[u'http://www.springerlink.com/index/bx4272h0771842u3.pdf', u'http://www.springerlink.com/content/bx4272h0771842u3']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1007~s00701-010-0857-5
10.1016/j.ijantimicag.2006.08.024,"Laxmi, S., Tunkel, A., , Healthcare-Associated Bacterial Meningitis, Current Infectious Disease Reports, 2011",cited-by,10.1007/s11908-011-0190-z,Healthcare-Associated Bacterial Meningitis,"[['Sheethal', '', 'Laxmi'], ['Allan', 'R.', 'Tunkel']]",Current Infectious Disease Reports,2011,"[u'http://www.springerlink.com/index/8130671576j9n8p0.pdf', u'http://www.springerlink.com/content/8130671576j9n8p0']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1007~s11908-011-0190-z
10.1016/j.ijantimicag.2006.08.024,"Wang, R., Bencic, D., Lazorchak, J., et. al, Transcriptional regulatory dynamics of the hypothalamic–pituitary–gonadal axis and its peripheral pathways as impacted by the 3-beta HSD inhibitor trilostane in zebrafish ( Danio rerio), Ecotoxicology and Environmental Safety, 2011",cited-by,10.1016/j.ecoenv.2011.05.001,Transcriptional regulatory dynamics of the hypothalamic–pituitary–gonadal axis and its peripheral pathways as impacted by the 3-beta HSD inhibitor trilostane in zebrafish ( Danio rerio),"[['Rong-Lin', '', 'Wang'], ['David', '', 'Bencic'], ['Jim', '', 'Lazorchak'], ['Daniel', '', 'Villeneuve'], ['Gerald', 'T.', 'Ankley']]",Ecotoxicology and Environmental Safety,2011,[u'http://www.sciencedirect.com/science/article/pii/S0147651311001308'],
10.1016/j.ijantimicag.2006.08.024,"Cordero, E., Palomino, J., Pachon, J., , Aminoglucosidos y polimixinas, , 2009",cited-by,6349126Aminoglucosidos y polimixinas,Aminoglucosidos y polimixinas,"[['Elisa', '', 'Cordero'], ['Julian', '', 'Palomino'], ['Jeronimo', '', 'Pachon']]",,2009,"[u'http://external.doyma.es/pdf/28/28v27n03a13134987pdf001.pdf', u'http://www.elsevier.es/watermark/ctl_servlet?_f=10&pident_articulo=13134987&pident_usuario=0&pcontactid=&pident_revista=28&ty=135&accion=L&origen=elsevier&web=www.elsevier.es&lan=es&fichero=28v27n03a13134987pdf001.pdf']",
10.1016/j.ijantimicag.2006.08.024,"Gelfand, M., Cleveland, K., Mazumder, S., , Successful treatment with doripenem and tobramycin of ventriculitis due to imipenem- and meropenem-resistant Pseudomonas aeruginosa, Journal of Antimicrobial Chemotherapy, 2009",cited-by,10.1093/jac/dkp134,Successful treatment with doripenem and tobramycin of ventriculitis due to imipenem- and meropenem-resistant Pseudomonas aeruginosa,"[['M.', 'S.', 'Gelfand'], ['K.', 'O.', 'Cleveland'], ['S.', 'A.', 'Mazumder']]",Journal of Antimicrobial Chemotherapy,2009,[u'http://www.jac.oxfordjournals.org/cgi/doi/10.1093/jac/dkp134'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1093~jac~dkp134
10.1016/j.ijantimicag.2006.08.024,"Vives, C., Duarte, G., Beltrán, S., et. al, Brain abscess caused by multidrug-resistant Acinetobacter baumannii : Case report, Journal of Neurosurgery, 2009",cited-by,10.3171/2008.10.JNS08918,Brain abscess caused by multidrug-resistant Acinetobacter baumannii : Case report,"[['Carlos', 'H. Guinand', 'Vives'], ['Guillermo', 'A. Monsalve', 'Duarte'], ['Sandra', 'Valderrama', 'Beltr\xc3\xa1n'], ['Johanna', 'Osorio', 'Pinz\xc3\xb3n']]",Journal of Neurosurgery,2009,[u'http://thejns.org/doi/abs/10.3171/2008.10.JNS08918'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.3171~2008.10.JNS08918
10.1016/j.ijantimicag.2006.08.024,"Dixon, K., Hassoun, A., , Intraventricular Colistin for the Treatment of Multidrug-Resistant Pseudomonas Aeruginosa Shunt Infection, Hospital Pharmacy, 2008",cited-by,10.1310/hpj4310-816,Intraventricular Colistin for the Treatment of Multidrug-Resistant Pseudomonas Aeruginosa Shunt Infection,"[['Kelly', 'S.', 'Dixon'], ['Ali', '', 'Hassoun']]",Hospital Pharmacy,2008,"[u'http://www.factsandcomparisons.com/assets/hpdatenamed/20081001_oct2008_peer2.pdf', u'https://www.factsandcomparisons.com/assets/hpdatenamed/20081001_oct2008_peer2.pdf', u'http://thomasland.metapress.com/openurl.asp?genre=article&id=doi:10.1310/hpj4310-816', u'http://thomasland.metapress.com/index/FL42174XM0983831.pdf']",
10.1016/j.ijantimicag.2006.08.024,"Smith, M., Pedrycz, W., , Perception issues in data mining, , 2001",cited-by,10.1109/ICSMC.2001.972944,Perception issues in data mining,"[['M.', 'H.', 'Smith'], ['W.', '', 'Pedrycz']]",,2001,[u'http://ieeexplore.ieee.org/xpls/abs_all.jsp?arnumber=972944'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1109~ICSMC.2001.972944
10.1016/j.ijantimicag.2006.08.024,"Hanberger, H., Giske, C., Giamarellou, H., , When and How to Cover for Resistant Gram-Negative Bacilli in Severe Sepsis and Septic Shock, Current Infectious Disease Reports, 0",cited-by,10.1007/s11908-011-0200-1,When and How to Cover for Resistant Gram-Negative Bacilli in Severe Sepsis and Septic Shock,"[['H\xc3\xa5kan', '', 'Hanberger'], ['Christian', 'G.', 'Giske'], ['Helen', '', 'Giamarellou']]",Current Infectious Disease Reports,0,"[u'http://www.springerlink.com/index/7px8w675u8122u1m.pdf', u'http://www.springerlink.com/content/7px8w675u8122u1m']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1007~s11908-011-0200-1
10.1517~13543784.17.7.973.pdf,"J Antimicrob Chemother 1997;39(2):255-60 12. Koike M, Iida K, Matsuo T. Electron microscopic studies on mode of action of polymyxin.",references,NOT found in MAS
10.1517~13543784.17.7.973.pdf,"J Bacteriol 1969;97(1):448-52 13. Gough M, Hancock RE, Kelly NM.",references,NOT found in MAS
10.1517~13543784.17.7.973.pdf,"Antiendotoxin activity of cationic peptide antimicrobial agents. Infect Immun 1996;64(12):4922-7 14. Levin AS, Barone AA, Penço J, et al. Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii.",references,NOT found in MAS
10.1517~13543784.17.7.973.pdf,"Clin Infect Dis 1999;28:1008-11 •• After approximately 20 years of almost total abandonment of the intravenous use of colistin, this study reported on the clinical effectiveness of the medication in patients without a history of cystic fibrosis. 15. Falagas ME, Kasiakou SK, Tsiodras S, Michalopoulos A. The use of intravenous and aerosolized polymyxins for the treatment of infections in critically ill patients: a review of the recent literature.",references,NOT found in MAS
10.1517~13543784.17.7.973.pdf,"Clin Med Res 2006;4(2):138-46 16. Garnacho-Montero J, Ortiz-Leyba C, Jiménez-Jiménez FJ, et al. Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-susceptible VAP. Clin Infect Dis 2003;36(9):1111-8 •• The first head-to-head comparison of colistin with an established treatment (imipenem-cilastatin) of ventilator-associated pneumonia due to multidrug-resistant A. baumannii, which showed comparable effectiveness and safety. 17. Linden PK, Kusne S, Coley K, et al. Use of parenteral colistin for the treatment of serious infection due to antimicrobial-resistant Pseudomonas aeruginosa.",references,NOT found in MAS
10.1517~13543784.17.7.973.pdf,"Clin Infect Dis 2003;37(11):E154-60 18. Markou N, Apostolakos H, Koumoudiou C, et al. Intravenous colistin in the treatment of sepsis from multiresistant Gram-negative bacilli in critically ill patients. Crit Care 2003;7(5):R78-83 19. Kasiakou SK, Michalopoulos A, Soteriades ES, et al. Combination therapy with intravenous colistin for management of infections due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis. Antimicrob Agents Chemother 2005;49(8):3136-46 20. Michalopoulos AS, Tsiodras S, Rellos K, et al. Colistin treatment in patients with ICU-acquired infections caused by multiresistant Gram-negative bacteria: the renaissance of an old antibiotic.",references,10.1186/cc2358,Intravenous colistin in the treatment of sepsis from multiresistant Gram-negative bacilli in critically ill patients,"[[u'Nikolaos', u'', u'Markou'], [u'Haralampos', u'', u'Apostolakos'], [u'Christiana', u'', u'Koumoudiou'], [u'Maria', u'', u'Athanasiou'], [u'Alexandra', u'', u'Koutsoukou'], [u'Ioannis', u'', u'Alamanos'], [u'Leonidas', u'', u'Gregorakos']]",Critical Care,2003,"[u'http://ccforum.com/content/7/5/R78', u'http://www.biomedcentral.com/content/pdf/cc2358.pdf', u'http://www.springerlink.com/content/d2q7x66887261914', u'http://www.springerlink.com/index/d2q7x66887261914.pdf']",./output/10.1517~13543784.17.7.973.pdf/10.1186~cc2358
10.1186/cc2358,"Levy, S., Marshall, B., , Antibacterial resistance worldwide: causes, challenges and responses, Nature Medicine, 2004",cited-by,10.1038/nm1145,"Antibacterial resistance worldwide: causes, challenges and responses","[['Stuart', 'B', 'Levy'], ['Bonnie', '', 'Marshall']]",Nature Medicine,2004,"[u'http://www.nature.com/doifinder/10.1038/nm1145', u'http://dx.doi.org/10.1038/nm1145']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1038~nm1145
10.1186/cc2358,"Walsh, T., Toleman, M., Poirel, L., et. al, Metallo -Lactamases: the Quiet before the Storm?, Clinical Microbiology Reviews, 2005",cited-by,10.1128/CMR.18.2.306-325.2005,Metallo -Lactamases: the Quiet before the Storm?,"[['Timothy', 'R.', 'Walsh'], ['Mark', 'A.', 'Toleman'], ['Laurent', '', 'Poirel'], ['Patrice', '', 'Nordmann']]",Clinical Microbiology Reviews,2005,"[u'http://cmr.asm.org/cgi/reprint/18/2/306.pdf', u'http://cmr.asm.org/cgi/doi/10.1128/CMR.18.2.306-325.2005']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1128~CMR.18.2.306-325.2005
10.1186/cc2358,"Li, J., Nation, R., Turnidge, J., et. al, Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections, Lancet Infectious Diseases, 2006",cited-by,10.1016/S1473-3099(06)70580-1,Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections,"[['Jian', '', 'Li'], ['Roger', 'L', 'Nation'], ['John', 'D', 'Turnidge'], ['Robert', 'W', 'Milne'], ['Kingsley', '', 'Coulthard'], ['Craig', 'R', 'Rayner'], ['David', 'L', 'Paterson']]",Lancet Infectious Diseases,2006,"[u'http://www.sld.cu/galerias/pdf/sitios/apua-cuba/r15-colistin._the_re-emerging_antibiotic_for_multidrug-resistant_gram-negative_bacterial_infections.pdf', u'http://www.sciencedirect.com/science/article/pii/S1473309906705801', u'http://www.sld.cu/galerias/pdf/sitios/apua-cuba/a21-colistin._the_re-emerging_antibiotic_for_multidrug-resistant_gram-negative_bacterial_infections.pdf', u'http://info.med.yale.edu/intmed/infdis/resources/docs/colistin-review-lancet.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S1473309906705801']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1016~S1473-3099(06)70580-1
10.1186/cc2358,"Li, J., Nation, R., Milne, R., et. al, Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria, International Journal of Antimicrobial Agents, 2005",cited-by,10.1016/j.ijantimicag.2004.10.001,Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria,"[['Jian', '', 'Li'], ['Roger', 'L.', 'Nation'], ['Robert', 'W.', 'Milne'], ['John', 'D.', 'Turnidge'], ['Kingsley', '', 'Coulthard']]",International Journal of Antimicrobial Agents,2005,"[u'http://www.sciencedirect.com/science/article/pii/S0924857904003656', u'http://linkinghub.elsevier.com/retrieve/pii/S0924857904003656']",
10.1186/cc2358,"Kasiakou, S., Michalopoulos, A., Soteriades, E., et. al, Combination Therapy with Intravenous Colistin for Management of Infections Due to Multidrug-Resistant Gram-Negative Bacteria in Patients without Cystic Fibrosis, Antimicrobial Agents and Chemotherapy, 2005",cited-by,10.1128/AAC.49.8.3136-3146.2005,Combination Therapy with Intravenous Colistin for Management of Infections Due to Multidrug-Resistant Gram-Negative Bacteria in Patients without Cystic Fibrosis,"[['S.', 'K.', 'Kasiakou'], ['A.', '', 'Michalopoulos'], ['E.', 'S.', 'Soteriades'], ['G.', '', 'Samonis'], ['G.', 'J.', 'Sermaides'], ['M.', 'E.', 'Falagas']]",Antimicrobial Agents and Chemotherapy,2005,[u'http://aac.asm.org/cgi/doi/10.1128/AAC.49.8.3136-3146.2005'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1128~AAC.49.8.3136-3146.2005
10.1186/cc2358,"Kwa, A., Loh, C., Low, J., et. al, Nebulized Colistin in the Treatment of Pneumonia Due to Multidrug‐Resistant Acinetobacter baumannii and Pseudomonas aeruginosa, Clinical Infectious Diseases, 2005",cited-by,10.1086/432583,Nebulized Colistin in the Treatment of Pneumonia Due to Multidrug‐Resistant Acinetobacter baumannii and Pseudomonas aeruginosa,"[['Andrea', 'L. H.', 'Kwa'], ['ChinSiew', '', 'Loh'], ['Jenny', 'G. H.', 'Low'], ['Asok', '', 'Kurup'], ['Vincent', 'H.', 'Tam']]",Clinical Infectious Diseases,2005,"[u'http://www.sld.cu/galerias/pdf/sitios/apua-cuba/a45-nebulized_colistin_in_the_tx_of_pneumonia_due_to_mdr_a.baumannii_&_p.aeruginosa.pdf', u'http://www.med.yale.edu/intmed/infdis/resources/docs/colistin-nebulized.pdf', u'http://www.journals.uchicago.edu/doi/abs/10.1086/432583']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1086~432583
10.1186/cc2358,"Reina, R., Estenssoro, E., Sáenz, G., et. al, Safety and efficacy of colistin in Acinetobacter and Pseudomonas infections: a prospective cohort study, Intensive Care Medicine, 2005",cited-by,10.1007/s00134-005-2691-4,Safety and efficacy of colistin in Acinetobacter and Pseudomonas infections: a prospective cohort study,"[['Rosa', '', 'Reina'], ['Elisa', '', 'Estenssoro'], ['Gabriela', '', 'S\xc3\xa1enz'], ['H\xc3\xa9ctor', 'S.', 'Canales'], ['Romina', '', 'Gonzalvo'], ['Gabriela', '', 'Vidal'], ['Gustavo', '', 'Martins'], ['Andrea', 'Das', 'Neves'], ['Oscar', '', 'Santander'], ['Carlos', '', 'Ramos']]",Intensive Care Medicine,2005,"[u'http://www.springerlink.com/index/v54l2472404l5576.pdf', u'http://www.springerlink.com/content/v54l2472404l5576', u'http://www.springerlink.com/index/10.1007/s00134-005-2691-4', u'http://www.springerlink.com/index/pdf/10.1007/s00134-005-2691-4']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1007~s00134-005-2691-4
10.1186/cc2358,"Coelho, J., Turton, J., Kaufmann, M., et. al, Occurrence of Carbapenem-Resistant Acinetobacter baumannii Clones at Multiple Hospitals in London and Southeast England, , 2006",cited-by,6781183Occurrence of Carbapenem-Resistant Acinetobacter baumannii Clones at Multiple Hospitals in London and Southeast England,Occurrence of Carbapenem-Resistant Acinetobacter baumannii Clones at Multiple Hospitals in London and Southeast England,"[['Juliana', 'M.', 'Coelho'], ['Jane', 'F.', 'Turton'], ['Mary', 'E.', 'Kaufmann'], ['Judith', '', 'Glover'], ['Neil', '', 'Woodford'], ['Marina', '', 'Warner'], ['Marie-France', '', 'Palepou'], ['Rachel', '', 'Pike'], ['Tyrone', 'L.', 'Pitt'], ['Bharat', 'C.', 'Patel'], ['David', 'M.', 'Livermore']]",,2006,[u'http://jcm.asm.org/cgi/reprint/44/10/3623.pdf'],./output/10.1517~13543784.17.7.973.pdf/citedby/6781183Occurrence of Carbapenem-Resistant Acinetobacter baumannii Clones at Multiple Hospitals in London and Southeast England
10.1186/cc2358,"Falagas, M., Kasiakou, S., , Toxicity of polymyxins: a systematic review of the evidence from old and recent studies, Critical Care, 2006",cited-by,10.1186/cc3995,Toxicity of polymyxins: a systematic review of the evidence from old and recent studies,"[['Matthew', 'E', 'Falagas'], ['Sofia', 'K', 'Kasiakou']]",Critical Care,2006,"[u'http://www.biomedcentral.com/content/pdf/cc3995.pdf', u'http://ccforum.com/content/10/1/R27', u'http://www.springerlink.com/content/4hp6047472k68157', u'http://www.springerlink.com/index/4hp6047472k68157.pdf']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1186~cc3995
10.1186/cc2358,"Giuliani, A., Pirri, G., Nicoletto, S., , Antimicrobial peptides: an overview of a promising class of therapeutics, Central European Journal of Biology, 2007",cited-by,10.2478/s11535-007-0010-5,Antimicrobial peptides: an overview of a promising class of therapeutics,"[['Andrea', '', 'Giuliani'], ['Giovanna', '', 'Pirri'], ['Silvia', 'Fabiole', 'Nicoletto']]",Central European Journal of Biology,2007,"[u'http://www.springerlink.com/index/j978p1v3145921u8.pdf', u'http://www.springerlink.com/content/j978p1v3145921u8', u'http://www.spiderbiotech.com/Giuliani_et_al.pdf', u'http://www.springerlink.com/index/10.2478/s11535-007-0010-5']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.2478~s11535-007-0010-5
10.1186/cc2358,"Karageorgopoulos, D., Falagas, M., , Current control and treatment of multidrug-resistant Acinetobacter baumannii infections, Lancet Infectious Diseases, 2008",cited-by,10.1016/S1473-3099(08)70279-2,Current control and treatment of multidrug-resistant Acinetobacter baumannii infections,"[['Drosos', 'E', 'Karageorgopoulos'], ['Matthew', 'E', 'Falagas']]",Lancet Infectious Diseases,2008,"[u'http://www.sciencedirect.com/science/article/pii/S1473309908702792', u'http://linkinghub.elsevier.com/retrieve/pii/S1473309908702792']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1016~S1473-3099(08)70279-2
10.1186/cc2358,"Falagas, M., Kasiakou, S., Tsiodras, S., et. al, The Use of Intravenous and Aerosolized Polymyxins for the Treatment of Infections in Critically Ill Patients: A Review of the Recent Literature, Clinical Medicine & Research, 2006",cited-by,10.3121/cmr.4.2.138,The Use of Intravenous and Aerosolized Polymyxins for the Treatment of Infections in Critically Ill Patients: A Review of the Recent Literature,"[['Matthew', 'E.', 'Falagas'], ['Sofia', 'K.', 'Kasiakou'], ['Sotirios', '', 'Tsiodras'], ['Argyris', '', 'Michalopoulos']]",Clinical Medicine & Research,2006,"[u'http://www.clinmedres.org/cgi/doi/10.3121/cmr.4.2.138', u'http://www.clinmedres.org/cgi/reprint/4/2/138.pdf']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.3121~cmr.4.2.138
10.1186/cc2358,"Motaouakkil, S., Charra, B., Hachimi, A., et. al, Colistin and rifampicin in the treatment of nosocomial infections from multiresistant Acinetobacter baumannii, Journal of Infection, 2006",cited-by,10.1016/j.jinf.2005.11.019,Colistin and rifampicin in the treatment of nosocomial infections from multiresistant Acinetobacter baumannii,"[['Said', '', 'Motaouakkil'], ['Boubaker', '', 'Charra'], ['Abdelhamid', '', 'Hachimi'], ['Hicham', '', 'Nejmi'], ['Abdellatif', '', 'Benslama'], ['Naima', '', 'Elmdaghri'], ['Habiba', '', 'Belabbes'], ['Mohamed', '', 'Benbachir']]",Journal of Infection,2006,"[u'http://www.sciencedirect.com/science/article/pii/S016344530500383X', u'http://linkinghub.elsevier.com/retrieve/pii/S016344530500383X']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1016~j.jinf.2005.11.019
10.1186/cc2358,"Pamp, S., Gjermansen, M., Johansen, H., et. al, Tolerance to the antimicrobial peptide colistin in Pseudomonas aeruginosa biofilms is linked to metabolically active cells, and depends on the pmr and mexAB-oprM genes, Molecular Microbiology, 2008",cited-by,10.1111/j.1365-2958.2008.06152.x,"Tolerance to the antimicrobial peptide colistin in Pseudomonas aeruginosa biofilms is linked to metabolically active cells, and depends on the pmr and mexAB-oprM genes","[['S\xc3\xbcnje', 'Johanna', 'Pamp'], ['Morten', '', 'Gjermansen'], ['Helle', 'Krogh', 'Johansen'], ['Tim', '', 'Tolker-Nielsen']]",Molecular Microbiology,2008,"[u'http://www.biochem.wisc.edu/faculty/weibel/lab/wiki/Tolker_2008.pdf', u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2958.2008.06152.x']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1111~j.1365-2958.2008.06152.x
10.1186/cc2358,"Kallel, H., Hergafi, L., Bahloul, M., et. al, Safety and efficacy of colistin compared with imipenem in the treatmentof ventilator-associated pneumonia: a matched case–control study, Intensive Care Medicine, 2007",cited-by,10.1007/s00134-007-0675-2,Safety and efficacy of colistin compared with imipenem in the treatmentof ventilator-associated pneumonia: a matched case–control study,"[['H.', '', 'Kallel'], ['L.', '', 'Hergafi'], ['M.', '', 'Bahloul'], ['A.', '', 'Hakim'], ['H.', '', 'Dammak'], ['H.', '', 'Chelly'], ['C.', 'Ben', 'Hamida'], ['A.', '', 'Chaari'], ['N.', '', 'Rekik'], ['M.', '', 'Bouaziz']]",Intensive Care Medicine,2007,"[u'http://www.springerlink.com/content/211g0x62127980k2', u'http://www.springerlink.com/index/211g0x62127980k2.pdf', u'http://www.springerlink.com/index/10.1007/s00134-007-0675-2', u'http://www.springerlink.com/index/pdf/10.1007/s00134-007-0675-2']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1007~s00134-007-0675-2
10.1186/cc2358,"Tam, V., Schilling, A., Vo, G., et. al, Pharmacodynamics of Polymyxin B against Pseudomonas aeruginosa, Antimicrobial Agents and Chemotherapy, 2005",cited-by,10.1128/AAC.49.9.3624-3630.2005,Pharmacodynamics of Polymyxin B against Pseudomonas aeruginosa,"[['Vincent', 'H.', 'Tam'], ['Amy', 'N.', 'Schilling'], ['Giao', '', 'Vo'], ['Samer', '', 'Kabbara'], ['Andrea', 'L.', 'Kwa'], ['Nathan', 'P.', 'Wiederhold'], ['Russell', 'E.', 'Lewis']]",Antimicrobial Agents and Chemotherapy,2005,"[u'http://aac.asm.org/cgi/reprint/49/9/3624.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.49.9.3624-3630.2005']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1128~AAC.49.9.3624-3630.2005
10.1186/cc2358,"Timurkaynak, F., Can, F., Azap, ., et. al, In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units, International Journal of Antimicrobial Agents, 2006",cited-by,10.1016/j.ijantimicag.2005.10.012,In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units,"[['Funda', '', 'Timurkaynak'], ['Fusun', '', 'Can'], ['\xc3\x96zlem', 'Kurt', 'Azap'], ['M\xc3\xbcge', '', 'Demirbilek'], ['Hande', '', 'Arslan'], ['Sedef', '\xc3\x96zbal\xc4\xb1k\xc3\xa7\xc4\xb1', 'Karaman']]",International Journal of Antimicrobial Agents,2006,"[u'http://www.sciencedirect.com/science/article/pii/S0924857905003316', u'http://linkinghub.elsevier.com/retrieve/pii/S0924857905003316']",
10.1186/cc2358,"Kallel, H., Bahloul, M., Hergafi, L., et. al, Colistin as a salvage therapy for nosocomial infections caused by multidrug-resistant bacteria in the ICU, International Journal of Antimicrobial Agents, 2006",cited-by,10.1016/j.ijantimicag.2006.07.008,Colistin as a salvage therapy for nosocomial infections caused by multidrug-resistant bacteria in the ICU,"[['Hatem', '', 'Kallel'], ['Mabrouk', '', 'Bahloul'], ['Leila', '', 'Hergafi'], ['Malek', '', 'Akrout'], ['Wajdi', '', 'Ketata'], ['Hedi', '', 'Chelly'], ['Chokri', 'Ben', 'Hamida'], ['Noureddine', '', 'Rekik'], ['Adnane', '', 'Hammami'], ['Mounir', '', 'Bouaziz']]",International Journal of Antimicrobial Agents,2006,"[u'http://www.sciencedirect.com/science/article/pii/S0924857906002901', u'http://linkinghub.elsevier.com/retrieve/pii/S0924857906002901']",
10.1186/cc2358,"Hachem, R., Chemaly, R., Ahmar, C., et. al, Colistin Is Effective in Treatment of Infections Caused by Multidrug-Resistant Pseudomonas aeruginosa in Cancer Patients, Antimicrobial Agents and Chemotherapy, 2007",cited-by,10.1128/AAC.01015-06,Colistin Is Effective in Treatment of Infections Caused by Multidrug-Resistant Pseudomonas aeruginosa in Cancer Patients,"[['Ray', 'Y.', 'Hachem'], ['Roy', 'F.', 'Chemaly'], ['Corine', 'A.', 'Ahmar'], ['Ying', '', 'Jiang'], ['Maha', 'R.', 'Boktour'], ['Georges', 'Abou', 'Rjaili'], ['Gerald', 'P.', 'Bodey'], ['Issam', 'I.', 'Raad']]",Antimicrobial Agents and Chemotherapy,2007,"[u'http://aac.asm.org/cgi/reprint/51/6/1905.pdf', u'http://www.sld.cu/galerias/pdf/sitios/apua-cuba/r14-colistin_is_effective_in_treatment_of_infections_caused_by_multidrug-resistant_pseudomonas_aeruginosa.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.01015-06']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1128~AAC.01015-06
10.1186/cc2358,"Falagas, M., Rizos, M., Bliziotis, I., et. al, Toxicity after prolonged (more than four weeks) administration of intravenous colistin, BMC Infectious Diseases, 2005",cited-by,10.1186/1471-2334-5-1,Toxicity after prolonged (more than four weeks) administration of intravenous colistin,"[['Matthew', 'E', 'Falagas'], ['Michael', '', 'Rizos'], ['Ioannis', 'A', 'Bliziotis'], ['Kostas', '', 'Rellos'], ['Sofia', 'K', 'Kasiakou'], ['Argyris', '', 'Michalopoulos']]",BMC Infectious Diseases,2005,"[u'http://www.springerlink.com/index/20543751048q8152.pdf', u'http://www.biomedcentral.com/content/pdf/1471-2334-5-1.pdf', u'http://www.biomedcentral.com/1471-2334/5/1', u'http://www.springerlink.com/content/20543751048q8152']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1186~1471-2334-5-1
10.1186/cc2358,"Bergen, P., Li, J., Rayner, C., et. al, Colistin Methanesulfonate Is an Inactive Prodrug of Colistin against Pseudomonas aeruginosa, Antimicrobial Agents and Chemotherapy, 2006",cited-by,10.1128/AAC.00035-06,Colistin Methanesulfonate Is an Inactive Prodrug of Colistin against Pseudomonas aeruginosa,"[['Phillip', 'J.', 'Bergen'], ['Jian', '', 'Li'], ['Craig', 'R.', 'Rayner'], ['Roger', 'L.', 'Nation']]",Antimicrobial Agents and Chemotherapy,2006,"[u'http://aac.asm.org/cgi/reprint/50/6/1953.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.00035-06']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1128~AAC.00035-06
10.1186/cc2358,"Falagas, M., Kasiakou, S., Kofteridis, D., et. al, Effectiveness and nephrotoxicity of intravenous colistin for treatment of patients with infections due to polymyxin-only-susceptible (POS) gram-negative bacteria, European Journal of Clinical Microbiology & Infectious Diseases, 2006",cited-by,10.1007/s10096-006-0191-2,Effectiveness and nephrotoxicity of intravenous colistin for treatment of patients with infections due to polymyxin-only-susceptible (POS) gram-negative bacteria,"[['M.', 'E.', 'Falagas'], ['S.', 'K.', 'Kasiakou'], ['D.', 'P.', 'Kofteridis'], ['G.', '', 'Roditakis'], ['G.', '', 'Samonis']]",European Journal of Clinical Microbiology & Infectious Diseases,2006,"[u'http://www.springerlink.com/content/ew01442514573t42', u'http://www.springerlink.com/index/ew01442514573t42.pdf', u'http://www.springerlink.com/index/10.1007/s10096-006-0191-2', u'http://www.springerlink.com/index/pdf/10.1007/s10096-006-0191-2']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1007~s10096-006-0191-2
10.1186/cc2358,"Bratu, S., Quale, J., Cebular, S., et. al, Multidrug-resistant Pseudomonas aeruginosa in Brooklyn, New York: molecular epidemiology and in vitro activity of polymyxin B, European Journal of Clinical Microbiology & Infectious Diseases, 2005",cited-by,10.1007/s10096-005-1294-x,"Multidrug-resistant Pseudomonas aeruginosa in Brooklyn, New York: molecular epidemiology and in vitro activity of polymyxin B","[['S.', '', 'Bratu'], ['J.', '', 'Quale'], ['S.', '', 'Cebular'], ['R.', '', 'Heddurshetti'], ['D.', '', 'Landman']]",European Journal of Clinical Microbiology & Infectious Diseases,2005,"[u'http://www.springerlink.com/content/w41q758x44088425', u'http://www.springerlink.com/index/w41q758x44088425.pdf', u'http://www.springerlink.com/index/10.1007/s10096-005-1294-x', u'http://www.springerlink.com/index/pdf/10.1007/s10096-005-1294-x']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1007~s10096-005-1294-x
10.1186/cc2358,"Pintado, V., Miguel, L., Grill, F., et. al, Intravenous colistin sulphomethate sodium for therapy of infections due to multidrug-resistant gram-negative bacteria, Journal of Infection, 2008",cited-by,10.1016/j.jinf.2008.01.003,Intravenous colistin sulphomethate sodium for therapy of infections due to multidrug-resistant gram-negative bacteria,"[['Vicente', '', 'Pintado'], ['Luc\xc3\xada', 'Garc\xc3\xada San', 'Miguel'], ['Fabio', '', 'Grill'], ['Blanca', '', 'Mej\xc3\xada'], ['Javier', '', 'Cobo'], ['Jes\xc3\xbas', '', 'Fort\xc3\xban'], ['Pilar', '', 'Mart\xc3\xadn-D\xc3\xa1vila'], ['Santiago', '', 'Moreno']]",Journal of Infection,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0163445308000078', u'http://linkinghub.elsevier.com/retrieve/pii/S0163445308000078']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1016~j.jinf.2008.01.003
10.1186/cc2358,"Sobieszczyk, M., Furuya, E., Hay, C., et. al, Combination therapy with polymyxin B for the treatment of multidrug-resistant Gram-negative respiratory tract infections, , 2004",cited-by,12192884Combination therapy with polymyxin B for the treatment of multidrug-resistant Gram-negative respiratory tract infections,Combination therapy with polymyxin B for the treatment of multidrug-resistant Gram-negative respiratory tract infections,"[['Magdalena', 'E.', 'Sobieszczyk'], ['E.', 'Yoko', 'Furuya'], ['Christine', 'M.', 'Hay'], ['Preeti', '', 'Pancholi'], ['Phyllis', '', 'Della-Latta'], ['Scott', 'M.', 'Hammer'], ['Christine', 'J.', 'Kubin']]",,2004,"[u'http://jac.oxfordjournals.org/cgi/reprint/54/2/566.pdf', u'http://jac.oxfordjournals.org/cgi/reprint/dkh369v1.pdf']",./output/10.1517~13543784.17.7.973.pdf/citedby/12192884Combination therapy with polymyxin B for the treatment of multidrug-resistant Gram-negative respiratory tract infections
10.1186/cc2358,"Koomanachai, P., Tiengrim, S., Kiratisin, P., et. al, Efficacy and safety of colistin (colistimethate sodium) for therapy of infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii in Siriraj Hospital, Bangkok, Thailand, International Journal of Infectious Diseases, 2007",cited-by,10.1016/j.ijid.2006.09.011,"Efficacy and safety of colistin (colistimethate sodium) for therapy of infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii in Siriraj Hospital, Bangkok, Thailand","[['Pornpan', '', 'Koomanachai'], ['Surapee', '', 'Tiengrim'], ['Pattarachai', '', 'Kiratisin'], ['Visanu', '', 'Thamlikitkul']]",International Journal of Infectious Diseases,2007,"[u'http://www.sciencedirect.com/science/article/pii/S1201971206001937', u'http://linkinghub.elsevier.com/retrieve/pii/S1201971206001937']",
10.1186/cc2358,"Hwang, Y., Park, B., Lim, J., et. al, Lipopolysaccharide-binding and neutralizing activities of surfactin C in experimental models of septic shock, European Journal of Pharmacology, 2007",cited-by,10.1016/j.ejphar.2006.10.031,Lipopolysaccharide-binding and neutralizing activities of surfactin C in experimental models of septic shock,"[['Youn-Hwan', '', 'Hwang'], ['Byung-Kwon', '', 'Park'], ['Jong-Hwan', '', 'Lim'], ['Myoung-Seok', '', 'Kim'], ['Seung-Chun', '', 'Park'], ['Mi-Hyun', '', 'Hwang'], ['Hyo-In', '', 'Yun']]",European Journal of Pharmacology,2007,"[u'http://www.sciencedirect.com/science/article/pii/S0014299906011514', u'http://linkinghub.elsevier.com/retrieve/pii/S0014299906011514']",
10.1186/cc2358,"Giamarellou, H., Antoniadou, A., Kanellakopoulou, K., , Acinetobacter baumannii: a universal threat to public health?, International Journal of Antimicrobial Agents, 2008",cited-by,10.1016/j.ijantimicag.2008.02.013,Acinetobacter baumannii: a universal threat to public health?,"[['Helen', '', 'Giamarellou'], ['Anastasia', '', 'Antoniadou'], ['Kyriaki', '', 'Kanellakopoulou']]",International Journal of Antimicrobial Agents,2008,"[u'http://www.sciencedirect.com/science/article/pii/S092485790800109X', u'http://linkinghub.elsevier.com/retrieve/pii/S092485790800109X']",
10.1186/cc2358,"Thiolas, A., Bollet, C., Scola, B., et. al, Successive Emergence of Enterobacter aerogenes Strains Resistant to Imipenem and Colistin in a Patient, Antimicrobial Agents and Chemotherapy, 2005",cited-by,10.1128/AAC.49.4.1354-1358.2005,Successive Emergence of Enterobacter aerogenes Strains Resistant to Imipenem and Colistin in a Patient,"[['Aurelie', '', 'Thiolas'], ['Claude', '', 'Bollet'], ['Bernard', 'La', 'Scola'], ['Didier', '', 'Raoult'], ['Jean-Marie', '', 'Pages']]",Antimicrobial Agents and Chemotherapy,2005,"[u'http://aac.highwire.org/cgi/reprint/49/4/1354.pdf', u'http://aac.asm.org/cgi/reprint/49/4/1354.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.49.4.1354-1358.2005']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1128~AAC.49.4.1354-1358.2005
10.1186/cc2358,"Michalopoulos, A., Falagas, M., , Colistin and Polymyxin B in Critical Care, Critical Care Clinics, 2008",cited-by,10.1016/j.ccc.2007.12.003,Colistin and Polymyxin B in Critical Care,"[['Argyris', '', 'Michalopoulos'], ['Matthew', 'E.', 'Falagas']]",Critical Care Clinics,2008,"[u'http://www.sciencedirect.com/science/article/pii/S074907040700098X', u'http://linkinghub.elsevier.com/retrieve/pii/S074907040700098X']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1016~j.ccc.2007.12.003
10.1186/cc2358,"Cunha, B., , New Uses for Older Antibiotics: Nitrofurantoin, Amikacin, Colistin, Polymyxin B, Doxycycline, and Minocycline Revisited, Medical Clinics of North America, 2006",cited-by,10.1016/j.mcna.2006.07.006,"New Uses for Older Antibiotics: Nitrofurantoin, Amikacin, Colistin, Polymyxin B, Doxycycline, and Minocycline Revisited","[['Burke', 'A.', 'Cunha']]",Medical Clinics of North America,2006,"[u'http://www.sciencedirect.com/science/article/pii/S0025712506000861', u'http://linkinghub.elsevier.com/retrieve/pii/S0025712506000861']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1016~j.mcna.2006.07.006
10.1186/cc2358,"Oliveira, M., Prado, G., Costa, S., et. al, Ampicillin/sulbactam compared with polymyxins for the treatment of infections caused by carbapenem-resistant Acinetobacter spp, Journal of Antimicrobial Chemotherapy, 2008",cited-by,10.1093/jac/dkn128,Ampicillin/sulbactam compared with polymyxins for the treatment of infections caused by carbapenem-resistant Acinetobacter spp,"[['M.', 'S.', 'Oliveira'], ['G.', 'V. B.', 'Prado'], ['S.', 'F.', 'Costa'], ['R.', 'S.', 'Grinbaum'], ['A.', 'S.', 'Levin']]",Journal of Antimicrobial Chemotherapy,2008,"[u'http://jac.oxfordjournals.org/cgi/reprint/61/6/1369.pdf', u'http://www.jac.oxfordjournals.org/cgi/doi/10.1093/jac/dkn128']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1093~jac~dkn128
10.1186/cc2358,"Calhoun, J., Murray, C., Manring, M., , Multidrug-resistant Organisms in Military Wounds from Iraq and Afghanistan, Clinical Orthopaedics and Related Research, 2008",cited-by,10.1007/s11999-008-0212-9,Multidrug-resistant Organisms in Military Wounds from Iraq and Afghanistan,"[['Jason', 'H.', 'Calhoun'], ['Clinton', 'K.', 'Murray'], ['M.', 'M.', 'Manring']]",Clinical Orthopaedics and Related Research,2008,"[u'http://www.springerlink.com/index/t36g164u58536403.pdf', u'http://www.springerlink.com/content/t36g164u58536403', u'http://www.springerlink.com/index/10.1007/s11999-008-0212-9', u'http://www.springerlink.com/index/pdf/10.1007/s11999-008-0212-9']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1007~s11999-008-0212-9
10.1186/cc2358,"Sarria, J., Angulo-Pernett, F., Kimbrough, R., et. al, Use of Intravenous Polymyxin B During Continuous Venovenous Hemodialysis, European Journal of Clinical Microbiology & Infectious Diseases, 2004",cited-by,10.1007/s10096-004-1106-8,Use of Intravenous Polymyxin B During Continuous Venovenous Hemodialysis,"[['J.', 'C.', 'Sarria'], ['F.', '', 'Angulo-Pernett'], ['R.', 'C.', 'Kimbrough'], ['C.', 'S.', 'McVay'], ['A.', 'M.', 'Vidal']]",European Journal of Clinical Microbiology & Infectious Diseases,2004,"[u'http://www.springerlink.com/content/eum1rcwt62h1vxlg', u'http://www.springerlink.com/index/eum1rcwt62h1vxlg.pdf', u'http://www.springerlink.com/openurl.asp?genre=article&id=doi:10.1007/s10096-004-1106-8', u'http://www.springerlink.com/index/pdf/10.1007/s10096-004-1106-8']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1007~s10096-004-1106-8
10.1186/cc2358,"Gounden, R., Bamford, C., Zyl-Smit, R., et. al, Safety and effectiveness of colistin compared with tobramycin for multi-drug resistant Acinetobacter baumannii infections, BMC Infectious Diseases, 2009",cited-by,10.1186/1471-2334-9-26,Safety and effectiveness of colistin compared with tobramycin for multi-drug resistant Acinetobacter baumannii infections,"[['Ronald', '', 'Gounden'], ['Colleen', '', 'Bamford'], ['Richard', 'van', 'Zyl-Smit'], ['Karen', '', 'Cohen'], ['Gary', '', 'Maartens']]",BMC Infectious Diseases,2009,"[u'http://www.biomedcentral.com/1471-2334/9/26', u'http://www.springerlink.com/content/6j89wl731j64q211', u'http://www.springerlink.com/index/6j89wl731j64q211.pdf', u'http://www.biomedcentral.com/content/pdf/1471-2334-9-26.pdf']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1186~1471-2334-9-26
10.1186/cc2358,"Kwa, A., Low, J., Lee, E., et. al, The impact of multidrug resistance on the outcomes of critically ill patients with Gram-negative bacterial pneumonia, Diagnostic Microbiology and Infectious Disease, 2007",cited-by,10.1016/j.diagmicrobio.2006.11.014,The impact of multidrug resistance on the outcomes of critically ill patients with Gram-negative bacterial pneumonia,"[['Andrea', 'L. H.', 'Kwa'], ['Jenny', 'G. H.', 'Low'], ['Erin', '', 'Lee'], ['Asok', '', 'Kurup'], ['Huei-Leng', '', 'Chee'], ['Vincent', 'H.', 'Tam']]",Diagnostic Microbiology and Infectious Disease,2007,"[u'http://www.sciencedirect.com/science/article/pii/S073288930600469X', u'http://linkinghub.elsevier.com/retrieve/pii/S073288930600469X']",
10.1186/cc2358,"Furtado, G., d’Azevedo, P., Santos, A., et. al, Intravenous polymyxin B for the treatment of nosocomial pneumonia caused by multidrug-resistant Pseudomonas aeruginosa, International Journal of Antimicrobial Agents, 2007",cited-by,10.1016/j.ijantimicag.2007.05.017,Intravenous polymyxin B for the treatment of nosocomial pneumonia caused by multidrug-resistant Pseudomonas aeruginosa,"[['Guilherme', 'Henrique Campos', 'Furtado'], ['Pedro', 'Alves', 'd\xe2\x80\x99Azevedo'], ['Anderson', 'Fernandes', 'Santos'], ['Ana', 'Cristina', 'Gales'], ['Ant\xc3\xb4nio', 'Carlos Campos', 'Pignatari'], ['Eduardo', 'Alexandrino Servolo', 'Medeiros']]",International Journal of Antimicrobial Agents,2007,"[u'http://www.sciencedirect.com/science/article/pii/S0924857907002622', u'http://linkinghub.elsevier.com/retrieve/pii/S0924857907002622']",
10.1186/cc2358,"a, M., guez-Hernandez, J., Docobo-Perez, F., et. al, Studies on the antimicrobial activity of cecropin A-melittin hybrid peptides in colistin-resistant clinical isolates of Acinetobacter baumannii, , 2006",cited-by,6824056Studies on the antimicrobial activity of cecropin A-melittin hybrid peptides in colistin-resistant clinical isolates of Acinetobacter baumannii,Studies on the antimicrobial activity of cecropin A-melittin hybrid peptides in colistin-resistant clinical isolates of Acinetobacter baumannii,"[['Mar\xc3\xb5', '\xc2\xb4', 'a'], ['Jesus', 'Rodr\xc3\xb5 \xc2\xb4', 'guez-Hernandez'], ['Fernando', '', 'Docobo-Perez'], ['Beatriz', 'G. de la', 'Torre'], ['Eugenia', '', 'Pachon-Ibanez'], ['Andres', 'Garc\xc3\xb5 \xc2\xb4', 'a-Curiel'], ['Felipe', '', 'Fernandez-Cuenca'], ['David', '', 'Andreu'], ['Luis', '', 'Rivas'], ['Jeronimo', '', 'Pachon']]",,2006,[u'http://jac.oxfordjournals.org/cgi/reprint/58/1/95.pdf'],
10.1186/cc2358,"Iosifidis, E., Antachopoulos, C., Ioannidou, M., et. al, Colistin administration to pediatric and neonatal patients, European Journal of Pediatrics, 2010",cited-by,10.1007/s00431-009-1137-3,Colistin administration to pediatric and neonatal patients,"[['Elias', '', 'Iosifidis'], ['Charalampos', '', 'Antachopoulos'], ['Maria', '', 'Ioannidou'], ['Magda', '', 'Mitroudi'], ['Maria', '', 'Sdougka'], ['Vassiliki', '', 'Drossou-Agakidou'], ['Maria', '', 'Tsivitanidou'], ['Emmanuel', '', 'Roilides']]",European Journal of Pediatrics,2010,"[u'http://www.springerlink.com/content/e38736115517wg75', u'http://www.springerlink.com/index/e38736115517wg75.pdf', u'http://www.springerlink.com/index/10.1007/s00431-009-1137-3', u'http://www.springerlink.com/index/pdf/10.1007/s00431-009-1137-3']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1007~s00431-009-1137-3
10.1186/cc2358,"Giamarellou, H., Kanellakopoulou, K., , Current Therapies for Pseudomonas Aeruginosa, Critical Care Clinics, 2008",cited-by,10.1016/j.ccc.2007.12.004,Current Therapies for Pseudomonas Aeruginosa,"[['Helen', '', 'Giamarellou'], ['Kyriaki', '', 'Kanellakopoulou']]",Critical Care Clinics,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0749070407000991', u'http://linkinghub.elsevier.com/retrieve/pii/S0749070407000991']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1016~j.ccc.2007.12.004
10.1186/cc2358,"Kwa, A., , Polymyxins: A Review of the Current Status Including Recent Developments, , 0",cited-by,12288617Polymyxins: A Review of the Current Status Including Recent Developments,Polymyxins: A Review of the Current Status Including Recent Developments,"[['Andrea', 'L', 'Kwa']]",,0,[u'http://www.annals.edu.sg/pdf/37VolNo10Oct2008/V37N10p870.pdf'],./output/10.1517~13543784.17.7.973.pdf/citedby/12288617Polymyxins: A Review of the Current Status Including Recent Developments
10.1186/cc2358,"Pournaras, S., Iosifidis, E., Roilides, E., , Advances in Antibacterial Therapy Against Emerging Bacterial Pathogens, Seminars in Hematology, 2009",cited-by,10.1053/j.seminhematol.2009.03.007,Advances in Antibacterial Therapy Against Emerging Bacterial Pathogens,"[['Spyros', '', 'Pournaras'], ['Elias', '', 'Iosifidis'], ['Emmanuel', '', 'Roilides']]",Seminars in Hematology,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0037196309000626', u'http://linkinghub.elsevier.com/retrieve/pii/S0037196309000626']",
10.1186/cc2358,"Wróblewska, M., , Novel therapies of multidrug-resistant Pseudomonas aeruginosa and Acinetobacter spp . infections: the state of the art, Archivum Immunologiae Et Therapiae Experimentalis, 2006",cited-by,10.1007/s00005-006-0012-4,Novel therapies of multidrug-resistant Pseudomonas aeruginosa and Acinetobacter spp . infections: the state of the art,"[['Marta', '', 'Wr\xc3\xb3blewska']]",Archivum Immunologiae Et Therapiae Experimentalis,2006,"[u'http://www.springerlink.com/index/a33242pj3713m001.pdf', u'http://www.springerlink.com/content/a33242pj3713m001', u'http://www.springerlink.com/index/10.1007/s00005-006-0012-4', u'http://www.springerlink.com/index/pdf/10.1007/s00005-006-0012-4']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1007~s00005-006-0012-4
10.1186/cc2358,"Enoch, D., Summers, C., Brown, N., et. al, Investigation and management of an outbreak of multidrug-carbapenem-resistant Acinetobacter baumannii in Cambridge, UK, Journal of Hospital Infection, 2008",cited-by,10.1016/j.jhin.2008.05.015,"Investigation and management of an outbreak of multidrug-carbapenem-resistant Acinetobacter baumannii in Cambridge, UK","[['D.', 'A.', 'Enoch'], ['C.', '', 'Summers'], ['N.', 'M.', 'Brown'], ['L.', '', 'Moore'], ['M.', 'I.', 'Gillham'], ['R.', 'M.', 'Burnstein'], ['R.', '', 'Thaxter'], ['L.', 'M.', 'Enoch'], ['B.', '', 'Matta'], ['O.', '', 'Sule']]",Journal of Hospital Infection,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0195670108002132', u'http://linkinghub.elsevier.com/retrieve/pii/S0195670108002132']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1016~j.jhin.2008.05.015
10.1186/cc2358,"Enoch, D., Birkett, C., Ludlam, H., , Non-fermentative Gram-negative bacteria, International Journal of Antimicrobial Agents, 2007",cited-by,10.1016/S0924-8579(07)72176-3,Non-fermentative Gram-negative bacteria,"[['D.', 'A.', 'Enoch'], ['C.', 'I.', 'Birkett'], ['H.', 'A.', 'Ludlam']]",International Journal of Antimicrobial Agents,2007,"[u'http://www.sciencedirect.com/science/article/pii/S0924857907721763', u'http://linkinghub.elsevier.com/retrieve/pii/S0924857907721763']",
10.1186/cc2358,"Nordmann, P., , Acinetobacter baumannii, le pathogène nosocomial par excellence, Pathologie Biologie, 2004",cited-by,10.1016/j.patbio.2004.03.001,"Acinetobacter baumannii, le pathogène nosocomial par excellence","[['P', '', 'Nordmann']]",Pathologie Biologie,2004,"[u'http://www.sciencedirect.com/science/article/pii/S0369811404000392', u'http://linkinghub.elsevier.com/retrieve/pii/S0369811404000392']",
10.1186/cc2358,"Kim, J., Lee, K., Yoo, S., et. al, Clinical characteristics and risk factors of colistin-induced nephrotoxicity, International Journal of Antimicrobial Agents, 2009",cited-by,10.1016/j.ijantimicag.2009.06.028,Clinical characteristics and risk factors of colistin-induced nephrotoxicity,"[['Jieun', '', 'Kim'], ['Kyoung-Ho', '', 'Lee'], ['Sunmi', '', 'Yoo'], ['Hyunjoo', '', 'Pai']]",International Journal of Antimicrobial Agents,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0924857909003525', u'http://linkinghub.elsevier.com/retrieve/pii/S0924857909003525']",
10.1186/cc2358,"Papagelopoulos, P., Mavrogenis, A., Giannitsioti, E., et. al, Management of a Multidrug-Resistant Pseudomonas Aeruginosa Infected Total Knee Arthroplasty Using Colistin. A Case Report and Review of the Literature, Journal of Arthroplasty, 2007",cited-by,10.1016/j.arth.2006.05.006,Management of a Multidrug-Resistant Pseudomonas Aeruginosa Infected Total Knee Arthroplasty Using Colistin. A Case Report and Review of the Literature,"[['Panayiotis', 'J.', 'Papagelopoulos'], ['Andreas', 'F.', 'Mavrogenis'], ['Efthymia', '', 'Giannitsioti'], ['Athanasios', '', 'Kikilas'], ['Kyriaki', '', 'Kanellakopoulou'], ['Panayotis', 'N.', 'Soucacos']]",Journal of Arthroplasty,2007,"[u'http://www.sciencedirect.com/science/article/pii/S0883540306003834', u'http://linkinghub.elsevier.com/retrieve/pii/S0883540306003834']",
10.1186/cc2358,"Alvarez, C., Cortes, J., Arango, ., et. al, Resistencia Antimicrobiana en Unidades de Cuidado Intensivo de Bogotá, Colombia, 2001-2003, , 2006",cited-by,10.1590/S0124-00642006000400008,"Resistencia Antimicrobiana en Unidades de Cuidado Intensivo de Bogotá, Colombia, 2001-2003","[['Carlos', '', 'Alvarez'], ['Jorge', '', 'Cortes'], ['\xc3\x81lvaro', '', 'Arango'], ['Constanza', '', 'Correa'], ['Aura', '', 'Leal']]",,2006,"[u'http://www.revmed.unal.edu.co/revistasp/v8n1sup/v8n1spdf/supv8n1a08.pdf', u'http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0124-00642006000400008&lng=es&nrm=iso&tlng=es']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1590~S0124-00642006000400008
10.1186/cc2358,"MUTA, O., AKAIWA, Y., , Adaptive channel selection in frequency-selective fading environment, , 1999",cited-by,10.1109/ICC.1999.765582,Adaptive channel selection in frequency-selective fading environment,"[['Osamu', '', 'MUTA'], ['Yoshihiko', '', 'AKAIWA']]",,1999,"[u'http://ieeexplore.ieee.org/xpls/abs_all.jsp?arnumber=765582', u'http://ieeexplore.ieee.org/stamp/stamp.jsp?arnumber=00765582']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1109~ICC.1999.765582
10.1186/cc2358,"Monteiro, D., Madrid, M., , Planning of robot trajectories with genetic algorithms, , 1999",cited-by,10.1109/ROMOCO.1999.791079,Planning of robot trajectories with genetic algorithms,"[['D.', 'C.', 'Monteiro'], ['M.', 'K.', 'Madrid']]",,1999,"[u'http://ieeexplore.ieee.org/xpls/abs_all.jsp?arnumber=791079', u'http://ieeexplore.ieee.org/stamp/stamp.jsp?arnumber=00791079']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1109~ROMOCO.1999.791079
10.1186/cc2358,"Bergen, P., Li, J., Nation, R., et. al, Comparison of once-, twice- and thrice-daily dosing of colistin on antibacterial effect and emergence of resistance: studies with Pseudomonas aeruginosa in an in vitro pharmacodynamic model, , 0",cited-by,"11438016Comparison of once-, twice- and thrice-daily dosing of colistin on antibacterial effect and emergence of resistance: studies with Pseudomonas aeruginosa in an in vitro pharmacodynamic model","Comparison of once-, twice- and thrice-daily dosing of colistin on antibacterial effect and emergence of resistance: studies with Pseudomonas aeruginosa in an in vitro pharmacodynamic model","[['Phillip', 'J.', 'Bergen'], ['Jian', '', 'Li'], ['Roger', 'L.', 'Nation'], ['John', 'D.', 'Turnidge'], ['Kingsley', '', 'Coulthard']]",,0,[u'http://jac.oxfordjournals.org/cgi/reprint/61/3/636.pdf'],
10.1186/cc2358,"Lin, C., Liu, T., Kuo, C., et. al, Aerosolized Colistin for the Treatment of Multidrug-resistant Acinetobacter baumannii Pneumonia: Experience in a Tertiary Care Hospital in Northern Taiwan, Journal of Microbiology Immunology and Infection, 2010",cited-by,10.1016/S1684-1182(10)60050-3,Aerosolized Colistin for the Treatment of Multidrug-resistant Acinetobacter baumannii Pneumonia: Experience in a Tertiary Care Hospital in Northern Taiwan,"[['Cheng-Chih', '', 'Lin'], ['Te-Chu', '', 'Liu'], ['Chen-Feng', '', 'Kuo'], ['Chang-Pan', '', 'Liu'], ['Chun-Ming', '', 'Lee']]",Journal of Microbiology Immunology and Infection,2010,"[u'http://www.sciencedirect.com/science/article/pii/S1684118210600503', u'http://linkinghub.elsevier.com/retrieve/pii/S1684118210600503']",
10.1186/cc2358,"Mastoraki, A., Douka, E., Kriaras, I., et. al, Preventing strategy of multidrug-resistant Acinetobacter baumanii susceptible only to colistin in cardiac surgical intensive care units, European Journal of Cardio-thoracic Surgery, 2008",cited-by,10.1016/j.ejcts.2008.02.012,Preventing strategy of multidrug-resistant Acinetobacter baumanii susceptible only to colistin in cardiac surgical intensive care units,"[['Aikaterini', '', 'Mastoraki'], ['Evangelia', '', 'Douka'], ['Ioannis', '', 'Kriaras'], ['Georgios', '', 'Stravopodis'], ['Georgios', '', 'Saroglou'], ['Stefanos', '', 'Geroulanos']]",European Journal of Cardio-thoracic Surgery,2008,"[u'http://www.sciencedirect.com/science/article/pii/S1010794008001760', u'http://linkinghub.elsevier.com/retrieve/pii/S1010794008001760']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1016~j.ejcts.2008.02.012
10.1186/cc2358,"Mastoraki, A., Douka, E., Kriaras, I., et. al, Preventing strategy of multidrug-resistant Acinetobacter baumanii susceptible only to colistin in cardiac surgical intensive care units, , 0",cited-by,11178240Preventing strategy of multidrug-resistant Acinetobacter baumanii susceptible only to colistin in cardiac surgical intensive care units,Preventing strategy of multidrug-resistant Acinetobacter baumanii susceptible only to colistin in cardiac surgical intensive care units,"[['Aikaterini', '', 'Mastoraki'], ['Evangelia', '', 'Douka'], ['Ioannis', '', 'Kriaras'], ['Georgios', '', 'Stravopodis'], ['Georgios', '', 'Saroglou'], ['Stefanos', '', 'Geroulanos']]",,0,[u'http://ejcts.ctsnetjournals.org/cgi/reprint/33/6/1086.pdf'],
10.1186/cc2358,"Spapen, H., Jacobs, R., Gorp, V., et. al, Renal and neurological side effects of colistin in critically ill patients, Annals of Intensive Care, 2011",cited-by,10.1186/2110-5820-1-14,Renal and neurological side effects of colistin in critically ill patients,"[['Herbert', '', 'Spapen'], ['Rita', '', 'Jacobs'], ['Viola', 'Van', 'Gorp'], ['Joris', '', 'Troubleyn'], ['Patrick', 'M', 'Honor\xc3\xa9']]",Annals of Intensive Care,2011,"[u'http://www.springerlink.com/index/j53j3l42kl32202u.pdf', u'http://www.springerlink.com/content/j53j3l42kl32202u']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1186~2110-5820-1-14
10.1186/cc2358,"Chan, J., Graves, J., Dellit, T., , Antimicrobial Treatment and Clinical Outcomes of Carbapenem-Resistant Acinetobacter baumannii Ventilator-Associated Pneumonia, Journal of Intensive Care Medicine, 2010",cited-by,10.1177/0885066610377975,Antimicrobial Treatment and Clinical Outcomes of Carbapenem-Resistant Acinetobacter baumannii Ventilator-Associated Pneumonia,"[['Jeannie', 'D.', 'Chan'], ['Joseph', 'A.', 'Graves'], ['Timothy', 'H.', 'Dellit']]",Journal of Intensive Care Medicine,2010,[u'http://dx.doi.org/10.1177/0885066610377975'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1177~0885066610377975
10.1186/cc2358,"Sınırtaş, M., Akalın, H., Gedikoğlu, S., , Investigation of colistin sensitivity via three different methods in Acinetobacter baumannii isolates with multiple antibiotic resistance, International Journal of Infectious Diseases, 2009",cited-by,10.1016/j.ijid.2008.12.012,Investigation of colistin sensitivity via three different methods in Acinetobacter baumannii isolates with multiple antibiotic resistance,"[['Melda', '', 'S\xc4\xb1n\xc4\xb1rta\xc5\x9f'], ['Halis', '', 'Akal\xc4\xb1n'], ['Suna', '', 'Gediko\xc4\x9flu']]",International Journal of Infectious Diseases,2009,"[u'http://www.sciencedirect.com/science/article/pii/S1201971209000216', u'http://linkinghub.elsevier.com/retrieve/pii/S1201971209000216']",
10.1186/cc2358,"Nasnas, R., Saliba, G., Hallak, P., , The revival of colistin: An old antibiotic for the 21st century, Pathologie Biologie, 2009",cited-by,10.1016/j.patbio.2007.09.013,The revival of colistin: An old antibiotic for the 21st century,"[['R.', '', 'Nasnas'], ['G.', '', 'Saliba'], ['P.', '', 'Hallak']]",Pathologie Biologie,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0369811407002234', u'http://linkinghub.elsevier.com/retrieve/pii/S0369811407002234']",
10.1186/cc2358,"Kim, C., Choi, J., Kang, H., et. al, A Trial of Aerosolized Colistin for the Treatment of Nosocomial Pneumonia due to Multidrug-resistant Acinetobacter baumannii, Tuberculosis and Respiratory Diseases, 2008",cited-by,10.4046/trd.2008.64.2.102,A Trial of Aerosolized Colistin for the Treatment of Nosocomial Pneumonia due to Multidrug-resistant Acinetobacter baumannii,"[['Changhwan', '', 'Kim'], ['Jeong-Hee', '', 'Choi'], ['Hye-Ryun', '', 'Kang'], ['Chang', 'Youl', 'Lee'], ['Yong', 'Il', 'Hwang'], ['Tae', 'Rim', 'Shin'], ['Sang', 'Myeon', 'Park'], ['Yong', 'Bum', 'Park'], ['Jae', 'Young', 'Lee'], ['Seung', 'Hun', 'Jang'], ['Cheol', 'Hong', 'Kim'], ['Eun', 'Kyung', 'Mo'], ['Myung', 'Goo', 'Lee'], ['In-Gyu', '', 'Hyun'], ['Ki-Suck', '', 'Jung'], ['Young-Jin', '', 'Choi'], ['Jae', 'Woong', 'Lee']]",Tuberculosis and Respiratory Diseases,2008,"[u'http://journals.lungkorea.org/upload/abstract/files/(102-108)-trd059.pdf', u'http://synapse.koreamed.org/DOIx.php?id=10.4046/trd.2008.64.2.102']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.4046~trd.2008.64.2.102
10.1186/cc2358,"Frasca, D., Dahyot-Fizelier, C., Mimoz, O., , La colistine en réanimation, , 2008",cited-by,10.1016/j.reaurg.2008.01.005,La colistine en réanimation,"[['D.', '', 'Frasca'], ['C.', '', 'Dahyot-Fizelier'], ['O.', '', 'Mimoz']]",,2008,"[u'http://www.sciencedirect.com/science/article/pii/S1624069308000340', u'http://linkinghub.elsevier.com/retrieve/pii/S1624069308000340']",
10.1186/cc2358,"Shearer, A., Bagust, A., Ampudia-Blasco, F., et. al, PDB8 THE IMPACT OF IMPROVED BETA-CELL FUNCTION ON MODELLING THE COST-EFFECTIVENESS OF ROSIGLITAZONE IN THE MANAGEMENT OF TYPE 2 DIABETES IN SPAIN, Value in Health, 2006",cited-by,10.1016/S1098-3015(10)63278-0,PDB8 THE IMPACT OF IMPROVED BETA-CELL FUNCTION ON MODELLING THE COST-EFFECTIVENESS OF ROSIGLITAZONE IN THE MANAGEMENT OF TYPE 2 DIABETES IN SPAIN,"[['A', '', 'Shearer'], ['A', '', 'Bagust'], ['FJ', '', 'Ampudia-Blasco'], ['MJ', '', 'TaylorJ'], ['S', 'Mendes da', 'Costa']]",Value in Health,2006,[u'http://www.sciencedirect.com/science/article/pii/S1098301510632780'],
10.1186/cc2358,"Le, T., Yu, H., , PIN10 A COST CONSEQUENCE ON CONCOMITANT DRUG USE DURING HCV THERAPY IN MANAGED CARE PATIENTS IN THE UNITED STATES, Value in Health, 2003",cited-by,10.1016/S1098-3015(10)61907-9,PIN10 A COST CONSEQUENCE ON CONCOMITANT DRUG USE DURING HCV THERAPY IN MANAGED CARE PATIENTS IN THE UNITED STATES,"[['TK', '', 'Le'], ['H', '', 'Yu']]",Value in Health,2003,[u'http://www.sciencedirect.com/science/article/pii/S1098301510619079'],
10.1186/cc2358,"Azap, ., Arslan, H., Ergin, F., et. al, In vitro activity of colistin against nonfermentative gram-negative bacilli, , 0",cited-by,11548926In vitro activity of colistin against nonfermentative gram-negative bacilli,In vitro activity of colistin against nonfermentative gram-negative bacilli,"[['\xc3\x96zlem', 'Kurt', 'Azap'], ['Hande', '', 'Arslan'], ['Funda', '', 'Ergin'], ['Emine', '', 'Kuru'], ['G\xc3\xb6knur', '', 'Yapar']]",,0,[u'http://www.medicine.ankara.edu.tr/fakulte/files/20052_4'],
10.1186/cc2358,"Abu-Salah, T., Dhand, R., , Inhaled antibiotic therapy for ventilator-associated tracheobronchitis and ventilator-associated pneumonia: an Update, Advances in Therapy, 0",cited-by,10.1007/s12325-011-0051-z,Inhaled antibiotic therapy for ventilator-associated tracheobronchitis and ventilator-associated pneumonia: an Update,"[['Tareq', '', 'Abu-Salah'], ['Rajiv', '', 'Dhand']]",Advances in Therapy,0,"[u'http://www.springerlink.com/index/hp62224831501166.pdf', u'http://www.springerlink.com/content/hp62224831501166']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1007~s12325-011-0051-z
10.1517~13543784.17.7.973.pdf,"Clin Microbiol Infect 2005;11(2):115-21 21. Berlana D, Llop JM, Fort E, et al.",references,NOT found in MAS
10.1517~13543784.17.7.973.pdf,"Use of colistin in the treatment of multiple-drug-resistant Gram-negative infections. Am J Health Syst Pharm 2005;62(1):39-47 22. Reina R, Estenssoro E, Sáenz G, et al. Safety and efficacy of colistin in Acinetobacter and Pseudomonas infections: a prospective cohort study.",references,NOT found in MAS
10.1517~13543784.17.7.973.pdf,"Intensive Care Med 2005;31(8):1058-65 23. Petrosillo N, Chinello P, Proietti MF, et al.",references,NOT found in MAS
10.1517~13543784.17.7.973.pdf,"Combined colistin and rifampicin therapy for carbapenem-resistant Acinetobacter baumannii infections: clinical outcome and adverse events. Clin Microbiol Infect 2005;11(8):682-3 24. Falagas ME, Rizos M, Bliziotis IA, et al.",references,10.1111/j.1469-0691.2005.01198.x,Combined colistin and rifampicin therapy for carbapenem-resistant Acinetobacter baumannii infections: clinical outcome and adverse events,"[[u'N.', u'', u'Petrosillo'], [u'P.', u'', u'Chinello'], [u'M.', u'F.', u'Proietti'], [u'L.', u'', u'Cecchini'], [u'M.', u'', u'Masala'], [u'C.', u'', u'Franchi'], [u'M.', u'', u'Venditti'], [u'S.', u'', u'Esposito'], [u'E.', u'', u'Nicastri']]",Clinical Microbiology and Infection,2005,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1469-0691.2005.01198.x'],./output/10.1517~13543784.17.7.973.pdf/10.1111~j.1469-0691.2005.01198.x
10.1111/j.1469-0691.2005.01198.x,"Li, J., Nation, R., Turnidge, J., et. al, Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections, Lancet Infectious Diseases, 2006",cited-by,10.1016/S1473-3099(06)70580-1,Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections,"[['Jian', '', 'Li'], ['Roger', 'L', 'Nation'], ['John', 'D', 'Turnidge'], ['Robert', 'W', 'Milne'], ['Kingsley', '', 'Coulthard'], ['Craig', 'R', 'Rayner'], ['David', 'L', 'Paterson']]",Lancet Infectious Diseases,2006,"[u'http://www.sld.cu/galerias/pdf/sitios/apua-cuba/r15-colistin._the_re-emerging_antibiotic_for_multidrug-resistant_gram-negative_bacterial_infections.pdf', u'http://www.sciencedirect.com/science/article/pii/S1473309906705801', u'http://www.sld.cu/galerias/pdf/sitios/apua-cuba/a21-colistin._the_re-emerging_antibiotic_for_multidrug-resistant_gram-negative_bacterial_infections.pdf', u'http://info.med.yale.edu/intmed/infdis/resources/docs/colistin-review-lancet.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S1473309906705801']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1016~S1473-3099(06)70580-1
10.1111/j.1469-0691.2005.01198.x,"Nemec, A., Seifert, H., Dijkshoorn, L., , An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii, Nature Reviews Microbiology, 2007",cited-by,10.1038/nrmicro1789,An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii,"[['Alexandr', '', 'Nemec'], ['Harald', '', 'Seifert'], ['Lenie', '', 'Dijkshoorn']]",Nature Reviews Microbiology,2007,"[u'http://dx.doi.org/10.1038/nrmicro1789', u'http://www.nature.com/doifinder/10.1038/nrmicro1789']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1038~nrmicro1789
10.1111/j.1469-0691.2005.01198.x,"Perez, F., Hujer, A., Hujer, K., et. al, Global Challenge of Multidrug-Resistant Acinetobacter baumannii, Antimicrobial Agents and Chemotherapy, 2007",cited-by,10.1128/AAC.01464-06,Global Challenge of Multidrug-Resistant Acinetobacter baumannii,"[['Federico', '', 'Perez'], ['Andrea', 'M.', 'Hujer'], ['Kristine', 'M.', 'Hujer'], ['Brooke', 'K.', 'Decker'], ['Robert', 'A.', 'Bonomo']]",Antimicrobial Agents and Chemotherapy,2007,"[u'http://aac.asm.org/cgi/reprint/51/10/3471.pdf', u'http://aac.highwire.org/cgi/reprint/51/10/3471.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.01464-06']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1128~AAC.01464-06
10.1111/j.1469-0691.2005.01198.x,"Falagas, M., Kasiakou, S., , Toxicity of polymyxins: a systematic review of the evidence from old and recent studies, Critical Care, 2006",cited-by,10.1186/cc3995,Toxicity of polymyxins: a systematic review of the evidence from old and recent studies,"[['Matthew', 'E', 'Falagas'], ['Sofia', 'K', 'Kasiakou']]",Critical Care,2006,"[u'http://www.biomedcentral.com/content/pdf/cc3995.pdf', u'http://ccforum.com/content/10/1/R27', u'http://www.springerlink.com/content/4hp6047472k68157', u'http://www.springerlink.com/index/4hp6047472k68157.pdf']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1186~cc3995
10.1111/j.1469-0691.2005.01198.x,"Karageorgopoulos, D., Falagas, M., , Current control and treatment of multidrug-resistant Acinetobacter baumannii infections, Lancet Infectious Diseases, 2008",cited-by,10.1016/S1473-3099(08)70279-2,Current control and treatment of multidrug-resistant Acinetobacter baumannii infections,"[['Drosos', 'E', 'Karageorgopoulos'], ['Matthew', 'E', 'Falagas']]",Lancet Infectious Diseases,2008,"[u'http://www.sciencedirect.com/science/article/pii/S1473309908702792', u'http://linkinghub.elsevier.com/retrieve/pii/S1473309908702792']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1016~S1473-3099(08)70279-2
10.1111/j.1469-0691.2005.01198.x,"Falagas, M., Kasiakou, S., Tsiodras, S., et. al, The Use of Intravenous and Aerosolized Polymyxins for the Treatment of Infections in Critically Ill Patients: A Review of the Recent Literature, Clinical Medicine & Research, 2006",cited-by,10.3121/cmr.4.2.138,The Use of Intravenous and Aerosolized Polymyxins for the Treatment of Infections in Critically Ill Patients: A Review of the Recent Literature,"[['Matthew', 'E.', 'Falagas'], ['Sofia', 'K.', 'Kasiakou'], ['Sotirios', '', 'Tsiodras'], ['Argyris', '', 'Michalopoulos']]",Clinical Medicine & Research,2006,"[u'http://www.clinmedres.org/cgi/doi/10.3121/cmr.4.2.138', u'http://www.clinmedres.org/cgi/reprint/4/2/138.pdf']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.3121~cmr.4.2.138
10.1111/j.1469-0691.2005.01198.x,"Bassetti, M., Repetto, E., Righi, E., et. al, Colistin and rifampicin in the treatment of multidrug-resistant Acinetobacter baumannii infections, Journal of Antimicrobial Chemotherapy, 2007",cited-by,10.1093/jac/dkm509,Colistin and rifampicin in the treatment of multidrug-resistant Acinetobacter baumannii infections,"[['M.', '', 'Bassetti'], ['E.', '', 'Repetto'], ['E.', '', 'Righi'], ['S.', '', 'Boni'], ['M.', '', 'Diverio'], ['M.', 'P.', 'Molinari'], ['M.', '', 'Mussap'], ['S.', '', 'Artioli'], ['F.', '', 'Ansaldi'], ['P.', '', 'Durando'], ['G.', '', 'Orengo'], ['F.', 'Bobbio', 'Pallavicini'], ['C.', '', 'Viscoli']]",Journal of Antimicrobial Chemotherapy,2007,"[u'http://jac.oxfordjournals.org/cgi/reprint/61/2/417.pdf', u'http://www.jac.oxfordjournals.org/cgi/doi/10.1093/jac/dkm509']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1093~jac~dkm509
10.1111/j.1469-0691.2005.01198.x,"Li, J., Nation, R., Owen, R., et. al, Antibiograms of Multidrug‐Resistant Clinical Acinetobacter baumannii: Promising Therapeutic Options for Treatment of Infection with Colistin‐Resistant Strains, Clinical Infectious Diseases, 2007",cited-by,10.1086/520658,Antibiograms of Multidrug‐Resistant Clinical Acinetobacter baumannii: Promising Therapeutic Options for Treatment of Infection with Colistin‐Resistant Strains,"[['Jian', '', 'Li'], ['Roger', 'L.', 'Nation'], ['Roxanne', 'J.', 'Owen'], ['Stephanie', '', 'Wong'], ['Denis', '', 'Spelman'], ['Clare', '', 'Franklin']]",Clinical Infectious Diseases,2007,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/520658'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1086~520658
10.1111/j.1469-0691.2005.01198.x,"Pintado, V., Miguel, L., Grill, F., et. al, Intravenous colistin sulphomethate sodium for therapy of infections due to multidrug-resistant gram-negative bacteria, Journal of Infection, 2008",cited-by,10.1016/j.jinf.2008.01.003,Intravenous colistin sulphomethate sodium for therapy of infections due to multidrug-resistant gram-negative bacteria,"[['Vicente', '', 'Pintado'], ['Luc\xc3\xada', 'Garc\xc3\xada San', 'Miguel'], ['Fabio', '', 'Grill'], ['Blanca', '', 'Mej\xc3\xada'], ['Javier', '', 'Cobo'], ['Jes\xc3\xbas', '', 'Fort\xc3\xban'], ['Pilar', '', 'Mart\xc3\xadn-D\xc3\xa1vila'], ['Santiago', '', 'Moreno']]",Journal of Infection,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0163445308000078', u'http://linkinghub.elsevier.com/retrieve/pii/S0163445308000078']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1016~j.jinf.2008.01.003
10.1111/j.1469-0691.2005.01198.x,"Petrosillo, N., Ioannidou, E., Falagas, M., , Colistin monotherapy vs. combination therapy: evidence from microbiological, animal and clinical studies, Clinical Microbiology and Infection, 2008",cited-by,10.1111/j.1469-0691.2008.02061.x,"Colistin monotherapy vs. combination therapy: evidence from microbiological, animal and clinical studies","[['N.', '', 'Petrosillo'], ['E.', '', 'Ioannidou'], ['M.', 'E.', 'Falagas']]",Clinical Microbiology and Infection,2008,[u'http://blackwell-synergy.com/doi/abs/10.1111/j.1469-0691.2008.02061.x'],
10.1111/j.1469-0691.2005.01198.x,"Vila, J., Pachón, J., , Therapeutic options for Acinetobacter baumannii infections, Expert Opinion on Pharmacotherapy, 2008",cited-by,10.1517/14656566.9.4.587,Therapeutic options for Acinetobacter baumannii infections,"[['Jordi', '', 'Vila'], ['Jer\xc3\xb3nimo', '', 'Pach\xc3\xb3n']]",Expert Opinion on Pharmacotherapy,2008,[u'http://www.informapharmascience.com/doi/abs/10.1517/14656566.9.4.587'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1517~14656566.9.4.587
10.1111/j.1469-0691.2005.01198.x,", Antimicrobial Resistance: Acinetobacter baumannii: Epidemiology, Antimicrobial Resistance, and Treatment Options, Clinical Infectious Diseases, 2008",cited-by,10.1086/529198,"Antimicrobial Resistance: Acinetobacter baumannii: Epidemiology, Antimicrobial Resistance, and Treatment Options",[],Clinical Infectious Diseases,2008,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/529198'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1086~529198
10.1111/j.1469-0691.2005.01198.x,"Falagas, M., Rafailidis, P., Kasiakou, S., et. al, Effectiveness and nephrotoxicity of colistin monotherapy vs. colistin?meropenem combination therapy for multidrug-resistant Gram-negative bacterial infections, Clinical Microbiology and Infection, 2006",cited-by,10.1111/j.1469-0691.2006.01559.x,Effectiveness and nephrotoxicity of colistin monotherapy vs. colistin?meropenem combination therapy for multidrug-resistant Gram-negative bacterial infections,"[['M.', 'E.', 'Falagas'], ['P.', 'I.', 'Rafailidis'], ['S.', 'K.', 'Kasiakou'], ['P.', '', 'Hatzopoulou'], ['A.', '', 'Michalopoulos']]",Clinical Microbiology and Infection,2006,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1469-0691.2006.01559.x'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1111~j.1469-0691.2006.01559.x
10.1111/j.1469-0691.2005.01198.x,"Guardado, A., Blanco, A., Asensi, V., et. al, Multidrug-resistant Acinetobacter meningitis in neurosurgical patients with intraventricular catheters: assessment of different treatments, Journal of Antimicrobial Chemotherapy, 2008",cited-by,10.1093/jac/dkn018,Multidrug-resistant Acinetobacter meningitis in neurosurgical patients with intraventricular catheters: assessment of different treatments,"[['A.', 'Rodriguez', 'Guardado'], ['A.', '', 'Blanco'], ['V.', '', 'Asensi'], ['F.', '', 'Perez'], ['J.', 'C.', 'Rial'], ['V.', '', 'Pintado'], ['E.', '', 'Bustillo'], ['M.', '', 'Lantero'], ['E.', '', 'Tenza'], ['M.', '', 'Alvarez'], ['J.', 'A.', 'Maradona'], ['J.', 'A.', 'Carton']]",Journal of Antimicrobial Chemotherapy,2008,"[u'http://jac.oxfordjournals.org/cgi/reprint/61/4/908.pdf', u'http://jac.oxfordjournals.org/cgi/reprint/dkn018v1.pdf', u'http://www.jac.oxfordjournals.org/cgi/doi/10.1093/jac/dkn018']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1093~jac~dkn018
10.1111/j.1469-0691.2005.01198.x,"Baran, G., Erbay, A., Bodur, H., et. al, Risk factors for nosocomial imipenem-resistant Acinetobacter baumannii infections, International Journal of Infectious Diseases, 2008",cited-by,10.1016/j.ijid.2007.03.005,Risk factors for nosocomial imipenem-resistant Acinetobacter baumannii infections,"[['G\xc3\xbclseren', '', 'Baran'], ['Ayse', '', 'Erbay'], ['H\xc3\xbcrrem', '', 'Bodur'], ['P\xc4\xb1nar', '', '\xc3\x96ng\xc3\xbcr\xc3\xbc'], ['Esrag\xc3\xbcl', '', 'Ak\xc4\xb1nc\xc4\xb1'], ['Neriman', '', 'Balaban'], ['Mustafa', 'A.', '\xc3\x87evik']]",International Journal of Infectious Diseases,2008,"[u'http://www.sciencedirect.com/science/article/pii/S1201971207000689', u'http://linkinghub.elsevier.com/retrieve/pii/S1201971207000689']",
10.1111/j.1469-0691.2005.01198.x,"Falagas, M., Rafailidis, P., , Re-emergence of colistin in today's world of multidrug-resistant organisms: personal perspectives, Expert Opinion on Investigational Drugs, 2008",cited-by,10.1517/13543784.17.7.973,Re-emergence of colistin in today's world of multidrug-resistant organisms: personal perspectives,"[['Matthew', 'E', 'Falagas'], ['Petros', 'I', 'Rafailidis']]",Expert Opinion on Investigational Drugs,2008,[u'http://www.informapharmascience.com/doi/abs/10.1517/13543784.17.7.973'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1517~13543784.17.7.973
10.1111/j.1469-0691.2005.01198.x,"Gilad, J., Carmeli, Y., , Treatment Options for??Multidrug-Resistant Acinetobacter Species, Drugs, 2008",cited-by,10.2165/00003495-200868020-00003,Treatment Options for??Multidrug-Resistant Acinetobacter Species,"[['Jacob', '', 'Gilad'], ['Yehuda', '', 'Carmeli']]",Drugs,2008,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00003495-200868020-00003'],
10.1111/j.1469-0691.2005.01198.x,"Tripodi, M., Durante-Mangoni, E., Fortunato, R., et. al, Comparative activities of colistin, rifampicin, imipenem and sulbactam/ampicillin alone or in combination against epidemic multidrug-resistant Acinetobacter baumannii isolates producing OXA-58 carbapenemases, International Journal of Antimicrobial Agents, 2007",cited-by,10.1016/j.ijantimicag.2007.07.007,"Comparative activities of colistin, rifampicin, imipenem and sulbactam/ampicillin alone or in combination against epidemic multidrug-resistant Acinetobacter baumannii isolates producing OXA-58 carbapenemases","[['Marie-Francoise', '', 'Tripodi'], ['Emanuele', '', 'Durante-Mangoni'], ['Rosaria', '', 'Fortunato'], ['Riccardo', '', 'Utili'], ['Raffaele', '', 'Zarrilli']]",International Journal of Antimicrobial Agents,2007,"[u'http://www.sciencedirect.com/science/article/pii/S0924857907003214', u'http://linkinghub.elsevier.com/retrieve/pii/S0924857907003214']",
10.1111/j.1469-0691.2005.01198.x,"Kim, B., Peleg, A., Lodise, T., et. al, Management of meningitis due to antibiotic-resistant Acinetobacter species, Lancet Infectious Diseases, 2009",cited-by,10.1016/S1473-3099(09)70055-6,Management of meningitis due to antibiotic-resistant Acinetobacter species,"[['Baek-Nam', '', 'Kim'], ['Anton', 'Y', 'Peleg'], ['Thomas', 'P', 'Lodise'], ['Jeffrey', '', 'Lipman'], ['Jian', '', 'Li'], ['Roger', '', 'Nation'], ['David', 'L', 'Paterson']]",Lancet Infectious Diseases,2009,"[u'http://www.sciencedirect.com/science/article/pii/S1473309909700556', u'http://linkinghub.elsevier.com/retrieve/pii/S1473309909700556']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1016~S1473-3099(09)70055-6
10.1111/j.1469-0691.2005.01198.x,"Tascini, C., Menichetti, F., Gemignani, G., et. al, Clinical and Microbiological Efficacy of Colistin Therapy in Combination With Rifampin and Imipenem in Multidrug-Resistant Pseudomonas aeruginosa Diabetic Foot Infection With Osteomyelitis, The International Journal of Lower Extremity Wounds, 2006",cited-by,10.1177/1534734606291676,Clinical and Microbiological Efficacy of Colistin Therapy in Combination With Rifampin and Imipenem in Multidrug-Resistant Pseudomonas aeruginosa Diabetic Foot Infection With Osteomyelitis,"[['Carlo', '', 'Tascini'], ['F.', '', 'Menichetti'], ['G.', '', 'Gemignani'], ['F.', '', 'Palumbo'], ['A.', '', 'Leonildi'], ['A.', '', 'Tedeschi'], ['A.', '', 'Piaggesi']]",The International Journal of Lower Extremity Wounds,2006,"[u'http://ijl.sagepub.com/cgi/doi/10.1177/1534734606291676', u'http://dx.doi.org/10.1177/1534734606291676']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1177~1534734606291676
10.1111/j.1469-0691.2005.01198.x,"Peleg, A., Paterson, D., , Multidrug-resistant Acinetobacter: a threat to the antibiotic era, Internal Medicine Journal, 2006",cited-by,10.1111/j.1445-5994.2006.01130.x,Multidrug-resistant Acinetobacter: a threat to the antibiotic era,"[['A.', 'Y.', 'Peleg'], ['D.', 'L.', 'Paterson']]",Internal Medicine Journal,2006,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1445-5994.2006.01130.x'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1111~j.1445-5994.2006.01130.x
10.1111/j.1469-0691.2005.01198.x,"Song, J., Kee, S., Hwang, I., et. al, In vitro activities of carbapenem/sulbactam combination, colistin, colistin/rifampicin combination and tigecycline against carbapenem-resistant Acinetobacter baumannii, , 0",cited-by,"11377509In vitro activities of carbapenem/sulbactam combination, colistin, colistin/rifampicin combination and tigecycline against carbapenem-resistant Acinetobacter baumannii","In vitro activities of carbapenem/sulbactam combination, colistin, colistin/rifampicin combination and tigecycline against carbapenem-resistant Acinetobacter baumannii","[['Joon', 'Young', 'Song'], ['Sae', 'Yoon', 'Kee'], ['In', 'Sook', 'Hwang'], ['Yu', 'Bin', 'Seo'], ['Hye', 'Won', 'Jeong']]",,0,[u'http://jac.oxfordjournals.org/cgi/reprint/60/2/317.pdf'],
10.1111/j.1469-0691.2005.01198.x,"Monteiro, D., Madrid, M., , Planning of robot trajectories with genetic algorithms, , 1999",cited-by,10.1109/ROMOCO.1999.791079,Planning of robot trajectories with genetic algorithms,"[['D.', 'C.', 'Monteiro'], ['M.', 'K.', 'Madrid']]",,1999,"[u'http://ieeexplore.ieee.org/xpls/abs_all.jsp?arnumber=791079', u'http://ieeexplore.ieee.org/stamp/stamp.jsp?arnumber=00791079']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1109~ROMOCO.1999.791079
10.1111/j.1469-0691.2005.01198.x,"Drapeau, C., Grilli, E., Petrosillo, N., , Rifampicin combined regimens for Gram-negative infections: data from the literature, International Journal of Antimicrobial Agents, 2010",cited-by,10.1016/j.ijantimicag.2009.08.011,Rifampicin combined regimens for Gram-negative infections: data from the literature,"[['C.', 'M. J.', 'Drapeau'], ['E.', '', 'Grilli'], ['N.', '', 'Petrosillo']]",International Journal of Antimicrobial Agents,2010,"[u'http://www.sciencedirect.com/science/article/pii/S092485790900404X', u'http://linkinghub.elsevier.com/retrieve/pii/S092485790900404X']",
10.1111/j.1469-0691.2005.01198.x,"Bassetti, M., Righi, E., Esposito, S., et. al, Drug treatment for multidrug-resistant Acinetobacter baumannii infections, Future Microbiology, 2008",cited-by,10.2217/17460913.3.6.649,Drug treatment for multidrug-resistant Acinetobacter baumannii infections,"[['Matteo', '', 'Bassetti'], ['Elda', '', 'Righi'], ['Silvano', '', 'Esposito'], ['Nicola', '', 'Petrosillo'], ['Laura', '', 'Nicolini']]",Future Microbiology,2008,[u'http://www.futuremedicine.com/doi/abs/10.2217/17460913.3.6.649'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.2217~17460913.3.6.649
10.1111/j.1469-0691.2005.01198.x,"Tan, T., Ng, L., Poh, K., , Susceptibility testing of unconventional antibiotics against multiresistant Acinetobacter spp. by agar dilution and Vitek 2, Diagnostic Microbiology and Infectious Disease, 2007",cited-by,10.1016/j.diagmicrobio.2007.02.008,Susceptibility testing of unconventional antibiotics against multiresistant Acinetobacter spp. by agar dilution and Vitek 2,"[['Thean', 'Yen', 'Tan'], ['Lily', 'Siew Yong', 'Ng'], ['Karen', '', 'Poh']]",Diagnostic Microbiology and Infectious Disease,2007,"[u'http://www.sciencedirect.com/science/article/pii/S0732889307000946', u'http://linkinghub.elsevier.com/retrieve/pii/S0732889307000946']",
10.1111/j.1469-0691.2005.01198.x,"Usher, J., Alexander, S., Thompson, J., , Predicting the reliability of new products at IBM, , 1991",cited-by,10.1109/ARMS.1991.154437,Predicting the reliability of new products at IBM,"[['J.', 'S.', 'Usher'], ['S.', 'M.', 'Alexander'], ['J.', 'D.', 'Thompson']]",,1991,[u'http://ieeexplore.ieee.org/xpls/abs_all.jsp?arnumber=154437'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1109~ARMS.1991.154437
10.1111/j.1469-0691.2005.01198.x,"Spapen, H., Jacobs, R., Gorp, V., et. al, Renal and neurological side effects of colistin in critically ill patients, Annals of Intensive Care, 2011",cited-by,10.1186/2110-5820-1-14,Renal and neurological side effects of colistin in critically ill patients,"[['Herbert', '', 'Spapen'], ['Rita', '', 'Jacobs'], ['Viola', 'Van', 'Gorp'], ['Joris', '', 'Troubleyn'], ['Patrick', 'M', 'Honor\xc3\xa9']]",Annals of Intensive Care,2011,"[u'http://www.springerlink.com/index/j53j3l42kl32202u.pdf', u'http://www.springerlink.com/content/j53j3l42kl32202u']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1186~2110-5820-1-14
10.1111/j.1469-0691.2005.01198.x,"Reddy, P., Chadaga, S., Noskin, G., , Antibiotic considerations in the treatment of multidrug-resistant (MDR) pathogens: A case-based review, Journal of Hospital Medicine, 2009",cited-by,10.1002/jhm.505,Antibiotic considerations in the treatment of multidrug-resistant (MDR) pathogens: A case-based review,"[['Pavani', '', 'Reddy'], ['Smitha', '', 'Chadaga'], ['Gary', 'A.', 'Noskin']]",Journal of Hospital Medicine,2009,[u'http://doi.wiley.com/10.1002/jhm.505'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1002~jhm.505
10.1111/j.1469-0691.2005.01198.x,", Colistín en infecciones nosocomiales por bacilos gramnegativos pan-resistentes, Revista Chilena De Infectologia, 2007",cited-by,10.4067/S0716-10182007000500002,Colistín en infecciones nosocomiales por bacilos gramnegativos pan-resistentes,[],Revista Chilena De Infectologia,2007,"[u'http://www.scielo.cl/pdf/rci/v24n5/art02.pdf', u'http://www.sld.cu/galerias/pdf/sitios/apua-cuba/colistin_en_infecciones_nosocomiales.pdf', u'http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-10182007000500002&lng=en&nrm=iso&tlng=en']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.4067~S0716-10182007000500002
10.1111/j.1469-0691.2005.01198.x,"Pennathur, S., Kwok, H., , Simulation of charge transfer in GaAs cermet-gate CCDs, , 1991",cited-by,10.1109/PACRIM.1991.160791,Simulation of charge transfer in GaAs cermet-gate CCDs,"[['S.', '', 'Pennathur'], ['H.', 'H. L.', 'Kwok']]",,1991,"[u'http://ieeexplore.ieee.org/stamp/stamp.jsp?arnumber=00160791', u'http://ieeexplore.ieee.org/xpls/abs_all.jsp?arnumber=160791']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1109~PACRIM.1991.160791
10.1111/j.1469-0691.2005.01198.x,"Vila, J., Pachón, J., , Antimicrobial Resistance and Therapeutic Alternatives, , 0",cited-by,10.1007/978-0-387-77944-7_11,Antimicrobial Resistance and Therapeutic Alternatives,"[['Jordi', '', 'Vila'], ['Jer\xc3\xb3nimo', '', 'Pach\xc3\xb3n']]",,0,"[u'http://www.springerlink.com/index/tx5723082146q005.pdf', u'http://www.springerlink.com/content/tx5723082146q005']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1007~978-0-387-77944-7_11
10.1517~13543784.17.7.973.pdf,"Toxicity after prolonged (more than four weeks) administration of intravenous colistin. BMC Infect Dis 2005;5(1):1 25. Kwa AL, Loh C, Low JG, et al. Nebulized colistin in the treatment of pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa.",references,10.1186/1471-2334-5-1,Toxicity after prolonged (more than four weeks) administration of intravenous colistin,"[[u'Matthew', u'E', u'Falagas'], [u'Michael', u'', u'Rizos'], [u'Ioannis', u'A', u'Bliziotis'], [u'Kostas', u'', u'Rellos'], [u'Sofia', u'K', u'Kasiakou'], [u'Argyris', u'', u'Michalopoulos']]",BMC Infectious Diseases,2005,"[u'http://www.springerlink.com/index/20543751048q8152.pdf', u'http://www.biomedcentral.com/content/pdf/1471-2334-5-1.pdf', u'http://www.biomedcentral.com/1471-2334/5/1', u'http://www.springerlink.com/content/20543751048q8152']",./output/10.1517~13543784.17.7.973.pdf/10.1186~1471-2334-5-1
10.1186/1471-2334-5-1,"Li, J., Nation, R., Turnidge, J., et. al, Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections, Lancet Infectious Diseases, 2006",cited-by,10.1016/S1473-3099(06)70580-1,Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections,"[['Jian', '', 'Li'], ['Roger', 'L', 'Nation'], ['John', 'D', 'Turnidge'], ['Robert', 'W', 'Milne'], ['Kingsley', '', 'Coulthard'], ['Craig', 'R', 'Rayner'], ['David', 'L', 'Paterson']]",Lancet Infectious Diseases,2006,"[u'http://www.sld.cu/galerias/pdf/sitios/apua-cuba/r15-colistin._the_re-emerging_antibiotic_for_multidrug-resistant_gram-negative_bacterial_infections.pdf', u'http://www.sciencedirect.com/science/article/pii/S1473309906705801', u'http://www.sld.cu/galerias/pdf/sitios/apua-cuba/a21-colistin._the_re-emerging_antibiotic_for_multidrug-resistant_gram-negative_bacterial_infections.pdf', u'http://info.med.yale.edu/intmed/infdis/resources/docs/colistin-review-lancet.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S1473309906705801']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1016~S1473-3099(06)70580-1
10.1186/1471-2334-5-1,"Perez, F., Hujer, A., Hujer, K., et. al, Global Challenge of Multidrug-Resistant Acinetobacter baumannii, Antimicrobial Agents and Chemotherapy, 2007",cited-by,10.1128/AAC.01464-06,Global Challenge of Multidrug-Resistant Acinetobacter baumannii,"[['Federico', '', 'Perez'], ['Andrea', 'M.', 'Hujer'], ['Kristine', 'M.', 'Hujer'], ['Brooke', 'K.', 'Decker'], ['Robert', 'A.', 'Bonomo']]",Antimicrobial Agents and Chemotherapy,2007,"[u'http://aac.asm.org/cgi/reprint/51/10/3471.pdf', u'http://aac.highwire.org/cgi/reprint/51/10/3471.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.01464-06']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1128~AAC.01464-06
10.1186/1471-2334-5-1,"Falagas, M., Kasiakou, S., , Toxicity of polymyxins: a systematic review of the evidence from old and recent studies, Critical Care, 2006",cited-by,10.1186/cc3995,Toxicity of polymyxins: a systematic review of the evidence from old and recent studies,"[['Matthew', 'E', 'Falagas'], ['Sofia', 'K', 'Kasiakou']]",Critical Care,2006,"[u'http://www.biomedcentral.com/content/pdf/cc3995.pdf', u'http://ccforum.com/content/10/1/R27', u'http://www.springerlink.com/content/4hp6047472k68157', u'http://www.springerlink.com/index/4hp6047472k68157.pdf']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1186~cc3995
10.1186/1471-2334-5-1,"Karageorgopoulos, D., Falagas, M., , Current control and treatment of multidrug-resistant Acinetobacter baumannii infections, Lancet Infectious Diseases, 2008",cited-by,10.1016/S1473-3099(08)70279-2,Current control and treatment of multidrug-resistant Acinetobacter baumannii infections,"[['Drosos', 'E', 'Karageorgopoulos'], ['Matthew', 'E', 'Falagas']]",Lancet Infectious Diseases,2008,"[u'http://www.sciencedirect.com/science/article/pii/S1473309908702792', u'http://linkinghub.elsevier.com/retrieve/pii/S1473309908702792']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1016~S1473-3099(08)70279-2
10.1186/1471-2334-5-1,"Falagas, M., Kasiakou, S., Tsiodras, S., et. al, The Use of Intravenous and Aerosolized Polymyxins for the Treatment of Infections in Critically Ill Patients: A Review of the Recent Literature, Clinical Medicine & Research, 2006",cited-by,10.3121/cmr.4.2.138,The Use of Intravenous and Aerosolized Polymyxins for the Treatment of Infections in Critically Ill Patients: A Review of the Recent Literature,"[['Matthew', 'E.', 'Falagas'], ['Sofia', 'K.', 'Kasiakou'], ['Sotirios', '', 'Tsiodras'], ['Argyris', '', 'Michalopoulos']]",Clinical Medicine & Research,2006,"[u'http://www.clinmedres.org/cgi/doi/10.3121/cmr.4.2.138', u'http://www.clinmedres.org/cgi/reprint/4/2/138.pdf']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.3121~cmr.4.2.138
10.1186/1471-2334-5-1,"Falagas, M., Kasiakou, S., Kofteridis, D., et. al, Effectiveness and nephrotoxicity of intravenous colistin for treatment of patients with infections due to polymyxin-only-susceptible (POS) gram-negative bacteria, European Journal of Clinical Microbiology & Infectious Diseases, 2006",cited-by,10.1007/s10096-006-0191-2,Effectiveness and nephrotoxicity of intravenous colistin for treatment of patients with infections due to polymyxin-only-susceptible (POS) gram-negative bacteria,"[['M.', 'E.', 'Falagas'], ['S.', 'K.', 'Kasiakou'], ['D.', 'P.', 'Kofteridis'], ['G.', '', 'Roditakis'], ['G.', '', 'Samonis']]",European Journal of Clinical Microbiology & Infectious Diseases,2006,"[u'http://www.springerlink.com/content/ew01442514573t42', u'http://www.springerlink.com/index/ew01442514573t42.pdf', u'http://www.springerlink.com/index/10.1007/s10096-006-0191-2', u'http://www.springerlink.com/index/pdf/10.1007/s10096-006-0191-2']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1007~s10096-006-0191-2
10.1186/1471-2334-5-1,"Pintado, V., Miguel, L., Grill, F., et. al, Intravenous colistin sulphomethate sodium for therapy of infections due to multidrug-resistant gram-negative bacteria, Journal of Infection, 2008",cited-by,10.1016/j.jinf.2008.01.003,Intravenous colistin sulphomethate sodium for therapy of infections due to multidrug-resistant gram-negative bacteria,"[['Vicente', '', 'Pintado'], ['Luc\xc3\xada', 'Garc\xc3\xada San', 'Miguel'], ['Fabio', '', 'Grill'], ['Blanca', '', 'Mej\xc3\xada'], ['Javier', '', 'Cobo'], ['Jes\xc3\xbas', '', 'Fort\xc3\xban'], ['Pilar', '', 'Mart\xc3\xadn-D\xc3\xa1vila'], ['Santiago', '', 'Moreno']]",Journal of Infection,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0163445308000078', u'http://linkinghub.elsevier.com/retrieve/pii/S0163445308000078']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1016~j.jinf.2008.01.003
10.1186/1471-2334-5-1,"Michalopoulos, A., Falagas, M., , Colistin and Polymyxin B in Critical Care, Critical Care Clinics, 2008",cited-by,10.1016/j.ccc.2007.12.003,Colistin and Polymyxin B in Critical Care,"[['Argyris', '', 'Michalopoulos'], ['Matthew', 'E.', 'Falagas']]",Critical Care Clinics,2008,"[u'http://www.sciencedirect.com/science/article/pii/S074907040700098X', u'http://linkinghub.elsevier.com/retrieve/pii/S074907040700098X']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1016~j.ccc.2007.12.003
10.1186/1471-2334-5-1,"Iosifidis, E., Antachopoulos, C., Ioannidou, M., et. al, Colistin administration to pediatric and neonatal patients, European Journal of Pediatrics, 2010",cited-by,10.1007/s00431-009-1137-3,Colistin administration to pediatric and neonatal patients,"[['Elias', '', 'Iosifidis'], ['Charalampos', '', 'Antachopoulos'], ['Maria', '', 'Ioannidou'], ['Magda', '', 'Mitroudi'], ['Maria', '', 'Sdougka'], ['Vassiliki', '', 'Drossou-Agakidou'], ['Maria', '', 'Tsivitanidou'], ['Emmanuel', '', 'Roilides']]",European Journal of Pediatrics,2010,"[u'http://www.springerlink.com/content/e38736115517wg75', u'http://www.springerlink.com/index/e38736115517wg75.pdf', u'http://www.springerlink.com/index/10.1007/s00431-009-1137-3', u'http://www.springerlink.com/index/pdf/10.1007/s00431-009-1137-3']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1007~s00431-009-1137-3
10.1186/1471-2334-5-1,"Giamarellou, H., Kanellakopoulou, K., , Current Therapies for Pseudomonas Aeruginosa, Critical Care Clinics, 2008",cited-by,10.1016/j.ccc.2007.12.004,Current Therapies for Pseudomonas Aeruginosa,"[['Helen', '', 'Giamarellou'], ['Kyriaki', '', 'Kanellakopoulou']]",Critical Care Clinics,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0749070407000991', u'http://linkinghub.elsevier.com/retrieve/pii/S0749070407000991']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1016~j.ccc.2007.12.004
10.1186/1471-2334-5-1,"Kwa, A., , Polymyxins: A Review of the Current Status Including Recent Developments, , 0",cited-by,12288617Polymyxins: A Review of the Current Status Including Recent Developments,Polymyxins: A Review of the Current Status Including Recent Developments,"[['Andrea', 'L', 'Kwa']]",,0,[u'http://www.annals.edu.sg/pdf/37VolNo10Oct2008/V37N10p870.pdf'],./output/10.1517~13543784.17.7.973.pdf/citedby/12288617Polymyxins: A Review of the Current Status Including Recent Developments
10.1186/1471-2334-5-1,"Pournaras, S., Iosifidis, E., Roilides, E., , Advances in Antibacterial Therapy Against Emerging Bacterial Pathogens, Seminars in Hematology, 2009",cited-by,10.1053/j.seminhematol.2009.03.007,Advances in Antibacterial Therapy Against Emerging Bacterial Pathogens,"[['Spyros', '', 'Pournaras'], ['Elias', '', 'Iosifidis'], ['Emmanuel', '', 'Roilides']]",Seminars in Hematology,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0037196309000626', u'http://linkinghub.elsevier.com/retrieve/pii/S0037196309000626']",
10.1186/1471-2334-5-1,"Montero, M., Horcajada, J., Sorlí, L., et. al, Effectiveness and safety of colistin for the treatment of multidrug-resistant Pseudomonas aeruginosa infections, Infection, 2009",cited-by,10.1007/s15010-009-8342-x,Effectiveness and safety of colistin for the treatment of multidrug-resistant Pseudomonas aeruginosa infections,"[['M.', '', 'Montero'], ['J.', 'P.', 'Horcajada'], ['L.', '', 'Sorl\xc3\xad'], ['F.', '', 'Alvarez-Lerma'], ['S.', '', 'Grau'], ['M.', '', 'Riu'], ['M.', '', 'Sala'], ['H.', '', 'Knobel']]",Infection,2009,"[u'http://www.springerlink.com/content/225961w455x24303', u'http://www.springerlink.com/index/225961w455x24303.pdf', u'http://www.springerlink.com/index/10.1007/s15010-009-8342-x', u'http://www.springerlink.com/index/pdf/10.1007/s15010-009-8342-x']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1007~s15010-009-8342-x
10.1186/1471-2334-5-1,"Leung, C., Wang, N., Liu, C., et. al, Antimicrobial therapy and control of multidrug-resistant Pseudomonas aeruginosa bacteremia in a teaching hospital in Taiwan, , 0",cited-by,11567345Antimicrobial therapy and control of multidrug-resistant Pseudomonas aeruginosa bacteremia in a teaching hospital in Taiwan,Antimicrobial therapy and control of multidrug-resistant Pseudomonas aeruginosa bacteremia in a teaching hospital in Taiwan,"[['Ching-Hsiang', '', 'Leung'], ['Nai-Yu', '', 'Wang'], ['Chang-Pan', '', 'Liu'], ['Li-Chuan', '', 'Weng'], ['Feng-Chih', '', 'Hsieh'], ['Chun-Ming', '', 'Lee']]",,0,[u'http://www.jmii.org/content/pdf/v41n6p491.pdf'],./output/10.1517~13543784.17.7.973.pdf/citedby/11567345Antimicrobial therapy and control of multidrug-resistant Pseudomonas aeruginosa bacteremia in a teaching hospital in Taiwan
10.1186/1471-2334-5-1,"Kim, J., Lee, K., Yoo, S., et. al, Clinical characteristics and risk factors of colistin-induced nephrotoxicity, International Journal of Antimicrobial Agents, 2009",cited-by,10.1016/j.ijantimicag.2009.06.028,Clinical characteristics and risk factors of colistin-induced nephrotoxicity,"[['Jieun', '', 'Kim'], ['Kyoung-Ho', '', 'Lee'], ['Sunmi', '', 'Yoo'], ['Hyunjoo', '', 'Pai']]",International Journal of Antimicrobial Agents,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0924857909003525', u'http://linkinghub.elsevier.com/retrieve/pii/S0924857909003525']",
10.1186/1471-2334-5-1,"Papagelopoulos, P., Mavrogenis, A., Giannitsioti, E., et. al, Management of a Multidrug-Resistant Pseudomonas Aeruginosa Infected Total Knee Arthroplasty Using Colistin. A Case Report and Review of the Literature, Journal of Arthroplasty, 2007",cited-by,10.1016/j.arth.2006.05.006,Management of a Multidrug-Resistant Pseudomonas Aeruginosa Infected Total Knee Arthroplasty Using Colistin. A Case Report and Review of the Literature,"[['Panayiotis', 'J.', 'Papagelopoulos'], ['Andreas', 'F.', 'Mavrogenis'], ['Efthymia', '', 'Giannitsioti'], ['Athanasios', '', 'Kikilas'], ['Kyriaki', '', 'Kanellakopoulou'], ['Panayotis', 'N.', 'Soucacos']]",Journal of Arthroplasty,2007,"[u'http://www.sciencedirect.com/science/article/pii/S0883540306003834', u'http://linkinghub.elsevier.com/retrieve/pii/S0883540306003834']",
10.1186/1471-2334-5-1,"Lin, C., Liu, T., Kuo, C., et. al, Aerosolized Colistin for the Treatment of Multidrug-resistant Acinetobacter baumannii Pneumonia: Experience in a Tertiary Care Hospital in Northern Taiwan, Journal of Microbiology Immunology and Infection, 2010",cited-by,10.1016/S1684-1182(10)60050-3,Aerosolized Colistin for the Treatment of Multidrug-resistant Acinetobacter baumannii Pneumonia: Experience in a Tertiary Care Hospital in Northern Taiwan,"[['Cheng-Chih', '', 'Lin'], ['Te-Chu', '', 'Liu'], ['Chen-Feng', '', 'Kuo'], ['Chang-Pan', '', 'Liu'], ['Chun-Ming', '', 'Lee']]",Journal of Microbiology Immunology and Infection,2010,"[u'http://www.sciencedirect.com/science/article/pii/S1684118210600503', u'http://linkinghub.elsevier.com/retrieve/pii/S1684118210600503']",
10.1186/1471-2334-5-1,"Koga, H., Miyano, G., Takahashi, T., et. al, Comparison of anorectal angle and continence after Georgeson and Peña procedures for high/intermediate imperforate anus, Journal of Pediatric Surgery, 2010",cited-by,10.1016/j.jpedsurg.2010.08.041,Comparison of anorectal angle and continence after Georgeson and Peña procedures for high/intermediate imperforate anus,"[['Hiroyuki', '', 'Koga'], ['Go', '', 'Miyano'], ['Tsubasa', '', 'Takahashi'], ['Akihiro', '', 'Shimotakahara'], ['Yoshifumi', '', 'Kato'], ['Tadaharu', '', 'Okazaki'], ['Atsuyuki', '', 'Yamataka']]",Journal of Pediatric Surgery,2010,[u'http://www.sciencedirect.com/science/article/pii/S0022346810007165'],
10.1186/1471-2334-5-1,"Usher, J., Alexander, S., Thompson, J., , Predicting the reliability of new products at IBM, , 1991",cited-by,10.1109/ARMS.1991.154437,Predicting the reliability of new products at IBM,"[['J.', 'S.', 'Usher'], ['S.', 'M.', 'Alexander'], ['J.', 'D.', 'Thompson']]",,1991,[u'http://ieeexplore.ieee.org/xpls/abs_all.jsp?arnumber=154437'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1109~ARMS.1991.154437
10.1186/1471-2334-5-1,"Ozyilmaz, E., Ebinc, F., Derici, U., et. al, Could nephrotoxicity due to colistin be ameliorated with the use of N -acetylcysteine?, Intensive Care Medicine, 2011",cited-by,10.1007/s00134-010-2038-7,Could nephrotoxicity due to colistin be ameliorated with the use of N -acetylcysteine?,"[['Ezgi', '', 'Ozyilmaz'], ['Fatma', 'Ayerden', 'Ebinc'], ['Ulver', '', 'Derici'], ['Ozlem', '', 'Gulbahar'], ['Guleser', '', 'Goktas'], ['Cigdem', '', 'Elmas'], ['I.', 'Kivilcim', 'Oguzulgen'], ['Sukru', '', 'Sindel']]",Intensive Care Medicine,2011,"[u'http://www.springerlink.com/index/l6685q7822382065.pdf', u'http://www.springerlink.com/content/l6685q7822382065']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1007~s00134-010-2038-7
10.1186/1471-2334-5-1,"Spapen, H., Jacobs, R., Gorp, V., et. al, Renal and neurological side effects of colistin in critically ill patients, Annals of Intensive Care, 2011",cited-by,10.1186/2110-5820-1-14,Renal and neurological side effects of colistin in critically ill patients,"[['Herbert', '', 'Spapen'], ['Rita', '', 'Jacobs'], ['Viola', 'Van', 'Gorp'], ['Joris', '', 'Troubleyn'], ['Patrick', 'M', 'Honor\xc3\xa9']]",Annals of Intensive Care,2011,"[u'http://www.springerlink.com/index/j53j3l42kl32202u.pdf', u'http://www.springerlink.com/content/j53j3l42kl32202u']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1186~2110-5820-1-14
10.1186/1471-2334-5-1,"Hortiwakul, T., Chayakul, P., Chayakul, V., , In Vitro Activity of Colistin, Fosfomycin, and Piperacillin/tazobactam Against Acinetobacter baumannii and Pseudomonas aeruginosa in Songklanagarind Hospital, Thailand, , 2009",cited-by,"13544157In Vitro Activity of Colistin, Fosfomycin, and Piperacillin/tazobactam Against Acinetobacter baumannii and Pseudomonas aeruginosa in Songklanagarind Hospital, Thailand","In Vitro Activity of Colistin, Fosfomycin, and Piperacillin/tazobactam Against Acinetobacter baumannii and Pseudomonas aeruginosa in Songklanagarind Hospital, Thailand","[['Thanaporn', '', 'Hortiwakul'], ['Pantip', '', 'Chayakul'], ['Vee', '', 'Chayakul']]",,2009,[u'http://www.idthai.org/Publication/pdf/Vol26-3/p.91-96.pdf'],
10.1186/1471-2334-5-1,"Nasnas, R., Saliba, G., Hallak, P., , The revival of colistin: An old antibiotic for the 21st century, Pathologie Biologie, 2009",cited-by,10.1016/j.patbio.2007.09.013,The revival of colistin: An old antibiotic for the 21st century,"[['R.', '', 'Nasnas'], ['G.', '', 'Saliba'], ['P.', '', 'Hallak']]",Pathologie Biologie,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0369811407002234', u'http://linkinghub.elsevier.com/retrieve/pii/S0369811407002234']",
10.1186/1471-2334-5-1,"Shearer, A., Bagust, A., Ampudia-Blasco, F., et. al, PDB8 THE IMPACT OF IMPROVED BETA-CELL FUNCTION ON MODELLING THE COST-EFFECTIVENESS OF ROSIGLITAZONE IN THE MANAGEMENT OF TYPE 2 DIABETES IN SPAIN, Value in Health, 2006",cited-by,10.1016/S1098-3015(10)63278-0,PDB8 THE IMPACT OF IMPROVED BETA-CELL FUNCTION ON MODELLING THE COST-EFFECTIVENESS OF ROSIGLITAZONE IN THE MANAGEMENT OF TYPE 2 DIABETES IN SPAIN,"[['A', '', 'Shearer'], ['A', '', 'Bagust'], ['FJ', '', 'Ampudia-Blasco'], ['MJ', '', 'TaylorJ'], ['S', 'Mendes da', 'Costa']]",Value in Health,2006,[u'http://www.sciencedirect.com/science/article/pii/S1098301510632780'],
10.1517~13543784.17.7.973.pdf,Clin Infect Dis 2005;41(5):754-7 • A retrospective study regarding the use of colistin in 21 patients that showed that the medication is reasonably effective and safe in the treatment of these severe infections. Expert Opin. Investig. Drugs Downloaded from informahealthcare.com by University New South Wales on 09/02/14 For personal use only.,references,NOT found in MAS
10.1517~13543784.17.7.973.pdf,"Re-emergence of colistin in today’s world of multidrug-resistant organisms: personal perspectives 980 Expert Opin. Investig. Drugs (2008) 17(7) 26. Michalopoulos A, Kasiakou SK, Mastora Z, et al. Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis.",references,10.1517/13543784.17.7.973,Re-emergence of colistin in today's world of multidrug-resistant organisms: personal perspectives,"[[u'Matthew', u'E', u'Falagas'], [u'Petros', u'I', u'Rafailidis']]",Expert Opinion on Investigational Drugs,2008,[u'http://www.informapharmascience.com/doi/abs/10.1517/13543784.17.7.973'],./output/10.1517~13543784.17.7.973.pdf/10.1517~13543784.17.7.973
10.1517/13543784.17.7.973,"Livermore, D., , Has the era of untreatable infections arrived?, Journal of Antimicrobial Chemotherapy, 2009",cited-by,10.1093/jac/dkp255,Has the era of untreatable infections arrived?,"[['D.', 'M.', 'Livermore']]",Journal of Antimicrobial Chemotherapy,2009,[u'http://www.jac.oxfordjournals.org/cgi/doi/10.1093/jac/dkp255'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1093~jac~dkp255
10.1517/13543784.17.7.973,"Falagas, M., Rafailidis, P., Ioannidou, E., et. al, Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients, International Journal of Antimicrobial Agents, 2010",cited-by,10.1016/j.ijantimicag.2009.10.005,Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients,"[['Matthew', 'E.', 'Falagas'], ['Petros', 'I.', 'Rafailidis'], ['Elda', '', 'Ioannidou'], ['Vangelis', 'G.', 'Alexiou'], ['Dimitrios', 'K.', 'Matthaiou'], ['Drosos', 'E.', 'Karageorgopoulos'], ['Anastasios', '', 'Kapaskelis'], ['Dimitra', '', 'Nikita'], ['Argyris', '', 'Michalopoulos']]",International Journal of Antimicrobial Agents,2010,"[u'http://www.sciencedirect.com/science/article/pii/S0924857909004695', u'http://linkinghub.elsevier.com/retrieve/pii/S0924857909004695']",
10.1517/13543784.17.7.973,"Livermore, D., , Has the era of untreatable infections arrived?, , 0",cited-by,10721172Has the era of untreatable infections arrived?,Has the era of untreatable infections arrived?,"[['David', 'M.', 'Livermore']]",,0,[u'http://jac.oxfordjournals.org/cgi/reprint/64/suppl_1/i29.pdf'],
10.1517/13543784.17.7.973,"Durante-Mangoni, E., Grammatikos, A., Utili, R., et. al, Do we still need the aminoglycosides?, International Journal of Antimicrobial Agents, 2009",cited-by,10.1016/j.ijantimicag.2008.09.001,Do we still need the aminoglycosides?,"[['Emanuele', '', 'Durante-Mangoni'], ['Alexandros', '', 'Grammatikos'], ['Riccardo', '', 'Utili'], ['Matthew', 'E.', 'Falagas']]",International Journal of Antimicrobial Agents,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0924857908003920', u'http://linkinghub.elsevier.com/retrieve/pii/S0924857908003920']",
10.1517/13543784.17.7.973,"Falagas, M., Vouloumanou, E., Rafailidis, P., , Systemic colistin use in children without cystic fibrosis: a systematic review of the literature, International Journal of Antimicrobial Agents, 2009",cited-by,10.1016/j.ijantimicag.2008.10.021,Systemic colistin use in children without cystic fibrosis: a systematic review of the literature,"[['Matthew', 'E.', 'Falagas'], ['Evridiki', 'K.', 'Vouloumanou'], ['Petros', 'I.', 'Rafailidis']]",International Journal of Antimicrobial Agents,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0924857908005505', u'http://linkinghub.elsevier.com/retrieve/pii/S0924857908005505']",
10.1517/13543784.17.7.973,"Marchand, S., Lamarche, I., Gobin, P., et. al, Dose-ranging pharmacokinetics of colistin methanesulphonate (CMS) and colistin in rats following single intravenous CMS doses, Journal of Antimicrobial Chemotherapy, 2010",cited-by,10.1093/jac/dkq183,Dose-ranging pharmacokinetics of colistin methanesulphonate (CMS) and colistin in rats following single intravenous CMS doses,"[['S.', '', 'Marchand'], ['I.', '', 'Lamarche'], ['P.', '', 'Gobin'], ['W.', '', 'Couet']]",Journal of Antimicrobial Chemotherapy,2010,[u'http://www.jac.oxfordjournals.org/cgi/doi/10.1093/jac/dkq183'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1093~jac~dkq183
10.1517/13543784.17.7.973,"Mamelli, L., Petit, S., Chevalier, J., et. al, New Antibiotic Molecules: Bypassing the Membrane Barrier of Gram Negative Bacteria Increases the Activity of Peptide Deformylase Inhibitors, PLOS One, 2009",cited-by,10.1371/journal.pone.0006443.t005,New Antibiotic Molecules: Bypassing the Membrane Barrier of Gram Negative Bacteria Increases the Activity of Peptide Deformylase Inhibitors,"[['Laurent', '', 'Mamelli'], ['Sylvain', '', 'Petit'], ['Jacqueline', '', 'Chevalier'], ['Carmela', '', 'Giglione'], ['Aur\xc3\xa9lie', '', 'Lieutaud'], ['Thierry', '', 'Meinnel'], ['Isabelle', '', 'Artaud'], ['Jean-Marie', '', 'Pag\xc3\xa8s']]",PLOS One,2009,"[u'http://www.unav.es/ciencias/estudios/doctorado/articulos/Mamellietal2009PloSOnePeptidemediatedsensitizationtodeformylaseinhibitors.pdf', u'http://dx.plos.org/10.1371/journal.pone.0006443', u'http://dx.plos.org/10.1371/journal.pone.0006443.g001', u'http://dx.plos.org/10.1371/journal.pone.0006443.g002', u'http://dx.plos.org/10.1371/journal.pone.0006443.t001', u'http://dx.plos.org/10.1371/journal.pone.0006443.t002', u'http://dx.plos.org/10.1371/journal.pone.0006443.t003', u'http://dx.plos.org/10.1371/journal.pone.0006443.t004', u'http://dx.plos.org/10.1371/journal.pone.0006443.t005']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1371~journal.pone.0006443.t005
10.1517/13543784.17.7.973,"Falagas, M., Koletsi, P., Vouloumanou, E., et. al, Effectiveness and safety of neuraminidase inhibitors in reducing influenza complications: a meta-analysis of randomized controlled trials, Journal of Antimicrobial Chemotherapy, 2010",cited-by,10.1093/jac/dkq158,Effectiveness and safety of neuraminidase inhibitors in reducing influenza complications: a meta-analysis of randomized controlled trials,"[['M.', 'E.', 'Falagas'], ['P.', 'K.', 'Koletsi'], ['E.', 'K.', 'Vouloumanou'], ['P.', 'I.', 'Rafailidis'], ['A.', 'M.', 'Kapaskelis'], ['J.', '', 'Rello']]",Journal of Antimicrobial Chemotherapy,2010,[u'http://www.jac.oxfordjournals.org/cgi/doi/10.1093/jac/dkq158'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1093~jac~dkq158
10.1517/13543784.17.7.973,"Barnos, B., , The electrified fence as a component of a physical protection system, , 1989",cited-by,10.1109/CCST.1989.751985,The electrified fence as a component of a physical protection system,"[['B.', 'W.', 'Barnos']]",,1989,[u'http://ieeexplore.ieee.org/xpls/abs_all.jsp?arnumber=751985'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1109~CCST.1989.751985
10.1517/13543784.17.7.973,"Peppas, G., Makris, M., Falagas, M., , Biological mesh for abdominal wall hernia synthetic mesh multidrug-resistant Pseudomonas aeruginosa infection: Report of a case, Surgery Today, 2011",cited-by,10.1007/s00595-010-4326-9,Biological mesh for abdominal wall hernia synthetic mesh multidrug-resistant Pseudomonas aeruginosa infection: Report of a case,"[['George', '', 'Peppas'], ['Marinos', 'C.', 'Makris'], ['Matthew', 'E.', 'Falagas']]",Surgery Today,2011,"[u'http://www.springerlink.com/index/qn883g80k8072142.pdf', u'http://www.springerlink.com/content/qn883g80k8072142']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1007~s00595-010-4326-9
10.1517/13543784.17.7.973,"Ko, H., Jeon, M., Choo, E., et. al, Early Acute Kidney Injury Is a Risk Factor That Predicts Mortality in Patients Treated with Colistin, Nephron Clinical Practice, 2011",cited-by,10.1159/000320746,Early Acute Kidney Injury Is a Risk Factor That Predicts Mortality in Patients Treated with Colistin,"[['Hee', 'ja', 'Ko'], ['Min', 'hyok', 'Jeon'], ['Eun', 'ju', 'Choo'], ['Eun', 'jung', 'Lee'], ['Tae', 'hyong', 'Kim'], ['Jae-Bum', '', 'Jun'], ['Hyo-Wook', '', 'Gil']]",Nephron Clinical Practice,2011,[u'http://content.karger.com/ProdukteDB/produkte.asp?doi=10.1159/000320746'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1159~000320746
10.1517/13543784.17.7.973,"Mamelli, L., Petit, S., Chevalier, J., et. al, New Antibiotic Molecules: Bypassing the Membrane Barrier of Gram Negative Bacteria Increases the Activity of Peptide Deformylase Inhibitors, PLOS One, 2009",cited-by,10.1371/journal.pone.0006443,New Antibiotic Molecules: Bypassing the Membrane Barrier of Gram Negative Bacteria Increases the Activity of Peptide Deformylase Inhibitors,"[['Laurent', '', 'Mamelli'], ['Sylvain', '', 'Petit'], ['Jacqueline', '', 'Chevalier'], ['Carmela', '', 'Giglione'], ['Aur\xc3\xa9lie', '', 'Lieutaud'], ['Thierry', '', 'Meinnel'], ['Isabelle', '', 'Artaud'], ['Jean-Marie', '', 'Pag\xc3\xa8s'], ['Stefan', '', 'Bereswill']]",PLOS One,2009,"[u'http://dx.doi.org/10.1371/journal.pone.0006443', u'http://adsabs.harvard.edu/abs/2009PLoSO...4.6443M']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1371~journal.pone.0006443
10.1517~13543784.17.7.973.pdf,"Crit Care 2005; 9(1):R53-9 27. Falagas ME, Kasiakou SK, Kofteridis DP, et al. Effectiveness and nephrotoxicity of intravenous colistin for treatment of patients with infections due to polymyxin-only-susceptible (POS) Gram-negative bacteria. Eur J Clin Microbiol Infect Dis 2006;25(9):596-9 28. Falagas ME, Rafailidis PI, Kasiakou SK, et al. Effectiveness and nephrotoxicity of colistin monotherapy vs. colistin-meropenem combination therapy for multidrug-resistant Gram-negative bacterial infections. Clin Microbiol Infect 2006;12(12):1227-30 29. Trottier V, Namias N, Pust DG, et al. Outcomes of Acinetobacter baumannii infection in critically ill surgical patients.",references,10.1007/s10096-006-0191-2,Effectiveness and nephrotoxicity of intravenous colistin for treatment of patients with infections due to polymyxin-only-susceptible (POS) gram-negative bacteria,"[[u'M.', u'E.', u'Falagas'], [u'S.', u'K.', u'Kasiakou'], [u'D.', u'P.', u'Kofteridis'], [u'G.', u'', u'Roditakis'], [u'G.', u'', u'Samonis']]",European Journal of Clinical Microbiology & Infectious Diseases,2006,"[u'http://www.springerlink.com/content/ew01442514573t42', u'http://www.springerlink.com/index/ew01442514573t42.pdf', u'http://www.springerlink.com/index/10.1007/s10096-006-0191-2', u'http://www.springerlink.com/index/pdf/10.1007/s10096-006-0191-2']",./output/10.1517~13543784.17.7.973.pdf/10.1007~s10096-006-0191-2
10.1007/s10096-006-0191-2,"Falagas, M., Bliziotis, I., , Pandrug-resistant Gram-negative bacteria: the dawn of the post-antibiotic era?, International Journal of Antimicrobial Agents, 2007",cited-by,10.1016/j.ijantimicag.2006.12.012,Pandrug-resistant Gram-negative bacteria: the dawn of the post-antibiotic era?,"[['Matthew', 'E.', 'Falagas'], ['Ioannis', 'A.', 'Bliziotis']]",International Journal of Antimicrobial Agents,2007,"[u'http://www.sciencedirect.com/science/article/pii/S0924857907000192', u'http://linkinghub.elsevier.com/retrieve/pii/S0924857907000192']",
10.1007/s10096-006-0191-2,"Karageorgopoulos, D., Falagas, M., , Current control and treatment of multidrug-resistant Acinetobacter baumannii infections, Lancet Infectious Diseases, 2008",cited-by,10.1016/S1473-3099(08)70279-2,Current control and treatment of multidrug-resistant Acinetobacter baumannii infections,"[['Drosos', 'E', 'Karageorgopoulos'], ['Matthew', 'E', 'Falagas']]",Lancet Infectious Diseases,2008,"[u'http://www.sciencedirect.com/science/article/pii/S1473309908702792', u'http://linkinghub.elsevier.com/retrieve/pii/S1473309908702792']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1016~S1473-3099(08)70279-2
10.1007/s10096-006-0191-2,"Chopra, I., Everett, M., O'Neill, A., et. al, Treatment of health-care-associated infections caused by Gram-negative bacteria: a consensus statement, , 2008",cited-by,13352062Treatment of health-care-associated infections caused by Gram-negative bacteria: a consensus statement,Treatment of health-care-associated infections caused by Gram-negative bacteria: a consensus statement,"[['Ian', '', 'Chopra'], ['Martin', '', 'Everett'], ['Alex', '', ""O'Neill""], ['Keith', '', 'Miller'], ['Mark', '', 'Wilcox'], ['Jean-Marie', '', 'Fr\xc3\xa8re'], ['Mike', '', 'Dawson'], ['Lloyd', '', 'Czaplewski'], ['Uros', '', 'Urleb'], ['Patrice', '', 'Courvalin']]",,2008,[u'http://www.congrex.ch/escmidsummerschool2008/pdf/pdfs/akova_references2/chopra_2008.pdf'],
10.1007/s10096-006-0191-2,"Pintado, V., Miguel, L., Grill, F., et. al, Intravenous colistin sulphomethate sodium for therapy of infections due to multidrug-resistant gram-negative bacteria, Journal of Infection, 2008",cited-by,10.1016/j.jinf.2008.01.003,Intravenous colistin sulphomethate sodium for therapy of infections due to multidrug-resistant gram-negative bacteria,"[['Vicente', '', 'Pintado'], ['Luc\xc3\xada', 'Garc\xc3\xada San', 'Miguel'], ['Fabio', '', 'Grill'], ['Blanca', '', 'Mej\xc3\xada'], ['Javier', '', 'Cobo'], ['Jes\xc3\xbas', '', 'Fort\xc3\xban'], ['Pilar', '', 'Mart\xc3\xadn-D\xc3\xa1vila'], ['Santiago', '', 'Moreno']]",Journal of Infection,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0163445308000078', u'http://linkinghub.elsevier.com/retrieve/pii/S0163445308000078']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1016~j.jinf.2008.01.003
10.1007/s10096-006-0191-2,"Falagas, M., Rafailidis, P., Kofteridis, D., et. al, Risk factors of carbapenem-resistant Klebsiella pneumoniae infections: a matched case - control study, , 2007",cited-by,12185794Risk factors of carbapenem-resistant Klebsiella pneumoniae infections: a matched case - control study,Risk factors of carbapenem-resistant Klebsiella pneumoniae infections: a matched case - control study,"[['Matthew', 'E.', 'Falagas'], ['Petros', 'I.', 'Rafailidis'], ['Diamantis', '', 'Kofteridis'], ['Simona', '', 'Virtzili'], ['Fotini', 'C.', 'Chelvatzoglou'], ['Vassiliki', '', 'Papaioannou'], ['Sofia', '', 'Maraki'], ['George', '', 'Samonis'], ['Argyris', '', 'Michalopoulos']]",,2007,"[u'http://jac.oxfordjournals.org/cgi/reprint/60/5/1124.pdf', u'http://jac.oxfordjournals.org/cgi/reprint/dkm356v1.pdf', u'http://jac.oxfordjournals.org/cgi/reprint/dkm356v2.pdf']",./output/10.1517~13543784.17.7.973.pdf/citedby/12185794Risk factors of carbapenem-resistant Klebsiella pneumoniae infections: a matched case - control study
10.1007/s10096-006-0191-2,"Falagas, M., Rafailidis, P., , Re-emergence of colistin in today's world of multidrug-resistant organisms: personal perspectives, Expert Opinion on Investigational Drugs, 2008",cited-by,10.1517/13543784.17.7.973,Re-emergence of colistin in today's world of multidrug-resistant organisms: personal perspectives,"[['Matthew', 'E', 'Falagas'], ['Petros', 'I', 'Rafailidis']]",Expert Opinion on Investigational Drugs,2008,[u'http://www.informapharmascience.com/doi/abs/10.1517/13543784.17.7.973'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1517~13543784.17.7.973
10.1007/s10096-006-0191-2,"Gilad, J., Carmeli, Y., , Treatment Options for??Multidrug-Resistant Acinetobacter Species, Drugs, 2008",cited-by,10.2165/00003495-200868020-00003,Treatment Options for??Multidrug-Resistant Acinetobacter Species,"[['Jacob', '', 'Gilad'], ['Yehuda', '', 'Carmeli']]",Drugs,2008,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00003495-200868020-00003'],
10.1007/s10096-006-0191-2,"Solh, A., Alhajhusain, A., , Update on the treatment of Pseudomonas aeruginosa pneumonia, Journal of Antimicrobial Chemotherapy, 2009",cited-by,10.1093/jac/dkp201,Update on the treatment of Pseudomonas aeruginosa pneumonia,"[['A.', 'A. El', 'Solh'], ['A.', '', 'Alhajhusain']]",Journal of Antimicrobial Chemotherapy,2009,[u'http://www.jac.oxfordjournals.org/cgi/doi/10.1093/jac/dkp201'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1093~jac~dkp201
10.1007/s10096-006-0191-2,"Falagas, M., Siempos, I., Rafailidis, P., et. al, Inhaled colistin as monotherapy for multidrug-resistant gram (−) nosocomial pneumonia: A case series, Respiratory Medicine, 2009",cited-by,10.1016/j.rmed.2008.11.018,Inhaled colistin as monotherapy for multidrug-resistant gram (−) nosocomial pneumonia: A case series,"[['Matthew', 'E.', 'Falagas'], ['Ilias', 'I.', 'Siempos'], ['Petros', 'I.', 'Rafailidis'], ['Ioanna', 'P.', 'Korbila'], ['Eleni', '', 'Ioannidou'], ['Argyris', '', 'Michalopoulos']]",Respiratory Medicine,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0954611108004228', u'http://linkinghub.elsevier.com/retrieve/pii/S0954611108004228']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1016~j.rmed.2008.11.018
10.1007/s10096-006-0191-2,"Garnacho-Montero, J., Amaya-Villar, R., , Multiresistant Acinetobacter baumannii infections: epidemiology and management, Current Opinion in Infectious Diseases, 2010",cited-by,10.1097/QCO.0b013e32833ae38b,Multiresistant Acinetobacter baumannii infections: epidemiology and management,"[['Jos\xc3\xa9', '', 'Garnacho-Montero'], ['Rosario', '', 'Amaya-Villar']]",Current Opinion in Infectious Diseases,2010,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00001432-201008000-00008'],
10.1007/s10096-006-0191-2,"Falagas, M., Vouloumanou, E., Rafailidis, P., , Systemic colistin use in children without cystic fibrosis: a systematic review of the literature, International Journal of Antimicrobial Agents, 2009",cited-by,10.1016/j.ijantimicag.2008.10.021,Systemic colistin use in children without cystic fibrosis: a systematic review of the literature,"[['Matthew', 'E.', 'Falagas'], ['Evridiki', 'K.', 'Vouloumanou'], ['Petros', 'I.', 'Rafailidis']]",International Journal of Antimicrobial Agents,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0924857908005505', u'http://linkinghub.elsevier.com/retrieve/pii/S0924857908005505']",
10.1007/s10096-006-0191-2,"Song, J., Kee, S., Hwang, I., et. al, In vitro activities of carbapenem/sulbactam combination, colistin, colistin/rifampicin combination and tigecycline against carbapenem-resistant Acinetobacter baumannii, , 0",cited-by,"11377509In vitro activities of carbapenem/sulbactam combination, colistin, colistin/rifampicin combination and tigecycline against carbapenem-resistant Acinetobacter baumannii","In vitro activities of carbapenem/sulbactam combination, colistin, colistin/rifampicin combination and tigecycline against carbapenem-resistant Acinetobacter baumannii","[['Joon', 'Young', 'Song'], ['Sae', 'Yoon', 'Kee'], ['In', 'Sook', 'Hwang'], ['Yu', 'Bin', 'Seo'], ['Hye', 'Won', 'Jeong']]",,0,[u'http://jac.oxfordjournals.org/cgi/reprint/60/2/317.pdf'],
10.1007/s10096-006-0191-2,"Tenover, F., McGowan, J., , The Epidemiology of Bacterial Resistance to Antimicrobial Agents, , 0",cited-by,10.1007/978-0-387-09843-2_4,The Epidemiology of Bacterial Resistance to Antimicrobial Agents,"[['Fred', 'C.', 'Tenover'], ['John', 'E.', 'McGowan']]",,0,"[u'http://www.springerlink.com/content/nnj7p8l7j732r623', u'http://www.springerlink.com/index/nnj7p8l7j732r623.pdf']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1007~978-0-387-09843-2_4
10.1007/s10096-006-0191-2,"Kwon, J., Lee, J., Huh, W., et. al, Predictors of acute kidney injury associated with intravenous colistin treatment, International Journal of Antimicrobial Agents, 2010",cited-by,10.1016/j.ijantimicag.2009.12.002,Predictors of acute kidney injury associated with intravenous colistin treatment,"[['Jeong-Ah', '', 'Kwon'], ['Jung', 'Eun', 'Lee'], ['Wooseong', '', 'Huh'], ['Kyong', 'Ran', 'Peck'], ['Yoon-Goo', '', 'Kim'], ['Dae', 'Joong', 'Kim'], ['Ha', 'Young', 'Oh']]",International Journal of Antimicrobial Agents,2010,"[u'http://www.sciencedirect.com/science/article/pii/S0924857909005755', u'http://linkinghub.elsevier.com/retrieve/pii/S0924857909005755']",
10.1007/s10096-006-0191-2,"Rosanova, M., Epelbaum, C., Noman, A., et. al, Use of Colistin in a Pediatric Burn Unit in Argentina, Journal of Burn Care & Research, 2009",cited-by,10.1097/BCR.0b013e3181abffb6,Use of Colistin in a Pediatric Burn Unit in Argentina,"[['Maria', '', 'Rosanova'], ['Carolina', '', 'Epelbaum'], ['Alejandro', '', 'Noman'], ['Mabel', '', 'Villasboas'], ['Veronica', '', 'Alvarez'], ['Griselda', '', 'Berberian'], ['Norma', '', 'Sberna'], ['Gabriela', '', 'Mudryck'], ['Roberto', '', 'Lede']]",Journal of Burn Care & Research,2009,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=01253092-200907000-00008'],
10.1007/s10096-006-0191-2,"Kim, J., Lee, K., Yoo, S., et. al, Clinical characteristics and risk factors of colistin-induced nephrotoxicity, International Journal of Antimicrobial Agents, 2009",cited-by,10.1016/j.ijantimicag.2009.06.028,Clinical characteristics and risk factors of colistin-induced nephrotoxicity,"[['Jieun', '', 'Kim'], ['Kyoung-Ho', '', 'Lee'], ['Sunmi', '', 'Yoo'], ['Hyunjoo', '', 'Pai']]",International Journal of Antimicrobial Agents,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0924857909003525', u'http://linkinghub.elsevier.com/retrieve/pii/S0924857909003525']",
10.1007/s10096-006-0191-2,"Ganapathy, H., Pal, S., Teare, L., et. al, Use of colistin in treating multi-resistant Gram-negative organisms in a specialised burns unit, Burns, 2010",cited-by,10.1016/j.burns.2009.07.010,Use of colistin in treating multi-resistant Gram-negative organisms in a specialised burns unit,"[['H.', '', 'Ganapathy'], ['S.', 'K.', 'Pal'], ['L.', '', 'Teare'], ['P.', '', 'Dziewulski']]",Burns,2010,"[u'http://www.sciencedirect.com/science/article/pii/S0305417909004513', u'http://linkinghub.elsevier.com/retrieve/pii/S0305417909004513']",
10.1007/s10096-006-0191-2,"Pappas, G., Saplaoura, K., Falagas, M., , Current Treatment of Pseudomonal Infections in the Elderly, Drugs & Aging, 2009",cited-by,10.2165/00002512-200926050-00001,Current Treatment of Pseudomonal Infections in the Elderly,"[['Georgios', '', 'Pappas'], ['Kaiti', '', 'Saplaoura'], ['Matthew', 'E.', 'Falagas']]",Drugs & Aging,2009,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00002512-200926050-00001'],
10.1007/s10096-006-0191-2,"Bassetti, M., Righi, E., Esposito, S., et. al, Drug treatment for multidrug-resistant Acinetobacter baumannii infections, Future Microbiology, 2008",cited-by,10.2217/17460913.3.6.649,Drug treatment for multidrug-resistant Acinetobacter baumannii infections,"[['Matteo', '', 'Bassetti'], ['Elda', '', 'Righi'], ['Silvano', '', 'Esposito'], ['Nicola', '', 'Petrosillo'], ['Laura', '', 'Nicolini']]",Future Microbiology,2008,[u'http://www.futuremedicine.com/doi/abs/10.2217/17460913.3.6.649'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.2217~17460913.3.6.649
10.1007/s10096-006-0191-2,"Chan, J., Graves, J., Dellit, T., , Antimicrobial Treatment and Clinical Outcomes of Carbapenem-Resistant Acinetobacter baumannii Ventilator-Associated Pneumonia, Journal of Intensive Care Medicine, 2010",cited-by,10.1177/0885066610377975,Antimicrobial Treatment and Clinical Outcomes of Carbapenem-Resistant Acinetobacter baumannii Ventilator-Associated Pneumonia,"[['Jeannie', 'D.', 'Chan'], ['Joseph', 'A.', 'Graves'], ['Timothy', 'H.', 'Dellit']]",Journal of Intensive Care Medicine,2010,[u'http://dx.doi.org/10.1177/0885066610377975'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1177~0885066610377975
10.1007/s10096-006-0191-2,"Filho, L., Kuti, J., Nicolau, D., , Employing pharmacokinetic and pharmacodynamic principles to optimize antimicrobial treatment in the face of emerging resistance, Brazilian Journal of Microbiology, 2007",cited-by,10.1590/S1517-83822007000200001,Employing pharmacokinetic and pharmacodynamic principles to optimize antimicrobial treatment in the face of emerging resistance,"[['Lauro', 'Santos', 'Filho'], ['Joseph', 'L.', 'Kuti'], ['David', 'P.', 'Nicolau']]",Brazilian Journal of Microbiology,2007,"[u'http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1517-83822007000200001&lng=en&nrm=iso&tlng=en', u'http://www.scielo.br/pdf/bjm/v38n2/v38n2a01.pdf']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1590~S1517-83822007000200001
10.1007/s10096-006-0191-2,"Shearer, A., Bagust, A., Ampudia-Blasco, F., et. al, PDB8 THE IMPACT OF IMPROVED BETA-CELL FUNCTION ON MODELLING THE COST-EFFECTIVENESS OF ROSIGLITAZONE IN THE MANAGEMENT OF TYPE 2 DIABETES IN SPAIN, Value in Health, 2006",cited-by,10.1016/S1098-3015(10)63278-0,PDB8 THE IMPACT OF IMPROVED BETA-CELL FUNCTION ON MODELLING THE COST-EFFECTIVENESS OF ROSIGLITAZONE IN THE MANAGEMENT OF TYPE 2 DIABETES IN SPAIN,"[['A', '', 'Shearer'], ['A', '', 'Bagust'], ['FJ', '', 'Ampudia-Blasco'], ['MJ', '', 'TaylorJ'], ['S', 'Mendes da', 'Costa']]",Value in Health,2006,[u'http://www.sciencedirect.com/science/article/pii/S1098301510632780'],
10.1517~13543784.17.7.973.pdf,"Surg Infect (Larchmt) 2007;8(4):437-43 30. Michalopoulos A, Fotakis D, Virtzili S, et al. Aerosolized colistin as adjunctive treatment of ventilator-associated pneumonia due to multidrug-resistant Gram-negative bacteria: a prospective study. Respir Med 2008;102(3):407-12 31. Koomanachai P, Tiengrim S, Kiratisin P, Thamlikitkul V. Efficacy and safety of colistin (colistimethate sodium) for therapy of infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii in Siriraj Hospital, Bangkok, Thailand. Int J Infect Dis 2007;11(5):402-6 32. Goverman J, Weber JM, Keaney TJ, Sheridan RL. Intravenous colistin for the treatment of multi-drug resistant, Gram-negative infection in the pediatric burn population. J Burn Care Res 2007;28(3):421-6 33. Hachem RY, Chemaly RF, Ahmar CA, et al. Colistin is effective in treatment of infections caused by multidrug-resistant Pseudomonas aeruginosa in cancer patients.",references,NOT found in MAS
10.1517~13543784.17.7.973.pdf,"Antimicrob Agents Chemother 2007;51(6):1905-11 34. Kallel H, Hergafi L, Bahloul M, et al. Safety and efficacy of colistin compared with imipenem in the treatment of ventilator-associated pneumonia: a matched case-control study.",references,NOT found in MAS
10.1517~13543784.17.7.973.pdf,"Intensive Care Med 2007;33(7):1162-7 35. Bassetti M, Repetto E, Righi E, et al. Colistin and rifampicin in the treatment of multidrug-resistant Acinetobacter baumannii infections.",references,10.1093/jac/dkm509,Colistin and rifampicin in the treatment of multidrug-resistant Acinetobacter baumannii infections,"[[u'M.', u'', u'Bassetti'], [u'E.', u'', u'Repetto'], [u'E.', u'', u'Righi'], [u'S.', u'', u'Boni'], [u'M.', u'', u'Diverio'], [u'M.', u'P.', u'Molinari'], [u'M.', u'', u'Mussap'], [u'S.', u'', u'Artioli'], [u'F.', u'', u'Ansaldi'], [u'P.', u'', u'Durando'], [u'G.', u'', u'Orengo'], [u'F.', u'Bobbio', u'Pallavicini'], [u'C.', u'', u'Viscoli']]",Journal of Antimicrobial Chemotherapy,2007,"[u'http://jac.oxfordjournals.org/cgi/reprint/61/2/417.pdf', u'http://www.jac.oxfordjournals.org/cgi/doi/10.1093/jac/dkm509']",./output/10.1517~13543784.17.7.973.pdf/10.1093~jac~dkm509
10.1093/jac/dkm509,"Karageorgopoulos, D., Falagas, M., , Current control and treatment of multidrug-resistant Acinetobacter baumannii infections, Lancet Infectious Diseases, 2008",cited-by,10.1016/S1473-3099(08)70279-2,Current control and treatment of multidrug-resistant Acinetobacter baumannii infections,"[['Drosos', 'E', 'Karageorgopoulos'], ['Matthew', 'E', 'Falagas']]",Lancet Infectious Diseases,2008,"[u'http://www.sciencedirect.com/science/article/pii/S1473309908702792', u'http://linkinghub.elsevier.com/retrieve/pii/S1473309908702792']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1016~S1473-3099(08)70279-2
10.1093/jac/dkm509,"Nation, R., Li, J., , Colistin in the 21st century, Current Opinion in Infectious Diseases, 2009",cited-by,10.1097/QCO.0b013e328332e672,Colistin in the 21st century,"[['Roger', 'L', 'Nation'], ['Jian', '', 'Li']]",Current Opinion in Infectious Diseases,2009,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00001432-200912000-00004'],
10.1093/jac/dkm509,"Falagas, M., Rafailidis, P., , Re-emergence of colistin in today's world of multidrug-resistant organisms: personal perspectives, Expert Opinion on Investigational Drugs, 2008",cited-by,10.1517/13543784.17.7.973,Re-emergence of colistin in today's world of multidrug-resistant organisms: personal perspectives,"[['Matthew', 'E', 'Falagas'], ['Petros', 'I', 'Rafailidis']]",Expert Opinion on Investigational Drugs,2008,[u'http://www.informapharmascience.com/doi/abs/10.1517/13543784.17.7.973'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1517~13543784.17.7.973
10.1093/jac/dkm509,"Falagas, M., Sideri, G., Vouloumanou, E., et. al, Intravenous Colistimethate (Colistin) Use in Critically Ill Children Without Cystic Fibrosis, Pediatric Infectious Disease Journal, 2009",cited-by,10.1097/INF.0b013e31818a5dbd,Intravenous Colistimethate (Colistin) Use in Critically Ill Children Without Cystic Fibrosis,"[['Matthew', 'E.', 'Falagas'], ['Georgia', '', 'Sideri'], ['Evridiki', 'K.', 'Vouloumanou'], ['John', 'H.', 'Papadatos'], ['Dimitris', 'A.', 'Kafetzis']]",Pediatric Infectious Disease Journal,2009,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00006454-200902000-00009'],
10.1093/jac/dkm509,"Paul, M., Bishara, J., Levcovich, A., et. al, Effectiveness and safety of colistin: prospective comparative cohort study, Journal of Antimicrobial Chemotherapy, 2010",cited-by,10.1093/jac/dkq069,Effectiveness and safety of colistin: prospective comparative cohort study,"[['M.', '', 'Paul'], ['J.', '', 'Bishara'], ['A.', '', 'Levcovich'], ['M.', '', 'Chowers'], ['E.', '', 'Goldberg'], ['P.', '', 'Singer'], ['S.', '', 'Lev'], ['P.', '', 'Leon'], ['M.', '', 'Raskin'], ['D.', '', 'Yahav'], ['L.', '', 'Leibovici']]",Journal of Antimicrobial Chemotherapy,2010,[u'http://www.jac.oxfordjournals.org/cgi/doi/10.1093/jac/dkq069'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1093~jac~dkq069
10.1093/jac/dkm509,"Garnacho-Montero, J., Amaya-Villar, R., , Multiresistant Acinetobacter baumannii infections: epidemiology and management, Current Opinion in Infectious Diseases, 2010",cited-by,10.1097/QCO.0b013e32833ae38b,Multiresistant Acinetobacter baumannii infections: epidemiology and management,"[['Jos\xc3\xa9', '', 'Garnacho-Montero'], ['Rosario', '', 'Amaya-Villar']]",Current Opinion in Infectious Diseases,2010,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00001432-201008000-00008'],
10.1093/jac/dkm509,"Robledo, I., Aquino, E., Sante, M., et. al, Detection of KPC in Acinetobacter spp. in Puerto Rico, Antimicrobial Agents and Chemotherapy, 2010",cited-by,10.1128/AAC.00899-09,Detection of KPC in Acinetobacter spp. in Puerto Rico,"[['Iraida', 'E.', 'Robledo'], ['Edna', 'E.', 'Aquino'], ['M.', 'I.', 'Sante'], ['Jorge', 'L.', 'Santana'], ['Diana', 'M.', 'Otero'], ['Carlos', 'F.', 'Leon'], ['Guillermo', 'J.', 'Vazquez']]",Antimicrobial Agents and Chemotherapy,2010,"[u'http://aac.asm.org/cgi/doi/10.1128/AAC.00899-09', u'http://aac.asm.org/cgi/reprint/54/3/1354.pdf']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1128~AAC.00899-09
10.1093/jac/dkm509,"Cascio, A., Conti, A., Sinardi, L., et. al, Post-neurosurgical multidrug-resistant Acinetobacter baumannii meningitis successfully treated with intrathecal colistin. A new case and a systematic review of the literature, International Journal of Infectious Diseases, 2010",cited-by,10.1016/j.ijid.2009.06.032,Post-neurosurgical multidrug-resistant Acinetobacter baumannii meningitis successfully treated with intrathecal colistin. A new case and a systematic review of the literature,"[['Antonio', '', 'Cascio'], ['Alfredo', '', 'Conti'], ['Luca', '', 'Sinardi'], ['Chiara', '', 'Iaria'], ['Filippo', 'Flavio', 'Angileri'], ['Giovanna', '', 'Stassi'], ['Teresa', '', 'David'], ['Antonio', '', 'Versaci'], ['Maurizio', '', 'Iaria'], ['Antonio', '', 'David']]",International Journal of Infectious Diseases,2010,"[u'http://www.sciencedirect.com/science/article/pii/S1201971209003191', u'http://linkinghub.elsevier.com/retrieve/pii/S1201971209003191']",
10.1093/jac/dkm509,"Visentin, B., Charrier, J., Roudier, D., et. al, Experimental results on 700 MHz multicell superconducting cavity for proton linac, , 2003",cited-by,10.1109/PAC.2003.1289686,Experimental results on 700 MHz multicell superconducting cavity for proton linac,"[['B.', '', 'Visentin'], ['J.', 'P.', 'Charrier'], ['D.', '', 'Roudier'], ['F.', '', 'Simoens'], ['E.', '', 'Jacques'], ['A.', '', 'Aspart'], ['Y.', '', 'Gasser'], ['J.', 'P.', 'Poupeau'], ['P.', '', 'Sahuquet'], ['D.', '', 'Braud'], ['H.', '', 'Saugnac'], ['Ph.', '', 'Szott'], ['S.', '', 'Bousson'], ['J.', 'L.', 'Biarrotte'], ['T.', '', 'Junquera'], ['S.', '', 'Blivet']]",,2003,"[u'http://ieeexplore.ieee.org/xpls/abs_all.jsp?arnumber=1289686', u'http://ieeexplore.ieee.org/stamp/stamp.jsp?arnumber=01289686', u'http://adsabs.harvard.edu/abs/2003pac..conf.1303V']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1109~PAC.2003.1289686
10.1093/jac/dkm509,"Monteiro, D., Madrid, M., , Planning of robot trajectories with genetic algorithms, , 1999",cited-by,10.1109/ROMOCO.1999.791079,Planning of robot trajectories with genetic algorithms,"[['D.', 'C.', 'Monteiro'], ['M.', 'K.', 'Madrid']]",,1999,"[u'http://ieeexplore.ieee.org/xpls/abs_all.jsp?arnumber=791079', u'http://ieeexplore.ieee.org/stamp/stamp.jsp?arnumber=00791079']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1109~ROMOCO.1999.791079
10.1093/jac/dkm509,"Drapeau, C., Grilli, E., Petrosillo, N., , Rifampicin combined regimens for Gram-negative infections: data from the literature, International Journal of Antimicrobial Agents, 2010",cited-by,10.1016/j.ijantimicag.2009.08.011,Rifampicin combined regimens for Gram-negative infections: data from the literature,"[['C.', 'M. J.', 'Drapeau'], ['E.', '', 'Grilli'], ['N.', '', 'Petrosillo']]",International Journal of Antimicrobial Agents,2010,"[u'http://www.sciencedirect.com/science/article/pii/S092485790900404X', u'http://linkinghub.elsevier.com/retrieve/pii/S092485790900404X']",
10.1093/jac/dkm509,"Bassetti, M., Righi, E., Esposito, S., et. al, Drug treatment for multidrug-resistant Acinetobacter baumannii infections, Future Microbiology, 2008",cited-by,10.2217/17460913.3.6.649,Drug treatment for multidrug-resistant Acinetobacter baumannii infections,"[['Matteo', '', 'Bassetti'], ['Elda', '', 'Righi'], ['Silvano', '', 'Esposito'], ['Nicola', '', 'Petrosillo'], ['Laura', '', 'Nicolini']]",Future Microbiology,2008,[u'http://www.futuremedicine.com/doi/abs/10.2217/17460913.3.6.649'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.2217~17460913.3.6.649
10.1093/jac/dkm509,"Usher, J., Alexander, S., Thompson, J., , Predicting the reliability of new products at IBM, , 1991",cited-by,10.1109/ARMS.1991.154437,Predicting the reliability of new products at IBM,"[['J.', 'S.', 'Usher'], ['S.', 'M.', 'Alexander'], ['J.', 'D.', 'Thompson']]",,1991,[u'http://ieeexplore.ieee.org/xpls/abs_all.jsp?arnumber=154437'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1109~ARMS.1991.154437
10.1093/jac/dkm509,"Barnos, B., , The electrified fence as a component of a physical protection system, , 1989",cited-by,10.1109/CCST.1989.751985,The electrified fence as a component of a physical protection system,"[['B.', 'W.', 'Barnos']]",,1989,[u'http://ieeexplore.ieee.org/xpls/abs_all.jsp?arnumber=751985'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1109~CCST.1989.751985
10.1093/jac/dkm509,"Spapen, H., Jacobs, R., Gorp, V., et. al, Renal and neurological side effects of colistin in critically ill patients, Annals of Intensive Care, 2011",cited-by,10.1186/2110-5820-1-14,Renal and neurological side effects of colistin in critically ill patients,"[['Herbert', '', 'Spapen'], ['Rita', '', 'Jacobs'], ['Viola', 'Van', 'Gorp'], ['Joris', '', 'Troubleyn'], ['Patrick', 'M', 'Honor\xc3\xa9']]",Annals of Intensive Care,2011,"[u'http://www.springerlink.com/index/j53j3l42kl32202u.pdf', u'http://www.springerlink.com/content/j53j3l42kl32202u']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1186~2110-5820-1-14
10.1093/jac/dkm509,"Wang, R., Bencic, D., Lazorchak, J., et. al, Transcriptional regulatory dynamics of the hypothalamic–pituitary–gonadal axis and its peripheral pathways as impacted by the 3-beta HSD inhibitor trilostane in zebrafish ( Danio rerio), Ecotoxicology and Environmental Safety, 2011",cited-by,10.1016/j.ecoenv.2011.05.001,Transcriptional regulatory dynamics of the hypothalamic–pituitary–gonadal axis and its peripheral pathways as impacted by the 3-beta HSD inhibitor trilostane in zebrafish ( Danio rerio),"[['Rong-Lin', '', 'Wang'], ['David', '', 'Bencic'], ['Jim', '', 'Lazorchak'], ['Daniel', '', 'Villeneuve'], ['Gerald', 'T.', 'Ankley']]",Ecotoxicology and Environmental Safety,2011,[u'http://www.sciencedirect.com/science/article/pii/S0147651311001308'],
10.1093/jac/dkm509,"Cunha, B., Mickail, N., Schoch, P., , Human parainfluenza virus type 3 (HPIV 3) community-acquired pneumonia (CAP) mimicking pertussis in an adult: The diagnostic importance of hoarseness and monocytosis, Heart & Lung, 2011",cited-by,10.1016/j.hrtlng.2010.06.004,Human parainfluenza virus type 3 (HPIV 3) community-acquired pneumonia (CAP) mimicking pertussis in an adult: The diagnostic importance of hoarseness and monocytosis,"[['Burke', 'A.', 'Cunha'], ['Nardeen', '', 'Mickail'], ['Paul', '', 'Schoch']]",Heart & Lung,2011,[u'http://www.sciencedirect.com/science/article/pii/S0147956310002190'],
10.1093/jac/dkm509,"Luca, M., Angelino, G., Carducci, F., et. al, Multidrug-resistant Acinetobacter baumannii infection in children, Case Reports, 2011",cited-by,10.1136/bcr.02.2011.3807,Multidrug-resistant Acinetobacter baumannii infection in children,"[['Maia', 'De', 'Luca'], ['Giulia', '', 'Angelino'], ['Francesca', 'Ippolita Cal\xc3\xb2', 'Carducci'], ['Alessandra', '', 'Martino'], ['Stefania', '', 'Bernardi'], ['Paola', '', 'Bernaschi'], ['Michaela', '', 'Carletti'], ['Patrizia', '', 'D\xe2\x80\x99Argenio'], ['Paolo', '', 'Palma']]",Case Reports,2011,[u'http://dx.doi.org/10.1136/bcr.02.2011.3807'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1136~bcr.02.2011.3807
10.1093/jac/dkm509,"Kokkonouzis, I., Christou, I., Athanasopoulos, I., et. al, Multiple lung abscesses due to acinetobacter infection: a case report, Cases Journal, 2009",cited-by,10.1186/1757-1626-2-9347,Multiple lung abscesses due to acinetobacter infection: a case report,"[['Ioannis', '', 'Kokkonouzis'], ['Ioannis', '', 'Christou'], ['Ioannis', '', 'Athanasopoulos'], ['Nikolaos', '', 'Saridis'], ['Vasilios', '', 'Skoufaras']]",Cases Journal,2009,"[u'http://www.biomedcentral.com/content/pdf/1757-1626-2-9347.pdf', u'http://www.casesjournal.com/content/2/1/9347']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1186~1757-1626-2-9347
10.1093/jac/dkm509,"Savini, V., Catavitello, C., Talia, M., et. al, Isolation of colistin-resistant Hafnia alvei, Journal of Medical Microbiology, 2009",cited-by,10.1099/jmm.0.001321-0,Isolation of colistin-resistant Hafnia alvei,"[['V.', '', 'Savini'], ['C.', '', 'Catavitello'], ['M.', '', 'Talia'], ['A.', '', 'Balbinot'], ['F.', '', 'Febbo'], ['A.', '', 'Pompilio'], ['G.', 'Di', 'Bonaventura'], ['R.', '', 'Piccolomini'], ['D.', '', ""D'Antonio""]]",Journal of Medical Microbiology,2009,[u'http://jmm.sgmjournals.org/cgi/doi/10.1099/jmm.0.001321-0'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1099~jmm.0.001321-0
10.1093/jac/dkm509,"Le, T., Yu, H., , PIN10 A COST CONSEQUENCE ON CONCOMITANT DRUG USE DURING HCV THERAPY IN MANAGED CARE PATIENTS IN THE UNITED STATES, Value in Health, 2003",cited-by,10.1016/S1098-3015(10)61907-9,PIN10 A COST CONSEQUENCE ON CONCOMITANT DRUG USE DURING HCV THERAPY IN MANAGED CARE PATIENTS IN THE UNITED STATES,"[['TK', '', 'Le'], ['H', '', 'Yu']]",Value in Health,2003,[u'http://www.sciencedirect.com/science/article/pii/S1098301510619079'],
10.1093/jac/dkm509,"Pennathur, S., Kwok, H., , Simulation of charge transfer in GaAs cermet-gate CCDs, , 1991",cited-by,10.1109/PACRIM.1991.160791,Simulation of charge transfer in GaAs cermet-gate CCDs,"[['S.', '', 'Pennathur'], ['H.', 'H. L.', 'Kwok']]",,1991,"[u'http://ieeexplore.ieee.org/stamp/stamp.jsp?arnumber=00160791', u'http://ieeexplore.ieee.org/xpls/abs_all.jsp?arnumber=160791']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1109~PACRIM.1991.160791
10.1517~13543784.17.7.973.pdf,"J Antimicrob Chemother 2008;61(2):417-20 36. Tascini C, Gemignani G, Palumbo F, et al. Clinical and microbiological efficacy of colistin therapy alone or in combination as treatment for multidrug resistant Pseudomonas aeruginosa diabetic foot infections with or without osteomyelitis.",references,NOT found in MAS
10.1517~13543784.17.7.973.pdf,"J Chemother 2006;18(6):648-51 37. Kallel H, Bahloul M, Hergafi L, et al.",references,NOT found in MAS
10.1517~13543784.17.7.973.pdf,"Colistin as a salvage therapy for nosocomial infections caused by multidrug-resistant bacteria in the ICU. Int J Antimicrob Agents 2006;28(4):366-9 38. Rios FG, Luna CM, Maskin B, et al. Ventilator-associated pneumonia due to colistin susceptible-only microorganisms.",references,10.1016/j.ijantimicag.2006.07.008,Colistin as a salvage therapy for nosocomial infections caused by multidrug-resistant bacteria in the ICU,"[[u'Hatem', u'', u'Kallel'], [u'Mabrouk', u'', u'Bahloul'], [u'Leila', u'', u'Hergafi'], [u'Malek', u'', u'Akrout'], [u'Wajdi', u'', u'Ketata'], [u'Hedi', u'', u'Chelly'], [u'Chokri', u'Ben', u'Hamida'], [u'Noureddine', u'', u'Rekik'], [u'Adnane', u'', u'Hammami'], [u'Mounir', u'', u'Bouaziz']]",International Journal of Antimicrobial Agents,2006,"[u'http://www.sciencedirect.com/science/article/pii/S0924857906002901', u'http://linkinghub.elsevier.com/retrieve/pii/S0924857906002901']",
10.1016/j.ijantimicag.2006.07.008,"Karageorgopoulos, D., Falagas, M., , Current control and treatment of multidrug-resistant Acinetobacter baumannii infections, Lancet Infectious Diseases, 2008",cited-by,10.1016/S1473-3099(08)70279-2,Current control and treatment of multidrug-resistant Acinetobacter baumannii infections,"[['Drosos', 'E', 'Karageorgopoulos'], ['Matthew', 'E', 'Falagas']]",Lancet Infectious Diseases,2008,"[u'http://www.sciencedirect.com/science/article/pii/S1473309908702792', u'http://linkinghub.elsevier.com/retrieve/pii/S1473309908702792']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1016~S1473-3099(08)70279-2
10.1016/j.ijantimicag.2006.07.008,"Kallel, H., Hergafi, L., Bahloul, M., et. al, Safety and efficacy of colistin compared with imipenem in the treatmentof ventilator-associated pneumonia: a matched case–control study, Intensive Care Medicine, 2007",cited-by,10.1007/s00134-007-0675-2,Safety and efficacy of colistin compared with imipenem in the treatmentof ventilator-associated pneumonia: a matched case–control study,"[['H.', '', 'Kallel'], ['L.', '', 'Hergafi'], ['M.', '', 'Bahloul'], ['A.', '', 'Hakim'], ['H.', '', 'Dammak'], ['H.', '', 'Chelly'], ['C.', 'Ben', 'Hamida'], ['A.', '', 'Chaari'], ['N.', '', 'Rekik'], ['M.', '', 'Bouaziz']]",Intensive Care Medicine,2007,"[u'http://www.springerlink.com/content/211g0x62127980k2', u'http://www.springerlink.com/index/211g0x62127980k2.pdf', u'http://www.springerlink.com/index/10.1007/s00134-007-0675-2', u'http://www.springerlink.com/index/pdf/10.1007/s00134-007-0675-2']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1007~s00134-007-0675-2
10.1016/j.ijantimicag.2006.07.008,"Pintado, V., Miguel, L., Grill, F., et. al, Intravenous colistin sulphomethate sodium for therapy of infections due to multidrug-resistant gram-negative bacteria, Journal of Infection, 2008",cited-by,10.1016/j.jinf.2008.01.003,Intravenous colistin sulphomethate sodium for therapy of infections due to multidrug-resistant gram-negative bacteria,"[['Vicente', '', 'Pintado'], ['Luc\xc3\xada', 'Garc\xc3\xada San', 'Miguel'], ['Fabio', '', 'Grill'], ['Blanca', '', 'Mej\xc3\xada'], ['Javier', '', 'Cobo'], ['Jes\xc3\xbas', '', 'Fort\xc3\xban'], ['Pilar', '', 'Mart\xc3\xadn-D\xc3\xa1vila'], ['Santiago', '', 'Moreno']]",Journal of Infection,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0163445308000078', u'http://linkinghub.elsevier.com/retrieve/pii/S0163445308000078']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1016~j.jinf.2008.01.003
10.1016/j.ijantimicag.2006.07.008,"Petrosillo, N., Ioannidou, E., Falagas, M., , Colistin monotherapy vs. combination therapy: evidence from microbiological, animal and clinical studies, Clinical Microbiology and Infection, 2008",cited-by,10.1111/j.1469-0691.2008.02061.x,"Colistin monotherapy vs. combination therapy: evidence from microbiological, animal and clinical studies","[['N.', '', 'Petrosillo'], ['E.', '', 'Ioannidou'], ['M.', 'E.', 'Falagas']]",Clinical Microbiology and Infection,2008,[u'http://blackwell-synergy.com/doi/abs/10.1111/j.1469-0691.2008.02061.x'],
10.1016/j.ijantimicag.2006.07.008,", Antimicrobial Resistance: Acinetobacter baumannii: Epidemiology, Antimicrobial Resistance, and Treatment Options, Clinical Infectious Diseases, 2008",cited-by,10.1086/529198,"Antimicrobial Resistance: Acinetobacter baumannii: Epidemiology, Antimicrobial Resistance, and Treatment Options",[],Clinical Infectious Diseases,2008,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/529198'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1086~529198
10.1016/j.ijantimicag.2006.07.008,"Betrosian, A., Frantzeskaki, F., Xanthaki, A., et. al, Efficacy and safety of high-dose ampicillin/sulbactam vs. colistin as monotherapy for the treatment of multidrug resistant Acinetobacter baumannii ventilator-associated pneumonia, Journal of Infection, 2008",cited-by,10.1016/j.jinf.2008.04.002,Efficacy and safety of high-dose ampicillin/sulbactam vs. colistin as monotherapy for the treatment of multidrug resistant Acinetobacter baumannii ventilator-associated pneumonia,"[['Alex', 'P.', 'Betrosian'], ['Frantzeska', '', 'Frantzeskaki'], ['Anna', '', 'Xanthaki'], ['Emmanuel', 'E.', 'Douzinas']]",Journal of Infection,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0163445308001497', u'http://linkinghub.elsevier.com/retrieve/pii/S0163445308001497']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1016~j.jinf.2008.04.002
10.1016/j.ijantimicag.2006.07.008,"Falagas, M., Rafailidis, P., , Re-emergence of colistin in today's world of multidrug-resistant organisms: personal perspectives, Expert Opinion on Investigational Drugs, 2008",cited-by,10.1517/13543784.17.7.973,Re-emergence of colistin in today's world of multidrug-resistant organisms: personal perspectives,"[['Matthew', 'E', 'Falagas'], ['Petros', 'I', 'Rafailidis']]",Expert Opinion on Investigational Drugs,2008,[u'http://www.informapharmascience.com/doi/abs/10.1517/13543784.17.7.973'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1517~13543784.17.7.973
10.1016/j.ijantimicag.2006.07.008,"Gilad, J., Carmeli, Y., , Treatment Options for??Multidrug-Resistant Acinetobacter Species, Drugs, 2008",cited-by,10.2165/00003495-200868020-00003,Treatment Options for??Multidrug-Resistant Acinetobacter Species,"[['Jacob', '', 'Gilad'], ['Yehuda', '', 'Carmeli']]",Drugs,2008,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00003495-200868020-00003'],
10.1016/j.ijantimicag.2006.07.008,"Hirsch, E., Tam, V., , Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection, Journal of Antimicrobial Chemotherapy, 2010",cited-by,10.1093/jac/dkq108,Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection,"[['E.', 'B.', 'Hirsch'], ['V.', 'H.', 'Tam']]",Journal of Antimicrobial Chemotherapy,2010,[u'http://www.jac.oxfordjournals.org/cgi/doi/10.1093/jac/dkq108'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1093~jac~dkq108
10.1016/j.ijantimicag.2006.07.008,"Tewes, F., Brillault, J., Couet, W., et. al, Formulation of rifampicin–cyclodextrin complexes for lung nebulization, Journal of Controlled Release, 2008",cited-by,10.1016/j.jconrel.2008.04.007,Formulation of rifampicin–cyclodextrin complexes for lung nebulization,"[['Fr\xc3\xa9d\xc3\xa9ric', '', 'Tewes'], ['Julien', '', 'Brillault'], ['William', '', 'Couet'], ['Jean-Christophe', '', 'Olivier']]",Journal of Controlled Release,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0168365908001946', u'http://linkinghub.elsevier.com/retrieve/pii/S0168365908001946']",
10.1016/j.ijantimicag.2006.07.008,"Furtado, G., d’Azevedo, P., Santos, A., et. al, Intravenous polymyxin B for the treatment of nosocomial pneumonia caused by multidrug-resistant Pseudomonas aeruginosa, International Journal of Antimicrobial Agents, 2007",cited-by,10.1016/j.ijantimicag.2007.05.017,Intravenous polymyxin B for the treatment of nosocomial pneumonia caused by multidrug-resistant Pseudomonas aeruginosa,"[['Guilherme', 'Henrique Campos', 'Furtado'], ['Pedro', 'Alves', 'd\xe2\x80\x99Azevedo'], ['Anderson', 'Fernandes', 'Santos'], ['Ana', 'Cristina', 'Gales'], ['Ant\xc3\xb4nio', 'Carlos Campos', 'Pignatari'], ['Eduardo', 'Alexandrino Servolo', 'Medeiros']]",International Journal of Antimicrobial Agents,2007,"[u'http://www.sciencedirect.com/science/article/pii/S0924857907002622', u'http://linkinghub.elsevier.com/retrieve/pii/S0924857907002622']",
10.1016/j.ijantimicag.2006.07.008,"Oteo, J., García-Estébanez, C., Migueláñez, S., et. al, Genotypic diversity of imipenem resistant isolates of Acinetobacter baumannii in Spain, Journal of Infection, 2007",cited-by,10.1016/j.jinf.2007.04.009,Genotypic diversity of imipenem resistant isolates of Acinetobacter baumannii in Spain,"[['Jes\xc3\xbas', '', 'Oteo'], ['Carmen', '', 'Garc\xc3\xada-Est\xc3\xa9banez'], ['Silvia', '', 'Miguel\xc3\xa1\xc3\xb1ez'], ['Jos\xc3\xa9', '', 'Campos'], ['Sara', '', 'Mart\xc3\xad'], ['Jordi', '', 'Vila'], ['Fernando', '', 'Docobo'], ['Nieves', '', 'Larrosa'], ['\xc3\x81lvaro', '', 'Pascual'], ['Vicente', '', 'Pintado'], ['Pere', '', 'Coll']]",Journal of Infection,2007,"[u'http://www.sciencedirect.com/science/article/pii/S0163445307000990', u'http://linkinghub.elsevier.com/retrieve/pii/S0163445307000990']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1016~j.jinf.2007.04.009
10.1016/j.ijantimicag.2006.07.008,"Nicasio, A., Kuti, J., Nicolau, D., , The Current State of Multidrug-Resistant Gram-Negative Bacilli in North America: Insights from the Society of Infectious Diseases Pharmacists, Pharmacotherapy, 2008",cited-by,10.1592/phco.28.2.235,The Current State of Multidrug-Resistant Gram-Negative Bacilli in North America: Insights from the Society of Infectious Diseases Pharmacists,"[['Anthony', 'M', 'Nicasio'], ['Joseph', 'L', 'Kuti'], ['David', 'P', 'Nicolau']]",Pharmacotherapy,2008,[u'http://www.atypon-link.com/PPI/doi/abs/10.1592/phco.28.2.235'],
10.1016/j.ijantimicag.2006.07.008,"Cheng, C., Sheng, W., Wang, J., et. al, Safety and efficacy of intravenous colistin (colistin methanesulphonate) for severe multidrug-resistant Gram-negative bacterial infections, International Journal of Antimicrobial Agents, 2010",cited-by,10.1016/j.ijantimicag.2009.11.016,Safety and efficacy of intravenous colistin (colistin methanesulphonate) for severe multidrug-resistant Gram-negative bacterial infections,"[['Chien-Yu', '', 'Cheng'], ['Wang-Huei', '', 'Sheng'], ['Jann-Tay', '', 'Wang'], ['Yee-Chun', '', 'Chen'], ['Shan-Chwen', '', 'Chang']]",International Journal of Antimicrobial Agents,2010,"[u'http://www.sciencedirect.com/science/article/pii/S0924857909005500', u'http://linkinghub.elsevier.com/retrieve/pii/S0924857909005500']",
10.1016/j.ijantimicag.2006.07.008,"Montero, M., Horcajada, J., Sorlí, L., et. al, Effectiveness and safety of colistin for the treatment of multidrug-resistant Pseudomonas aeruginosa infections, Infection, 2009",cited-by,10.1007/s15010-009-8342-x,Effectiveness and safety of colistin for the treatment of multidrug-resistant Pseudomonas aeruginosa infections,"[['M.', '', 'Montero'], ['J.', 'P.', 'Horcajada'], ['L.', '', 'Sorl\xc3\xad'], ['F.', '', 'Alvarez-Lerma'], ['S.', '', 'Grau'], ['M.', '', 'Riu'], ['M.', '', 'Sala'], ['H.', '', 'Knobel']]",Infection,2009,"[u'http://www.springerlink.com/content/225961w455x24303', u'http://www.springerlink.com/index/225961w455x24303.pdf', u'http://www.springerlink.com/index/10.1007/s15010-009-8342-x', u'http://www.springerlink.com/index/pdf/10.1007/s15010-009-8342-x']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1007~s15010-009-8342-x
10.1016/j.ijantimicag.2006.07.008,"Dizbay, M., Tozlu, D., Cirak, M., et. al, In vitro synergistic activity of tigecycline and colistin against XDR-Acinetobacter baumannii, Journal of Antibiotics, 2010",cited-by,10.1038/ja.2009.117,In vitro synergistic activity of tigecycline and colistin against XDR-Acinetobacter baumannii,"[['Murat', '', 'Dizbay'], ['Derya', 'Keten', 'Tozlu'], ['Meltem', 'Yalinay', 'Cirak'], ['Yasemin', '', 'Isik'], ['Kevser', '', 'Ozdemir'], ['Dilek', '', 'Arman']]",Journal of Antibiotics,2010,"[u'http://www.nature.com/doifinder/10.1038/ja.2009.117', u'http://dx.doi.org/10.1038/ja.2009.117']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1038~ja.2009.117
10.1016/j.ijantimicag.2006.07.008,"Miyajima, Y., Hiramatsu, K., Mizukami, E., et. al, In vitro and in vivo potency of polymyxin B against IMP-type metallo-β-lactamase-producing Pseudomonas aeruginosa, International Journal of Antimicrobial Agents, 2008",cited-by,10.1016/j.ijantimicag.2008.05.006,In vitro and in vivo potency of polymyxin B against IMP-type metallo-β-lactamase-producing Pseudomonas aeruginosa,"[['Yoshiko', '', 'Miyajima'], ['Kazufumi', '', 'Hiramatsu'], ['Eri', '', 'Mizukami'], ['Ryotaro', '', 'Morinaga'], ['Hiroshi', '', 'Ishii'], ['Ryo', '', 'Shirai'], ['Kenji', '', 'Kishi'], ['Issei', '', 'Tokimatsu'], ['Tetsunori', '', 'Saikawa'], ['Jun-ichi', '', 'Kadota']]",International Journal of Antimicrobial Agents,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0924857908002379', u'http://linkinghub.elsevier.com/retrieve/pii/S0924857908002379']",
10.1016/j.ijantimicag.2006.07.008,"Routsias, J., Karagounis, P., Parvulesku, G., et. al, In vitro bactericidal activity of human β-defensin 2 against nosocomial strains, Peptides, 2010",cited-by,10.1016/j.peptides.2010.06.010,In vitro bactericidal activity of human β-defensin 2 against nosocomial strains,"[['John', 'G.', 'Routsias'], ['Panagiotis', '', 'Karagounis'], ['Georgeta', '', 'Parvulesku'], ['Nikolaos', 'J.', 'Legakis'], ['Athanassios', '', 'Tsakris']]",Peptides,2010,"[u'http://www.sciencedirect.com/science/article/pii/S0196978110002548', u'http://linkinghub.elsevier.com/retrieve/pii/S0196978110002548']",
10.1016/j.ijantimicag.2006.07.008,"Kim, J., Lee, K., Yoo, S., et. al, Clinical characteristics and risk factors of colistin-induced nephrotoxicity, International Journal of Antimicrobial Agents, 2009",cited-by,10.1016/j.ijantimicag.2009.06.028,Clinical characteristics and risk factors of colistin-induced nephrotoxicity,"[['Jieun', '', 'Kim'], ['Kyoung-Ho', '', 'Lee'], ['Sunmi', '', 'Yoo'], ['Hyunjoo', '', 'Pai']]",International Journal of Antimicrobial Agents,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0924857909003525', u'http://linkinghub.elsevier.com/retrieve/pii/S0924857909003525']",
10.1016/j.ijantimicag.2006.07.008,"MUTA, O., AKAIWA, Y., , Adaptive channel selection in frequency-selective fading environment, , 1999",cited-by,10.1109/ICC.1999.765582,Adaptive channel selection in frequency-selective fading environment,"[['Osamu', '', 'MUTA'], ['Yoshihiko', '', 'AKAIWA']]",,1999,"[u'http://ieeexplore.ieee.org/xpls/abs_all.jsp?arnumber=765582', u'http://ieeexplore.ieee.org/stamp/stamp.jsp?arnumber=00765582']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1109~ICC.1999.765582
10.1016/j.ijantimicag.2006.07.008,"Lin, C., Liu, T., Kuo, C., et. al, Aerosolized Colistin for the Treatment of Multidrug-resistant Acinetobacter baumannii Pneumonia: Experience in a Tertiary Care Hospital in Northern Taiwan, Journal of Microbiology Immunology and Infection, 2010",cited-by,10.1016/S1684-1182(10)60050-3,Aerosolized Colistin for the Treatment of Multidrug-resistant Acinetobacter baumannii Pneumonia: Experience in a Tertiary Care Hospital in Northern Taiwan,"[['Cheng-Chih', '', 'Lin'], ['Te-Chu', '', 'Liu'], ['Chen-Feng', '', 'Kuo'], ['Chang-Pan', '', 'Liu'], ['Chun-Ming', '', 'Lee']]",Journal of Microbiology Immunology and Infection,2010,"[u'http://www.sciencedirect.com/science/article/pii/S1684118210600503', u'http://linkinghub.elsevier.com/retrieve/pii/S1684118210600503']",
10.1016/j.ijantimicag.2006.07.008,"Volles, D., Branan, T., , Antibiotics in the Intensive Care Unit: Focus on Agents for Resistant Pathogens, Emergency Medicine Clinics of North America, 2008",cited-by,10.1016/j.emc.2008.04.006,Antibiotics in the Intensive Care Unit: Focus on Agents for Resistant Pathogens,"[['David', 'F.', 'Volles'], ['Trisha', 'N.', 'Branan']]",Emergency Medicine Clinics of North America,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0733862708000515', u'http://linkinghub.elsevier.com/retrieve/pii/S0733862708000515']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1016~j.emc.2008.04.006
10.1016/j.ijantimicag.2006.07.008,"Levin, A., Oliveira, M., , THE CHALLENGE OF MULTIDRUG RESISTANCE: THE TREATMENT OF GRAM-NEGATIVE ROD INFECTIONS, Shock, 2008",cited-by,10.1097/SHK.0b013e3181819cb8,THE CHALLENGE OF MULTIDRUG RESISTANCE: THE TREATMENT OF GRAM-NEGATIVE ROD INFECTIONS,"[['Anna', 'S.', 'Levin'], ['Maura', 'S.', 'Oliveira']]",Shock,2008,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00024382-200810001-00007'],
10.1016/j.ijantimicag.2006.07.008,"Spapen, H., Jacobs, R., Gorp, V., et. al, Renal and neurological side effects of colistin in critically ill patients, Annals of Intensive Care, 2011",cited-by,10.1186/2110-5820-1-14,Renal and neurological side effects of colistin in critically ill patients,"[['Herbert', '', 'Spapen'], ['Rita', '', 'Jacobs'], ['Viola', 'Van', 'Gorp'], ['Joris', '', 'Troubleyn'], ['Patrick', 'M', 'Honor\xc3\xa9']]",Annals of Intensive Care,2011,"[u'http://www.springerlink.com/index/j53j3l42kl32202u.pdf', u'http://www.springerlink.com/content/j53j3l42kl32202u']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1186~2110-5820-1-14
10.1016/j.ijantimicag.2006.07.008,"Korbila, I., Michalopoulos, A., Rafailidis, P., et. al, Inhaled colistin as adjunctive therapy to intravenous colistin for the treatment of microbiologically documented ventilator-associated pneumonia: a comparative cohort study: Inhaled plus i.v. colistin for VAP, Clinical Microbiology and Infection, 2009",cited-by,10.1111/j.1469-0691.2009.03040.x,Inhaled colistin as adjunctive therapy to intravenous colistin for the treatment of microbiologically documented ventilator-associated pneumonia: a comparative cohort study: Inhaled plus i.v. colistin for VAP,"[['I.', 'P.', 'Korbila'], ['A.', '', 'Michalopoulos'], ['P.', 'I.', 'Rafailidis'], ['D.', '', 'Nikita'], ['G.', '', 'Samonis'], ['M.', 'E.', 'Falagas']]",Clinical Microbiology and Infection,2009,[u'http://doi.wiley.com/10.1111/j.1469-0691.2009.03040.x'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1111~j.1469-0691.2009.03040.x
10.1016/j.ijantimicag.2006.07.008,"Abu-Salah, T., Dhand, R., , Inhaled antibiotic therapy for ventilator-associated tracheobronchitis and ventilator-associated pneumonia: an Update, Advances in Therapy, 0",cited-by,10.1007/s12325-011-0051-z,Inhaled antibiotic therapy for ventilator-associated tracheobronchitis and ventilator-associated pneumonia: an Update,"[['Tareq', '', 'Abu-Salah'], ['Rajiv', '', 'Dhand']]",Advances in Therapy,0,"[u'http://www.springerlink.com/index/hp62224831501166.pdf', u'http://www.springerlink.com/content/hp62224831501166']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1007~s12325-011-0051-z
10.1517~13543784.17.7.973.pdf,"Eur Respir J 2007;30(2):307-13 39. Kasiakou SK, Rafailidis PI, Liaropoulos K, Falagas ME. Cure of post-traumatic recurrent multiresistant Gram-negative rod meningitis with intraventricular colistin. J Infect 2005;50(4):348-52 40. Ng J, Gosbell IB, Kelly JA, et al. Cure of multiresistant Acinetobacter baumannii central nervous system infections with intraventricular or intrathecal colistin: case series and literature review.",references,10.1016/j.jinf.2004.05.008,Cure of post-traumatic recurrent multiresistant Gram-negative rod meningitis with intraventricular colistin,"[[u'Sofia', u'K.', u'Kasiakou'], [u'Petros', u'I.', u'Rafailidis'], [u'Konstantinos', u'', u'Liaropoulos'], [u'Matthew', u'E.', u'Falagas']]",Journal of Infection,2005,"[u'http://www.sciencedirect.com/science/article/pii/S0163445304000982', u'http://linkinghub.elsevier.com/retrieve/pii/S0163445304000982']",./output/10.1517~13543784.17.7.973.pdf/10.1016~j.jinf.2004.05.008
10.1016/j.jinf.2004.05.008,"Li, J., Nation, R., Turnidge, J., et. al, Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections, Lancet Infectious Diseases, 2006",cited-by,10.1016/S1473-3099(06)70580-1,Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections,"[['Jian', '', 'Li'], ['Roger', 'L', 'Nation'], ['John', 'D', 'Turnidge'], ['Robert', 'W', 'Milne'], ['Kingsley', '', 'Coulthard'], ['Craig', 'R', 'Rayner'], ['David', 'L', 'Paterson']]",Lancet Infectious Diseases,2006,"[u'http://www.sld.cu/galerias/pdf/sitios/apua-cuba/r15-colistin._the_re-emerging_antibiotic_for_multidrug-resistant_gram-negative_bacterial_infections.pdf', u'http://www.sciencedirect.com/science/article/pii/S1473309906705801', u'http://www.sld.cu/galerias/pdf/sitios/apua-cuba/a21-colistin._the_re-emerging_antibiotic_for_multidrug-resistant_gram-negative_bacterial_infections.pdf', u'http://info.med.yale.edu/intmed/infdis/resources/docs/colistin-review-lancet.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S1473309906705801']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1016~S1473-3099(06)70580-1
10.1016/j.jinf.2004.05.008,"Ng, J., Gosbell, I., Kelly, J., et. al, Cure of multiresistant Acinetobacter baumannii central nervous system infections with intraventricular or intrathecal colistin: case series and literature review, , 2006",cited-by,11796000Cure of multiresistant Acinetobacter baumannii central nervous system infections with intraventricular or intrathecal colistin: case series and literature review,Cure of multiresistant Acinetobacter baumannii central nervous system infections with intraventricular or intrathecal colistin: case series and literature review,"[['John', '', 'Ng'], ['Iain', 'B.', 'Gosbell'], ['John', 'A.', 'Kelly'], ['Michael', 'J.', 'Boyle'], ['John', 'K.', 'Ferguson']]",,2006,[u'http://jac.oxfordjournals.org/cgi/reprint/58/5/1078.pdf'],
10.1016/j.jinf.2004.05.008,"Falagas, M., Bliziotis, I., Tam, V., , Intraventricular or intrathecal use of polymyxins in patients with Gram-negative meningitis: a systematic review of the available evidence, International Journal of Antimicrobial Agents, 2007",cited-by,10.1016/j.ijantimicag.2006.08.024,Intraventricular or intrathecal use of polymyxins in patients with Gram-negative meningitis: a systematic review of the available evidence,"[['Matthew', 'E.', 'Falagas'], ['Ioannis', 'A.', 'Bliziotis'], ['Vincent', 'H.', 'Tam']]",International Journal of Antimicrobial Agents,2007,"[u'http://www.sciencedirect.com/science/article/pii/S0924857906003815', u'http://www.infeksiyon.org/docs/pdf/makale1.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S0924857906003815']",
10.1016/j.jinf.2004.05.008,"Falagas, M., Rafailidis, P., , Re-emergence of colistin in today's world of multidrug-resistant organisms: personal perspectives, Expert Opinion on Investigational Drugs, 2008",cited-by,10.1517/13543784.17.7.973,Re-emergence of colistin in today's world of multidrug-resistant organisms: personal perspectives,"[['Matthew', 'E', 'Falagas'], ['Petros', 'I', 'Rafailidis']]",Expert Opinion on Investigational Drugs,2008,[u'http://www.informapharmascience.com/doi/abs/10.1517/13543784.17.7.973'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1517~13543784.17.7.973
10.1016/j.jinf.2004.05.008,"Gilad, J., Carmeli, Y., , Treatment Options for??Multidrug-Resistant Acinetobacter Species, Drugs, 2008",cited-by,10.2165/00003495-200868020-00003,Treatment Options for??Multidrug-Resistant Acinetobacter Species,"[['Jacob', '', 'Gilad'], ['Yehuda', '', 'Carmeli']]",Drugs,2008,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00003495-200868020-00003'],
10.1016/j.jinf.2004.05.008,"Ho, Y., Wang, L., Chao, H., et. al, Successful treatment of meningitis caused by multidrug- resistant Acinetobacter baumannii with intravenous and intrathecal colistin, , 0",cited-by,12360341Successful treatment of meningitis caused by multidrug- resistant Acinetobacter baumannii with intravenous and intrathecal colistin,Successful treatment of meningitis caused by multidrug- resistant Acinetobacter baumannii with intravenous and intrathecal colistin,"[['Yu-Huai', '', 'Ho'], ['Lih-Shinn', '', 'Wang'], ['Hui-Jen', '', 'Chao'], ['Kia-Chich', '', 'Chang'], ['Chain-Fa', '', 'Su']]",,0,[u'http://www.jmii.org/content/pdf/v40n6p537.pdf'],
10.1016/j.jinf.2004.05.008,"Kim, B., Peleg, A., Lodise, T., et. al, Management of meningitis due to antibiotic-resistant Acinetobacter species, Lancet Infectious Diseases, 2009",cited-by,10.1016/S1473-3099(09)70055-6,Management of meningitis due to antibiotic-resistant Acinetobacter species,"[['Baek-Nam', '', 'Kim'], ['Anton', 'Y', 'Peleg'], ['Thomas', 'P', 'Lodise'], ['Jeffrey', '', 'Lipman'], ['Jian', '', 'Li'], ['Roger', '', 'Nation'], ['David', 'L', 'Paterson']]",Lancet Infectious Diseases,2009,"[u'http://www.sciencedirect.com/science/article/pii/S1473309909700556', u'http://linkinghub.elsevier.com/retrieve/pii/S1473309909700556']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1016~S1473-3099(09)70055-6
10.1016/j.jinf.2004.05.008,"Cascio, A., Conti, A., Sinardi, L., et. al, Post-neurosurgical multidrug-resistant Acinetobacter baumannii meningitis successfully treated with intrathecal colistin. A new case and a systematic review of the literature, International Journal of Infectious Diseases, 2010",cited-by,10.1016/j.ijid.2009.06.032,Post-neurosurgical multidrug-resistant Acinetobacter baumannii meningitis successfully treated with intrathecal colistin. A new case and a systematic review of the literature,"[['Antonio', '', 'Cascio'], ['Alfredo', '', 'Conti'], ['Luca', '', 'Sinardi'], ['Chiara', '', 'Iaria'], ['Filippo', 'Flavio', 'Angileri'], ['Giovanna', '', 'Stassi'], ['Teresa', '', 'David'], ['Antonio', '', 'Versaci'], ['Maurizio', '', 'Iaria'], ['Antonio', '', 'David']]",International Journal of Infectious Diseases,2010,"[u'http://www.sciencedirect.com/science/article/pii/S1201971209003191', u'http://linkinghub.elsevier.com/retrieve/pii/S1201971209003191']",
10.1016/j.jinf.2004.05.008,"Kasiakou, S., Fragoulis, K., Tzagarakis, G., et. al, Cure of Multidrug-Resistant Acinetobacter baumannii Fixation Device-Related Orthopedic Infections in Two Patients with Intravenous Colistin, Microbial Drug Resistance, 2005",cited-by,10.1089/mdr.2005.11.287,Cure of Multidrug-Resistant Acinetobacter baumannii Fixation Device-Related Orthopedic Infections in Two Patients with Intravenous Colistin,"[['Sofia', 'K.', 'Kasiakou'], ['Kostas', '', 'Fragoulis'], ['George', '', 'Tzagarakis'], ['Panagiotis', '', 'Mistidis'], ['Anastasios', '', 'Kapaskelis'], ['Matthew', 'E.', 'Falagas']]",Microbial Drug Resistance,2005,[u'http://www.liebertonline.com/doi/abs/10.1089/mdr.2005.11.287'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1089~mdr.2005.11.287
10.1016/j.jinf.2004.05.008,"Krol, V., Hamid, N., Cunha, B., , Neurosurgically related nosocomial Acinetobacter baumannii meningitis: report of two cases and literature review, Journal of Hospital Infection, 2009",cited-by,10.1016/j.jhin.2008.09.018,Neurosurgically related nosocomial Acinetobacter baumannii meningitis: report of two cases and literature review,"[['V.', '', 'Krol'], ['N.', 'S.', 'Hamid'], ['B.', 'A.', 'Cunha']]",Journal of Hospital Infection,2009,"[u'http://www.sciencedirect.com/science/article/pii/S019567010800399X', u'http://linkinghub.elsevier.com/retrieve/pii/S019567010800399X']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1016~j.jhin.2008.09.018
10.1016/j.jinf.2004.05.008,"Wallace, S., Li, J., Rayner, C., et. al, Stability of Colistin Methanesulfonate in Pharmaceutical Products and Solutions for Administration to Patients, Antimicrobial Agents and Chemotherapy, 2008",cited-by,10.1128/AAC.00103-08,Stability of Colistin Methanesulfonate in Pharmaceutical Products and Solutions for Administration to Patients,"[['Stephanie', 'J.', 'Wallace'], ['Jian', '', 'Li'], ['Craig.', 'R.', 'Rayner'], ['Kingsley', '', 'Coulthard'], ['Roger', 'L.', 'Nation']]",Antimicrobial Agents and Chemotherapy,2008,"[u'http://aac.asm.org/cgi/reprint/52/9/3047.pdf', u'http://aac.asm.org/cgi/issue_pdf/toc_pdf/52/9.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.00103-08']",
10.1016/j.jinf.2004.05.008,"Rafailidis, P., Ioannidou, E., Falagas, M., , Ampicillin/Sulbactam: Current Status in Severe Bacterial Infections, Drugs, 2007",cited-by,10.2165/00003495-200767130-00003,Ampicillin/Sulbactam: Current Status in Severe Bacterial Infections,"[['Petros', 'I', 'Rafailidis'], ['Eleni', 'N', 'Ioannidou'], ['Matthew', 'E', 'Falagas']]",Drugs,2007,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00003495-200767130-00003'],
10.1016/j.jinf.2004.05.008,"Papagelopoulos, P., Mavrogenis, A., Giannitsioti, E., et. al, Management of a Multidrug-Resistant Pseudomonas Aeruginosa Infected Total Knee Arthroplasty Using Colistin. A Case Report and Review of the Literature, Journal of Arthroplasty, 2007",cited-by,10.1016/j.arth.2006.05.006,Management of a Multidrug-Resistant Pseudomonas Aeruginosa Infected Total Knee Arthroplasty Using Colistin. A Case Report and Review of the Literature,"[['Panayiotis', 'J.', 'Papagelopoulos'], ['Andreas', 'F.', 'Mavrogenis'], ['Efthymia', '', 'Giannitsioti'], ['Athanasios', '', 'Kikilas'], ['Kyriaki', '', 'Kanellakopoulou'], ['Panayotis', 'N.', 'Soucacos']]",Journal of Arthroplasty,2007,"[u'http://www.sciencedirect.com/science/article/pii/S0883540306003834', u'http://linkinghub.elsevier.com/retrieve/pii/S0883540306003834']",
10.1016/j.jinf.2004.05.008,"Monteiro, D., Madrid, M., , Planning of robot trajectories with genetic algorithms, , 1999",cited-by,10.1109/ROMOCO.1999.791079,Planning of robot trajectories with genetic algorithms,"[['D.', 'C.', 'Monteiro'], ['M.', 'K.', 'Madrid']]",,1999,"[u'http://ieeexplore.ieee.org/xpls/abs_all.jsp?arnumber=791079', u'http://ieeexplore.ieee.org/stamp/stamp.jsp?arnumber=00791079']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1109~ROMOCO.1999.791079
10.1016/j.jinf.2004.05.008,"López-Álvarez, B., Martín-Láez, R., Fariñas, M., et. al, Multidrug-resistant Acinetobacter baumannii ventriculitis: successful treatment with intraventricular colistin, Acta Neurochirurgica, 2009",cited-by,10.1007/s00701-009-0382-6,Multidrug-resistant Acinetobacter baumannii ventriculitis: successful treatment with intraventricular colistin,"[['B.', '', 'L\xc3\xb3pez-\xc3\x81lvarez'], ['R.', '', 'Mart\xc3\xadn-L\xc3\xa1ez'], ['M.', 'C.', 'Fari\xc3\xb1as'], ['B.', '', 'Paternina-Vidal'], ['J.', 'D.', 'Garc\xc3\xada-Palomo'], ['A.', '', 'V\xc3\xa1zquez-Barquero']]",Acta Neurochirurgica,2009,"[u'http://www.springerlink.com/index/q761x4mxu710w574.pdf', u'http://www.springerlink.com/content/q761x4mxu710w574', u'http://www.springerlink.com/index/10.1007/s00701-009-0382-6', u'http://www.springerlink.com/index/pdf/10.1007/s00701-009-0382-6']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1007~s00701-009-0382-6
10.1016/j.jinf.2004.05.008,"Kim, K., Kang, H., Sohn, C., et. al, Cauda equina syndrome misdiagnosed as aggravated hydrocephalus: neurological complication of intrathecal colistin in post-surgical meningitis, Acta Neurochirurgica, 2011",cited-by,10.1007/s00701-010-0810-7,Cauda equina syndrome misdiagnosed as aggravated hydrocephalus: neurological complication of intrathecal colistin in post-surgical meningitis,"[['Keewon', '', 'Kim'], ['Hyun-Seung', '', 'Kang'], ['Chul-Ho', '', 'Sohn'], ['Byung-Mo', '', 'Oh']]",Acta Neurochirurgica,2011,"[u'http://www.springerlink.com/index/q3661k3x4k237322.pdf', u'http://www.springerlink.com/content/q3661k3x4k237322']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1007~s00701-010-0810-7
10.1016/j.jinf.2004.05.008,"Khawcharoenporn, T., Apisarnthanarak, A., Mundy, L., , Intrathecal colistin for drug-resistant Acinetobacter baumannii central nervous system infection: a case series and systematic review, Clinical Microbiology and Infection, 2009",cited-by,10.1111/j.1469-0691.2009.03019.x,Intrathecal colistin for drug-resistant Acinetobacter baumannii central nervous system infection: a case series and systematic review,"[['T.', '', 'Khawcharoenporn'], ['A.', '', 'Apisarnthanarak'], ['L.', 'M.', 'Mundy']]",Clinical Microbiology and Infection,2009,[u'http://blackwell-synergy.com/doi/abs/10.1111/j.1469-0691.2009.03019.x'],
10.1016/j.jinf.2004.05.008,"Bergogne-Bérézin, E., , Acinetobacter infections: Unusual infection sites, Antibiotiques, 2008",cited-by,10.1016/j.antib.2007.12.009,Acinetobacter infections: Unusual infection sites,"[['E.', '', 'Bergogne-B\xc3\xa9r\xc3\xa9zin']]",Antibiotiques,2008,"[u'http://www.sciencedirect.com/science/article/pii/S1294550107000106', u'http://linkinghub.elsevier.com/retrieve/pii/S1294550107000106']",
10.1517~13543784.17.7.973.pdf,"J Antimicrob Chemother 2006;58(5):1078-81 41. Evagelopoulou P, Katsaros A, Myrianthefs P, et al. Colistin and rhabdomyolysis: a causative agent or an innocent bystander? Intensive Care Med 2007;33(3):556-7 42. McCoy KS. Compounded colistimethate as possible cause of fatal acute respiratory distress syndrome. N Engl J Med 2007;357(22):2310-1 43. Alothman GA, Ho B, Alsaadi MM, et al.",references,NOT found in MAS
10.1517~13543784.17.7.973.pdf,"Bronchial constriction and inhaled colistin in cystic fibrosis. Chest 2005;127(2):522-9 44. Falagas ME, Bliziotis IA, Kasiakou SK, et al. Outcome of infections due to pandrug-resistant (PDR) Gram-negative bacteria. BMC Infect Dis 2005;5(1):24 45. Antoniadou A, Kontopidou F, Poulakou G, et al. Colistin-resistant isolates of Klebsiella pneumoniae emerging in intensive care unit patients: first report of a multiclonal cluster. J Antimicrob Chemother 2007;59(4):786-90 46. Matthaiou DK, Michalopoulos A, Rafailidis PI, et al. Risk factors associated with the isolation of colistin resistant Gram-negative bacteria: a matched case-co ntrol study. Crit Care Med 2008;36(3):807-11 47. Goldstein FW, Ly A, Kitzis MD. Comparison of Etest with agar dilution for testing the susceptibility of Pseudomonas aeruginosa and other multidrug-resistant bacteria to colistin.",references,10.1378/chest.127.2.522,Bronchial Constriction and Inhaled Colistin in Cystic Fibrosis,"[[u'G.', u'A.', u'Alothman']]",Chest,2005,[u'http://www.chestjournal.org/cgi/doi/10.1378/chest.127.2.522'],
10.1378/chest.127.2.522,"Li, J., Nation, R., Turnidge, J., et. al, Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections, Lancet Infectious Diseases, 2006",cited-by,10.1016/S1473-3099(06)70580-1,Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections,"[['Jian', '', 'Li'], ['Roger', 'L', 'Nation'], ['John', 'D', 'Turnidge'], ['Robert', 'W', 'Milne'], ['Kingsley', '', 'Coulthard'], ['Craig', 'R', 'Rayner'], ['David', 'L', 'Paterson']]",Lancet Infectious Diseases,2006,"[u'http://www.sld.cu/galerias/pdf/sitios/apua-cuba/r15-colistin._the_re-emerging_antibiotic_for_multidrug-resistant_gram-negative_bacterial_infections.pdf', u'http://www.sciencedirect.com/science/article/pii/S1473309906705801', u'http://www.sld.cu/galerias/pdf/sitios/apua-cuba/a21-colistin._the_re-emerging_antibiotic_for_multidrug-resistant_gram-negative_bacterial_infections.pdf', u'http://info.med.yale.edu/intmed/infdis/resources/docs/colistin-review-lancet.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S1473309906705801']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1016~S1473-3099(06)70580-1
10.1378/chest.127.2.522,"Falagas, M., Kasiakou, S., , Toxicity of polymyxins: a systematic review of the evidence from old and recent studies, Critical Care, 2006",cited-by,10.1186/cc3995,Toxicity of polymyxins: a systematic review of the evidence from old and recent studies,"[['Matthew', 'E', 'Falagas'], ['Sofia', 'K', 'Kasiakou']]",Critical Care,2006,"[u'http://www.biomedcentral.com/content/pdf/cc3995.pdf', u'http://ccforum.com/content/10/1/R27', u'http://www.springerlink.com/content/4hp6047472k68157', u'http://www.springerlink.com/index/4hp6047472k68157.pdf']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1186~cc3995
10.1378/chest.127.2.522,"Michalopoulos, A., Fotakis, D., Virtzili, S., et. al, Aerosolized colistin as adjunctive treatment of ventilator-associated pneumonia due to multidrug-resistant Gram-negative bacteria: A prospective study, Respiratory Medicine, 2008",cited-by,10.1016/j.rmed.2007.10.011,Aerosolized colistin as adjunctive treatment of ventilator-associated pneumonia due to multidrug-resistant Gram-negative bacteria: A prospective study,"[['Argyris', '', 'Michalopoulos'], ['Dimitrios', '', 'Fotakis'], ['Simona', '', 'Virtzili'], ['Christodoulos', '', 'Vletsas'], ['Sylvia', '', 'Raftopoulou'], ['Zefi', '', 'Mastora'], ['Matthew', 'E.', 'Falagas']]",Respiratory Medicine,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0954611107004337', u'http://linkinghub.elsevier.com/retrieve/pii/S0954611107004337']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1016~j.rmed.2007.10.011
10.1378/chest.127.2.522,"Pereira, G., Muller, P., Levin, A., , Salvage treatment of pneumonia and initial treatment of tracheobronchitis caused by multidrug-resistant Gram-negative bacilli with inhaled polymyxin B, Diagnostic Microbiology and Infectious Disease, 2007",cited-by,10.1016/j.diagmicrobio.2007.01.008,Salvage treatment of pneumonia and initial treatment of tracheobronchitis caused by multidrug-resistant Gram-negative bacilli with inhaled polymyxin B,"[['Graziella', 'H.', 'Pereira'], ['Patr\xc3\xadcia', 'R.', 'Muller'], ['Anna', 'S.', 'Levin']]",Diagnostic Microbiology and Infectious Disease,2007,"[u'http://www.sciencedirect.com/science/article/pii/S0732889307000326', u'http://linkinghub.elsevier.com/retrieve/pii/S0732889307000326']",
10.1378/chest.127.2.522,"Falagas, M., Siempos, I., Bliziotis, I., et. al, Administration of antibiotics via the respiratory tract for the prevention of ICU-acquired pneumonia: a meta-analysis of comparative trials, Critical Care, 2006",cited-by,10.1186/cc5032,Administration of antibiotics via the respiratory tract for the prevention of ICU-acquired pneumonia: a meta-analysis of comparative trials,"[['Matthew', 'E', 'Falagas'], ['Ilias', 'I', 'Siempos'], ['Ioannis', 'A', 'Bliziotis'], ['Argyris', '', 'Michalopoulos']]",Critical Care,2006,"[u'http://www.springerlink.com/content/x16321425223v401', u'http://www.springerlink.com/index/x16321425223v401.pdf']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1186~cc5032
10.1378/chest.127.2.522,"Ioannidou, E., Siempos, I., Falagas, M., , Administration of antimicrobials via the respiratory tract for the treatment of patients with nosocomial pneumonia: a meta-analysis, , 2007",cited-by,5759764Administration of antimicrobials via the respiratory tract for the treatment of patients with nosocomial pneumonia: a meta-analysis,Administration of antimicrobials via the respiratory tract for the treatment of patients with nosocomial pneumonia: a meta-analysis,"[['Eleni', '', 'Ioannidou'], ['Ilias', 'I.', 'Siempos'], ['Matthew', 'E.', 'Falagas']]",,2007,"[u'http://jac.oxfordjournals.org/cgi/reprint/dkm385v1.pdf', u'http://jac.oxfordjournals.org/cgi/reprint/dkm385v2.pdf', u'http://jac.oxfordjournals.org/cgi/reprint/60/6/1216.pdf']",
10.1378/chest.127.2.522,"Michalopoulos, A., Falagas, M., , Colistin and Polymyxin B in Critical Care, Critical Care Clinics, 2008",cited-by,10.1016/j.ccc.2007.12.003,Colistin and Polymyxin B in Critical Care,"[['Argyris', '', 'Michalopoulos'], ['Matthew', 'E.', 'Falagas']]",Critical Care Clinics,2008,"[u'http://www.sciencedirect.com/science/article/pii/S074907040700098X', u'http://linkinghub.elsevier.com/retrieve/pii/S074907040700098X']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1016~j.ccc.2007.12.003
10.1378/chest.127.2.522,"Rowe, S., Clancy, J., , Advances in cystic fibrosis therapies, Current Opinion in Pediatrics, 2006",cited-by,10.1097/MOP.0b013e3280109b90,Advances in cystic fibrosis therapies,"[['Steven', 'M', 'Rowe'], ['John', 'P', 'Clancy']]",Current Opinion in Pediatrics,2006,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00008480-200612000-00004'],
10.1378/chest.127.2.522,"Heijerman, H., Westerman, E., Conway, S., et. al, Inhaled medication and inhalation devices for lung disease in patients with cystic fibrosis: A European consensus, Journal of Cystic Fibrosis, 2009",cited-by,10.1016/j.jcf.2009.04.005,Inhaled medication and inhalation devices for lung disease in patients with cystic fibrosis: A European consensus,"[['Harry', '', 'Heijerman'], ['Elsbeth', '', 'Westerman'], ['Steven', '', 'Conway'], ['Daan', '', 'Touw']]",Journal of Cystic Fibrosis,2009,"[u'http://www.sgpp-schweiz.ch/downloads_cms/inhaled_medication_and_inhalation_devices_for_lung_disease_in_patients_with_cf_j_of_cf_2009_.pdf', u'http://www.sciencedirect.com/science/article/pii/S1569199309000356', u'http://linkinghub.elsevier.com/retrieve/pii/S1569199309000356']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1016~j.jcf.2009.04.005
10.1378/chest.127.2.522,"Falagas, M., Rafailidis, P., , Re-emergence of colistin in today's world of multidrug-resistant organisms: personal perspectives, Expert Opinion on Investigational Drugs, 2008",cited-by,10.1517/13543784.17.7.973,Re-emergence of colistin in today's world of multidrug-resistant organisms: personal perspectives,"[['Matthew', 'E', 'Falagas'], ['Petros', 'I', 'Rafailidis']]",Expert Opinion on Investigational Drugs,2008,[u'http://www.informapharmascience.com/doi/abs/10.1517/13543784.17.7.973'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1517~13543784.17.7.973
10.1378/chest.127.2.522,"Rubin, B., , Aerosolized Antibiotics for Non-Cystic Fibrosis Bronchiectasis, Journal of Aerosol Medicine-deposition Clearance and Effects in The Lung, 2008",cited-by,10.1089/jam.2007.0652,Aerosolized Antibiotics for Non-Cystic Fibrosis Bronchiectasis,"[['Bruce', 'K.', 'Rubin']]",Journal of Aerosol Medicine-deposition Clearance and Effects in The Lung,2008,[u'http://www.liebertonline.com/doi/abs/10.1089/jam.2007.0652'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1089~jam.2007.0652
10.1378/chest.127.2.522,"Michalopoulos, A., Papadakis, E., , Inhaled Anti-infective Agents: Emphasis on Colistin, Infection, 2010",cited-by,10.1007/s15010-009-9148-6,Inhaled Anti-infective Agents: Emphasis on Colistin,"[['A.', '', 'Michalopoulos'], ['E.', '', 'Papadakis']]",Infection,2010,"[u'http://www.springerlink.com/index/731n322p40558m05.pdf', u'http://www.springerlink.com/content/731n322p40558m05', u'http://www.springerlink.com/index/10.1007/s15010-009-9148-6', u'http://www.springerlink.com/index/pdf/10.1007/s15010-009-9148-6']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1007~s15010-009-9148-6
10.1378/chest.127.2.522,"Falagas, M., Vouloumanou, E., Rafailidis, P., , Systemic colistin use in children without cystic fibrosis: a systematic review of the literature, International Journal of Antimicrobial Agents, 2009",cited-by,10.1016/j.ijantimicag.2008.10.021,Systemic colistin use in children without cystic fibrosis: a systematic review of the literature,"[['Matthew', 'E.', 'Falagas'], ['Evridiki', 'K.', 'Vouloumanou'], ['Petros', 'I.', 'Rafailidis']]",International Journal of Antimicrobial Agents,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0924857908005505', u'http://linkinghub.elsevier.com/retrieve/pii/S0924857908005505']",
10.1378/chest.127.2.522,"Wallace, S., Li, J., Rayner, C., et. al, Stability of Colistin Methanesulfonate in Pharmaceutical Products and Solutions for Administration to Patients, Antimicrobial Agents and Chemotherapy, 2008",cited-by,10.1128/AAC.00103-08,Stability of Colistin Methanesulfonate in Pharmaceutical Products and Solutions for Administration to Patients,"[['Stephanie', 'J.', 'Wallace'], ['Jian', '', 'Li'], ['Craig.', 'R.', 'Rayner'], ['Kingsley', '', 'Coulthard'], ['Roger', 'L.', 'Nation']]",Antimicrobial Agents and Chemotherapy,2008,"[u'http://aac.asm.org/cgi/reprint/52/9/3047.pdf', u'http://aac.asm.org/cgi/issue_pdf/toc_pdf/52/9.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.00103-08']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1128~AAC.00103-08
10.1378/chest.127.2.522,"Rubin, B., , Aerosolized Antibiotics for Non-Cystic Fibrosis Bronchiectasis, Journal of Aerosol Medicine and Pulmonary Drug Delivery, 2008",cited-by,10.1089/jamp.2007.0652,Aerosolized Antibiotics for Non-Cystic Fibrosis Bronchiectasis,"[['Bruce', 'K.', 'Rubin']]",Journal of Aerosol Medicine and Pulmonary Drug Delivery,2008,[u'http://www.liebertonline.com/doi/abs/10.1089/jamp.2007.0652'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1089~jamp.2007.0652
10.1378/chest.127.2.522,"Cook, A., Mieure, K., Owen, R., et. al, Intracerebroventricular Administration of Drugs, Pharmacotherapy, 2009",cited-by,10.1592/phco.29.7.832,Intracerebroventricular Administration of Drugs,"[['Aaron', 'M', 'Cook'], ['Katherine', 'D', 'Mieure'], ['Robert', 'D', 'Owen'], ['Adam', 'B', 'Pesaturo'], ['Jimmi', '', 'Hatton']]",Pharmacotherapy,2009,[u'http://www.atypon-link.com/PPI/doi/abs/10.1592/phco.29.7.832'],
10.1378/chest.127.2.522,"Monteiro, D., Madrid, M., , Planning of robot trajectories with genetic algorithms, , 1999",cited-by,10.1109/ROMOCO.1999.791079,Planning of robot trajectories with genetic algorithms,"[['D.', 'C.', 'Monteiro'], ['M.', 'K.', 'Madrid']]",,1999,"[u'http://ieeexplore.ieee.org/xpls/abs_all.jsp?arnumber=791079', u'http://ieeexplore.ieee.org/stamp/stamp.jsp?arnumber=00791079']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1109~ROMOCO.1999.791079
10.1378/chest.127.2.522,"Falagas, M., Sideri, G., Korbila, I., et. al, Inhaled colistin for the treatment of tracheobronchitis and pneumonia in critically ill children without cystic fibrosis, Pediatric Pulmonology, 2010",cited-by,10.1002/ppul.21302,Inhaled colistin for the treatment of tracheobronchitis and pneumonia in critically ill children without cystic fibrosis,"[['Matthew', 'E.', 'Falagas'], ['Georgia', '', 'Sideri'], ['Ioanna', 'P.', 'Korbila'], ['Evridiki', 'K.', 'Vouloumanou'], ['John', 'H.', 'Papadatos'], ['Dimitris', 'A.', 'Kafetzis']]",Pediatric Pulmonology,2010,[u'http://doi.wiley.com/10.1002/ppul.21302'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1002~ppul.21302
10.1378/chest.127.2.522,"Koga, H., Miyano, G., Takahashi, T., et. al, Comparison of anorectal angle and continence after Georgeson and Peña procedures for high/intermediate imperforate anus, Journal of Pediatric Surgery, 2010",cited-by,10.1016/j.jpedsurg.2010.08.041,Comparison of anorectal angle and continence after Georgeson and Peña procedures for high/intermediate imperforate anus,"[['Hiroyuki', '', 'Koga'], ['Go', '', 'Miyano'], ['Tsubasa', '', 'Takahashi'], ['Akihiro', '', 'Shimotakahara'], ['Yoshifumi', '', 'Kato'], ['Tadaharu', '', 'Okazaki'], ['Atsuyuki', '', 'Yamataka']]",Journal of Pediatric Surgery,2010,[u'http://www.sciencedirect.com/science/article/pii/S0022346810007165'],
10.1378/chest.127.2.522,"Kim, S., Kuti, J., Nicolau, D., , Inhaled antimicrobial therapies for respiratory infections, Current Infectious Disease Reports, 2008",cited-by,10.1007/s11908-008-0007-x,Inhaled antimicrobial therapies for respiratory infections,"[['Shin-Woo', '', 'Kim'], ['Joseph', 'L.', 'Kuti'], ['David', 'P.', 'Nicolau']]",Current Infectious Disease Reports,2008,"[u'http://www.springerlink.com/content/h556127hv6274476', u'http://www.springerlink.com/index/10.1007/s11908-008-0007-x', u'http://www.springerlink.com/index/pdf/10.1007/s11908-008-0007-x']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1007~s11908-008-0007-x
10.1378/chest.127.2.522,"Dronda, S., Justribó, M., , ¿Seguiremos teniendo antibióticos mañana?, Archivos De Bronconeumologia, 2007",cited-by,10.1157/13108785,¿Seguiremos teniendo antibióticos mañana?,"[['Salvador', 'Bello', 'Dronda'], ['Manuel', 'Vil\xc3\xa1', 'Justrib\xc3\xb3']]",Archivos De Bronconeumologia,2007,"[u'http://www.sciencedirect.com/science/article/pii/S0300289607711067', u'http://linkinghub.elsevier.com/retrieve/pii/S0300289607711067']",
10.1378/chest.127.2.522,"Kim, C., Choi, J., Kang, H., et. al, A Trial of Aerosolized Colistin for the Treatment of Nosocomial Pneumonia due to Multidrug-resistant Acinetobacter baumannii, Tuberculosis and Respiratory Diseases, 2008",cited-by,10.4046/trd.2008.64.2.102,A Trial of Aerosolized Colistin for the Treatment of Nosocomial Pneumonia due to Multidrug-resistant Acinetobacter baumannii,"[['Changhwan', '', 'Kim'], ['Jeong-Hee', '', 'Choi'], ['Hye-Ryun', '', 'Kang'], ['Chang', 'Youl', 'Lee'], ['Yong', 'Il', 'Hwang'], ['Tae', 'Rim', 'Shin'], ['Sang', 'Myeon', 'Park'], ['Yong', 'Bum', 'Park'], ['Jae', 'Young', 'Lee'], ['Seung', 'Hun', 'Jang'], ['Cheol', 'Hong', 'Kim'], ['Eun', 'Kyung', 'Mo'], ['Myung', 'Goo', 'Lee'], ['In-Gyu', '', 'Hyun'], ['Ki-Suck', '', 'Jung'], ['Young-Jin', '', 'Choi'], ['Jae', 'Woong', 'Lee']]",Tuberculosis and Respiratory Diseases,2008,"[u'http://journals.lungkorea.org/upload/abstract/files/(102-108)-trd059.pdf', u'http://synapse.koreamed.org/DOIx.php?id=10.4046/trd.2008.64.2.102']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.4046~trd.2008.64.2.102
10.1378/chest.127.2.522,"Choi, H., Hwang, Y., Park, M., et. al, Effects of Aerosol Colistin Treatment of Pneumonia Caused by Multi-drug Resistant Acinetobacter baumannii, Tuberculosis and Respiratory Diseases, 2008",cited-by,10.4046/trd.2008.64.1.8,Effects of Aerosol Colistin Treatment of Pneumonia Caused by Multi-drug Resistant Acinetobacter baumannii,"[['Hye', 'Sook', 'Choi'], ['Yeon', 'Hee', 'Hwang'], ['Myung', 'Jae', 'Park'], ['Hong', 'Mo', 'Kang']]",Tuberculosis and Respiratory Diseases,2008,[u'http://synapse.koreamed.org/DOIx.php?id=10.4046/trd.2008.64.1.8'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.4046~trd.2008.64.1.8
10.1378/chest.127.2.522,"Drond, S., Justribó, M., , Will We Still Have Antibiotics Tomorrow?, Archivos De Bronconeumologia, 2007",cited-by,10.1016/S1579-2129(07)60102-5,Will We Still Have Antibiotics Tomorrow?,"[['Salvador', 'Bello', 'Drond'], ['Manuel', 'Vil\xc3\xa1', 'Justrib\xc3\xb3']]",Archivos De Bronconeumologia,2007,"[u'http://www.sciencedirect.com/science/article/pii/S1579212907601025', u'http://linkinghub.elsevier.com/retrieve/pii/S1579212907601025']",
10.1378/chest.127.2.522,"Domínguez-Ortega, J., Manteiga, E., Abad-Schilling, C., et. al, Induced Tolerance to Nebulized Colistin After Severe Reaction to the Drug, , 0",cited-by,11515638Induced Tolerance to Nebulized Colistin After Severe Reaction to the Drug,Induced Tolerance to Nebulized Colistin After Severe Reaction to the Drug,"[['J', '', 'Dom\xc3\xadnguez-Ortega'], ['E', '', 'Manteiga'], ['C', '', 'Abad-Schilling'], ['J', '', 'S\xc3\xa1nchez-Rubio']]",,0,[u'http://www.jiaci.org/issues/vol17issue01/12.pdf'],./output/10.1517~13543784.17.7.973.pdf/citedby/11515638Induced Tolerance to Nebulized Colistin After Severe Reaction to the Drug
10.1517~13543784.17.7.973.pdf,"J Antimicrob Chemother 2007;59(5):1039-40 48. Lo-Ten-Foe JR, De Smet AM, Diederen BM, et al. Comparative evaluation of the VITEK 2, disk diffusion, etest, broth microdilution, and agar dilution susceptibility testing methods for colistin in clinical isolates, including heteroresistant Enterobacter cloacae and Acinetobacter baumannii strains.",references,10.1128/AAC.01406-06,"Comparative Evaluation of the VITEK 2, Disk Diffusion, Etest, Broth Microdilution, and Agar Dilution Susceptibility Testing Methods for Colistin in Clinical Isolates, Including Heteroresistant Enterobacter cloacae and Acinetobacter baumannii Strains","[[u'Jerome', u'R.', u'Lo-Ten-Foe'], [u'A.', u'M. G. A. de', u'Smet'], [u'Bram', u'M. W.', u'Diederen'], [u'Jan', u'A. J. W.', u'Kluytmans'], [u'Peter', u'H. J. van', u'Keulen']]",Antimicrobial Agents and Chemotherapy,2007,"[u'http://aac.asm.org/cgi/doi/10.1128/AAC.01406-06', u'http://aac.asm.org/cgi/reprint/51/10/3726.pdf']",./output/10.1517~13543784.17.7.973.pdf/10.1128~AAC.01406-06
10.1128/AAC.01406-06,"Galani, I., Kontopidou, F., Souli, M., et. al, Colistin susceptibility testing by Etest and disk diffusion methods, International Journal of Antimicrobial Agents, 2008",cited-by,10.1016/j.ijantimicag.2008.01.011,Colistin susceptibility testing by Etest and disk diffusion methods,"[['Irene', '', 'Galani'], ['Flora', '', 'Kontopidou'], ['Maria', '', 'Souli'], ['Panagiota-Danai', '', 'Rekatsina'], ['Evangelos', '', 'Koratzanis'], ['John', '', 'Deliolanis'], ['Helen', '', 'Giamarellou']]",International Journal of Antimicrobial Agents,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0924857908000344', u'http://linkinghub.elsevier.com/retrieve/pii/S0924857908000344']",
10.1128/AAC.01406-06,"Falagas, M., Rafailidis, P., , Re-emergence of colistin in today's world of multidrug-resistant organisms: personal perspectives, Expert Opinion on Investigational Drugs, 2008",cited-by,10.1517/13543784.17.7.973,Re-emergence of colistin in today's world of multidrug-resistant organisms: personal perspectives,"[['Matthew', 'E', 'Falagas'], ['Petros', 'I', 'Rafailidis']]",Expert Opinion on Investigational Drugs,2008,[u'http://www.informapharmascience.com/doi/abs/10.1517/13543784.17.7.973'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1517~13543784.17.7.973
10.1128/AAC.01406-06,"Gordon, N., Wareham, D., , Multidrug-resistant Acinetobacter baumannii: mechanisms of virulence and resistance, International Journal of Antimicrobial Agents, 2010",cited-by,10.1016/j.ijantimicag.2009.10.024,Multidrug-resistant Acinetobacter baumannii: mechanisms of virulence and resistance,"[['Nicola', 'C.', 'Gordon'], ['David', 'W.', 'Wareham']]",International Journal of Antimicrobial Agents,2010,"[u'http://www.sciencedirect.com/science/article/pii/S0924857909005159', u'http://linkinghub.elsevier.com/retrieve/pii/S0924857909005159']",
10.1128/AAC.01406-06,"Kwa, A., , Polymyxins: A Review of the Current Status Including Recent Developments, , 0",cited-by,12288617Polymyxins: A Review of the Current Status Including Recent Developments,Polymyxins: A Review of the Current Status Including Recent Developments,"[['Andrea', 'L', 'Kwa']]",,0,[u'http://www.annals.edu.sg/pdf/37VolNo10Oct2008/V37N10p870.pdf'],./output/10.1517~13543784.17.7.973.pdf/citedby/12288617Polymyxins: A Review of the Current Status Including Recent Developments
10.1128/AAC.01406-06,"Hernan, R., Karina, B., Gabriela, G., et. al, Selection of colistin-resistant Acinetobacter baumannii isolates in postneurosurgical meningitis in an intensive care unit with high presence of heteroresistance to colistin, Diagnostic Microbiology and Infectious Disease, 2009",cited-by,10.1016/j.diagmicrobio.2009.05.019,Selection of colistin-resistant Acinetobacter baumannii isolates in postneurosurgical meningitis in an intensive care unit with high presence of heteroresistance to colistin,"[['Rodriguez', 'Carlos', 'Hernan'], ['Bombicino', '', 'Karina'], ['Granados', '', 'Gabriela'], ['Nastro', '', 'Marcela'], ['Vay', '', 'Carlos'], ['Famiglietti', '', 'Angela']]",Diagnostic Microbiology and Infectious Disease,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0732889309002302', u'http://linkinghub.elsevier.com/retrieve/pii/S0732889309002302']",
10.1128/AAC.01406-06,"Shi, M., Kretlow, J., Nguyen, A., et. al, Antibiotic-releasing porous polymethylmethacrylate constructs for osseous space maintenance and infection control, Biomaterials, 2010",cited-by,10.1016/j.biomaterials.2010.01.112,Antibiotic-releasing porous polymethylmethacrylate constructs for osseous space maintenance and infection control,"[['Meng', '', 'Shi'], ['James', 'D.', 'Kretlow'], ['Anson', '', 'Nguyen'], ['Simon', '', 'Young'], ['L.', 'Scott', 'Baggett'], ['Mark', 'E.', 'Wong'], ['F.', 'Kurtis', 'Kasper'], ['Antonios', 'G.', 'Mikos']]",Biomaterials,2010,"[u'http://www.sciencedirect.com/science/article/pii/S0142961210001444', u'http://linkinghub.elsevier.com/retrieve/pii/S0142961210001444']",
10.1128/AAC.01406-06,"Monteiro, D., Madrid, M., , Planning of robot trajectories with genetic algorithms, , 1999",cited-by,10.1109/ROMOCO.1999.791079,Planning of robot trajectories with genetic algorithms,"[['D.', 'C.', 'Monteiro'], ['M.', 'K.', 'Madrid']]",,1999,"[u'http://ieeexplore.ieee.org/xpls/abs_all.jsp?arnumber=791079', u'http://ieeexplore.ieee.org/stamp/stamp.jsp?arnumber=00791079']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1109~ROMOCO.1999.791079
10.1128/AAC.01406-06,"Boyen, F., Vangroenweghe, F., Butaye, P., et. al, Disk prediffusion is a reliable method for testing colistin susceptibility in porcine E. coli strains, Veterinary Microbiology, 2010",cited-by,10.1016/j.vetmic.2010.01.010,Disk prediffusion is a reliable method for testing colistin susceptibility in porcine E. coli strains,"[['F.', '', 'Boyen'], ['F.', '', 'Vangroenweghe'], ['P.', '', 'Butaye'], ['E.', 'De', 'Graef'], ['F.', '', 'Castryck'], ['P.', '', 'Heylen'], ['M.', '', 'Vanrobaeys'], ['F.', '', 'Haesebrouck']]",Veterinary Microbiology,2010,"[u'http://www.sciencedirect.com/science/article/pii/S0378113510000465', u'http://linkinghub.elsevier.com/retrieve/pii/S0378113510000465']",
10.1128/AAC.01406-06,"Usher, J., Alexander, S., Thompson, J., , Predicting the reliability of new products at IBM, , 1991",cited-by,10.1109/ARMS.1991.154437,Predicting the reliability of new products at IBM,"[['J.', 'S.', 'Usher'], ['S.', 'M.', 'Alexander'], ['J.', 'D.', 'Thompson']]",,1991,[u'http://ieeexplore.ieee.org/xpls/abs_all.jsp?arnumber=154437'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1109~ARMS.1991.154437
10.1128/AAC.01406-06,"Sınırtaş, M., Akalın, H., Gedikoğlu, S., , Investigation of colistin sensitivity via three different methods in Acinetobacter baumannii isolates with multiple antibiotic resistance, International Journal of Infectious Diseases, 2009",cited-by,10.1016/j.ijid.2008.12.012,Investigation of colistin sensitivity via three different methods in Acinetobacter baumannii isolates with multiple antibiotic resistance,"[['Melda', '', 'S\xc4\xb1n\xc4\xb1rta\xc5\x9f'], ['Halis', '', 'Akal\xc4\xb1n'], ['Suna', '', 'Gediko\xc4\x9flu']]",International Journal of Infectious Diseases,2009,"[u'http://www.sciencedirect.com/science/article/pii/S1201971209000216', u'http://linkinghub.elsevier.com/retrieve/pii/S1201971209000216']",
10.1517~13543784.17.7.973.pdf,"Antimicrob Agents Chemother 2007;51(10):3726-30 49. Mentzelopoulos SD, Pratikaki M, Platsouka E, et al. Prolonged use of carbapenems and colistin predisposes to ventilator-associated pneumonia by pandrug-resistant Pseudomonas aeruginosa.",references,10.1007/s00134-007-0683-2,Prolonged use of carbapenems and colistin predisposes to ventilator-associated pneumonia by pandrug-resistant  Pseudomonas aeruginosa,"[[u'Spyros', u'D.', u'Mentzelopoulos'], [u'Maria', u'', u'Pratikaki'], [u'Evangelia', u'', u'Platsouka'], [u'Helen', u'', u'Kraniotaki'], [u'Dimitris', u'', u'Zervakis'], [u'Antonia', u'', u'Koutsoukou'], [u'Serafim', u'', u'Nanas'], [u'Olga', u'', u'Paniara'], [u'Charis', u'', u'Roussos'], [u'Evangelos', u'', u'Giamarellos-Bourboulis'], [u'Christina', u'', u'Routsi'], [u'Spyros', u'G.', u'Zakynthinos']]",Intensive Care Medicine,2007,"[u'http://www.springerlink.com/content/d4t8737111762m48', u'http://www.springerlink.com/index/d4t8737111762m48.pdf', u'http://www.springerlink.com/index/10.1007/s00134-007-0683-2', u'http://www.springerlink.com/index/pdf/10.1007/s00134-007-0683-2']",./output/10.1517~13543784.17.7.973.pdf/10.1007~s00134-007-0683-2
10.1007/s00134-007-0683-2,"Matthaiou, D., Michalopoulos, A., Rafailidis, P., et. al, Risk factors associated with the isolation of colistin-resistant Gram-negative bacteria: A matched case-control study, Critical Care Medicine, 2008",cited-by,10.1097/CCM.0B013E3181652FAE,Risk factors associated with the isolation of colistin-resistant Gram-negative bacteria: A matched case-control study,"[['Dimitrios', 'K.', 'Matthaiou'], ['Argyris', '', 'Michalopoulos'], ['Petros', 'I.', 'Rafailidis'], ['Drosos', 'E.', 'Karageorgopoulos'], ['Vassiliki', '', 'Papaioannou'], ['Georgia', '', 'Ntani'], ['George', '', 'Samonis'], ['Matthew', 'E.', 'Falagas']]",Critical Care Medicine,2008,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00003246-200803000-00021'],
10.1007/s00134-007-0683-2,"Giamarellou, H., Poulakou, G., , Multidrug-Resistant Gram-Negative Infections: What are the Treatment Options?, Drugs, 2009",cited-by,10.2165/11315690-000000000-00000,Multidrug-Resistant Gram-Negative Infections: What are the Treatment Options?,"[['Helen', '', 'Giamarellou'], ['Garyphallia', '', 'Poulakou']]",Drugs,2009,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00003495-200969140-00001'],
10.1007/s00134-007-0683-2,"Michalopoulos, A., Falagas, M., , Colistin and Polymyxin B in Critical Care, Critical Care Clinics, 2008",cited-by,10.1016/j.ccc.2007.12.003,Colistin and Polymyxin B in Critical Care,"[['Argyris', '', 'Michalopoulos'], ['Matthew', 'E.', 'Falagas']]",Critical Care Clinics,2008,"[u'http://www.sciencedirect.com/science/article/pii/S074907040700098X', u'http://linkinghub.elsevier.com/retrieve/pii/S074907040700098X']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1016~j.ccc.2007.12.003
10.1007/s00134-007-0683-2,"Falagas, M., Rafailidis, P., , Re-emergence of colistin in today's world of multidrug-resistant organisms: personal perspectives, Expert Opinion on Investigational Drugs, 2008",cited-by,10.1517/13543784.17.7.973,Re-emergence of colistin in today's world of multidrug-resistant organisms: personal perspectives,"[['Matthew', 'E', 'Falagas'], ['Petros', 'I', 'Rafailidis']]",Expert Opinion on Investigational Drugs,2008,[u'http://www.informapharmascience.com/doi/abs/10.1517/13543784.17.7.973'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1517~13543784.17.7.973
10.1007/s00134-007-0683-2,"Solh, A., Alhajhusain, A., , Update on the treatment of Pseudomonas aeruginosa pneumonia, Journal of Antimicrobial Chemotherapy, 2009",cited-by,10.1093/jac/dkp201,Update on the treatment of Pseudomonas aeruginosa pneumonia,"[['A.', 'A. El', 'Solh'], ['A.', '', 'Alhajhusain']]",Journal of Antimicrobial Chemotherapy,2009,[u'http://www.jac.oxfordjournals.org/cgi/doi/10.1093/jac/dkp201'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1093~jac~dkp201
10.1007/s00134-007-0683-2,"Falagas, M., Rafailidis, P., Matthaiou, D., et. al, Pandrug-resistant Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumannii infections: Characteristics and outcome in a series of 28 patients, International Journal of Antimicrobial Agents, 2008",cited-by,10.1016/j.ijantimicag.2008.05.016,"Pandrug-resistant Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumannii infections: Characteristics and outcome in a series of 28 patients","[['Matthew', 'E.', 'Falagas'], ['Petros', 'I.', 'Rafailidis'], ['Dimitrios', 'K.', 'Matthaiou'], ['Simona', '', 'Virtzili'], ['Dimitra', '', 'Nikita'], ['Argyris', '', 'Michalopoulos']]",International Journal of Antimicrobial Agents,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0924857908002690', u'http://linkinghub.elsevier.com/retrieve/pii/S0924857908002690']",
10.1007/s00134-007-0683-2,"Maltezou, H., , Metallo-β-lactamases in Gram-negative bacteria: introducing the era of pan-resistance?, International Journal of Antimicrobial Agents, 2009",cited-by,10.1016/j.ijantimicag.2008.09.003,Metallo-β-lactamases in Gram-negative bacteria: introducing the era of pan-resistance?,"[['Helen', 'C.', 'Maltezou']]",International Journal of Antimicrobial Agents,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0924857908004135', u'http://linkinghub.elsevier.com/retrieve/pii/S0924857908004135']",
10.1007/s00134-007-0683-2,"Poulakou, G., Giamarellou, H., , Doripenem: an expected arrival in the treatment of infections caused by multidrug-resistant Gram-negative pathogens, Expert Opinion on Investigational Drugs, 2008",cited-by,10.1517/13543784.17.5.749,Doripenem: an expected arrival in the treatment of infections caused by multidrug-resistant Gram-negative pathogens,"[['Garyphallia', '', 'Poulakou'], ['Helen', '', 'Giamarellou']]",Expert Opinion on Investigational Drugs,2008,[u'http://www.informapharmascience.com/doi/abs/10.1517/13543784.17.5.749'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1517~13543784.17.5.749
10.1007/s00134-007-0683-2,"Konkimalla, P., LaValle, S., , Efficient computation of optimal navigation functions for nonholonomic planning, , 1999",cited-by,10.1109/ROMOCO.1999.791074,Efficient computation of optimal navigation functions for nonholonomic planning,"[['P.', '', 'Konkimalla'], ['Steven', 'M.', 'LaValle']]",,1999,"[u'http://ieeexplore.ieee.org/stamp/stamp.jsp?arnumber=00791074', u'http://ieeexplore.ieee.org/xpls/abs_all.jsp?arnumber=791074']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1109~ROMOCO.1999.791074
10.1007/s00134-007-0683-2,"Giamarellou, H., Kanellakopoulou, K., , Current Therapies for Pseudomonas Aeruginosa, Critical Care Clinics, 2008",cited-by,10.1016/j.ccc.2007.12.004,Current Therapies for Pseudomonas Aeruginosa,"[['Helen', '', 'Giamarellou'], ['Kyriaki', '', 'Kanellakopoulou']]",Critical Care Clinics,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0749070407000991', u'http://linkinghub.elsevier.com/retrieve/pii/S0749070407000991']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1016~j.ccc.2007.12.004
10.1007/s00134-007-0683-2,"Heimann, D., Mittal, N., Trivedi, K., , Dependability modeling for computer systems, , 1991",cited-by,10.1109/ARMS.1991.154425,Dependability modeling for computer systems,"[['David', 'I.', 'Heimann'], ['N.', '', 'Mittal'], ['K.', 'S.', 'Trivedi']]",,1991,"[u'http://ieeexplore.ieee.org/xpls/abs_all.jsp?arnumber=154425', u'http://ieeexplore.ieee.org/stamp/stamp.jsp?arnumber=00154425']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1109~ARMS.1991.154425
10.1007/s00134-007-0683-2,"Routsi, C., Pratikaki, M., Platsouka, E., et. al, Carbapenem-resistant versus carbapenem-susceptible Acinetobacter baumannii bacteremia in a Greek intensive care unit: risk factors, clinical features and outcomes, Infection, 2010",cited-by,10.1007/s15010-010-0008-1,"Carbapenem-resistant versus carbapenem-susceptible Acinetobacter baumannii bacteremia in a Greek intensive care unit: risk factors, clinical features and outcomes","[['C.', '', 'Routsi'], ['M.', '', 'Pratikaki'], ['E.', '', 'Platsouka'], ['C.', '', 'Sotiropoulou'], ['S.', '', 'Nanas'], ['V.', '', 'Markaki'], ['C.', '', 'Vrettou'], ['O.', '', 'Paniara'], ['H.', '', 'Giamarellou'], ['C.', '', 'Roussos']]",Infection,2010,"[u'http://www.springerlink.com/index/q0433173p021u110.pdf', u'http://www.springerlink.com/content/q0433173p021u110', u'http://www.springerlink.com/index/10.1007/s15010-010-0008-1', u'http://www.springerlink.com/index/pdf/10.1007/s15010-010-0008-1']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1007~s15010-010-0008-1
10.1007/s00134-007-0683-2,"Furtado, G., Bergamasco, M., Menezes, F., et. al, Imipenem-resistant Pseudomonas aeruginosa infection at a medical-surgical intensive care unit: Risk factors and mortality, Journal of Critical Care, 2009",cited-by,10.1016/j.jcrc.2009.03.006,Imipenem-resistant Pseudomonas aeruginosa infection at a medical-surgical intensive care unit: Risk factors and mortality,"[['Guilherme', 'H. C.', 'Furtado'], ['Maria', 'D.', 'Bergamasco'], ['Fernando', 'G.', 'Menezes'], ['Daniel', '', 'Marques'], ['Adriana', '', 'Silva'], ['Luciana', 'B.', 'Perdiz'], ['S\xc3\xa9rgio', 'B.', 'Wey'], ['Eduardo', 'A. S.', 'Medeiros']]",Journal of Critical Care,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0883944109000781', u'http://linkinghub.elsevier.com/retrieve/pii/S0883944109000781']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1016~j.jcrc.2009.03.006
10.1007/s00134-007-0683-2,"Antonelli, M., Azoulay, E., Bonten, M., et. al, Year in review in Intensive Care Medicine, 2007. II. Haemodynamics, pneumonia, infections and sepsis, invasive and non-invasive mechanical ventilation, acute respiratory distress syndrome, Intensive Care Medicine, 2008",cited-by,10.1007/s00134-008-1009-8,"Year in review in Intensive Care Medicine, 2007. II. Haemodynamics, pneumonia, infections and sepsis, invasive and non-invasive mechanical ventilation, acute respiratory distress syndrome","[['Massimo', '', 'Antonelli'], ['Elie', '', 'Azoulay'], ['Marc', '', 'Bonten'], ['Jean', '', 'Chastre'], ['Giuseppe', '', 'Citerio'], ['Giorgio', '', 'Conti'], ['Daniel', 'De', 'Backer'], ['Fran\xc3\xa7ois', '', 'Lemaire'], ['Herwig', '', 'Gerlach'], ['Johan', '', 'Groeneveld'], ['Goran', '', 'Hedenstierna'], ['Duncan', '', 'Macrae'], ['Jordi', '', 'Mancebo'], ['Salvatore', 'M.', 'Maggiore'], ['Alexandre', '', 'Mebazaa'], ['Philipp', '', 'Metnitz'], ['Jerme', '', 'Pugin'], ['Jan', '', 'Wernerman'], ['Haibo', '', 'Zhang']]",Intensive Care Medicine,2008,"[u'http://www.smartonweb.org/documenti/editoriali/yir%202007%20-%202.pdf', u'http://www.springerlink.com/index/x2374n108w477376.pdf', u'http://www.springerlink.com/content/x2374n108w477376', u'http://en.smartonweb.org/documenti/Editoriali/YIR%202007%20-%202.pdf', u'http://www.springerlink.com/index/10.1007/s00134-008-1009-8', u'http://www.springerlink.com/index/pdf/10.1007/s00134-008-1009-8']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1007~s00134-008-1009-8
10.1007/s00134-007-0683-2,"Monteiro, D., Madrid, M., , Planning of robot trajectories with genetic algorithms, , 1999",cited-by,10.1109/ROMOCO.1999.791079,Planning of robot trajectories with genetic algorithms,"[['D.', 'C.', 'Monteiro'], ['M.', 'K.', 'Madrid']]",,1999,"[u'http://ieeexplore.ieee.org/xpls/abs_all.jsp?arnumber=791079', u'http://ieeexplore.ieee.org/stamp/stamp.jsp?arnumber=00791079']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1109~ROMOCO.1999.791079
10.1007/s00134-007-0683-2,"Tsioutis, C., Kritsotakis, E., Maraki, S., et. al, Infections by pandrug-resistant gram-negative bacteria: clinical profile, therapeutic management, and outcome in a series of 21 patients, European Journal of Clinical Microbiology & Infectious Diseases, 2010",cited-by,10.1007/s10096-009-0857-7,"Infections by pandrug-resistant gram-negative bacteria: clinical profile, therapeutic management, and outcome in a series of 21 patients","[['C.', '', 'Tsioutis'], ['E.', 'I.', 'Kritsotakis'], ['S.', '', 'Maraki'], ['A.', '', 'Gikas']]",European Journal of Clinical Microbiology & Infectious Diseases,2010,"[u'http://www.springerlink.com/content/7l700g537h4993v3', u'http://www.springerlink.com/index/7l700g537h4993v3.pdf', u'http://www.springerlink.com/index/10.1007/s10096-009-0857-7', u'http://www.springerlink.com/index/pdf/10.1007/s10096-009-0857-7']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1007~s10096-009-0857-7
10.1007/s00134-007-0683-2,"Moir, D., Di, M., Wong, E., et. al, Development and Application of a Cellular, Gain-of-Signal, Bioluminescent Reporter Screen for Inhibitors of Type II Secretion in Pseudomonas aeruginosa and Burkholderia pseudomallei, Journal of Biomolecular Screening, 2011",cited-by,10.1177/1087057111408605,"Development and Application of a Cellular, Gain-of-Signal, Bioluminescent Reporter Screen for Inhibitors of Type II Secretion in Pseudomonas aeruginosa and Burkholderia pseudomallei","[['Donald', 'T.', 'Moir'], ['Ming', '', 'Di'], ['Erica', '', 'Wong'], ['Richard', 'A.', 'Moore'], ['Herbert', 'P.', 'Schweizer'], ['Donald', 'E.', 'Woods'], ['Terry', 'L.', 'Bowlin']]",Journal of Biomolecular Screening,2011,[u'http://dx.doi.org/10.1177/1087057111408605'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1177~1087057111408605
10.1007/s00134-007-0683-2,"Morel, J., Casoetto, J., Jospé, R., et. al, De-escalation as part of a global strategy of empiric antibiotherapy management. A retrospective study in a medico-surgical intensive care unit, Critical Care, 2010",cited-by,10.1186/cc9373,De-escalation as part of a global strategy of empiric antibiotherapy management. A retrospective study in a medico-surgical intensive care unit,"[['J\xc3\xa9r\xc3\xb4me', '', 'Morel'], ['Julie', '', 'Casoetto'], ['Richard', '', 'Josp\xc3\xa9'], ['G\xc3\xa9rald', '', 'Aubert'], ['Raphael', '', 'Terrana'], ['Alain', '', 'Dumont'], ['Serge', '', 'Molliex'], ['Christian', '', 'Auboyer']]",Critical Care,2010,"[u'http://www.springerlink.com/content/u407484775668283', u'http://www.biomedcentral.com/content/pdf/cc9373.pdf', u'http://ccforum.com/content/14/6/R225', u'http://www.springerlink.com/index/u407484775668283.pdf']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1186~cc9373
10.1517~13543784.17.7.973.pdf,"Intensive Care Med 2007;33(9):1524-32 50. Bergen PJ, Li J, Nation RL, et al.",references,NOT found in MAS
10.1517~13543784.17.7.973.pdf,"Comparison of once-, twice- and thrice-daily dosing of colistin on antibacterial effect and emergence of resistance: studies with Pseudomonas aeruginosa in an in vitro pharmacodynamic model. J Antimicrob Chemother 2008;61(3):636-42 51. David MD, Gill MJ. Potential for underdosing and emergence of resistance in Acinetobacter baumannii during treatment with colistin. J Antimicrob Chemother 2008;61(4):962-4 52. Groisman EA, Kayser J, Soncini FC. Regulation of polymyxin resistance and adaptation to low-Mg2+ environments.",references,10.1093/jac/dkm511,"Comparison of once-, twice- and thrice-daily dosing of colistin on antibacterial effect and emergence of resistance: studies with Pseudomonas aeruginosa in an in vitro pharmacodynamic model","[[u'P.', u'J.', u'Bergen'], [u'J.', u'', u'Li'], [u'R.', u'L.', u'Nation'], [u'J.', u'D.', u'Turnidge'], [u'K.', u'', u'Coulthard'], [u'R.', u'W.', u'Milne']]",Journal of Antimicrobial Chemotherapy,2008,[u'http://www.jac.oxfordjournals.org/cgi/doi/10.1093/jac/dkm511'],./output/10.1517~13543784.17.7.973.pdf/10.1093~jac~dkm511
10.1093/jac/dkm511,"Giamarellou, H., Poulakou, G., , Multidrug-Resistant Gram-Negative Infections: What are the Treatment Options?, Drugs, 2009",cited-by,10.2165/11315690-000000000-00000,Multidrug-Resistant Gram-Negative Infections: What are the Treatment Options?,"[['Helen', '', 'Giamarellou'], ['Garyphallia', '', 'Poulakou']]",Drugs,2009,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00003495-200969140-00001'],
10.1093/jac/dkm511,"Falagas, M., Grammatikos, A., Michalopoulos, A., , Potential of old-generation antibiotics to address current need for new antibiotics, Expert Review of Anti-infective Therapy, 2008",cited-by,10.1586/14787210.6.5.593,Potential of old-generation antibiotics to address current need for new antibiotics,"[['Matthew', 'E', 'Falagas'], ['Alexandros', 'P', 'Grammatikos'], ['Argyris', '', 'Michalopoulos']]",Expert Review of Anti-infective Therapy,2008,[u'http://www.expert-reviews.com/doi/abs/10.1586/14787210.6.5.593'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1586~14787210.6.5.593
10.1093/jac/dkm511,"Nation, R., Li, J., , Colistin in the 21st century, Current Opinion in Infectious Diseases, 2009",cited-by,10.1097/QCO.0b013e328332e672,Colistin in the 21st century,"[['Roger', 'L', 'Nation'], ['Jian', '', 'Li']]",Current Opinion in Infectious Diseases,2009,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00001432-200912000-00004'],
10.1093/jac/dkm511,"Falagas, M., Rafailidis, P., , Re-emergence of colistin in today's world of multidrug-resistant organisms: personal perspectives, Expert Opinion on Investigational Drugs, 2008",cited-by,10.1517/13543784.17.7.973,Re-emergence of colistin in today's world of multidrug-resistant organisms: personal perspectives,"[['Matthew', 'E', 'Falagas'], ['Petros', 'I', 'Rafailidis']]",Expert Opinion on Investigational Drugs,2008,[u'http://www.informapharmascience.com/doi/abs/10.1517/13543784.17.7.973'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1517~13543784.17.7.973
10.1093/jac/dkm511,"Monteiro, D., Madrid, M., , Planning of robot trajectories with genetic algorithms, , 1999",cited-by,10.1109/ROMOCO.1999.791079,Planning of robot trajectories with genetic algorithms,"[['D.', 'C.', 'Monteiro'], ['M.', 'K.', 'Madrid']]",,1999,"[u'http://ieeexplore.ieee.org/xpls/abs_all.jsp?arnumber=791079', u'http://ieeexplore.ieee.org/stamp/stamp.jsp?arnumber=00791079']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1109~ROMOCO.1999.791079
10.1093/jac/dkm511,"Connolly, C., Grupen, R., , Harmonic control [robot applications], , 1992",cited-by,10.1109/ISIC.1992.225142,Harmonic control [robot applications],"[['C.', 'I.', 'Connolly'], ['R.', 'A.', 'Grupen']]",,1992,[u'http://ieeexplore.ieee.org/xpls/abs_all.jsp?arnumber=225142'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1109~ISIC.1992.225142
10.1093/jac/dkm511,"Barnos, B., , The electrified fence as a component of a physical protection system, , 1989",cited-by,10.1109/CCST.1989.751985,The electrified fence as a component of a physical protection system,"[['B.', 'W.', 'Barnos']]",,1989,[u'http://ieeexplore.ieee.org/xpls/abs_all.jsp?arnumber=751985'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1109~CCST.1989.751985
10.1093/jac/dkm511,"Spapen, H., Jacobs, R., Gorp, V., et. al, Renal and neurological side effects of colistin in critically ill patients, Annals of Intensive Care, 2011",cited-by,10.1186/2110-5820-1-14,Renal and neurological side effects of colistin in critically ill patients,"[['Herbert', '', 'Spapen'], ['Rita', '', 'Jacobs'], ['Viola', 'Van', 'Gorp'], ['Joris', '', 'Troubleyn'], ['Patrick', 'M', 'Honor\xc3\xa9']]",Annals of Intensive Care,2011,"[u'http://www.springerlink.com/index/j53j3l42kl32202u.pdf', u'http://www.springerlink.com/content/j53j3l42kl32202u']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1186~2110-5820-1-14
10.1093/jac/dkm511,"Wang, R., Bencic, D., Lazorchak, J., et. al, Transcriptional regulatory dynamics of the hypothalamic–pituitary–gonadal axis and its peripheral pathways as impacted by the 3-beta HSD inhibitor trilostane in zebrafish ( Danio rerio), Ecotoxicology and Environmental Safety, 2011",cited-by,10.1016/j.ecoenv.2011.05.001,Transcriptional regulatory dynamics of the hypothalamic–pituitary–gonadal axis and its peripheral pathways as impacted by the 3-beta HSD inhibitor trilostane in zebrafish ( Danio rerio),"[['Rong-Lin', '', 'Wang'], ['David', '', 'Bencic'], ['Jim', '', 'Lazorchak'], ['Daniel', '', 'Villeneuve'], ['Gerald', 'T.', 'Ankley']]",Ecotoxicology and Environmental Safety,2011,[u'http://www.sciencedirect.com/science/article/pii/S0147651311001308'],
10.1093/jac/dkm511,"Shearer, A., Bagust, A., Ampudia-Blasco, F., et. al, PDB8 THE IMPACT OF IMPROVED BETA-CELL FUNCTION ON MODELLING THE COST-EFFECTIVENESS OF ROSIGLITAZONE IN THE MANAGEMENT OF TYPE 2 DIABETES IN SPAIN, Value in Health, 2006",cited-by,10.1016/S1098-3015(10)63278-0,PDB8 THE IMPACT OF IMPROVED BETA-CELL FUNCTION ON MODELLING THE COST-EFFECTIVENESS OF ROSIGLITAZONE IN THE MANAGEMENT OF TYPE 2 DIABETES IN SPAIN,"[['A', '', 'Shearer'], ['A', '', 'Bagust'], ['FJ', '', 'Ampudia-Blasco'], ['MJ', '', 'TaylorJ'], ['S', 'Mendes da', 'Costa']]",Value in Health,2006,[u'http://www.sciencedirect.com/science/article/pii/S1098301510632780'],
10.1093/jac/dkm511,"Morris, M., Hobson, R., , Neural network design of a dishwasher control board, , 2002",cited-by,10.1109/IJCNN.2002.1007534,Neural network design of a dishwasher control board,"[['M.', '', 'Morris'], ['R.', 'S.', 'Hobson']]",,2002,"[u'http://ieeexplore.ieee.org/stamp/stamp.jsp?arnumber=01007534', u'http://ieeexplore.ieee.org/xpls/abs_all.jsp?arnumber=1007534']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1109~IJCNN.2002.1007534
10.1093/jac/dkm511,"Chiba, J., Murakami, Y., , Security communication in tunnels underground, , 1989",cited-by,10.1109/CCST.1989.751989,Security communication in tunnels underground,"[['Jiro', '', 'Chiba'], ['Yasushi', '', 'Murakami']]",,1989,"[u'http://ieeexplore.ieee.org/xpls/abs_all.jsp?arnumber=751989', u'http://ieeexplore.ieee.org/stamp/stamp.jsp?arnumber=00751989']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1109~CCST.1989.751989
10.1517~13543784.17.7.973.pdf,"J Bacteriol 1997;179:7040-5 53. Falagas ME, Kasiakou SK, Michalopoulos A. Polymyxins: a word of caution for prudent use of valuable ‘old antibiotics’.",references,10.1086/507290,Polymyxins: A Word of Caution for Prudent Use of Valuable “Old Antibiotics”,"[[u'Matthew', u'E.', u'Falagas'], [u'Sofia', u'K.', u'Kasiakou'], [u'Argyris', u'', u'Michalopoulos']]",Infection Control and Hospital Epidemiology,2006,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/507290'],./output/10.1517~13543784.17.7.973.pdf/10.1086~507290
10.1086/507290,"Matthaiou, D., Michalopoulos, A., Rafailidis, P., et. al, Risk factors associated with the isolation of colistin-resistant Gram-negative bacteria: A matched case-control study, Critical Care Medicine, 2008",cited-by,10.1097/CCM.0B013E3181652FAE,Risk factors associated with the isolation of colistin-resistant Gram-negative bacteria: A matched case-control study,"[['Dimitrios', 'K.', 'Matthaiou'], ['Argyris', '', 'Michalopoulos'], ['Petros', 'I.', 'Rafailidis'], ['Drosos', 'E.', 'Karageorgopoulos'], ['Vassiliki', '', 'Papaioannou'], ['Georgia', '', 'Ntani'], ['George', '', 'Samonis'], ['Matthew', 'E.', 'Falagas']]",Critical Care Medicine,2008,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00003246-200803000-00021'],
10.1086/507290,"Falagas, M., Rafailidis, P., , Re-emergence of colistin in today's world of multidrug-resistant organisms: personal perspectives, Expert Opinion on Investigational Drugs, 2008",cited-by,10.1517/13543784.17.7.973,Re-emergence of colistin in today's world of multidrug-resistant organisms: personal perspectives,"[['Matthew', 'E', 'Falagas'], ['Petros', 'I', 'Rafailidis']]",Expert Opinion on Investigational Drugs,2008,[u'http://www.informapharmascience.com/doi/abs/10.1517/13543784.17.7.973'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1517~13543784.17.7.973
10.1086/507290,"Falagas, M., Rafailidis, P., , WHEN TO INCLUDE POLYMYXINS IN THE EMPIRICAL ANTIBIOTIC REGIMEN IN CRITICALLY ILL PATIENTS WITH FEVER? A DECISION ANALYSIS APPROACH, Shock, 2007",cited-by,10.1097/01.shk.0000246899.73315.cb,WHEN TO INCLUDE POLYMYXINS IN THE EMPIRICAL ANTIBIOTIC REGIMEN IN CRITICALLY ILL PATIENTS WITH FEVER? A DECISION ANALYSIS APPROACH,"[['Matthew', 'E.', 'Falagas'], ['Petros', 'I.', 'Rafailidis']]",Shock,2007,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00024382-200706000-00003'],
10.1086/507290,"Costa, S., , IMPACT OF ANTIMICROBIAL RESISTANCE ON THE TREATMENT AND OUTCOME OF PATIENTS WITH SEPSIS, Shock, 2008",cited-by,10.1097/SHK.0b013e3181818990,IMPACT OF ANTIMICROBIAL RESISTANCE ON THE TREATMENT AND OUTCOME OF PATIENTS WITH SEPSIS,"[['Silvia', 'Figueiredo', 'Costa']]",Shock,2008,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00024382-200810001-00006'],
10.1517~13543784.17.7.973.pdf,"Infect Control Hosp Epidemiol 2006;27(9):995 54. Nessi R, Fowst G. Clinical use of rifampicin in combination for non-mycobacterial Expert Opin. Investig. Drugs Downloaded from informahealthcare.com by University New South Wales on 09/02/14 For personal use only.",references,NOT found in MAS
10.1517~13543784.17.7.973.pdf,Falagas Et Rafailidis Expert Opin. Investig. Drugs (2008) 17(7) 981 infections: a survey of published evidence.,references,NOT found in MAS
10.1517~13543784.17.7.973.pdf,"J Int Med Res 1979;7(3):179-86 55. Giamarellos-Bourboulis EJ, Xirouchaki E, Giamarellou H. Interactions of colistin and rifampin on multidrug-resistant Acinetobacter baumannii.",references,10.1016/S0732-8893(01)00258-9,Interactions of colistin and rifampin on multidrug-resistant Acinetobacter baumannii,"[[u'Evangelos', u'J', u'Giamarellos-Bourboulis'], [u'Evangelia', u'', u'Xirouchaki'], [u'Helen', u'', u'Giamarellou']]",Diagnostic Microbiology and Infectious Disease,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0732889301002589', u'http://linkinghub.elsevier.com/retrieve/pii/S0732889301002589']",
10.1016/S0732-8893(01)00258-9,", Treatment of Multidrug‐Resistant Acinetobacter baumannii Ventilator‐Associated Pneumonia (VAP) with Intravenous Colistin: A Comparison with Imipenem‐Susceptible VAP, Clinical Infectious Diseases, 2003",cited-by,10.1086/374337,Treatment of Multidrug‐Resistant Acinetobacter baumannii Ventilator‐Associated Pneumonia (VAP) with Intravenous Colistin: A Comparison with Imipenem‐Susceptible VAP,[],Clinical Infectious Diseases,2003,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/374337'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1086~374337
10.1016/S0732-8893(01)00258-9,"Li, J., Nation, R., Turnidge, J., et. al, Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections, Lancet Infectious Diseases, 2006",cited-by,10.1016/S1473-3099(06)70580-1,Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections,"[['Jian', '', 'Li'], ['Roger', 'L', 'Nation'], ['John', 'D', 'Turnidge'], ['Robert', 'W', 'Milne'], ['Kingsley', '', 'Coulthard'], ['Craig', 'R', 'Rayner'], ['David', 'L', 'Paterson']]",Lancet Infectious Diseases,2006,"[u'http://www.sld.cu/galerias/pdf/sitios/apua-cuba/r15-colistin._the_re-emerging_antibiotic_for_multidrug-resistant_gram-negative_bacterial_infections.pdf', u'http://www.sciencedirect.com/science/article/pii/S1473309906705801', u'http://www.sld.cu/galerias/pdf/sitios/apua-cuba/a21-colistin._the_re-emerging_antibiotic_for_multidrug-resistant_gram-negative_bacterial_infections.pdf', u'http://info.med.yale.edu/intmed/infdis/resources/docs/colistin-review-lancet.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S1473309906705801']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1016~S1473-3099(06)70580-1
10.1016/S0732-8893(01)00258-9,"Perez, F., Hujer, A., Hujer, K., et. al, Global Challenge of Multidrug-Resistant Acinetobacter baumannii, Antimicrobial Agents and Chemotherapy, 2007",cited-by,10.1128/AAC.01464-06,Global Challenge of Multidrug-Resistant Acinetobacter baumannii,"[['Federico', '', 'Perez'], ['Andrea', 'M.', 'Hujer'], ['Kristine', 'M.', 'Hujer'], ['Brooke', 'K.', 'Decker'], ['Robert', 'A.', 'Bonomo']]",Antimicrobial Agents and Chemotherapy,2007,"[u'http://aac.asm.org/cgi/reprint/51/10/3471.pdf', u'http://aac.highwire.org/cgi/reprint/51/10/3471.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.01464-06']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1128~AAC.01464-06
10.1016/S0732-8893(01)00258-9,"Markou, N., Apostolakos, H., Koumoudiou, C., et. al, Intravenous colistin in the treatment of sepsis from multiresistant Gram-negative bacilli in critically ill patients, Critical Care, 2003",cited-by,10.1186/cc2358,Intravenous colistin in the treatment of sepsis from multiresistant Gram-negative bacilli in critically ill patients,"[['Nikolaos', '', 'Markou'], ['Haralampos', '', 'Apostolakos'], ['Christiana', '', 'Koumoudiou'], ['Maria', '', 'Athanasiou'], ['Alexandra', '', 'Koutsoukou'], ['Ioannis', '', 'Alamanos'], ['Leonidas', '', 'Gregorakos']]",Critical Care,2003,"[u'http://ccforum.com/content/7/5/R78', u'http://www.biomedcentral.com/content/pdf/cc2358.pdf', u'http://www.springerlink.com/content/d2q7x66887261914', u'http://www.springerlink.com/index/d2q7x66887261914.pdf']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1186~cc2358
10.1016/S0732-8893(01)00258-9,"Kasiakou, S., Michalopoulos, A., Soteriades, E., et. al, Combination Therapy with Intravenous Colistin for Management of Infections Due to Multidrug-Resistant Gram-Negative Bacteria in Patients without Cystic Fibrosis, Antimicrobial Agents and Chemotherapy, 2005",cited-by,10.1128/AAC.49.8.3136-3146.2005,Combination Therapy with Intravenous Colistin for Management of Infections Due to Multidrug-Resistant Gram-Negative Bacteria in Patients without Cystic Fibrosis,"[['S.', 'K.', 'Kasiakou'], ['A.', '', 'Michalopoulos'], ['E.', 'S.', 'Soteriades'], ['G.', '', 'Samonis'], ['G.', 'J.', 'Sermaides'], ['M.', 'E.', 'Falagas']]",Antimicrobial Agents and Chemotherapy,2005,[u'http://aac.asm.org/cgi/doi/10.1128/AAC.49.8.3136-3146.2005'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1128~AAC.49.8.3136-3146.2005
10.1016/S0732-8893(01)00258-9,"Yoon, J., Urban, C., Terzian, C., et. al, In Vitro Double and Triple Synergistic Activities of Polymyxin B, Imipenem, and Rifampin against Multidrug-Resistant Acinetobacter baumannii, Antimicrobial Agents and Chemotherapy, 2004",cited-by,10.1128/AAC.48.3.753-757.2004,"In Vitro Double and Triple Synergistic Activities of Polymyxin B, Imipenem, and Rifampin against Multidrug-Resistant Acinetobacter baumannii","[['Jimmy', '', 'Yoon'], ['Carl', '', 'Urban'], ['Christian', '', 'Terzian'], ['Noriel', '', 'Mariano'], ['James', 'J.', 'Rahal']]",Antimicrobial Agents and Chemotherapy,2004,"[u'http://aac.asm.org/cgi/reprint/48/3/753.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.48.3.753-757.2004']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1128~AAC.48.3.753-757.2004
10.1016/S0732-8893(01)00258-9,"Falagas, M., Koletsi, P., Bliziotis, I., , The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa, Journal of Medical Microbiology, 2006",cited-by,10.1099/jmm.0.46747-0,The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa,"[['Matthew', 'E.', 'Falagas'], ['Patra', 'K.', 'Koletsi'], ['Ioannis', 'A.', 'Bliziotis']]",Journal of Medical Microbiology,2006,"[u'http://jmm.sgmjournals.org/cgi/reprint/55/12/1619.pdf', u'http://jmm.sgmjournals.org/cgi/doi/10.1099/jmm.0.46747-0']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1099~jmm.0.46747-0
10.1016/S0732-8893(01)00258-9,"Karageorgopoulos, D., Falagas, M., , Current control and treatment of multidrug-resistant Acinetobacter baumannii infections, Lancet Infectious Diseases, 2008",cited-by,10.1016/S1473-3099(08)70279-2,Current control and treatment of multidrug-resistant Acinetobacter baumannii infections,"[['Drosos', 'E', 'Karageorgopoulos'], ['Matthew', 'E', 'Falagas']]",Lancet Infectious Diseases,2008,"[u'http://www.sciencedirect.com/science/article/pii/S1473309908702792', u'http://linkinghub.elsevier.com/retrieve/pii/S1473309908702792']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1016~S1473-3099(08)70279-2
10.1016/S0732-8893(01)00258-9,"Linden, P., Paterson, D., , Parenteral and Inhaled Colistin for Treatment of Ventilator‐Associated Pneumonia, Clinical Infectious Diseases, 2006",cited-by,10.1086/504485,Parenteral and Inhaled Colistin for Treatment of Ventilator‐Associated Pneumonia,"[['Peter', 'K.', 'Linden'], ['David', 'L.', 'Paterson']]",Clinical Infectious Diseases,2006,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/504485'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1086~504485
10.1016/S0732-8893(01)00258-9,"Tomas, M., Cartelle, M., Pertega, S., et. al, Hospital outbreak caused by a carbapenem-resistant strain of Acinetobacter baumannii: patient prognosis and risk-factors for colonisation and infection, Clinical Microbiology and Infection, 2005",cited-by,10.1111/j.1469-0691.2005.01184.x,Hospital outbreak caused by a carbapenem-resistant strain of Acinetobacter baumannii: patient prognosis and risk-factors for colonisation and infection,"[['M.', 'del Mar', 'Tomas'], ['M.', '', 'Cartelle'], ['S.', '', 'Pertega'], ['A.', '', 'Beceiro'], ['P.', '', 'Llinares'], ['D.', '', 'Canle'], ['F.', '', 'Molina'], ['R.', '', 'Villanueva'], ['J.', 'M.', 'Cisneros'], ['G.', '', 'Bou']]",Clinical Microbiology and Infection,2005,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1469-0691.2005.01184.x'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1111~j.1469-0691.2005.01184.x
10.1016/S0732-8893(01)00258-9,"Rahal, J., , Novel Antibiotic Combinations against Infections with Almost Completely Resistant Pseudomonas aeruginosa and Acinetobacter Species, Clinical Infectious Diseases, 2006",cited-by,10.1086/504486,Novel Antibiotic Combinations against Infections with Almost Completely Resistant Pseudomonas aeruginosa and Acinetobacter Species,"[['James', 'J.', 'Rahal']]",Clinical Infectious Diseases,2006,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/504486'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1086~504486
10.1016/S0732-8893(01)00258-9,"Giamarellou, H., , Treatment options for multidrug-resistant bacteria, Expert Review of Anti-infective Therapy, 2006",cited-by,10.1586/14787210.4.4.601,Treatment options for multidrug-resistant bacteria,"[['Helen', '', 'Giamarellou']]",Expert Review of Anti-infective Therapy,2006,[u'http://www.future-drugs.com/doi/abs/10.1586/14787210.4.4.601'],
10.1016/S0732-8893(01)00258-9,"Timurkaynak, F., Can, F., Azap, ., et. al, In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units, International Journal of Antimicrobial Agents, 2006",cited-by,10.1016/j.ijantimicag.2005.10.012,In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units,"[['Funda', '', 'Timurkaynak'], ['Fusun', '', 'Can'], ['\xc3\x96zlem', 'Kurt', 'Azap'], ['M\xc3\xbcge', '', 'Demirbilek'], ['Hande', '', 'Arslan'], ['Sedef', '\xc3\x96zbal\xc4\xb1k\xc3\xa7\xc4\xb1', 'Karaman']]",International Journal of Antimicrobial Agents,2006,"[u'http://www.sciencedirect.com/science/article/pii/S0924857905003316', u'http://linkinghub.elsevier.com/retrieve/pii/S0924857905003316']",
10.1016/S0732-8893(01)00258-9,"Montero, A., Ariza, J., Corbella, X., et. al, Antibiotic combinations for serious infections caused by carbapenem-resistant Acinetobacter baumannii in a mouse pneumonia model, , 2004",cited-by,6522270Antibiotic combinations for serious infections caused by carbapenem-resistant Acinetobacter baumannii in a mouse pneumonia model,Antibiotic combinations for serious infections caused by carbapenem-resistant Acinetobacter baumannii in a mouse pneumonia model,"[['Abelardo', '', 'Montero'], ['Javier', '', 'Ariza'], ['Xavier', '', 'Corbella'], ['Alejandro', '', 'Domenech'], ['Carmen', '', 'Cabellos'], ['Josefina', '', 'Ayats'], ['Fe', '', 'Tubau'], ['Carmen', '', 'Borraz'], ['Francesc', '', 'Gudiol']]",,2004,"[u'http://jac.oxfordjournals.org/cgi/reprint/54/6/1085.pdf', u'http://jac.oxfordjournals.org/cgi/reprint/dkh485v1.pdf']",
10.1016/S0732-8893(01)00258-9,"Hujer, K., Hamza, N., Hujer, A., et. al, Identification of a New Allelic Variant of the Acinetobacter baumannii Cephalosporinase, ADC7  Lactamase: Defining a Unique Family of Class C Enzymes, Antimicrobial Agents and Chemotherapy, 2005",cited-by,10.1128/AAC.49.7.2941-2948.2005,"Identification of a New Allelic Variant of the Acinetobacter baumannii Cephalosporinase, ADC7  Lactamase: Defining a Unique Family of Class C Enzymes","[['Kristine', 'M.', 'Hujer'], ['Nashaat', 'S.', 'Hamza'], ['Andrea', 'M.', 'Hujer'], ['Federico', '', 'Perez'], ['Marion', 'S.', 'Helfand'], ['Christopher', 'R.', 'Bethel'], ['Jodi', 'M.', 'Thomson'], ['Vernon', 'E.', 'Anderson'], ['Miriam', '', 'Barlow'], ['Louis', 'B.', 'Rice'], ['Fred', 'C.', 'Tenover'], ['Robert', 'A.', 'Bonomo']]",Antimicrobial Agents and Chemotherapy,2005,"[u'http://aac.asm.org/cgi/reprint/49/7/2941.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.49.7.2941-2948.2005']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1128~AAC.49.7.2941-2948.2005
10.1016/S0732-8893(01)00258-9,"Giamarellos-Bourboulis, E., Karnesis, L., Giamarellou, H., , Synergy of colistin with rifampin and trimethoprim/sulfamethoxazole on multidrug-resistant Stenotrophomonas maltophilia, Diagnostic Microbiology and Infectious Disease, 2002",cited-by,10.1016/S0732-8893(02)00443-1,Synergy of colistin with rifampin and trimethoprim/sulfamethoxazole on multidrug-resistant Stenotrophomonas maltophilia,"[['Evangelos', 'J', 'Giamarellos-Bourboulis'], ['Lazaros', '', 'Karnesis'], ['Helen', '', 'Giamarellou']]",Diagnostic Microbiology and Infectious Disease,2002,"[u'http://www.sciencedirect.com/science/article/pii/S0732889302004431', u'http://linkinghub.elsevier.com/retrieve/pii/S0732889302004431']",
10.1016/S0732-8893(01)00258-9,"Pantopoulou, A., Giamarellos-Bourboulis, E., Raftogannis, M., et. al, Colistin offers prolonged survival in experimental infection by multidrug-resistant Acinetobacter baumannii: the significance of co-administration of rifampicin, International Journal of Antimicrobial Agents, 2007",cited-by,10.1016/j.ijantimicag.2006.09.009,Colistin offers prolonged survival in experimental infection by multidrug-resistant Acinetobacter baumannii: the significance of co-administration of rifampicin,"[['Alkistis', '', 'Pantopoulou'], ['Evangelos', 'J.', 'Giamarellos-Bourboulis'], ['Maria', '', 'Raftogannis'], ['Thomas', '', 'Tsaganos'], ['Ismini', '', 'Dontas'], ['Pantelis', '', 'Koutoukas'], ['Fotini', '', 'Baziaka'], ['Helen', '', 'Giamarellou'], ['Despina', '', 'Perrea']]",International Journal of Antimicrobial Agents,2007,"[u'http://www.sciencedirect.com/science/article/pii/S0924857906004146', u'http://linkinghub.elsevier.com/retrieve/pii/S0924857906004146']",
10.1016/S0732-8893(01)00258-9,"Petrosillo, N., Ioannidou, E., Falagas, M., , Colistin monotherapy vs. combination therapy: evidence from microbiological, animal and clinical studies, Clinical Microbiology and Infection, 2008",cited-by,10.1111/j.1469-0691.2008.02061.x,"Colistin monotherapy vs. combination therapy: evidence from microbiological, animal and clinical studies","[['N.', '', 'Petrosillo'], ['E.', '', 'Ioannidou'], ['M.', 'E.', 'Falagas']]",Clinical Microbiology and Infection,2008,[u'http://blackwell-synergy.com/doi/abs/10.1111/j.1469-0691.2008.02061.x'],
10.1016/S0732-8893(01)00258-9,", Antimicrobial Resistance: Acinetobacter baumannii: Epidemiology, Antimicrobial Resistance, and Treatment Options, Clinical Infectious Diseases, 2008",cited-by,10.1086/529198,"Antimicrobial Resistance: Acinetobacter baumannii: Epidemiology, Antimicrobial Resistance, and Treatment Options",[],Clinical Infectious Diseases,2008,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/529198'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1086~529198
10.1016/S0732-8893(01)00258-9,"Falagas, M., Rafailidis, P., Kasiakou, S., et. al, Effectiveness and nephrotoxicity of colistin monotherapy vs. colistin?meropenem combination therapy for multidrug-resistant Gram-negative bacterial infections, Clinical Microbiology and Infection, 2006",cited-by,10.1111/j.1469-0691.2006.01559.x,Effectiveness and nephrotoxicity of colistin monotherapy vs. colistin?meropenem combination therapy for multidrug-resistant Gram-negative bacterial infections,"[['M.', 'E.', 'Falagas'], ['P.', 'I.', 'Rafailidis'], ['S.', 'K.', 'Kasiakou'], ['P.', '', 'Hatzopoulou'], ['A.', '', 'Michalopoulos']]",Clinical Microbiology and Infection,2006,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1469-0691.2006.01559.x'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1111~j.1469-0691.2006.01559.x
10.1016/S0732-8893(01)00258-9,"Giamarellou, H., Antoniadou, A., Kanellakopoulou, K., , Acinetobacter baumannii: a universal threat to public health?, International Journal of Antimicrobial Agents, 2008",cited-by,10.1016/j.ijantimicag.2008.02.013,Acinetobacter baumannii: a universal threat to public health?,"[['Helen', '', 'Giamarellou'], ['Anastasia', '', 'Antoniadou'], ['Kyriaki', '', 'Kanellakopoulou']]",International Journal of Antimicrobial Agents,2008,"[u'http://www.sciencedirect.com/science/article/pii/S092485790800109X', u'http://linkinghub.elsevier.com/retrieve/pii/S092485790800109X']",
10.1016/S0732-8893(01)00258-9,"Cunha, B., , New Uses for Older Antibiotics: Nitrofurantoin, Amikacin, Colistin, Polymyxin B, Doxycycline, and Minocycline Revisited, Medical Clinics of North America, 2006",cited-by,10.1016/j.mcna.2006.07.006,"New Uses for Older Antibiotics: Nitrofurantoin, Amikacin, Colistin, Polymyxin B, Doxycycline, and Minocycline Revisited","[['Burke', 'A.', 'Cunha']]",Medical Clinics of North America,2006,"[u'http://www.sciencedirect.com/science/article/pii/S0025712506000861', u'http://linkinghub.elsevier.com/retrieve/pii/S0025712506000861']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1016~j.mcna.2006.07.006
10.1016/S0732-8893(01)00258-9,"Falagas, M., Rafailidis, P., , Re-emergence of colistin in today's world of multidrug-resistant organisms: personal perspectives, Expert Opinion on Investigational Drugs, 2008",cited-by,10.1517/13543784.17.7.973,Re-emergence of colistin in today's world of multidrug-resistant organisms: personal perspectives,"[['Matthew', 'E', 'Falagas'], ['Petros', 'I', 'Rafailidis']]",Expert Opinion on Investigational Drugs,2008,[u'http://www.informapharmascience.com/doi/abs/10.1517/13543784.17.7.973'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1517~13543784.17.7.973
10.1016/S0732-8893(01)00258-9,"Gilad, J., Carmeli, Y., , Treatment Options for??Multidrug-Resistant Acinetobacter Species, Drugs, 2008",cited-by,10.2165/00003495-200868020-00003,Treatment Options for??Multidrug-Resistant Acinetobacter Species,"[['Jacob', '', 'Gilad'], ['Yehuda', '', 'Carmeli']]",Drugs,2008,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00003495-200868020-00003'],
10.1016/S0732-8893(01)00258-9,"Tripodi, M., Durante-Mangoni, E., Fortunato, R., et. al, Comparative activities of colistin, rifampicin, imipenem and sulbactam/ampicillin alone or in combination against epidemic multidrug-resistant Acinetobacter baumannii isolates producing OXA-58 carbapenemases, International Journal of Antimicrobial Agents, 2007",cited-by,10.1016/j.ijantimicag.2007.07.007,"Comparative activities of colistin, rifampicin, imipenem and sulbactam/ampicillin alone or in combination against epidemic multidrug-resistant Acinetobacter baumannii isolates producing OXA-58 carbapenemases","[['Marie-Francoise', '', 'Tripodi'], ['Emanuele', '', 'Durante-Mangoni'], ['Rosaria', '', 'Fortunato'], ['Riccardo', '', 'Utili'], ['Raffaele', '', 'Zarrilli']]",International Journal of Antimicrobial Agents,2007,"[u'http://www.sciencedirect.com/science/article/pii/S0924857907003214', u'http://linkinghub.elsevier.com/retrieve/pii/S0924857907003214']",
10.1016/S0732-8893(01)00258-9,"Hermsen, E., Sullivan, C., Rotschafer, J., , Polymyxins, Infectious Disease Clinics of North America, 2003",cited-by,10.1016/S0891-5520(03)00058-8,Polymyxins,"[['Elizabeth', 'D', 'Hermsen'], ['Christopher', 'J', 'Sullivan'], ['John', 'C', 'Rotschafer']]",Infectious Disease Clinics of North America,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0891552003000588', u'http://linkinghub.elsevier.com/retrieve/pii/S0891552003000588']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1016~S0891-5520(03)00058-8
10.1016/S0732-8893(01)00258-9,"Rodriguez-Hernandez, M., Jimenez-Mejias, M., Pichardo, C., et. al, Colistin efficacy in an experimental model of Acinetobacter baumannii endocarditis, Clinical Microbiology and Infection, 2004",cited-by,10.1111/j.1469-0691.2004.00910.x,Colistin efficacy in an experimental model of Acinetobacter baumannii endocarditis,"[['M.-J.', '', 'Rodriguez-Hernandez'], ['M.', 'E.', 'Jimenez-Mejias'], ['C.', '', 'Pichardo'], ['L.', '', 'Cuberos'], ['A.', '', 'Garcia-Curiel'], ['J.', '', 'Pachon']]",Clinical Microbiology and Infection,2004,[u'http://www.blackwell-synergy.com/links/doi/10.1111%2Fj.1469-0691.2004.00910.x'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1111~j.1469-0691.2004.00910.x
10.1016/S0732-8893(01)00258-9,"Kendirli, T., Aydı́n, H., Hacı́hamdioğlu, D., et. al, Meningitis with multidrug-resistant Acinetobacter baumannii treated with ampicillin/sulbactam, Journal of Hospital Infection, 2004",cited-by,10.1016/j.jhin.2003.12.006,Meningitis with multidrug-resistant Acinetobacter baumannii treated with ampicillin/sulbactam,"[['T', '', 'Kendirli'], ['H.', '\xc4\xb0', 'Ayd\xc4\xb1\xcc\x81n'], ['D', '', 'Hac\xc4\xb1\xcc\x81hamdio\xc4\x9flu'], ['M', '', 'G\xc3\xbclg\xc3\xbcn'], ['B', '', '\xc3\x9cnay'], ['R', '', 'Ak\xc4\xb1\xcc\x81n'], ['M.', 'K', 'Lenk'], ['E', '', 'G\xc3\xb6k\xc3\xa7ay']]",Journal of Hospital Infection,2004,"[u'http://www.sciencedirect.com/science/article/pii/S0195670103004894', u'http://linkinghub.elsevier.com/retrieve/pii/S0195670103004894']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1016~j.jhin.2003.12.006
10.1016/S0732-8893(01)00258-9,"Haddad, F., Horn, K., Carbonaro, C., et. al, Evaluation of antibiotic combinations against multidrug-resistant Acinetobacter baumannii using the E-test, European Journal of Clinical Microbiology & Infectious Diseases, 2005",cited-by,10.1007/s10096-005-1366-y,Evaluation of antibiotic combinations against multidrug-resistant Acinetobacter baumannii using the E-test,"[['F.', 'A.', 'Haddad'], ['K.', 'Van', 'Horn'], ['C.', '', 'Carbonaro'], ['M.', '', 'Aguero-Rosenfeld'], ['G.', 'P.', 'Wormser']]",European Journal of Clinical Microbiology & Infectious Diseases,2005,"[u'http://www.springerlink.com/content/uw8824456122tx91', u'http://www.springerlink.com/index/uw8824456122tx91.pdf', u'http://www.springerlink.com/index/10.1007/s10096-005-1366-y', u'http://www.springerlink.com/index/pdf/10.1007/s10096-005-1366-y']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1007~s10096-005-1366-y
10.1016/S0732-8893(01)00258-9,"Dı́ez, A., Pérez, M., Bouza, J., et. al, Susceptibility of the Acinetobacter calcoaceticus– A. baumannii complex to imipenem, meropenem, sulbactam and colistin, International Journal of Antimicrobial Agents, 2004",cited-by,10.1016/j.ijantimicag.2003.09.026,"Susceptibility of the Acinetobacter calcoaceticus– A. baumannii complex to imipenem, meropenem, sulbactam and colistin","[['Ana', 'Isabel Due\xc3\xb1as', 'D\xc4\xb1\xcc\x81ez'], ['Miguel', 'Angel Bratos', 'P\xc3\xa9rez'], ['Jos\xc3\xa9', 'Mar\xc4\xb1\xcc\x81a Eiros', 'Bouza'], ['Ana', 'Almaraz', 'G\xc3\xb3mez'], ['Purificaci\xc3\xb3n', 'Guti\xc3\xa9rrez', 'Rodr\xc4\xb1\xcc\x81guez'], ['Mar\xc4\xb1\xcc\x81a', 'Antonia Miguel', 'G\xc3\xb3mez'], ['Antonio', 'Ordu\xc3\xb1a', 'Domingo'], ['Antonio', '', 'Rodr\xc4\xb1\xcc\x81guez-Torres']]",International Journal of Antimicrobial Agents,2004,"[u'http://www.sciencedirect.com/science/article/pii/S0924857904000342', u'http://linkinghub.elsevier.com/retrieve/pii/S0924857904000342']",
10.1016/S0732-8893(01)00258-9,"Song, J., Kee, S., Hwang, I., et. al, In vitro activities of carbapenem/sulbactam combination, colistin, colistin/rifampicin combination and tigecycline against carbapenem-resistant Acinetobacter baumannii, , 0",cited-by,"11377509In vitro activities of carbapenem/sulbactam combination, colistin, colistin/rifampicin combination and tigecycline against carbapenem-resistant Acinetobacter baumannii","In vitro activities of carbapenem/sulbactam combination, colistin, colistin/rifampicin combination and tigecycline against carbapenem-resistant Acinetobacter baumannii","[['Joon', 'Young', 'Song'], ['Sae', 'Yoon', 'Kee'], ['In', 'Sook', 'Hwang'], ['Yu', 'Bin', 'Seo'], ['Hye', 'Won', 'Jeong']]",,0,[u'http://jac.oxfordjournals.org/cgi/reprint/60/2/317.pdf'],
10.1016/S0732-8893(01)00258-9,"Wieczorek, P., Sacha, P., Hauschild, T., et. al, Multidrug resistant Acinetobacter baumannii — the role of AdeABC (RND family) efflux pump in resistance to antibiotics, Folia Histochemica Et Cytobiologica, 2008",cited-by,10.2478/v10042-008-0056-x,Multidrug resistant Acinetobacter baumannii — the role of AdeABC (RND family) efflux pump in resistance to antibiotics,"[['Piotr', '', 'Wieczorek'], ['Pawe\xc5\x82', '', 'Sacha'], ['Tomasz', '', 'Hauschild'], ['Marcin', '', '\xc5\xbb\xc3\xb3rawski'], ['Ma\xc5\x82gorzata', '', 'Krawczyk'], ['El\xc5\xbcbieta', '', 'Tryniszewska']]",Folia Histochemica Et Cytobiologica,2008,"[u'http://versita.metapress.com/openurl.asp?genre=article&id=doi:10.2478/v10042-008-0056-x', u'http://versita.metapress.com/index/D6744M302119U45R.pdf']",
10.1016/S0732-8893(01)00258-9,"Visentin, B., Charrier, J., Roudier, D., et. al, Experimental results on 700 MHz multicell superconducting cavity for proton linac, , 2003",cited-by,10.1109/PAC.2003.1289686,Experimental results on 700 MHz multicell superconducting cavity for proton linac,"[['B.', '', 'Visentin'], ['J.', 'P.', 'Charrier'], ['D.', '', 'Roudier'], ['F.', '', 'Simoens'], ['E.', '', 'Jacques'], ['A.', '', 'Aspart'], ['Y.', '', 'Gasser'], ['J.', 'P.', 'Poupeau'], ['P.', '', 'Sahuquet'], ['D.', '', 'Braud'], ['H.', '', 'Saugnac'], ['Ph.', '', 'Szott'], ['S.', '', 'Bousson'], ['J.', 'L.', 'Biarrotte'], ['T.', '', 'Junquera'], ['S.', '', 'Blivet']]",,2003,"[u'http://ieeexplore.ieee.org/xpls/abs_all.jsp?arnumber=1289686', u'http://ieeexplore.ieee.org/stamp/stamp.jsp?arnumber=01289686', u'http://adsabs.harvard.edu/abs/2003pac..conf.1303V']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1109~PAC.2003.1289686
10.1016/S0732-8893(01)00258-9,"Monteiro, D., Madrid, M., , Planning of robot trajectories with genetic algorithms, , 1999",cited-by,10.1109/ROMOCO.1999.791079,Planning of robot trajectories with genetic algorithms,"[['D.', 'C.', 'Monteiro'], ['M.', 'K.', 'Madrid']]",,1999,"[u'http://ieeexplore.ieee.org/xpls/abs_all.jsp?arnumber=791079', u'http://ieeexplore.ieee.org/stamp/stamp.jsp?arnumber=00791079']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1109~ROMOCO.1999.791079
10.1016/S0732-8893(01)00258-9,"Sartelli, M., , A focus on intra-abdominal infections, World Journal of Emergency Surgery, 2010",cited-by,10.1186/1749-7922-5-9,A focus on intra-abdominal infections,"[['Massimo', '', 'Sartelli']]",World Journal of Emergency Surgery,2010,"[u'http://www.springerlink.com/index/j42703817xu074k4.pdf', u'http://www.biomedcentral.com/content/pdf/1749-7922-5-9.pdf', u'http://www.wjes.org/content/5/1/9', u'http://www.springerlink.com/content/j42703817xu074k4']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1186~1749-7922-5-9
10.1016/S0732-8893(01)00258-9,"Drapeau, C., Grilli, E., Petrosillo, N., , Rifampicin combined regimens for Gram-negative infections: data from the literature, International Journal of Antimicrobial Agents, 2010",cited-by,10.1016/j.ijantimicag.2009.08.011,Rifampicin combined regimens for Gram-negative infections: data from the literature,"[['C.', 'M. J.', 'Drapeau'], ['E.', '', 'Grilli'], ['N.', '', 'Petrosillo']]",International Journal of Antimicrobial Agents,2010,"[u'http://www.sciencedirect.com/science/article/pii/S092485790900404X', u'http://linkinghub.elsevier.com/retrieve/pii/S092485790900404X']",
10.1016/S0732-8893(01)00258-9,"Cirioni, O., Silvestri, C., Ghiselli, R., et. al, Protective effects of the combination of a-helical antimicrobial peptides and rifampicin in three rat models of Pseudomonas aeruginosa infection, , 2008",cited-by,6897595Protective effects of the combination of a-helical antimicrobial peptides and rifampicin in three rat models of Pseudomonas aeruginosa infection,Protective effects of the combination of a-helical antimicrobial peptides and rifampicin in three rat models of Pseudomonas aeruginosa infection,"[['Oscar', '', 'Cirioni'], ['Carmela', '', 'Silvestri'], ['Roberto', '', 'Ghiselli'], ['Fiorenza', '', 'Orlando'], ['Alessandra', '', 'Riva'], ['Federico', '', 'Mocchegiani'], ['Leonardo', '', 'Chiodi'], ['Sefora', '', 'Castelletti'], ['Eleonora', '', 'Gabrielli'], ['Vittorio', '', 'Saba'], ['Giorgio', '', 'Scalise'], ['Andrea', '', 'Giacometti']]",,2008,[u'http://jac.oxfordjournals.org/cgi/reprint/dkn393v1.pdf'],
10.1016/S0732-8893(01)00258-9,"Bassetti, M., Righi, E., Esposito, S., et. al, Drug treatment for multidrug-resistant Acinetobacter baumannii infections, Future Microbiology, 2008",cited-by,10.2217/17460913.3.6.649,Drug treatment for multidrug-resistant Acinetobacter baumannii infections,"[['Matteo', '', 'Bassetti'], ['Elda', '', 'Righi'], ['Silvano', '', 'Esposito'], ['Nicola', '', 'Petrosillo'], ['Laura', '', 'Nicolini']]",Future Microbiology,2008,[u'http://www.futuremedicine.com/doi/abs/10.2217/17460913.3.6.649'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.2217~17460913.3.6.649
10.1016/S0732-8893(01)00258-9,"Usher, J., Alexander, S., Thompson, J., , Predicting the reliability of new products at IBM, , 1991",cited-by,10.1109/ARMS.1991.154437,Predicting the reliability of new products at IBM,"[['J.', 'S.', 'Usher'], ['S.', 'M.', 'Alexander'], ['J.', 'D.', 'Thompson']]",,1991,[u'http://ieeexplore.ieee.org/xpls/abs_all.jsp?arnumber=154437'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1109~ARMS.1991.154437
10.1016/S0732-8893(01)00258-9,"Bozkurt-Güzel, ., Gerçeker, A., , Post-antibiotic effect of colistin, alone and in combination with amikacin, on Pseudomonas aeruginosa strains isolated from cystic fibrosis patients, Journal of Antibiotics, 2012",cited-by,10.1038/ja.2011.101,"Post-antibiotic effect of colistin, alone and in combination with amikacin, on Pseudomonas aeruginosa strains isolated from cystic fibrosis patients","[['\xc3\x87agla', '', 'Bozkurt-G\xc3\xbczel'], ['Ayse', 'Alev', 'Ger\xc3\xa7eker']]",Journal of Antibiotics,2012,[u'http://dx.doi.org/10.1038/ja.2011.101'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1038~ja.2011.101
10.1016/S0732-8893(01)00258-9,"Flemme, I., Hallberg, U., Johansson, I., et. al, Uncertainty is a major concern for patients with implantable cardioverter defibrillators, Heart & Lung, 2011",cited-by,10.1016/j.hrtlng.2011.02.003,Uncertainty is a major concern for patients with implantable cardioverter defibrillators,"[['Inger', '', 'Flemme'], ['Ulrika', '', 'Hallberg'], ['Ingela', '', 'Johansson'], ['Anna', '', 'Str\xc3\xb6mberg']]",Heart & Lung,2011,[u'http://www.sciencedirect.com/science/article/pii/S0147956311000719'],
10.1016/S0732-8893(01)00258-9,"Celebi, S., Hacimustafaoglu, M., Koksal, N., et. al, Colistimethate sodium therapy for multidrug-resistant isolates in pediatric patients: Colistimethate sodium therapy, Pediatrics International, 2009",cited-by,10.1111/j.1442-200X.2009.03015.x,Colistimethate sodium therapy for multidrug-resistant isolates in pediatric patients: Colistimethate sodium therapy,"[['Solmaz', '', 'Celebi'], ['Mustafa', '', 'Hacimustafaoglu'], ['Nilgun', '', 'Koksal'], ['Hilal', '', 'Ozkan'], ['Merih', '', '\xc3\x87etinkaya']]",Pediatrics International,2009,[u'http://blackwell-synergy.com/doi/abs/10.1111/j.1442-200X.2009.03015.x'],
10.1016/S0732-8893(01)00258-9,"Cirioni, O., Silvestri, C., Ghiselli, R., et. al, Protective effects of the combination of  -helical antimicrobial peptides and rifampicin in three rat models of Pseudomonas aeruginosa infection, Journal of Antimicrobial Chemotherapy, 2008",cited-by,10.1093/jac/dkn393,Protective effects of the combination of  -helical antimicrobial peptides and rifampicin in three rat models of Pseudomonas aeruginosa infection,"[['O.', '', 'Cirioni'], ['C.', '', 'Silvestri'], ['R.', '', 'Ghiselli'], ['F.', '', 'Orlando'], ['A.', '', 'Riva'], ['F.', '', 'Mocchegiani'], ['L.', '', 'Chiodi'], ['S.', '', 'Castelletti'], ['E.', '', 'Gabrielli'], ['V.', '', 'Saba'], ['G.', '', 'Scalise'], ['A.', '', 'Giacometti']]",Journal of Antimicrobial Chemotherapy,2008,[u'http://www.jac.oxfordjournals.org/cgi/doi/10.1093/jac/dkn393'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1093~jac~dkn393
10.1016/S0732-8893(01)00258-9,"Kaiser, J., Little, J., , Phase comparison properties of the dual mode spiral with application to direction finding, , 1964",cited-by,10.1109/APS.1964.1150166,Phase comparison properties of the dual mode spiral with application to direction finding,"[['J.', 'A.', 'Kaiser'], ['J.', '', 'Little']]",,1964,"[u'http://ieeexplore.ieee.org/xpls/abs_all.jsp?arnumber=1150166', u'http://ieeexplore.ieee.org/stamp/stamp.jsp?arnumber=01150166']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1109~APS.1964.1150166
10.1016/S0732-8893(01)00258-9,"Azap, ., Arslan, H., Ergin, F., et. al, In vitro activity of colistin against nonfermentative gram-negative bacilli, , 0",cited-by,11548926In vitro activity of colistin against nonfermentative gram-negative bacilli,In vitro activity of colistin against nonfermentative gram-negative bacilli,"[['\xc3\x96zlem', 'Kurt', 'Azap'], ['Hande', '', 'Arslan'], ['Funda', '', 'Ergin'], ['Emine', '', 'Kuru'], ['G\xc3\xb6knur', '', 'Yapar']]",,0,[u'http://www.medicine.ankara.edu.tr/fakulte/files/20052_4'],
10.1517~13543784.17.7.973.pdf,"Diagn Microbiol Infect Dis 2001;40(3):117-20 56. Cirioni O, Ghiselli R, Orlando F, et al.",references,NOT found in MAS
10.1517~13543784.17.7.973.pdf,"Efficacy of colistin/rifampin combination in experimental rat models of sepsis due to a multiresistant Pseudomonas aeruginosa strain. Crit Care Med 2007;35(7):1717-23 57. Pantopoulou A, Giamarellos-Bourboulis EJ, Raftogannis M, et al. Colistin offers prolonged survival in experimental infection by multidrug-resistant Acinetobacter baumannii: the significance of co-administration of rifampicin. Int J Antimicrob Agents 2007;29(1):51-5 58. Li J, Nation RL, Owen RJ, et al.",references,10.1097/01.CCM.0000266685.25436.03,Efficacy of colistin/rifampin combination in experimental rat models of sepsis due to a multiresistant Pseudomonas aeruginosa strain,"[[u'Oscar', u'', u'Cirioni'], [u'Roberto', u'', u'Ghiselli'], [u'Fiorenza', u'', u'Orlando'], [u'Carmela', u'', u'Silvestri'], [u'Federico', u'', u'Mocchegiani'], [u'Marco', u'', u'Rocchi'], [u'Leonardo', u'', u'Chiodi'], [u'Alessandra', u'', u'Abbruzzetti'], [u'Vittorio', u'', u'Saba'], [u'Giorgio', u'', u'Scalise'], [u'Andrea', u'', u'Giacometti']]",Critical Care Medicine,2007,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00003246-200707000-00015'],
10.1097/01.CCM.0000266685.25436.03,"Petrosillo, N., Ioannidou, E., Falagas, M., , Colistin monotherapy vs. combination therapy: evidence from microbiological, animal and clinical studies, Clinical Microbiology and Infection, 2008",cited-by,10.1111/j.1469-0691.2008.02061.x,"Colistin monotherapy vs. combination therapy: evidence from microbiological, animal and clinical studies","[['N.', '', 'Petrosillo'], ['E.', '', 'Ioannidou'], ['M.', 'E.', 'Falagas']]",Clinical Microbiology and Infection,2008,[u'http://blackwell-synergy.com/doi/abs/10.1111/j.1469-0691.2008.02061.x'],
10.1097/01.CCM.0000266685.25436.03,"Falagas, M., Rafailidis, P., , Re-emergence of colistin in today's world of multidrug-resistant organisms: personal perspectives, Expert Opinion on Investigational Drugs, 2008",cited-by,10.1517/13543784.17.7.973,Re-emergence of colistin in today's world of multidrug-resistant organisms: personal perspectives,"[['Matthew', 'E', 'Falagas'], ['Petros', 'I', 'Rafailidis']]",Expert Opinion on Investigational Drugs,2008,[u'http://www.informapharmascience.com/doi/abs/10.1517/13543784.17.7.973'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1517~13543784.17.7.973
10.1097/01.CCM.0000266685.25436.03,"Pan, C., Yu, C., Yu, C., et. al, Antimicrobial peptides of an anti-lipopolysaccharide factor, epinecidin-1, and hepcidin reduce the lethality of Riemerella anatipestifer sepsis in ducks, Peptides, 2010",cited-by,10.1016/j.peptides.2010.01.013,"Antimicrobial peptides of an anti-lipopolysaccharide factor, epinecidin-1, and hepcidin reduce the lethality of Riemerella anatipestifer sepsis in ducks","[['Chieh-Yu', '', 'Pan'], ['Chao-Yuan', '', 'Yu'], ['Chang-You', '', 'Yu'], ['Jian-Chyi', '', 'Chen'], ['Jyh-Yih', '', 'Chen']]",Peptides,2010,"[u'http://www.sciencedirect.com/science/article/pii/S0196978110000331', u'http://linkinghub.elsevier.com/retrieve/pii/S0196978110000331']",
10.1097/01.CCM.0000266685.25436.03,"Monteiro, D., Madrid, M., , Planning of robot trajectories with genetic algorithms, , 1999",cited-by,10.1109/ROMOCO.1999.791079,Planning of robot trajectories with genetic algorithms,"[['D.', 'C.', 'Monteiro'], ['M.', 'K.', 'Madrid']]",,1999,"[u'http://ieeexplore.ieee.org/xpls/abs_all.jsp?arnumber=791079', u'http://ieeexplore.ieee.org/stamp/stamp.jsp?arnumber=00791079']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1109~ROMOCO.1999.791079
10.1097/01.CCM.0000266685.25436.03,"Cirioni, O., Silvestri, C., Ghiselli, R., et. al, Protective effects of the combination of a-helical antimicrobial peptides and rifampicin in three rat models of Pseudomonas aeruginosa infection, , 2008",cited-by,6897595Protective effects of the combination of a-helical antimicrobial peptides and rifampicin in three rat models of Pseudomonas aeruginosa infection,Protective effects of the combination of a-helical antimicrobial peptides and rifampicin in three rat models of Pseudomonas aeruginosa infection,"[['Oscar', '', 'Cirioni'], ['Carmela', '', 'Silvestri'], ['Roberto', '', 'Ghiselli'], ['Fiorenza', '', 'Orlando'], ['Alessandra', '', 'Riva'], ['Federico', '', 'Mocchegiani'], ['Leonardo', '', 'Chiodi'], ['Sefora', '', 'Castelletti'], ['Eleonora', '', 'Gabrielli'], ['Vittorio', '', 'Saba'], ['Giorgio', '', 'Scalise'], ['Andrea', '', 'Giacometti']]",,2008,[u'http://jac.oxfordjournals.org/cgi/reprint/dkn393v1.pdf'],
10.1097/01.CCM.0000266685.25436.03,"Stevens, C., , Analgesia in Amphibians: Preclinical Studies and Clinical Applications, Veterinary Clinics of North America: Exotic Animal Practice, 2011",cited-by,10.1016/j.cvex.2010.09.007,Analgesia in Amphibians: Preclinical Studies and Clinical Applications,"[['Craig', 'W.', 'Stevens']]",Veterinary Clinics of North America: Exotic Animal Practice,2011,[u'http://www.sciencedirect.com/science/article/pii/S1094919410001234'],
10.1097/01.CCM.0000266685.25436.03,"Cirioni, O., Silvestri, C., Ghiselli, R., et. al, Protective effects of the combination of  -helical antimicrobial peptides and rifampicin in three rat models of Pseudomonas aeruginosa infection, Journal of Antimicrobial Chemotherapy, 2008",cited-by,10.1093/jac/dkn393,Protective effects of the combination of  -helical antimicrobial peptides and rifampicin in three rat models of Pseudomonas aeruginosa infection,"[['O.', '', 'Cirioni'], ['C.', '', 'Silvestri'], ['R.', '', 'Ghiselli'], ['F.', '', 'Orlando'], ['A.', '', 'Riva'], ['F.', '', 'Mocchegiani'], ['L.', '', 'Chiodi'], ['S.', '', 'Castelletti'], ['E.', '', 'Gabrielli'], ['V.', '', 'Saba'], ['G.', '', 'Scalise'], ['A.', '', 'Giacometti']]",Journal of Antimicrobial Chemotherapy,2008,[u'http://www.jac.oxfordjournals.org/cgi/doi/10.1093/jac/dkn393'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1093~jac~dkn393
10.1517~13543784.17.7.973.pdf,"Antibiograms of multidrug-resistant clinical Acinetobacter baumannii: promising therapeutic options for treatment of infection with colistin-resistant strains. Clin Infect Dis 2007;45(5):594-8 • A paper detailing in vitro synergistic effectiveness of colistin in combination with rifampicin and other antibiotics on colistin-resistant strains of A. baumannii. 59. Falagas ME, Fragoulis KN, Kasiakou SK, et al. Nephrotoxicity of intravenous colistin: a prospective evaluation.",references,NOT found in MAS
10.1517~13543784.17.7.973.pdf,"Int J Antimicrob Agents 2005;26(6):504-7 60. Rafailidis PI, Kakisi OK, Vardakas K, Falagas ME. Infectious complications of monoclonal antibodies used in cancer therapy: a systematic review of the evidence from randomized controlled trials. Cancer 2007;109(11):2182-9 61. Falagas ME, Rafailidis PI. Attributable mortality of Acinetobacter baumannii: no longer a controversial issue. Crit Care 2007;11(3):134 62. Falagas ME, Rafailidis PI. When to include polymyxins in the empirical antibiotic regimen in critically ill patients with fever? A decision analysis approach. Shock 2007;27(6):605-9 • A practical guide addressing issues related to the decision analysis on the empirical use of polymyxins based on local epidemiology data of antimicrobial resistance. 63. Ratjen F, Rietschel E, Kasel D, et al. Pharmacokinetics of inhaled colistin in patients with cystic fibrosis.",references,10.1016/S0924-8579(07)71787-9,P1948 Infectious complications of monoclonal antibodies used in cancer therapy,"[[u'P.', u'I.', u'Rafailidis'], [u'O.', u'K.', u'Kakisi'], [u'K.', u'Z.', u'Vardakas'], [u'M.', u'E.', u'Falagas']]",International Journal of Antimicrobial Agents,2007,"[u'http://www.sciencedirect.com/science/article/pii/S0924857907717879', u'http://linkinghub.elsevier.com/retrieve/pii/S0924857907717879']",
10.1016/S0924-8579(07)71787-9,"Jones, R., Ferraro, A., Chaudhry, A., et. al, A multicenter survey of rituximab therapy for refractory antineutrophil cytoplasmic antibody-associated vasculitis, Arthritis and Rheumatism, 2009",cited-by,10.1002/art.24637,A multicenter survey of rituximab therapy for refractory antineutrophil cytoplasmic antibody-associated vasculitis,"[['Rachel', 'B.', 'Jones'], ['Alastair', 'J.', 'Ferraro'], ['Afzal', 'N.', 'Chaudhry'], ['Paul', '', 'Brogan'], ['Alan', 'D.', 'Salama'], ['Kenneth', 'G. C.', 'Smith'], ['Caroline', 'O. S.', 'Savage'], ['David', 'R. W.', 'Jayne']]",Arthritis and Rheumatism,2009,[u'http://doi.wiley.com/10.1002/art.24637'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1002~art.24637
10.1016/S0924-8579(07)71787-9,"Looney, R., Srinivasan, R., Calabrese, L., , The effects of rituximab on immunocompetency in patients with autoimmune disease, Arthritis and Rheumatism, 2008",cited-by,10.1002/art.23171,The effects of rituximab on immunocompetency in patients with autoimmune disease,"[['R.', 'John', 'Looney'], ['Renganathan', '', 'Srinivasan'], ['Leonard', 'H.', 'Calabrese']]",Arthritis and Rheumatism,2008,[u'http://doi.wiley.com/10.1002/art.23171'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1002~art.23171
10.1016/S0924-8579(07)71787-9,"Kamar, N., Milioto, O., Puissant-Lubrano, B., et. al, Incidence and Predictive Factors for Infectious Disease after Rituximab Therapy in Kidney-Transplant Patients, American Journal of Transplantation, 2010",cited-by,10.1111/j.1600-6143.2009.02785.x,Incidence and Predictive Factors for Infectious Disease after Rituximab Therapy in Kidney-Transplant Patients,"[['N.', '', 'Kamar'], ['O.', '', 'Milioto'], ['B.', '', 'Puissant-Lubrano'], ['L.', '', 'Esposito'], ['M.', 'C.', 'Pierre'], ['A.', 'Ould', 'Mohamed'], ['O.', '', 'Cointault'], ['D.', '', 'Ribes'], ['I.', '', 'Cardeau'], ['M.', 'B.', 'Nogier'], ['D.', '', 'Durand'], ['M.', '', 'Abbal'], ['A.', '', 'Blancher'], ['L.', '', 'Rostaing']]",American Journal of Transplantation,2010,[u'http://blackwell-synergy.com/doi/abs/10.1111/j.1600-6143.2009.02785.x'],
10.1016/S0924-8579(07)71787-9,"Falagas, M., Rafailidis, P., , Re-emergence of colistin in today's world of multidrug-resistant organisms: personal perspectives, Expert Opinion on Investigational Drugs, 2008",cited-by,10.1517/13543784.17.7.973,Re-emergence of colistin in today's world of multidrug-resistant organisms: personal perspectives,"[['Matthew', 'E', 'Falagas'], ['Petros', 'I', 'Rafailidis']]",Expert Opinion on Investigational Drugs,2008,[u'http://www.informapharmascience.com/doi/abs/10.1517/13543784.17.7.973'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1517~13543784.17.7.973
10.1016/S0924-8579(07)71787-9,"Bitzan, M., Anselmo, M., Carpineta, L., , Rituximab (B-cell depleting antibody) associated lung injury (RALI): A pediatric case and systematic review of the literature, Pediatric Pulmonology, 2009",cited-by,10.1002/ppul.20864,Rituximab (B-cell depleting antibody) associated lung injury (RALI): A pediatric case and systematic review of the literature,"[['Martin', '', 'Bitzan'], ['Mark', '', 'Anselmo'], ['Lucy', '', 'Carpineta']]",Pediatric Pulmonology,2009,[u'http://doi.wiley.com/10.1002/ppul.20864'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1002~ppul.20864
10.1016/S0924-8579(07)71787-9,"Liu, L., Cao, Y., Tan, A., et. al, Cetuximab-based therapy versus non-cetuximab therapy for advanced cancer: a meta-analysis of 17 randomized controlled trials, Cancer Chemotherapy and Pharmacology, 2010",cited-by,10.1007/s00280-009-1090-x,Cetuximab-based therapy versus non-cetuximab therapy for advanced cancer: a meta-analysis of 17 randomized controlled trials,"[['Lidan', '', 'Liu'], ['Yunfei', '', 'Cao'], ['Aihua', '', 'Tan'], ['Cun', '', 'Liao'], ['Feng', '', 'Gao']]",Cancer Chemotherapy and Pharmacology,2010,"[u'http://www.springerlink.com/index/3201l17025574208.pdf', u'http://www.springerlink.com/content/3201l17025574208', u'http://www.springerlink.com/index/10.1007/s00280-009-1090-x', u'http://www.springerlink.com/index/pdf/10.1007/s00280-009-1090-x']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1007~s00280-009-1090-x
10.1016/S0924-8579(07)71787-9,"Cooper, N., Arnold, D., , The effect of rituximab on humoral and cell mediated immunity and infection in the treatment of autoimmune diseases, British Journal of Haematology, 2010",cited-by,10.1111/j.1365-2141.2010.08076.x,The effect of rituximab on humoral and cell mediated immunity and infection in the treatment of autoimmune diseases,"[['Nichola', '', 'Cooper'], ['Donald', 'M.', 'Arnold']]",British Journal of Haematology,2010,[u'http://blackwell-synergy.com/doi/abs/10.1111/j.1365-2141.2010.08076.x'],
10.1016/S0924-8579(07)71787-9,"Kochenderfer, J., Feldman, S., Zhao, Y., et. al, Construction and Preclinical Evaluation of an Anti-CD19 Chimeric Antigen Receptor, Journal of Immunotherapy, 2009",cited-by,10.1097/CJI.0b013e3181ac6138,Construction and Preclinical Evaluation of an Anti-CD19 Chimeric Antigen Receptor,"[['James', 'N.', 'Kochenderfer'], ['Steven', 'A.', 'Feldman'], ['Yangbing', '', 'Zhao'], ['Hui', '', 'Xu'], ['Mary', 'A.', 'Black'], ['Richard', 'A.', 'Morgan'], ['Wyndham', 'H.', 'Wilson'], ['Steven', 'A.', 'Rosenberg']]",Journal of Immunotherapy,2009,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00002371-200909000-00002'],
10.1016/S0924-8579(07)71787-9,"Descotes, J., Gouraud, A., , Clinical immunotoxicity of therapeutic proteins, Expert Opinion on Drug Metabolism & Toxicology, 2008",cited-by,10.1517/17425250802525496,Clinical immunotoxicity of therapeutic proteins,"[['Jacques', '', 'Descotes'], ['Aurore', '', 'Gouraud']]",Expert Opinion on Drug Metabolism & Toxicology,2008,[u'http://informahealthcare.com/doi/abs/10.1517/17425250802525496'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1517~17425250802525496
10.1016/S0924-8579(07)71787-9,"Cooper, N., Bussel, J., , The Long-term Impact of Rituximab for Childhood Immune Thrombocytopenia, Current Rheumatology Reports, 2010",cited-by,10.1007/s11926-010-0090-5,The Long-term Impact of Rituximab for Childhood Immune Thrombocytopenia,"[['Nichola', '', 'Cooper'], ['James', 'B.', 'Bussel']]",Current Rheumatology Reports,2010,"[u'http://www.springerlink.com/content/y36m3l6823604572', u'http://www.springerlink.com/index/y36m3l6823604572.pdf', u'http://www.springerlink.com/index/pdf/10.1007/s11926-010-0090-5', u'http://www.springerlink.com/index/10.1007/s11926-010-0090-5']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1007~s11926-010-0090-5
10.1016/S0924-8579(07)71787-9,"Haller, W., Hind, J., Height, S., et. al, Successful treatment of mixed-type autoimmune hemolytic anemia with rituximab in a child following liver transplantation, Pediatric Transplantation, 2010",cited-by,10.1111/j.1399-3046.2009.01128.x,Successful treatment of mixed-type autoimmune hemolytic anemia with rituximab in a child following liver transplantation,"[['Wolfram', '', 'Haller'], ['Jonathan', '', 'Hind'], ['Sue', '', 'Height'], ['Ragai', '', 'Mitry'], ['Anil', '', 'Dhawan']]",Pediatric Transplantation,2010,[u'http://blackwell-synergy.com/doi/abs/10.1111/j.1399-3046.2009.01128.x'],
10.1016/S0924-8579(07)71787-9,"Hirai, Y., Ainoda, Y., Shoji, T., et. al, Disseminated Cryptococcosis in a Non-Hodgkin’s Lymphoma Patient with Late-Onset Neutropenia Following Rituximab-CHOP Chemotherapy: A Case Report and Literature Review, Mycopathologia, 0",cited-by,10.1007/s11046-011-9423-9,Disseminated Cryptococcosis in a Non-Hodgkin’s Lymphoma Patient with Late-Onset Neutropenia Following Rituximab-CHOP Chemotherapy: A Case Report and Literature Review,"[['Yuji', '', 'Hirai'], ['Yusuke', '', 'Ainoda'], ['Takayo', '', 'Shoji'], ['Takahiro', '', 'Fujita'], ['Kentaro', '', 'Yoshinaga'], ['Masayuki', '', 'Shiseki'], ['Naoki', '', 'Mori'], ['Masanao', '', 'Teramura'], ['Kyoichi', '', 'Totsuka'], ['Toshiko', '', 'Motoji']]",Mycopathologia,0,"[u'http://www.springerlink.com/index/j6516x523147084x.pdf', u'http://www.springerlink.com/content/j6516x523147084x']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1007~s11046-011-9423-9
10.1016/S0924-8579(07)71787-9,"Huang, Y., Liu, C., Liu, C., et. al, Low absolute lymphocyte count and addition of rituximab confer high risk for interstitial pneumonia in patients with diffuse large B-cell lymphoma, Annals of Hematology, 0",cited-by,10.1007/s00277-011-1268-2,Low absolute lymphocyte count and addition of rituximab confer high risk for interstitial pneumonia in patients with diffuse large B-cell lymphoma,"[['Yu-Chung', '', 'Huang'], ['Chia-Jen', '', 'Liu'], ['Chun-Yu', '', 'Liu'], ['Jih-Tung', '', 'Pai'], ['Ying-Chung', '', 'Hong'], ['Hao-Wei', '', 'Teng'], ['Liang-Tsai', '', 'Hsiao'], ['Ta-Chung', '', 'Chao'], ['Jyh-Pyng', '', 'Gau'], ['Jin-Hwang', '', 'Liu'], ['Hui-Chi', '', 'Hsu'], ['Tzeon-Jye', '', 'Chiou'], ['Po-Min', '', 'Chen'], ['Yuan-Bin', '', 'Yu'], ['Cheng-Hwai', '', 'Tzeng']]",Annals of Hematology,0,"[u'http://www.springerlink.com/content/yr18030005153260', u'http://www.springerlink.com/index/yr18030005153260.pdf']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1007~s00277-011-1268-2
10.1517~13543784.17.7.973.pdf,"J Antimicrob Chemother 2006;57(2):306-11 64. Li J, Coulthard K, Milne R, et al. Steady-state pharmacokinetics of intravenous colistin methanesulphonate in patients with cystic fibrosis.",references,11242170Steady-state pharmacokinetics of intravenous colistin methanesulphonate in patients with cystic fibrosis,Steady-state pharmacokinetics of intravenous colistin methanesulphonate in patients with cystic fibrosis,"[[u'Jian', u'', u'Li'], [u'Kingsley', u'', u'Coulthard'], [u'Robert', u'', u'Milne'], [u'Roger', u'L.', u'Nation'], [u'Steven', u'', u'Conway'], [u'Daniel', u'', u'Peckham'], [u'Christine', u'', u'Etherington'], [u'John', u'', u'Turnidge']]",,2003,[u'http://jac.oxfordjournals.org/cgi/reprint/dkg468v1.pdf'],./output/10.1517~13543784.17.7.973.pdf/11242170
11242170Steady-state pharmacokinetics of intravenous colistin methanesulphonate in patients with cystic fibrosis,"Li, J., Nation, R., Turnidge, J., et. al, Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections, Lancet Infectious Diseases, 2006",cited-by,10.1016/S1473-3099(06)70580-1,Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections,"[['Jian', '', 'Li'], ['Roger', 'L', 'Nation'], ['John', 'D', 'Turnidge'], ['Robert', 'W', 'Milne'], ['Kingsley', '', 'Coulthard'], ['Craig', 'R', 'Rayner'], ['David', 'L', 'Paterson']]",Lancet Infectious Diseases,2006,"[u'http://www.sld.cu/galerias/pdf/sitios/apua-cuba/r15-colistin._the_re-emerging_antibiotic_for_multidrug-resistant_gram-negative_bacterial_infections.pdf', u'http://www.sciencedirect.com/science/article/pii/S1473309906705801', u'http://www.sld.cu/galerias/pdf/sitios/apua-cuba/a21-colistin._the_re-emerging_antibiotic_for_multidrug-resistant_gram-negative_bacterial_infections.pdf', u'http://info.med.yale.edu/intmed/infdis/resources/docs/colistin-review-lancet.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S1473309906705801']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1016~S1473-3099(06)70580-1
11242170Steady-state pharmacokinetics of intravenous colistin methanesulphonate in patients with cystic fibrosis,"Li, J., Nation, R., Milne, R., et. al, Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria, International Journal of Antimicrobial Agents, 2005",cited-by,10.1016/j.ijantimicag.2004.10.001,Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria,"[['Jian', '', 'Li'], ['Roger', 'L.', 'Nation'], ['Robert', 'W.', 'Milne'], ['John', 'D.', 'Turnidge'], ['Kingsley', '', 'Coulthard']]",International Journal of Antimicrobial Agents,2005,"[u'http://www.sciencedirect.com/science/article/pii/S0924857904003656', u'http://linkinghub.elsevier.com/retrieve/pii/S0924857904003656']",
11242170Steady-state pharmacokinetics of intravenous colistin methanesulphonate in patients with cystic fibrosis,"Li, J., Rayner, C., Nation, R., et. al, Heteroresistance to Colistin in Multidrug-Resistant Acinetobacter baumannii, Antimicrobial Agents and Chemotherapy, 2006",cited-by,10.1128/AAC.00103-06,Heteroresistance to Colistin in Multidrug-Resistant Acinetobacter baumannii,"[['Jian', '', 'Li'], ['Craig', 'R.', 'Rayner'], ['Roger', 'L.', 'Nation'], ['Roxanne', 'J.', 'Owen'], ['Denis', '', 'Spelman'], ['Kar', 'Eng', 'Tan'], ['Lisa', '', 'Liolios']]",Antimicrobial Agents and Chemotherapy,2006,"[u'http://aac.asm.org/cgi/reprint/50/9/2946.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.00103-06']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1128~AAC.00103-06
11242170Steady-state pharmacokinetics of intravenous colistin methanesulphonate in patients with cystic fibrosis,"Ratjen, F., Rietschel, E., Kasel, D., et. al, Pharmacokinetics of inhaled colistin in patients with cystic fibrosis, Journal of Antimicrobial Chemotherapy, 2006",cited-by,10.1093/jac/dki461,Pharmacokinetics of inhaled colistin in patients with cystic fibrosis,"[['F.', '', 'Ratjen'], ['E.', '', 'Rietschel'], ['D.', '', 'Kasel'], ['R.', '', 'Schwiertz'], ['K.', '', 'Starke'], ['H.', '', 'Beier'], ['S.', 'van', 'Koningsbruggen'], ['H.', '', 'Grasemann']]",Journal of Antimicrobial Chemotherapy,2006,"[u'http://jac.oxfordjournals.org/cgi/reprint/57/2/306.pdf', u'http://www.jac.oxfordjournals.org/cgi/doi/10.1093/jac/dki461']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1093~jac~dki461
11242170Steady-state pharmacokinetics of intravenous colistin methanesulphonate in patients with cystic fibrosis,"Bergen, P., Li, J., Rayner, C., et. al, Colistin Methanesulfonate Is an Inactive Prodrug of Colistin against Pseudomonas aeruginosa, Antimicrobial Agents and Chemotherapy, 2006",cited-by,10.1128/AAC.00035-06,Colistin Methanesulfonate Is an Inactive Prodrug of Colistin against Pseudomonas aeruginosa,"[['Phillip', 'J.', 'Bergen'], ['Jian', '', 'Li'], ['Craig', 'R.', 'Rayner'], ['Roger', 'L.', 'Nation']]",Antimicrobial Agents and Chemotherapy,2006,"[u'http://aac.asm.org/cgi/reprint/50/6/1953.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.00035-06']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1128~AAC.00035-06
11242170Steady-state pharmacokinetics of intravenous colistin methanesulphonate in patients with cystic fibrosis,"Plachouras, D., Karvanen, M., Friberg, L., et. al, Population Pharmacokinetic Analysis of Colistin Methanesulfonate and Colistin after Intravenous Administration in Critically Ill Patients with Infections Caused by Gram-Negative Bacteria, Antimicrobial Agents and Chemotherapy, 2009",cited-by,10.1128/AAC.01361-08,Population Pharmacokinetic Analysis of Colistin Methanesulfonate and Colistin after Intravenous Administration in Critically Ill Patients with Infections Caused by Gram-Negative Bacteria,"[['D.', '', 'Plachouras'], ['M.', '', 'Karvanen'], ['L.', 'E.', 'Friberg'], ['E.', '', 'Papadomichelakis'], ['A.', '', 'Antoniadou'], ['I.', '', 'Tsangaris'], ['I.', '', 'Karaiskos'], ['G.', '', 'Poulakou'], ['F.', '', 'Kontopidou'], ['A.', '', 'Armaganidis'], ['O.', '', 'Cars'], ['H.', '', 'Giamarellou']]",Antimicrobial Agents and Chemotherapy,2009,"[u'http://aac.asm.org/cgi/reprint/53/8/3430.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.01361-08']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1128~AAC.01361-08
11242170Steady-state pharmacokinetics of intravenous colistin methanesulphonate in patients with cystic fibrosis,"Hawley, J., Murray, C., Jorgensen, J., , Colistin Heteroresistance in Acinetobacter and Its Association with Previous Colistin Therapy, Antimicrobial Agents and Chemotherapy, 2008",cited-by,10.1128/AAC.00766-07,Colistin Heteroresistance in Acinetobacter and Its Association with Previous Colistin Therapy,"[['Joshua', 'S.', 'Hawley'], ['Clinton', 'K.', 'Murray'], ['James', 'H.', 'Jorgensen']]",Antimicrobial Agents and Chemotherapy,2008,"[u'http://aac.asm.org/cgi/reprint/52/1/351.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.00766-07']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1128~AAC.00766-07
11242170Steady-state pharmacokinetics of intravenous colistin methanesulphonate in patients with cystic fibrosis,"Tan, C., Li, J., Nation, R., , Activity of Colistin against Heteroresistant Acinetobacter baumannii and Emergence of Resistance in an In Vitro Pharmacokinetic/Pharmacodynamic Model, Antimicrobial Agents and Chemotherapy, 2007",cited-by,10.1128/AAC.01571-06,Activity of Colistin against Heteroresistant Acinetobacter baumannii and Emergence of Resistance in an In Vitro Pharmacokinetic/Pharmacodynamic Model,"[['Chun-Hong', '', 'Tan'], ['Jian', '', 'Li'], ['Roger', 'L.', 'Nation']]",Antimicrobial Agents and Chemotherapy,2007,"[u'http://aac.asm.org/cgi/reprint/51/9/3413.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.01571-06']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1128~AAC.01571-06
11242170Steady-state pharmacokinetics of intravenous colistin methanesulphonate in patients with cystic fibrosis,"Li, J., Milne, R., Nation, R., et. al, Pharmacokinetics of colistin methanesulphonate and colistin in rats following an intravenous dose of colistin methanesulphonate, , 2004",cited-by,10933570Pharmacokinetics of colistin methanesulphonate and colistin in rats following an intravenous dose of colistin methanesulphonate,Pharmacokinetics of colistin methanesulphonate and colistin in rats following an intravenous dose of colistin methanesulphonate,"[['Jian', '', 'Li'], ['Robert', 'W.', 'Milne'], ['Roger', 'L.', 'Nation'], ['John', 'D.', 'Turnidge'], ['Timothy', 'C.', 'Smeaton'], ['Kingsley', '', 'Coulthard']]",,2004,"[u'http://jac.oxfordjournals.org/cgi/reprint/53/5/837.pdf', u'http://jac.oxfordjournals.org/cgi/reprint/dkh167v1.pdf']",
11242170Steady-state pharmacokinetics of intravenous colistin methanesulphonate in patients with cystic fibrosis,"Markou, N., Markantonis, S., Dimitrakis, E., et. al, Colistin serum concentrations after intravenous administration in critically ill patients with serious multidrug-resistant, gram-negative bacilli infections: A prospective, open-label, uncontrolled study, Clinical Therapeutics, 2008",cited-by,10.1016/j.clinthera.2008.01.015,"Colistin serum concentrations after intravenous administration in critically ill patients with serious multidrug-resistant, gram-negative bacilli infections: A prospective, open-label, uncontrolled study","[['Nikolaos', '', 'Markou'], ['Sophia', 'L', 'Markantonis'], ['Efthimios', '', 'Dimitrakis'], ['Dimitris', '', 'Panidis'], ['Eleni', '', 'Boutzouka'], ['Stylianos', '', 'Karatzas'], ['Petros', '', 'Rafailidis'], ['Haralampos', '', 'Apostolakos'], ['George', '', 'Baltopoulos']]",Clinical Therapeutics,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0149291808000635', u'http://linkinghub.elsevier.com/retrieve/pii/S0149291808000635']",
11242170Steady-state pharmacokinetics of intravenous colistin methanesulphonate in patients with cystic fibrosis,"Michalopoulos, A., Falagas, M., , Colistin and Polymyxin B in Critical Care, Critical Care Clinics, 2008",cited-by,10.1016/j.ccc.2007.12.003,Colistin and Polymyxin B in Critical Care,"[['Argyris', '', 'Michalopoulos'], ['Matthew', 'E.', 'Falagas']]",Critical Care Clinics,2008,"[u'http://www.sciencedirect.com/science/article/pii/S074907040700098X', u'http://linkinghub.elsevier.com/retrieve/pii/S074907040700098X']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1016~j.ccc.2007.12.003
11242170Steady-state pharmacokinetics of intravenous colistin methanesulphonate in patients with cystic fibrosis,"Yau, W., Owen, R., Poudyal, A., et. al, Colistin hetero-resistance in multidrug-resistant Acinetobacter baumannii clinical isolates from the Western Pacific region in the SENTRY antimicrobial surveillance programme, Journal of Infection, 2009",cited-by,10.1016/j.jinf.2008.11.002,Colistin hetero-resistance in multidrug-resistant Acinetobacter baumannii clinical isolates from the Western Pacific region in the SENTRY antimicrobial surveillance programme,"[['Wing', '', 'Yau'], ['Roxanne', 'J.', 'Owen'], ['Anima', '', 'Poudyal'], ['Jan', 'M.', 'Bell'], ['John', 'D.', 'Turnidge'], ['Heidi', 'H.', 'Yu'], ['Roger', 'L.', 'Nation'], ['Jian', '', 'Li']]",Journal of Infection,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0163445308003733', u'http://linkinghub.elsevier.com/retrieve/pii/S0163445308003733']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1016~j.jinf.2008.11.002
11242170Steady-state pharmacokinetics of intravenous colistin methanesulphonate in patients with cystic fibrosis,"Jones, R., Anderegg, T., Swenson, J., , Quality Control Guidelines for Testing Gram-Negative Control Strains with Polymyxin B and Colistin (Polymyxin E) by Standardized Methods, Journal of Clinical Microbiology, 2005",cited-by,10.1128/JCM.43.2.925-927.2005,Quality Control Guidelines for Testing Gram-Negative Control Strains with Polymyxin B and Colistin (Polymyxin E) by Standardized Methods,"[['Ronald', 'N.', 'Jones'], ['Tamara', 'R.', 'Anderegg'], ['Jana', 'M.', 'Swenson']]",Journal of Clinical Microbiology,2005,"[u'http://jcm.asm.org/cgi/reprint/43/2/925.pdf', u'http://jcm.asm.org/cgi/doi/10.1128/JCM.43.2.925-927.2005']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1128~JCM.43.2.925-927.2005
11242170Steady-state pharmacokinetics of intravenous colistin methanesulphonate in patients with cystic fibrosis,"Etherington, C., Bosomworth, M., Clifton, I., et. al, Measurement of urinary N-acetyl- b- d-glucosaminidase in adult patients with cystic fibrosis: Before, during and after treatment with intravenous antibiotics, Journal of Cystic Fibrosis, 2007",cited-by,10.1016/j.jcf.2006.05.013,"Measurement of urinary N-acetyl- b- d-glucosaminidase in adult patients with cystic fibrosis: Before, during and after treatment with intravenous antibiotics","[['C.', '', 'Etherington'], ['M.', '', 'Bosomworth'], ['I.', '', 'Clifton'], ['D.', 'G.', 'Peckham'], ['S.', 'P.', 'Conway']]",Journal of Cystic Fibrosis,2007,"[u'http://www.sciencedirect.com/science/article/pii/S1569199306000853', u'http://linkinghub.elsevier.com/retrieve/pii/S1569199306000853']",
11242170Steady-state pharmacokinetics of intravenous colistin methanesulphonate in patients with cystic fibrosis,"Lu, Q., Girardi, C., Zhang, M., et. al, Nebulized and intravenous colistin in experimental pneumonia caused by Pseudomonas aeruginosa, Intensive Care Medicine, 2010",cited-by,10.1007/s00134-010-1879-4,Nebulized and intravenous colistin in experimental pneumonia caused by Pseudomonas aeruginosa,"[['Qin', '', 'Lu'], ['Cassio', '', 'Girardi'], ['Mao', '', 'Zhang'], ['Bela\xc3\xafd', '', 'Bouhemad'], ['Kamel', '', 'Louchahi'], ['Olivier', '', 'Petitjean'], ['Fr\xc3\xa9d\xc3\xa9ric', '', 'Wallet'], ['Marie-Helene', '', 'Becquemin'], ['Gilles', 'Le', 'Naour'], ['Charles-Hugo', '', 'Marquette'], ['Jean-Jacques', '', 'Rouby']]",Intensive Care Medicine,2010,"[u'http://www.springerlink.com/content/036470128688121x', u'http://www.springerlink.com/index/036470128688121x.pdf', u'http://www.springerlink.com/index/10.1007/s00134-010-1879-4', u'http://www.springerlink.com/index/pdf/10.1007/s00134-010-1879-4']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1007~s00134-010-1879-4
11242170Steady-state pharmacokinetics of intravenous colistin methanesulphonate in patients with cystic fibrosis,"Poudyal, A., Howden, B., Bell, J., et. al, In vitro pharmacodynamics of colistin against multidrug-resistant Klebsiella pneumoniae, , 2008",cited-by,11075581In vitro pharmacodynamics of colistin against multidrug-resistant Klebsiella pneumoniae,In vitro pharmacodynamics of colistin against multidrug-resistant Klebsiella pneumoniae,"[['Anima', '', 'Poudyal'], ['Benjamin', 'P.', 'Howden'], ['Jan', 'M.', 'Bell'], ['Wei', '', 'Gao'], ['Roxanne', 'J.', 'Owen'], ['John', 'D.', 'Turnidge'], ['Roger', 'L.', 'Nation'], ['Jian', '', 'Li']]",,2008,"[u'http://jac.oxfordjournals.org/cgi/reprint/dkn425v1.pdf', u'http://jac.oxfordjournals.org/cgi/reprint/62/6/1311.pdf']",./output/10.1517~13543784.17.7.973.pdf/citedby/11075581In vitro pharmacodynamics of colistin against multidrug-resistant Klebsiella pneumoniae
11242170Steady-state pharmacokinetics of intravenous colistin methanesulphonate in patients with cystic fibrosis,"Hogardt, M., Schmoldt, S., Gotzfried, M., et. al, Pitfalls of polymyxin antimicrobial susceptibility testing of Pseudomonas aeruginosa isolated from cystic fibrosis patients, , 0",cited-by,12115655Pitfalls of polymyxin antimicrobial susceptibility testing of Pseudomonas aeruginosa isolated from cystic fibrosis patients,Pitfalls of polymyxin antimicrobial susceptibility testing of Pseudomonas aeruginosa isolated from cystic fibrosis patients,"[['Michael', '', 'Hogardt'], ['Sabine', '', 'Schmoldt'], ['Monika', '', 'Gotzfried'], ['Kristin', '', 'Adler'], ['Jurgen', '', 'Heesemann']]",,0,[],
11242170Steady-state pharmacokinetics of intravenous colistin methanesulphonate in patients with cystic fibrosis,"Wallace, S., Li, J., Nation, R., et. al, Subacute Toxicity of Colistin Methanesulfonate in Rats: Comparison of Various Intravenous Dosage Regimens, Antimicrobial Agents and Chemotherapy, 2008",cited-by,10.1128/AAC.01101-07,Subacute Toxicity of Colistin Methanesulfonate in Rats: Comparison of Various Intravenous Dosage Regimens,"[['Stephanie', 'J.', 'Wallace'], ['Jian', '', 'Li'], ['Roger', 'L.', 'Nation'], ['Craig', 'R.', 'Rayner'], ['David', '', 'Taylor'], ['Deborah', '', 'Middleton'], ['Robert', 'W.', 'Milne'], ['Kingsley', '', 'Coulthard'], ['John', 'D.', 'Turnidge']]",Antimicrobial Agents and Chemotherapy,2008,"[u'http://aac.asm.org/cgi/reprint/52/3/1159.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.01101-07']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1128~AAC.01101-07
11242170Steady-state pharmacokinetics of intravenous colistin methanesulphonate in patients with cystic fibrosis,"Kwa, A., Lim, T., Low, J., et. al, Pharmacokinetics of polymyxin B1 in patients with multidrug-resistant Gram-negative bacterial infections, Diagnostic Microbiology and Infectious Disease, 2008",cited-by,10.1016/j.diagmicrobio.2007.08.008,Pharmacokinetics of polymyxin B1 in patients with multidrug-resistant Gram-negative bacterial infections,"[['Andrea', 'L. H.', 'Kwa'], ['Tze-Peng', '', 'Lim'], ['Jenny', 'G. H.', 'Low'], ['JingGuo', '', 'Hou'], ['Asok', '', 'Kurup'], ['Randall', 'A.', 'Prince'], ['Vincent', 'H.', 'Tam']]",Diagnostic Microbiology and Infectious Disease,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0732889307003859', u'http://linkinghub.elsevier.com/retrieve/pii/S0732889307003859']",
11242170Steady-state pharmacokinetics of intravenous colistin methanesulphonate in patients with cystic fibrosis,"Iosifidis, E., Antachopoulos, C., Ioannidou, M., et. al, Colistin administration to pediatric and neonatal patients, European Journal of Pediatrics, 2010",cited-by,10.1007/s00431-009-1137-3,Colistin administration to pediatric and neonatal patients,"[['Elias', '', 'Iosifidis'], ['Charalampos', '', 'Antachopoulos'], ['Maria', '', 'Ioannidou'], ['Magda', '', 'Mitroudi'], ['Maria', '', 'Sdougka'], ['Vassiliki', '', 'Drossou-Agakidou'], ['Maria', '', 'Tsivitanidou'], ['Emmanuel', '', 'Roilides']]",European Journal of Pediatrics,2010,"[u'http://www.springerlink.com/content/e38736115517wg75', u'http://www.springerlink.com/index/e38736115517wg75.pdf', u'http://www.springerlink.com/index/10.1007/s00431-009-1137-3', u'http://www.springerlink.com/index/pdf/10.1007/s00431-009-1137-3']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1007~s00431-009-1137-3
11242170Steady-state pharmacokinetics of intravenous colistin methanesulphonate in patients with cystic fibrosis,"Giamarellou, H., Kanellakopoulou, K., , Current Therapies for Pseudomonas Aeruginosa, Critical Care Clinics, 2008",cited-by,10.1016/j.ccc.2007.12.004,Current Therapies for Pseudomonas Aeruginosa,"[['Helen', '', 'Giamarellou'], ['Kyriaki', '', 'Kanellakopoulou']]",Critical Care Clinics,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0749070407000991', u'http://linkinghub.elsevier.com/retrieve/pii/S0749070407000991']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1016~j.ccc.2007.12.004
11242170Steady-state pharmacokinetics of intravenous colistin methanesulphonate in patients with cystic fibrosis,"Michalopoulos, A., Kasiakou, S., Falagas, M., , The significance of different formulations of aerosolized colistin, Critical Care, 2005",cited-by,10.1186/cc3506,The significance of different formulations of aerosolized colistin,"[['Argyris', '', 'Michalopoulos'], ['Sofia', 'K', 'Kasiakou'], ['Matthew', 'E', 'Falagas']]",Critical Care,2005,"[u'http://www.biomedcentral.com/content/pdf/cc3506.pdf', u'http://www.springerlink.com/content/121hnp1v25026t30', u'http://www.springerlink.com/index/121hnp1v25026t30.pdf']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1186~cc3506
11242170Steady-state pharmacokinetics of intravenous colistin methanesulphonate in patients with cystic fibrosis,"Owen, R., Li, J., Nation, R., et. al, In vitro pharmacodynamics of colistin against Acinetobacter baumannii clinical isolates, , 0",cited-by,12192714In vitro pharmacodynamics of colistin against Acinetobacter baumannii clinical isolates,In vitro pharmacodynamics of colistin against Acinetobacter baumannii clinical isolates,"[['Roxanne', 'J.', 'Owen'], ['Jian', '', 'Li'], ['Roger', 'L.', 'Nation'], ['Denis', '', 'Spelman']]",,0,"[u'http://jac.oxfordjournals.org/cgi/reprint/59/3/473.pdf', u'http://jac.oxfordjournals.org/cgi/reprint/dkl512v1.pdf']",./output/10.1517~13543784.17.7.973.pdf/citedby/12192714In vitro pharmacodynamics of colistin against Acinetobacter baumannii clinical isolates
11242170Steady-state pharmacokinetics of intravenous colistin methanesulphonate in patients with cystic fibrosis,"Kwa, A., , Polymyxins: A Review of the Current Status Including Recent Developments, , 0",cited-by,12288617Polymyxins: A Review of the Current Status Including Recent Developments,Polymyxins: A Review of the Current Status Including Recent Developments,"[['Andrea', 'L', 'Kwa']]",,0,[u'http://www.annals.edu.sg/pdf/37VolNo10Oct2008/V37N10p870.pdf'],./output/10.1517~13543784.17.7.973.pdf/citedby/12288617Polymyxins: A Review of the Current Status Including Recent Developments
11242170Steady-state pharmacokinetics of intravenous colistin methanesulphonate in patients with cystic fibrosis,"Jones, R., Anderegg, T., Swenson, J., , Quality Control Guidelines for Testing Gram-Negative Control Strains with Polymyxin B and Colistin (Polymyxin E) by Standardized Methods, , 0",cited-by,11161178Quality Control Guidelines for Testing Gram-Negative Control Strains with Polymyxin B and Colistin (Polymyxin E) by Standardized Methods,Quality Control Guidelines for Testing Gram-Negative Control Strains with Polymyxin B and Colistin (Polymyxin E) by Standardized Methods,"[['Ronald', 'N.', 'Jones'], ['Tamara', 'R.', 'Anderegg'], ['Jana', 'M.', 'Swenson']]",,0,[u'http://jcm.asm.org/cgi/reprint/43/2/925.pdf'],
11242170Steady-state pharmacokinetics of intravenous colistin methanesulphonate in patients with cystic fibrosis,"Wallace, S., Li, J., Rayner, C., et. al, Stability of Colistin Methanesulfonate in Pharmaceutical Products and Solutions for Administration to Patients, Antimicrobial Agents and Chemotherapy, 2008",cited-by,10.1128/AAC.00103-08,Stability of Colistin Methanesulfonate in Pharmaceutical Products and Solutions for Administration to Patients,"[['Stephanie', 'J.', 'Wallace'], ['Jian', '', 'Li'], ['Craig.', 'R.', 'Rayner'], ['Kingsley', '', 'Coulthard'], ['Roger', 'L.', 'Nation']]",Antimicrobial Agents and Chemotherapy,2008,"[u'http://aac.asm.org/cgi/reprint/52/9/3047.pdf', u'http://aac.asm.org/cgi/issue_pdf/toc_pdf/52/9.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.00103-08']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1128~AAC.00103-08
11242170Steady-state pharmacokinetics of intravenous colistin methanesulphonate in patients with cystic fibrosis,"Monteiro, D., Madrid, M., , Planning of robot trajectories with genetic algorithms, , 1999",cited-by,10.1109/ROMOCO.1999.791079,Planning of robot trajectories with genetic algorithms,"[['D.', 'C.', 'Monteiro'], ['M.', 'K.', 'Madrid']]",,1999,"[u'http://ieeexplore.ieee.org/xpls/abs_all.jsp?arnumber=791079', u'http://ieeexplore.ieee.org/stamp/stamp.jsp?arnumber=00791079']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1109~ROMOCO.1999.791079
11242170Steady-state pharmacokinetics of intravenous colistin methanesulphonate in patients with cystic fibrosis,"Bergen, P., Li, J., Nation, R., et. al, Comparison of once-, twice- and thrice-daily dosing of colistin on antibacterial effect and emergence of resistance: studies with Pseudomonas aeruginosa in an in vitro pharmacodynamic model, , 0",cited-by,"11438016Comparison of once-, twice- and thrice-daily dosing of colistin on antibacterial effect and emergence of resistance: studies with Pseudomonas aeruginosa in an in vitro pharmacodynamic model","Comparison of once-, twice- and thrice-daily dosing of colistin on antibacterial effect and emergence of resistance: studies with Pseudomonas aeruginosa in an in vitro pharmacodynamic model","[['Phillip', 'J.', 'Bergen'], ['Jian', '', 'Li'], ['Roger', 'L.', 'Nation'], ['John', 'D.', 'Turnidge'], ['Kingsley', '', 'Coulthard']]",,0,[u'http://jac.oxfordjournals.org/cgi/reprint/61/3/636.pdf'],
11242170Steady-state pharmacokinetics of intravenous colistin methanesulphonate in patients with cystic fibrosis,"Molina, J., Cordero, E., Palomino, J., et. al, Aminoglucósidos y polimixinas, Enfermedades Infecciosas Y Microbiologia Clinica, 2009",cited-by,10.1016/j.eimc.2009.02.001,Aminoglucósidos y polimixinas,"[['Jos\xc3\xa9', '', 'Molina'], ['Elisa', '', 'Cordero'], ['Juli\xc3\xa1n', '', 'Palomino'], ['Jer\xc3\xb3nimo', '', 'Pach\xc3\xb3n']]",Enfermedades Infecciosas Y Microbiologia Clinica,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0213005X09000986', u'http://linkinghub.elsevier.com/retrieve/pii/S0213005X09000986']",
11242170Steady-state pharmacokinetics of intravenous colistin methanesulphonate in patients with cystic fibrosis,"Usher, J., Alexander, S., Thompson, J., , Predicting the reliability of new products at IBM, , 1991",cited-by,10.1109/ARMS.1991.154437,Predicting the reliability of new products at IBM,"[['J.', 'S.', 'Usher'], ['S.', 'M.', 'Alexander'], ['J.', 'D.', 'Thompson']]",,1991,[u'http://ieeexplore.ieee.org/xpls/abs_all.jsp?arnumber=154437'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1109~ARMS.1991.154437
11242170Steady-state pharmacokinetics of intravenous colistin methanesulphonate in patients with cystic fibrosis,"Cordero, E., Palomino, J., Pachon, J., , Aminoglucosidos y polimixinas, , 2009",cited-by,6349126Aminoglucosidos y polimixinas,Aminoglucosidos y polimixinas,"[['Elisa', '', 'Cordero'], ['Julian', '', 'Palomino'], ['Jeronimo', '', 'Pachon']]",,2009,"[u'http://external.doyma.es/pdf/28/28v27n03a13134987pdf001.pdf', u'http://www.elsevier.es/watermark/ctl_servlet?_f=10&pident_articulo=13134987&pident_usuario=0&pcontactid=&pident_revista=28&ty=135&accion=L&origen=elsevier&web=www.elsevier.es&lan=es&fichero=28v27n03a13134987pdf001.pdf']",
11242170Steady-state pharmacokinetics of intravenous colistin methanesulphonate in patients with cystic fibrosis,"Frasca, D., Dahyot-Fizelier, C., Mimoz, O., , La colistine en réanimation, , 2008",cited-by,10.1016/j.reaurg.2008.01.005,La colistine en réanimation,"[['D.', '', 'Frasca'], ['C.', '', 'Dahyot-Fizelier'], ['O.', '', 'Mimoz']]",,2008,"[u'http://www.sciencedirect.com/science/article/pii/S1624069308000340', u'http://linkinghub.elsevier.com/retrieve/pii/S1624069308000340']",
11242170Steady-state pharmacokinetics of intravenous colistin methanesulphonate in patients with cystic fibrosis,"Morris, M., Hobson, R., , Neural network design of a dishwasher control board, , 2002",cited-by,10.1109/IJCNN.2002.1007534,Neural network design of a dishwasher control board,"[['M.', '', 'Morris'], ['R.', 'S.', 'Hobson']]",,2002,"[u'http://ieeexplore.ieee.org/stamp/stamp.jsp?arnumber=01007534', u'http://ieeexplore.ieee.org/xpls/abs_all.jsp?arnumber=1007534']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1109~IJCNN.2002.1007534
10.1517~13543784.17.7.973.pdf,"J Antimicrob Chemother 2003;52(6):987-92 65. Tascini C, Urbani L, Biancofiore G, et al. Colistin in combination with rifampin and imipenem for treating a bla(VIM-1) metallo-beta-lactamase-producing Enterobacter cloacae disseminated infection in a liver transplant patient.",references,NOT found in MAS
10.1517~13543784.17.7.973.pdf,"Minerva Anestesiol 2008;74(1-2):47-9 66. Bliziotis IA, Samonis G, Vardakas KZ, et al. Effect of aminoglycoside and beta-lactam combination therapy versus beta-lactam monotherapy on the emergence of antimicrobial resistance: a meta-analysis of randomized, controlled trials. Clin Infect Dis 2005;41(2):149-58 67. Li J, Rayner CR, Nation RL, Owen RJ, et al. Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother 2006;50(9):2946-50 68. Hawley JS, Murray CK, Jorgensen JH.",references,NOT found in MAS
10.1517~13543784.17.7.973.pdf,"Colistin heteroresistance in Acinetobacter and its association with previous colistin therapy. Antimicrob Agents Chemother 2008;52(1):351-2 69. Owen RJ, Li J, Nation RL, Spelman D.",references,10.1128/AAC.00766-07,Colistin Heteroresistance in Acinetobacter and Its Association with Previous Colistin Therapy,"[[u'Joshua', u'S.', u'Hawley'], [u'Clinton', u'K.', u'Murray'], [u'James', u'H.', u'Jorgensen']]",Antimicrobial Agents and Chemotherapy,2008,"[u'http://aac.asm.org/cgi/reprint/52/1/351.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.00766-07']",./output/10.1517~13543784.17.7.973.pdf/10.1128~AAC.00766-07
10.1128/AAC.00766-07,"Giamarellou, H., Poulakou, G., , Multidrug-Resistant Gram-Negative Infections: What are the Treatment Options?, Drugs, 2009",cited-by,10.2165/11315690-000000000-00000,Multidrug-Resistant Gram-Negative Infections: What are the Treatment Options?,"[['Helen', '', 'Giamarellou'], ['Garyphallia', '', 'Poulakou']]",Drugs,2009,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00003495-200969140-00001'],
10.1128/AAC.00766-07,"Falagas, M., Rafailidis, P., Ioannidou, E., et. al, Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients, International Journal of Antimicrobial Agents, 2010",cited-by,10.1016/j.ijantimicag.2009.10.005,Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients,"[['Matthew', 'E.', 'Falagas'], ['Petros', 'I.', 'Rafailidis'], ['Elda', '', 'Ioannidou'], ['Vangelis', 'G.', 'Alexiou'], ['Dimitrios', 'K.', 'Matthaiou'], ['Drosos', 'E.', 'Karageorgopoulos'], ['Anastasios', '', 'Kapaskelis'], ['Dimitra', '', 'Nikita'], ['Argyris', '', 'Michalopoulos']]",International Journal of Antimicrobial Agents,2010,"[u'http://www.sciencedirect.com/science/article/pii/S0924857909004695', u'http://linkinghub.elsevier.com/retrieve/pii/S0924857909004695']",
10.1128/AAC.00766-07,"Vila, J., Pachón, J., , Therapeutic options for Acinetobacter baumannii infections, Expert Opinion on Pharmacotherapy, 2008",cited-by,10.1517/14656566.9.4.587,Therapeutic options for Acinetobacter baumannii infections,"[['Jordi', '', 'Vila'], ['Jer\xc3\xb3nimo', '', 'Pach\xc3\xb3n']]",Expert Opinion on Pharmacotherapy,2008,[u'http://www.informapharmascience.com/doi/abs/10.1517/14656566.9.4.587'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1517~14656566.9.4.587
10.1128/AAC.00766-07,"Nation, R., Li, J., , Colistin in the 21st century, Current Opinion in Infectious Diseases, 2009",cited-by,10.1097/QCO.0b013e328332e672,Colistin in the 21st century,"[['Roger', 'L', 'Nation'], ['Jian', '', 'Li']]",Current Opinion in Infectious Diseases,2009,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00001432-200912000-00004'],
10.1128/AAC.00766-07,"Yau, W., Owen, R., Poudyal, A., et. al, Colistin hetero-resistance in multidrug-resistant Acinetobacter baumannii clinical isolates from the Western Pacific region in the SENTRY antimicrobial surveillance programme, Journal of Infection, 2009",cited-by,10.1016/j.jinf.2008.11.002,Colistin hetero-resistance in multidrug-resistant Acinetobacter baumannii clinical isolates from the Western Pacific region in the SENTRY antimicrobial surveillance programme,"[['Wing', '', 'Yau'], ['Roxanne', 'J.', 'Owen'], ['Anima', '', 'Poudyal'], ['Jan', 'M.', 'Bell'], ['John', 'D.', 'Turnidge'], ['Heidi', 'H.', 'Yu'], ['Roger', 'L.', 'Nation'], ['Jian', '', 'Li']]",Journal of Infection,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0163445308003733', u'http://linkinghub.elsevier.com/retrieve/pii/S0163445308003733']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1016~j.jinf.2008.11.002
10.1128/AAC.00766-07,"Falagas, M., Rafailidis, P., , Re-emergence of colistin in today's world of multidrug-resistant organisms: personal perspectives, Expert Opinion on Investigational Drugs, 2008",cited-by,10.1517/13543784.17.7.973,Re-emergence of colistin in today's world of multidrug-resistant organisms: personal perspectives,"[['Matthew', 'E', 'Falagas'], ['Petros', 'I', 'Rafailidis']]",Expert Opinion on Investigational Drugs,2008,[u'http://www.informapharmascience.com/doi/abs/10.1517/13543784.17.7.973'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1517~13543784.17.7.973
10.1128/AAC.00766-07,"Gordon, N., Wareham, D., , Multidrug-resistant Acinetobacter baumannii: mechanisms of virulence and resistance, International Journal of Antimicrobial Agents, 2010",cited-by,10.1016/j.ijantimicag.2009.10.024,Multidrug-resistant Acinetobacter baumannii: mechanisms of virulence and resistance,"[['Nicola', 'C.', 'Gordon'], ['David', 'W.', 'Wareham']]",International Journal of Antimicrobial Agents,2010,"[u'http://www.sciencedirect.com/science/article/pii/S0924857909005159', u'http://linkinghub.elsevier.com/retrieve/pii/S0924857909005159']",
10.1128/AAC.00766-07,"Adams, M., Nickel, G., Bajaksouzian, S., et. al, Resistance to Colistin in Acinetobacter baumannii Associated with Mutations in the PmrAB Two-Component System, Antimicrobial Agents and Chemotherapy, 2009",cited-by,10.1128/AAC.00284-09,Resistance to Colistin in Acinetobacter baumannii Associated with Mutations in the PmrAB Two-Component System,"[['Mark', 'D.', 'Adams'], ['Gabrielle', 'C.', 'Nickel'], ['Saralee', '', 'Bajaksouzian'], ['Heather', '', 'Lavender'], ['A.', 'Rekha', 'Murthy'], ['Michael', 'R.', 'Jacobs'], ['Robert', 'A.', 'Bonomo']]",Antimicrobial Agents and Chemotherapy,2009,"[u'http://aac.highwire.org/cgi/reprint/53/9/3628.pdf', u'http://aac.asm.org/cgi/reprint/53/9/3628.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.00284-09']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1128~AAC.00284-09
10.1128/AAC.00766-07,"Park, Y., Jung, S., Park, K., et. al, Independent emergence of colistin-resistant Acinetobacter spp. isolates from Korea, Diagnostic Microbiology and Infectious Disease, 2009",cited-by,10.1016/j.diagmicrobio.2009.01.012,Independent emergence of colistin-resistant Acinetobacter spp. isolates from Korea,"[['Young', 'Kyoung', 'Park'], ['Sook-In', '', 'Jung'], ['Kyong-Hwa', '', 'Park'], ['Hae', 'Suk', 'Cheong'], ['Kyong', 'Ran', 'Peck'], ['Jae-Hoon', '', 'Song'], ['Kwan', 'Soo', 'Ko']]",Diagnostic Microbiology and Infectious Disease,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0732889309000170', u'http://linkinghub.elsevier.com/retrieve/pii/S0732889309000170']",
10.1128/AAC.00766-07,"Kwa, A., , Polymyxins: A Review of the Current Status Including Recent Developments, , 0",cited-by,12288617Polymyxins: A Review of the Current Status Including Recent Developments,Polymyxins: A Review of the Current Status Including Recent Developments,"[['Andrea', 'L', 'Kwa']]",,0,[u'http://www.annals.edu.sg/pdf/37VolNo10Oct2008/V37N10p870.pdf'],./output/10.1517~13543784.17.7.973.pdf/citedby/12288617Polymyxins: A Review of the Current Status Including Recent Developments
10.1128/AAC.00766-07,"Sun, S., Negrea, A., Rhen, M., et. al, Genetic Analysis of Colistin Resistance in Salmonella enterica Serovar Typhimurium, Antimicrobial Agents and Chemotherapy, 2009",cited-by,10.1128/AAC.01016-08,Genetic Analysis of Colistin Resistance in Salmonella enterica Serovar Typhimurium,"[['Song', '', 'Sun'], ['Aurel', '', 'Negrea'], ['Mikael', '', 'Rhen'], ['Dan', 'I.', 'Andersson']]",Antimicrobial Agents and Chemotherapy,2009,"[u'http://aac.asm.org/cgi/reprint/53/6/2298.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.01016-08']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1128~AAC.01016-08
10.1128/AAC.00766-07,"Crane, D., Gromov, K., Li, D., et. al, Efficacy of colistin-impregnated beads to prevent multidrug-resistant A. baumannii implant-associated osteomyelitis, Journal of Orthopaedic Research, 2009",cited-by,10.1002/jor.20847,Efficacy of colistin-impregnated beads to prevent multidrug-resistant A. baumannii implant-associated osteomyelitis,"[['Daniel', 'P.', 'Crane'], ['Kirill', '', 'Gromov'], ['Dan', '', 'Li'], ['Kjeld', '', 'S\xc3\xb8balle'], ['Christian', '', 'Wahnes'], ['Hubert', '', 'B\xc3\xbcchner'], ['Matthew', 'J.', 'Hilton'], ['Regis', 'J.', ""O'Keefe""], ['Clinton', 'K.', 'Murray'], ['Edward', 'M.', 'Schwarz']]",Journal of Orthopaedic Research,2009,[u'http://doi.wiley.com/10.1002/jor.20847'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1002~jor.20847
10.1128/AAC.00766-07,"Hernan, R., Karina, B., Gabriela, G., et. al, Selection of colistin-resistant Acinetobacter baumannii isolates in postneurosurgical meningitis in an intensive care unit with high presence of heteroresistance to colistin, Diagnostic Microbiology and Infectious Disease, 2009",cited-by,10.1016/j.diagmicrobio.2009.05.019,Selection of colistin-resistant Acinetobacter baumannii isolates in postneurosurgical meningitis in an intensive care unit with high presence of heteroresistance to colistin,"[['Rodriguez', 'Carlos', 'Hernan'], ['Bombicino', '', 'Karina'], ['Granados', '', 'Gabriela'], ['Nastro', '', 'Marcela'], ['Vay', '', 'Carlos'], ['Famiglietti', '', 'Angela']]",Diagnostic Microbiology and Infectious Disease,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0732889309002302', u'http://linkinghub.elsevier.com/retrieve/pii/S0732889309002302']",
10.1128/AAC.00766-07,"Lee, C., Kao, Y., Luo, J., et. al, The enhanced Q spiral inductors with MEMS technology for RF applications, , 2000",cited-by,10.1109/APMC.2000.926079,The enhanced Q spiral inductors with MEMS technology for RF applications,"[['Chia-Ying', '', 'Lee'], ['Yao-Huang', '', 'Kao'], ['Jiunn-Jye', '', 'Luo'], ['Kow-Ming', '', 'Chang']]",,2000,"[u'http://ieeexplore.ieee.org/xpls/abs_all.jsp?arnumber=926079', u'http://ieeexplore.ieee.org/stamp/stamp.jsp?arnumber=00926079']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1109~APMC.2000.926079
10.1128/AAC.00766-07,"Dudhani, R., Turnidge, J., Nation, R., et. al, fAUC/MIC is the most predictive pharmacokinetic/pharmacodynamic index of colistin against Acinetobacter baumannii in murine thigh and lung infection models, Journal of Antimicrobial Chemotherapy, 2010",cited-by,10.1093/jac/dkq226,fAUC/MIC is the most predictive pharmacokinetic/pharmacodynamic index of colistin against Acinetobacter baumannii in murine thigh and lung infection models,"[['R.', 'V.', 'Dudhani'], ['J.', 'D.', 'Turnidge'], ['R.', 'L.', 'Nation'], ['J.', '', 'Li']]",Journal of Antimicrobial Chemotherapy,2010,[u'http://www.jac.oxfordjournals.org/cgi/doi/10.1093/jac/dkq226'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1093~jac~dkq226
10.1128/AAC.00766-07,"Lin, C., Liu, T., Kuo, C., et. al, Aerosolized Colistin for the Treatment of Multidrug-resistant Acinetobacter baumannii Pneumonia: Experience in a Tertiary Care Hospital in Northern Taiwan, Journal of Microbiology Immunology and Infection, 2010",cited-by,10.1016/S1684-1182(10)60050-3,Aerosolized Colistin for the Treatment of Multidrug-resistant Acinetobacter baumannii Pneumonia: Experience in a Tertiary Care Hospital in Northern Taiwan,"[['Cheng-Chih', '', 'Lin'], ['Te-Chu', '', 'Liu'], ['Chen-Feng', '', 'Kuo'], ['Chang-Pan', '', 'Liu'], ['Chun-Ming', '', 'Lee']]",Journal of Microbiology Immunology and Infection,2010,"[u'http://www.sciencedirect.com/science/article/pii/S1684118210600503', u'http://linkinghub.elsevier.com/retrieve/pii/S1684118210600503']",
10.1128/AAC.00766-07,"Usher, J., Alexander, S., Thompson, J., , Predicting the reliability of new products at IBM, , 1991",cited-by,10.1109/ARMS.1991.154437,Predicting the reliability of new products at IBM,"[['J.', 'S.', 'Usher'], ['S.', 'M.', 'Alexander'], ['J.', 'D.', 'Thompson']]",,1991,[u'http://ieeexplore.ieee.org/xpls/abs_all.jsp?arnumber=154437'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1109~ARMS.1991.154437
10.1128/AAC.00766-07,"Wang, R., Bencic, D., Lazorchak, J., et. al, Transcriptional regulatory dynamics of the hypothalamic–pituitary–gonadal axis and its peripheral pathways as impacted by the 3-beta HSD inhibitor trilostane in zebrafish ( Danio rerio), Ecotoxicology and Environmental Safety, 2011",cited-by,10.1016/j.ecoenv.2011.05.001,Transcriptional regulatory dynamics of the hypothalamic–pituitary–gonadal axis and its peripheral pathways as impacted by the 3-beta HSD inhibitor trilostane in zebrafish ( Danio rerio),"[['Rong-Lin', '', 'Wang'], ['David', '', 'Bencic'], ['Jim', '', 'Lazorchak'], ['Daniel', '', 'Villeneuve'], ['Gerald', 'T.', 'Ankley']]",Ecotoxicology and Environmental Safety,2011,[u'http://www.sciencedirect.com/science/article/pii/S0147651311001308'],
10.1128/AAC.00766-07,"Lim, T., Tan, T., Lee, W., et. al, In-Vitro Activity of Polymyxin B, Rifampicin, Tigecycline Alone and in Combination against Carbapenem-Resistant Acinetobacter baumannii in Singapore, PLOS One, 2011",cited-by,10.1371/journal.pone.0018485,"In-Vitro Activity of Polymyxin B, Rifampicin, Tigecycline Alone and in Combination against Carbapenem-Resistant Acinetobacter baumannii in Singapore","[['Tze-Peng', '', 'Lim'], ['Thean-Yen', '', 'Tan'], ['Winnie', '', 'Lee'], ['S.', '', 'Sasikala'], ['Thuan-Tong', '', 'Tan'], ['Li-Yang', '', 'Hsu'], ['Andrea', 'L.', 'Kwa'], ['Roy', 'Martin', 'Roop']]",PLOS One,2011,"[u'http://adsabs.harvard.edu/abs/2011PLoSO...6E8485L', u'http://dx.doi.org/10.1371/journal.pone.0018485']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1371~journal.pone.0018485
10.1128/AAC.00766-07,"Cummins, J., Reen, F., Baysse, C., et. al, Subinhibitory concentrations of the cationic antimicrobial peptide colistin induce the pseudomonas quinolone signal in Pseudomonas aeruginosa, Microbiology-sgm, 2009",cited-by,10.1099/mic.0.025643-0,Subinhibitory concentrations of the cationic antimicrobial peptide colistin induce the pseudomonas quinolone signal in Pseudomonas aeruginosa,"[['J.', '', 'Cummins'], ['F.', 'J.', 'Reen'], ['C.', '', 'Baysse'], ['M.', 'J.', 'Mooij'], ['F.', '', ""O'Gara""]]",Microbiology-sgm,2009,[u'http://mic.sgmjournals.org/cgi/doi/10.1099/mic.0.025643-0'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1099~mic.0.025643-0
10.1128/AAC.00766-07,"Kaiser, J., Little, J., , Phase comparison properties of the dual mode spiral with application to direction finding, , 1964",cited-by,10.1109/APS.1964.1150166,Phase comparison properties of the dual mode spiral with application to direction finding,"[['J.', 'A.', 'Kaiser'], ['J.', '', 'Little']]",,1964,"[u'http://ieeexplore.ieee.org/xpls/abs_all.jsp?arnumber=1150166', u'http://ieeexplore.ieee.org/stamp/stamp.jsp?arnumber=01150166']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1109~APS.1964.1150166
10.1517~13543784.17.7.973.pdf,"In vitro pharmacodynamics of colistin against Acinetobacter baumannii clinical isolates. J Antimicrob Chemother 2007;59(3):473-7 70. Tan CH, Li J, Nation RL. Activity of colistin against heteroresistant Acinetobacter baumannii and emergence of resistance in an in vitro pharmacokinetic/pharmacodynamic model. Antimicrob Agents Chemother 2007;51(9):3413-5 71. Jensen T, Pedersen SS, Garne S, et al. Colistin inhalation therapy in cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection.",references,10.1093/jac/dkl512,In vitro pharmacodynamics of colistin against Acinetobacter baumannii clinical isolates,"[[u'R.', u'J.', u'Owen'], [u'J.', u'', u'Li'], [u'R.', u'L.', u'Nation'], [u'D.', u'', u'Spelman']]",Journal of Antimicrobial Chemotherapy,2007,[u'http://www.jac.oxfordjournals.org/cgi/doi/10.1093/jac/dkl512'],./output/10.1517~13543784.17.7.973.pdf/10.1093~jac~dkl512
10.1093/jac/dkl512,"Giamarellou, H., Poulakou, G., , Multidrug-Resistant Gram-Negative Infections: What are the Treatment Options?, Drugs, 2009",cited-by,10.2165/11315690-000000000-00000,Multidrug-Resistant Gram-Negative Infections: What are the Treatment Options?,"[['Helen', '', 'Giamarellou'], ['Garyphallia', '', 'Poulakou']]",Drugs,2009,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00003495-200969140-00001'],
10.1093/jac/dkl512,"Vila, J., Pachón, J., , Therapeutic options for Acinetobacter baumannii infections, Expert Opinion on Pharmacotherapy, 2008",cited-by,10.1517/14656566.9.4.587,Therapeutic options for Acinetobacter baumannii infections,"[['Jordi', '', 'Vila'], ['Jer\xc3\xb3nimo', '', 'Pach\xc3\xb3n']]",Expert Opinion on Pharmacotherapy,2008,[u'http://www.informapharmascience.com/doi/abs/10.1517/14656566.9.4.587'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1517~14656566.9.4.587
10.1093/jac/dkl512,", Antimicrobial Resistance: Acinetobacter baumannii: Epidemiology, Antimicrobial Resistance, and Treatment Options, Clinical Infectious Diseases, 2008",cited-by,10.1086/529198,"Antimicrobial Resistance: Acinetobacter baumannii: Epidemiology, Antimicrobial Resistance, and Treatment Options",[],Clinical Infectious Diseases,2008,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/529198'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1086~529198
10.1093/jac/dkl512,"Michalopoulos, A., Falagas, M., , Colistin and Polymyxin B in Critical Care, Critical Care Clinics, 2008",cited-by,10.1016/j.ccc.2007.12.003,Colistin and Polymyxin B in Critical Care,"[['Argyris', '', 'Michalopoulos'], ['Matthew', 'E.', 'Falagas']]",Critical Care Clinics,2008,"[u'http://www.sciencedirect.com/science/article/pii/S074907040700098X', u'http://linkinghub.elsevier.com/retrieve/pii/S074907040700098X']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1016~j.ccc.2007.12.003
10.1093/jac/dkl512,"Nation, R., Li, J., , Colistin in the 21st century, Current Opinion in Infectious Diseases, 2009",cited-by,10.1097/QCO.0b013e328332e672,Colistin in the 21st century,"[['Roger', 'L', 'Nation'], ['Jian', '', 'Li']]",Current Opinion in Infectious Diseases,2009,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00001432-200912000-00004'],
10.1093/jac/dkl512,"Yau, W., Owen, R., Poudyal, A., et. al, Colistin hetero-resistance in multidrug-resistant Acinetobacter baumannii clinical isolates from the Western Pacific region in the SENTRY antimicrobial surveillance programme, Journal of Infection, 2009",cited-by,10.1016/j.jinf.2008.11.002,Colistin hetero-resistance in multidrug-resistant Acinetobacter baumannii clinical isolates from the Western Pacific region in the SENTRY antimicrobial surveillance programme,"[['Wing', '', 'Yau'], ['Roxanne', 'J.', 'Owen'], ['Anima', '', 'Poudyal'], ['Jan', 'M.', 'Bell'], ['John', 'D.', 'Turnidge'], ['Heidi', 'H.', 'Yu'], ['Roger', 'L.', 'Nation'], ['Jian', '', 'Li']]",Journal of Infection,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0163445308003733', u'http://linkinghub.elsevier.com/retrieve/pii/S0163445308003733']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1016~j.jinf.2008.11.002
10.1093/jac/dkl512,"Falagas, M., Rafailidis, P., , Re-emergence of colistin in today's world of multidrug-resistant organisms: personal perspectives, Expert Opinion on Investigational Drugs, 2008",cited-by,10.1517/13543784.17.7.973,Re-emergence of colistin in today's world of multidrug-resistant organisms: personal perspectives,"[['Matthew', 'E', 'Falagas'], ['Petros', 'I', 'Rafailidis']]",Expert Opinion on Investigational Drugs,2008,[u'http://www.informapharmascience.com/doi/abs/10.1517/13543784.17.7.973'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1517~13543784.17.7.973
10.1093/jac/dkl512,"Kwa, A., Kasiakou, S., Tam, V., et. al, Polymyxin B: similarities to and differences from colistin (polymyxin E), Expert Review of Anti-infective Therapy, 2007",cited-by,10.1586/14787210.5.5.811,Polymyxin B: similarities to and differences from colistin (polymyxin E),"[['Andrea', '', 'Kwa'], ['Sofia', 'K', 'Kasiakou'], ['Vincent', 'H', 'Tam'], ['Matthew', 'E', 'Falagas']]",Expert Review of Anti-infective Therapy,2007,[u'http://www.future-drugs.com/doi/abs/10.1586/14787210.5.5.811'],
10.1093/jac/dkl512,"Cao, G., Lutz, L., Ramos, F., et. al, Pharmacokinetics of Intravenous Polymyxin B in Critically Ill Patients, Clinical Infectious Diseases, 2008",cited-by,10.1086/592577,Pharmacokinetics of Intravenous Polymyxin B in Critically Ill Patients,"[['Guoying', '', 'Cao'], ['Larissa', '', 'Lutz'], ['Fabiano', '', 'Ramos'], ['Jian', '', 'Li']]",Clinical Infectious Diseases,2008,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/592577'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1086~592577
10.1093/jac/dkl512,"Kwa, A., , Polymyxins: A Review of the Current Status Including Recent Developments, , 0",cited-by,12288617Polymyxins: A Review of the Current Status Including Recent Developments,Polymyxins: A Review of the Current Status Including Recent Developments,"[['Andrea', 'L', 'Kwa']]",,0,[u'http://www.annals.edu.sg/pdf/37VolNo10Oct2008/V37N10p870.pdf'],./output/10.1517~13543784.17.7.973.pdf/citedby/12288617Polymyxins: A Review of the Current Status Including Recent Developments
10.1093/jac/dkl512,"Lee, C., Tang, Y., Su, L., et. al, Antimicrobial Effects of Varied Combinations of Meropenem, Sulbactam, and Colistin on a Multidrug-Resistant Acinetobacter baumannii Isolate That Caused Meningitis and Bacteremia, Microbial Drug Resistance, 2008",cited-by,10.1089/mdr.2008.0840,"Antimicrobial Effects of Varied Combinations of Meropenem, Sulbactam, and Colistin on a Multidrug-Resistant Acinetobacter baumannii Isolate That Caused Meningitis and Bacteremia","[['Chen-Hsiang', '', 'Lee'], ['Ya-Fen', '', 'Tang'], ['Lin-Hui', '', 'Su'], ['Chun-Chih', '', 'Chien'], ['Jien-Wei', '', 'Liu']]",Microbial Drug Resistance,2008,[u'http://www.liebertonline.com/doi/abs/10.1089/mdr.2008.0840'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1089~mdr.2008.0840
10.1093/jac/dkl512,"Johnson, K., , Photodiode signal enhancement effect at avalanche breakdown voltage, , 1964",cited-by,10.1109/ISSCC.1964.1157526,Photodiode signal enhancement effect at avalanche breakdown voltage,"[['K.', '', 'Johnson']]",,1964,[u'http://ieeexplore.ieee.org/xpls/abs_all.jsp?arnumber=1157526'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1109~ISSCC.1964.1157526
10.1093/jac/dkl512,"Dudhani, R., Turnidge, J., Nation, R., et. al, fAUC/MIC is the most predictive pharmacokinetic/pharmacodynamic index of colistin against Acinetobacter baumannii in murine thigh and lung infection models, Journal of Antimicrobial Chemotherapy, 2010",cited-by,10.1093/jac/dkq226,fAUC/MIC is the most predictive pharmacokinetic/pharmacodynamic index of colistin against Acinetobacter baumannii in murine thigh and lung infection models,"[['R.', 'V.', 'Dudhani'], ['J.', 'D.', 'Turnidge'], ['R.', 'L.', 'Nation'], ['J.', '', 'Li']]",Journal of Antimicrobial Chemotherapy,2010,[u'http://www.jac.oxfordjournals.org/cgi/doi/10.1093/jac/dkq226'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1093~jac~dkq226
10.1093/jac/dkl512,"Burgess, D., , Curbing Resistance Development: Maximizing the Utility of Available Agents, , 2009",cited-by,5357638Curbing Resistance Development: Maximizing the Utility of Available Agents,Curbing Resistance Development: Maximizing the Utility of Available Agents,"[['David', 'S.', 'Burgess']]",,2009,"[u'http://69.0.204.76/data/jmcp/S5-S9.pdf', u'https://www.amcp.org/data/jmcp/S5-S9.pdf']",
10.1093/jac/dkl512,"Song, J., Cheong, H., Lee, J., et. al, Efficacy of monotherapy and combined antibiotic therapy for carbapenem-resistant Acinetobacter baumannii pneumonia in an immunosuppressed mouse model, International Journal of Antimicrobial Agents, 2009",cited-by,10.1016/j.ijantimicag.2008.07.008,Efficacy of monotherapy and combined antibiotic therapy for carbapenem-resistant Acinetobacter baumannii pneumonia in an immunosuppressed mouse model,"[['Joon', 'Young', 'Song'], ['Hee', 'Jin', 'Cheong'], ['Jacob', '', 'Lee'], ['Ah', 'Kyeong', 'Sung'], ['Woo', 'Joo', 'Kim']]",International Journal of Antimicrobial Agents,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0924857908003178', u'http://linkinghub.elsevier.com/retrieve/pii/S0924857908003178']",
10.1093/jac/dkl512,"Cao, G., Ali, F., Chiu, F., et. al, Development and validation of a reversed-phase high-performance liquid chromatography assay for polymyxin B in human plasma, Journal of Antimicrobial Chemotherapy, 2008",cited-by,10.1093/jac/dkn343,Development and validation of a reversed-phase high-performance liquid chromatography assay for polymyxin B in human plasma,"[['G.', '', 'Cao'], ['F.', 'E. A.', 'Ali'], ['F.', '', 'Chiu'], ['A.', 'P.', 'Zavascki'], ['R.', 'L.', 'Nation'], ['J.', '', 'Li']]",Journal of Antimicrobial Chemotherapy,2008,[u'http://www.jac.oxfordjournals.org/cgi/doi/10.1093/jac/dkn343'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1093~jac~dkn343
10.1093/jac/dkl512,"Poudyal, A., Howden, B., Bell, J., et. al, In vitro pharmacodynamics of colistin against multidrug-resistant Klebsiella pneumoniae, Journal of Antimicrobial Chemotherapy, 2008",cited-by,10.1093/jac/dkn425,In vitro pharmacodynamics of colistin against multidrug-resistant Klebsiella pneumoniae,"[['A.', '', 'Poudyal'], ['B.', 'P.', 'Howden'], ['J.', 'M.', 'Bell'], ['W.', '', 'Gao'], ['R.', 'J.', 'Owen'], ['J.', 'D.', 'Turnidge'], ['R.', 'L.', 'Nation'], ['J.', '', 'Li']]",Journal of Antimicrobial Chemotherapy,2008,[u'http://www.jac.oxfordjournals.org/cgi/doi/10.1093/jac/dkn425'],
10.1093/jac/dkl512,"Murray, C., Hospenthal, D., , Acinetobacter Infection in the ICU, Critical Care Clinics, 2008",cited-by,10.1016/j.ccc.2007.12.005,Acinetobacter Infection in the ICU,"[['Clinton', 'K.', 'Murray'], ['Duane', 'R.', 'Hospenthal']]",Critical Care Clinics,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0749070407001005', u'http://linkinghub.elsevier.com/retrieve/pii/S0749070407001005']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1016~j.ccc.2007.12.005
10.1093/jac/dkl512,"Monteiro, D., Madrid, M., , Planning of robot trajectories with genetic algorithms, , 1999",cited-by,10.1109/ROMOCO.1999.791079,Planning of robot trajectories with genetic algorithms,"[['D.', 'C.', 'Monteiro'], ['M.', 'K.', 'Madrid']]",,1999,"[u'http://ieeexplore.ieee.org/xpls/abs_all.jsp?arnumber=791079', u'http://ieeexplore.ieee.org/stamp/stamp.jsp?arnumber=00791079']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1109~ROMOCO.1999.791079
10.1093/jac/dkl512,"Connolly, C., Grupen, R., , Harmonic control [robot applications], , 1992",cited-by,10.1109/ISIC.1992.225142,Harmonic control [robot applications],"[['C.', 'I.', 'Connolly'], ['R.', 'A.', 'Grupen']]",,1992,[u'http://ieeexplore.ieee.org/xpls/abs_all.jsp?arnumber=225142'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1109~ISIC.1992.225142
10.1093/jac/dkl512,"Lin, C., Liu, T., Kuo, C., et. al, Aerosolized Colistin for the Treatment of Multidrug-resistant Acinetobacter baumannii Pneumonia: Experience in a Tertiary Care Hospital in Northern Taiwan, Journal of Microbiology Immunology and Infection, 2010",cited-by,10.1016/S1684-1182(10)60050-3,Aerosolized Colistin for the Treatment of Multidrug-resistant Acinetobacter baumannii Pneumonia: Experience in a Tertiary Care Hospital in Northern Taiwan,"[['Cheng-Chih', '', 'Lin'], ['Te-Chu', '', 'Liu'], ['Chen-Feng', '', 'Kuo'], ['Chang-Pan', '', 'Liu'], ['Chun-Ming', '', 'Lee']]",Journal of Microbiology Immunology and Infection,2010,"[u'http://www.sciencedirect.com/science/article/pii/S1684118210600503', u'http://linkinghub.elsevier.com/retrieve/pii/S1684118210600503']",
10.1093/jac/dkl512,"Molina, J., Cordero, E., Palomino, J., et. al, Aminoglucósidos y polimixinas, Enfermedades Infecciosas Y Microbiologia Clinica, 2009",cited-by,10.1016/j.eimc.2009.02.001,Aminoglucósidos y polimixinas,"[['Jos\xc3\xa9', '', 'Molina'], ['Elisa', '', 'Cordero'], ['Juli\xc3\xa1n', '', 'Palomino'], ['Jer\xc3\xb3nimo', '', 'Pach\xc3\xb3n']]",Enfermedades Infecciosas Y Microbiologia Clinica,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0213005X09000986', u'http://linkinghub.elsevier.com/retrieve/pii/S0213005X09000986']",
10.1093/jac/dkl512,"Barnos, B., , The electrified fence as a component of a physical protection system, , 1989",cited-by,10.1109/CCST.1989.751985,The electrified fence as a component of a physical protection system,"[['B.', 'W.', 'Barnos']]",,1989,[u'http://ieeexplore.ieee.org/xpls/abs_all.jsp?arnumber=751985'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1109~CCST.1989.751985
10.1093/jac/dkl512,"Wang, R., Bencic, D., Lazorchak, J., et. al, Transcriptional regulatory dynamics of the hypothalamic–pituitary–gonadal axis and its peripheral pathways as impacted by the 3-beta HSD inhibitor trilostane in zebrafish ( Danio rerio), Ecotoxicology and Environmental Safety, 2011",cited-by,10.1016/j.ecoenv.2011.05.001,Transcriptional regulatory dynamics of the hypothalamic–pituitary–gonadal axis and its peripheral pathways as impacted by the 3-beta HSD inhibitor trilostane in zebrafish ( Danio rerio),"[['Rong-Lin', '', 'Wang'], ['David', '', 'Bencic'], ['Jim', '', 'Lazorchak'], ['Daniel', '', 'Villeneuve'], ['Gerald', 'T.', 'Ankley']]",Ecotoxicology and Environmental Safety,2011,[u'http://www.sciencedirect.com/science/article/pii/S0147651311001308'],
10.1093/jac/dkl512,"Elias, L., Konzen, D., Krebs, J., et. al, The impact of polymyxin B dosage on in-hospital mortality of patients treated with this antibiotic, Journal of Antimicrobial Chemotherapy, 2010",cited-by,10.1093/jac/dkq285,The impact of polymyxin B dosage on in-hospital mortality of patients treated with this antibiotic,"[['L.', 'S.', 'Elias'], ['D.', '', 'Konzen'], ['J.', 'M.', 'Krebs'], ['A.', 'P.', 'Zavascki']]",Journal of Antimicrobial Chemotherapy,2010,[u'http://www.jac.oxfordjournals.org/cgi/doi/10.1093/jac/dkq285'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1093~jac~dkq285
10.1093/jac/dkl512,"Cordero, E., Palomino, J., Pachon, J., , Aminoglucosidos y polimixinas, , 2009",cited-by,6349126Aminoglucosidos y polimixinas,Aminoglucosidos y polimixinas,"[['Elisa', '', 'Cordero'], ['Julian', '', 'Palomino'], ['Jeronimo', '', 'Pachon']]",,2009,"[u'http://external.doyma.es/pdf/28/28v27n03a13134987pdf001.pdf', u'http://www.elsevier.es/watermark/ctl_servlet?_f=10&pident_articulo=13134987&pident_usuario=0&pcontactid=&pident_revista=28&ty=135&accion=L&origen=elsevier&web=www.elsevier.es&lan=es&fichero=28v27n03a13134987pdf001.pdf']",
10.1093/jac/dkl512,"Towner, K., , Therapeutic options for infections caused by Acinetobacter baumannii, Antibiotiques, 2009",cited-by,10.1016/j.antib.2009.06.003,Therapeutic options for infections caused by Acinetobacter baumannii,"[['K.', 'J.', 'Towner']]",Antibiotiques,2009,"[u'http://www.sciencedirect.com/science/article/pii/S1294550109000569', u'http://linkinghub.elsevier.com/retrieve/pii/S1294550109000569']",
10.1093/jac/dkl512,"Morris, M., Hobson, R., , Neural network design of a dishwasher control board, , 2002",cited-by,10.1109/IJCNN.2002.1007534,Neural network design of a dishwasher control board,"[['M.', '', 'Morris'], ['R.', 'S.', 'Hobson']]",,2002,"[u'http://ieeexplore.ieee.org/stamp/stamp.jsp?arnumber=01007534', u'http://ieeexplore.ieee.org/xpls/abs_all.jsp?arnumber=1007534']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1109~IJCNN.2002.1007534
10.1093/jac/dkl512,"Chiba, J., Murakami, Y., , Security communication in tunnels underground, , 1989",cited-by,10.1109/CCST.1989.751989,Security communication in tunnels underground,"[['Jiro', '', 'Chiba'], ['Yasushi', '', 'Murakami']]",,1989,"[u'http://ieeexplore.ieee.org/xpls/abs_all.jsp?arnumber=751989', u'http://ieeexplore.ieee.org/stamp/stamp.jsp?arnumber=00751989']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1109~CCST.1989.751989
10.1093/jac/dkl512,"Vila, J., Pachón, J., , Antimicrobial Resistance and Therapeutic Alternatives, , 0",cited-by,10.1007/978-0-387-77944-7_11,Antimicrobial Resistance and Therapeutic Alternatives,"[['Jordi', '', 'Vila'], ['Jer\xc3\xb3nimo', '', 'Pach\xc3\xb3n']]",,0,"[u'http://www.springerlink.com/index/tx5723082146q005.pdf', u'http://www.springerlink.com/content/tx5723082146q005']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1007~978-0-387-77944-7_11
10.1517~13543784.17.7.973.pdf,"J Antimicrob Chemother 1987;19(6):831-8 72. Falagas ME, Kasiakou SK, Rafailidis PI, et al. Comparison of mortality of patients with Acinetobacter baumannii bacteraemia receiving appropriate and inappropriate empirical therapy. J Antimicrob Chemother 2006;57(6):1251-4 73. Hsueh PR, Tseng SP, Teng LJ, Ho SW.",references,NOT found in MAS
10.1517~13543784.17.7.973.pdf,"Pan-drug-resistant Pseudomonas aeruginosa causing nosocomial infection at a university hospital in Taiwan. Clin Microbiol Infect 2005;11(8):670-3 Affiliation Matthew E Falagas†1,2,3 MD MSc DSc Et Petros I Rafailidis1,3 MD MRCP UK MSc †Author for correspondence †1Alfa Institute of Biomedical Sciences (AIBS), 9 Neapoleos Street, 15123 Marousi, Athens, Greece Tel: +30 694 611 0000; Fax: +30 210 683 9605; E-mail: m.falagas@aibs.gr 2Tufts University School of Medicine, Department of Medicine, Boston, MA, USA 3Henry Dunant Hospital, Department of Medicine, Athens, Greece Expert Opin. Investig. Drugs Downloaded from informahealthcare.com by University New South Wales on 09/02/14 For personal use only. Expert Opin. Investig. Drugs Downloaded from informahealthcare.com by University New South Wales on 09/02/14 For personal use only.",references,10.1111/j.1469-0691.2005.01196.x,Pan-drug-resistant Pseudomonas aeruginosa causing nosocomial infection at a university hospital in Taiwan,"[[u'P.', u'R.', u'Hsueh'], [u'S.', u'P.', u'Tseng'], [u'L.', u'J.', u'Teng'], [u'S.', u'W.', u'Ho']]",Clinical Microbiology and Infection,2005,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1469-0691.2005.01196.x'],./output/10.1517~13543784.17.7.973.pdf/10.1111~j.1469-0691.2005.01196.x
10.1111/j.1469-0691.2005.01196.x,"Falagas, M., Koletsi, P., Bliziotis, I., , The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa, Journal of Medical Microbiology, 2006",cited-by,10.1099/jmm.0.46747-0,The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa,"[['Matthew', 'E.', 'Falagas'], ['Patra', 'K.', 'Koletsi'], ['Ioannis', 'A.', 'Bliziotis']]",Journal of Medical Microbiology,2006,"[u'http://jmm.sgmjournals.org/cgi/reprint/55/12/1619.pdf', u'http://jmm.sgmjournals.org/cgi/doi/10.1099/jmm.0.46747-0']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1099~jmm.0.46747-0
10.1111/j.1469-0691.2005.01196.x,"Wang, C., Jerng, J., Cheng, K., et. al, Pandrug-resistant Pseudomonas aeruginosa among hospitalised patients: clinical features, risk-factors and outcomes, Clinical Microbiology and Infection, 2006",cited-by,10.1111/j.1469-0691.2005.01305.x,"Pandrug-resistant Pseudomonas aeruginosa among hospitalised patients: clinical features, risk-factors and outcomes","[['C.', 'Y.', 'Wang'], ['J.', 'S.', 'Jerng'], ['K.', 'Y.', 'Cheng'], ['L.', 'N.', 'Lee'], ['C.', 'J.', 'Yu'], ['P.', 'R.', 'Hsueh'], ['P.', 'C.', 'Yang']]",Clinical Microbiology and Infection,2006,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1469-0691.2005.01305.x'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1111~j.1469-0691.2005.01305.x
10.1111/j.1469-0691.2005.01196.x,"Falagas, M., Rafailidis, P., , Re-emergence of colistin in today's world of multidrug-resistant organisms: personal perspectives, Expert Opinion on Investigational Drugs, 2008",cited-by,10.1517/13543784.17.7.973,Re-emergence of colistin in today's world of multidrug-resistant organisms: personal perspectives,"[['Matthew', 'E', 'Falagas'], ['Petros', 'I', 'Rafailidis']]",Expert Opinion on Investigational Drugs,2008,[u'http://www.informapharmascience.com/doi/abs/10.1517/13543784.17.7.973'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1517~13543784.17.7.973
10.1111/j.1469-0691.2005.01196.x,"Yan, J., Hsueh, P., Lu, J., et. al, Characterization of acquired b-lactamases and their genetic support in multidrug-resistant Pseudomonas aeruginosa isolates in Taiwan: the prevalence of unusual integrons, , 2006",cited-by,11125925Characterization of acquired b-lactamases and their genetic support in multidrug-resistant Pseudomonas aeruginosa isolates in Taiwan: the prevalence of unusual integrons,Characterization of acquired b-lactamases and their genetic support in multidrug-resistant Pseudomonas aeruginosa isolates in Taiwan: the prevalence of unusual integrons,"[['Jing-Jou', '', 'Yan'], ['Po-Ren', '', 'Hsueh'], ['Jang-Jih', '', 'Lu'], ['Feng-Yee', '', 'Chang'], ['Wen-Chien', '', 'Ko'], ['Jiunn-Jong', '', 'Wu']]",,2006,"[u'http://jac.oxfordjournals.org/cgi/reprint/58/3/530.pdf', u'http://jac.oxfordjournals.org/cgi/reprint/dkl266v1.pdf']",
10.1111/j.1469-0691.2005.01196.x,"Huang, Y., Chang, S., Lauderdale, T., et. al, Molecular epidemiology of carbapenem-resistant Pseudomonas aeruginosa carrying metallo-β-lactamase genes in Taiwan, Diagnostic Microbiology and Infectious Disease, 2007",cited-by,10.1016/j.diagmicrobio.2007.01.009,Molecular epidemiology of carbapenem-resistant Pseudomonas aeruginosa carrying metallo-β-lactamase genes in Taiwan,"[['Yu-Tsung', '', 'Huang'], ['Shan-Chwen', '', 'Chang'], ['Tsai-Ling', '', 'Lauderdale'], ['Almira', 'J.', 'Yang'], ['Jann-Tay', '', 'Wang']]",Diagnostic Microbiology and Infectious Disease,2007,"[u'http://www.sciencedirect.com/science/article/pii/S0732889307000338', u'http://linkinghub.elsevier.com/retrieve/pii/S0732889307000338']",
10.1111/j.1469-0691.2005.01196.x,"Gould, I., , Antibiotic resistance: the perfect storm, International Journal of Antimicrobial Agents, 2009",cited-by,10.1016/S0924-8579(09)70549-7,Antibiotic resistance: the perfect storm,"[['I.', 'M.', 'Gould']]",International Journal of Antimicrobial Agents,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0924857909705497', u'http://linkinghub.elsevier.com/retrieve/pii/S0924857909705497']",
10.1111/j.1469-0691.2005.01196.x,"Vettoretti, L., Floret, N., Hocquet, D., et. al, Emergence of extensive-drug-resistant Pseudomonas aeruginosa in a French university hospital, European Journal of Clinical Microbiology & Infectious Diseases, 2009",cited-by,10.1007/s10096-009-0767-8,Emergence of extensive-drug-resistant Pseudomonas aeruginosa in a French university hospital,"[['L.', '', 'Vettoretti'], ['N.', '', 'Floret'], ['D.', '', 'Hocquet'], ['B.', '', 'Dehecq'], ['P.', '', 'Pl\xc3\xa9siat'], ['D.', '', 'Talon'], ['X.', '', 'Bertrand']]",European Journal of Clinical Microbiology & Infectious Diseases,2009,"[u'http://www.springerlink.com/content/k207892073tl9308', u'http://www.springerlink.com/index/k207892073tl9308.pdf', u'http://www.springerlink.com/index/10.1007/s10096-009-0767-8', u'http://www.springerlink.com/index/pdf/10.1007/s10096-009-0767-8']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1007~s10096-009-0767-8
10.1111/j.1469-0691.2005.01196.x,"Tan, C., Liaw, S., Yu, C., et. al, Extensively drug-resistant Stenotrophomonas maltophilia in a tertiary care hospital in Taiwan: microbiologic characteristics, clinical features, and outcomes, Diagnostic Microbiology and Infectious Disease, 2008",cited-by,10.1016/j.diagmicrobio.2007.09.007,"Extensively drug-resistant Stenotrophomonas maltophilia in a tertiary care hospital in Taiwan: microbiologic characteristics, clinical features, and outcomes","[['Che-Kim', '', 'Tan'], ['Shwu-Jen', '', 'Liaw'], ['Chong-Jen', '', 'Yu'], ['Lee-Jene', '', 'Teng'], ['Po-Ren', '', 'Hsueh']]",Diagnostic Microbiology and Infectious Disease,2008,"[u'http://www.sciencedirect.com/science/article/pii/S073288930700394X', u'http://linkinghub.elsevier.com/retrieve/pii/S073288930700394X']",
10.1111/j.1469-0691.2005.01196.x,"Tseng, S., Hsueh, P., Tsai, J., et. al, Tn6001, a Transposon-Like Element Containing the blaVIM-3-Harboring Integron In450, Antimicrobial Agents and Chemotherapy, 2007",cited-by,10.1128/AAC.00542-07,"Tn6001, a Transposon-Like Element Containing the blaVIM-3-Harboring Integron In450","[['Sung-Pin', '', 'Tseng'], ['Po-Ren', '', 'Hsueh'], ['Jui-Chang', '', 'Tsai'], ['Lee-Jene', '', 'Teng']]",Antimicrobial Agents and Chemotherapy,2007,"[u'http://aac.asm.org/cgi/reprint/51/11/4187.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.00542-07']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1128~AAC.00542-07
10.1111/j.1469-0691.2005.01196.x,"Isturiz, R., , Global resistance trends and the potential impact on empirical therapy, International Journal of Antimicrobial Agents, 2008",cited-by,10.1016/S0924-8579(09)70003-2,Global resistance trends and the potential impact on empirical therapy,"[['Raul', '', 'Isturiz']]",International Journal of Antimicrobial Agents,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0924857909700032', u'http://linkinghub.elsevier.com/retrieve/pii/S0924857909700032']",
10.1111/j.1469-0691.2005.01196.x,"Tseng, S., Tsai, J., Teng, L., et. al, Dissemination of transposon Tn6001 in carbapenem-non-susceptible and extensively drug-resistant Pseudomonas aeruginosa in Taiwan, Journal of Antimicrobial Chemotherapy, 2009",cited-by,10.1093/jac/dkp341,Dissemination of transposon Tn6001 in carbapenem-non-susceptible and extensively drug-resistant Pseudomonas aeruginosa in Taiwan,"[['S.-P.', '', 'Tseng'], ['J.-C.', '', 'Tsai'], ['L.-J.', '', 'Teng'], ['P.-R.', '', 'Hsueh']]",Journal of Antimicrobial Chemotherapy,2009,[u'http://www.jac.oxfordjournals.org/cgi/doi/10.1093/jac/dkp341'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1093~jac~dkp341
10.1111/j.1469-0691.2005.01196.x,"Tseng, S., Teng, L., Chen, C., et. al, Toluidine blue O photodynamic inactivation on multidrug-resistant pseudomonas aeruginosa, Lasers in Surgery and Medicine, 2009",cited-by,10.1002/lsm.20765,Toluidine blue O photodynamic inactivation on multidrug-resistant pseudomonas aeruginosa,"[['S.', 'P.', 'Tseng'], ['L.', 'J.', 'Teng'], ['C.', 'T.', 'Chen'], ['T.', 'H.', 'Lo'], ['W.', 'C.', 'Hung'], ['H.', 'J.', 'Chen'], ['P.', 'R.', 'Hsueh'], ['J.', 'C.', 'Tsai']]",Lasers in Surgery and Medicine,2009,[u'http://doi.wiley.com/10.1002/lsm.20765'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1002~lsm.20765
10.1111/j.1469-0691.2005.01196.x,"Liang, M., Yang, C., Li, S., et. al, Antibacterial and antioxidant properties of Ramulus Cinnamomi using supercritical CO 2 extraction, European Food Research and Technology, 2008",cited-by,10.1007/s00217-008-0857-3,Antibacterial and antioxidant properties of Ramulus Cinnamomi using supercritical CO 2 extraction,"[['Ming-Tsai', '', 'Liang'], ['Cheng-Hong', '', 'Yang'], ['Shun-Tai', '', 'Li'], ['Cheng-San', '', 'Yang'], ['Hsueh-Wei', '', 'Chang'], ['Ching-Shen', '', 'Liu'], ['Thau-Ming', '', 'Cham'], ['Li-Yeh', '', 'Chuang']]",European Food Research and Technology,2008,"[u'http://www.springerlink.com/index/u0377h587l484761.pdf', u'http://www.springerlink.com/content/u0377h587l484761', u'http://www.springerlink.com/index/10.1007/s00217-008-0857-3', u'http://www.springerlink.com/index/pdf/10.1007/s00217-008-0857-3']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1007~s00217-008-0857-3
10.1111/j.1469-0691.2005.01196.x,"Cholley, P., Gbaguidi-Haore, H., Bertrand, X., et. al, Molecular epidemiology of multidrug-resistant Pseudomonas aeruginosa in a French university hospital, Journal of Hospital Infection, 2010",cited-by,10.1016/j.jhin.2010.06.007,Molecular epidemiology of multidrug-resistant Pseudomonas aeruginosa in a French university hospital,"[['P.', '', 'Cholley'], ['H.', '', 'Gbaguidi-Haore'], ['X.', '', 'Bertrand'], ['M.', '', 'Thouverez'], ['P.', '', 'Pl\xc3\xa9siat'], ['D.', '', 'Hocquet'], ['D.', '', 'Talon']]",Journal of Hospital Infection,2010,"[u'http://www.sciencedirect.com/science/article/pii/S0195670110002835', u'http://linkinghub.elsevier.com/retrieve/pii/S0195670110002835']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1016~j.jhin.2010.06.007
10.1111/j.1469-0691.2005.01196.x,"Xu, G., Xiong, W., Hu, Q., et. al, Lactoferrin-derived peptides and Lactoferricin chimera inhibit virulence factor production and biofilm formation in Pseudomonas aeruginosa: LF-derived peptides inhibit virulence of P. aeruginosa, Journal of Applied Microbiology, 2010",cited-by,10.1111/j.1365-2672.2010.04751.x,Lactoferrin-derived peptides and Lactoferricin chimera inhibit virulence factor production and biofilm formation in Pseudomonas aeruginosa: LF-derived peptides inhibit virulence of P. aeruginosa,"[['G.', '', 'Xu'], ['W.', '', 'Xiong'], ['Q.', '', 'Hu'], ['P.', '', 'Zuo'], ['B.', '', 'Shao'], ['F.', '', 'Lan'], ['X.', '', 'Lu'], ['Y.', '', 'Xu'], ['S.', '', 'Xiong']]",Journal of Applied Microbiology,2010,[u'http://doi.wiley.com/10.1111/j.1365-2672.2010.04751.x'],./output/10.1517~13543784.17.7.973.pdf/citedby/10.1111~j.1365-2672.2010.04751.x
10.1111/j.1469-0691.2005.01196.x,"WATERER, G., WUNDERINK, R., , Respiratory infections: A current and future threat, Respirology, 2009",cited-by,10.1111/j.1440-1843.2009.01554.x,Respiratory infections: A current and future threat,"[['Grant', '', 'WATERER'], ['Richard', '', 'WUNDERINK']]",Respirology,2009,[u'http://blackwell-synergy.com/doi/abs/10.1111/j.1440-1843.2009.01554.x'],
10.1111/j.1469-0691.2005.01196.x,"Yakupogullari, Y., Otlu, B., Dogukan, M., et. al, Investigation of a nosocomial outbreak by alginate-producing pan–antibiotic-resistant Pseudomonas aeruginosa, American Journal of Infection Control, 2008",cited-by,10.1016/j.ajic.2008.07.006,Investigation of a nosocomial outbreak by alginate-producing pan–antibiotic-resistant Pseudomonas aeruginosa,"[['Yusuf', '', 'Yakupogullari'], ['Bar\xc4\xb1s', '', 'Otlu'], ['Muruvvet', '', 'Dogukan'], ['Canan', '', 'Gursoy'], ['Ebru', '', 'Korkmaz'], ['Ahmet', '', 'Kizirgil'], ['Mehmet', '', 'Ozden'], ['Riza', '', 'Durmaz']]",American Journal of Infection Control,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0196655308007475', u'http://linkinghub.elsevier.com/retrieve/pii/S0196655308007475']",./output/10.1517~13543784.17.7.973.pdf/citedby/10.1016~j.ajic.2008.07.006
10.1111/j.1469-0691.2005.01196.x,"Tseng, S., Tsai, J., Teng, L., et. al, Dissemination of transposon Tn6001 in carbapenem-non-susceptible and extensively drug-resistant Pseudomonas aeruginosa in Taiwan, , 0",cited-by,11615722Dissemination of transposon Tn6001 in carbapenem-non-susceptible and extensively drug-resistant Pseudomonas aeruginosa in Taiwan,Dissemination of transposon Tn6001 in carbapenem-non-susceptible and extensively drug-resistant Pseudomonas aeruginosa in Taiwan,"[['Sung-Pin', '', 'Tseng'], ['Jui-Chang', '', 'Tsai'], ['Lee-Jene', '', 'Teng'], ['Po-Ren', '', 'Hsueh']]",,0,[u'http://jac.oxfordjournals.org/cgi/reprint/64/6/1170.pdf'],
